<Products xmlns="https://assets.hpra.ie/products//xml/Animal" xsi:schemaLocation="https://assets.hpra.ie/products//xml/Animal https://assets.hpra.ie/products//xml/Animal.xsd" schemaVersion="1.0" datePublished="2026-08-15T02:40:03" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Product>
    <DrugIDPK>VPA10793/004/001</DrugIDPK>
    <LicenceNumber>VPA10793/004/001</LicenceNumber>
    <ProductName>Abacare 1% w/v Pour-On Solution</ProductName>
    <PAHolder>Acravet Limited</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA02</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/035/001</DrugIDPK>
    <LicenceNumber>VPA22033/035/001</LicenceNumber>
    <ProductName>Abinex Forte 1 % w/v Pour On Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA02</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/009/001</DrugIDPK>
    <LicenceNumber>VPA10491/009/001</LicenceNumber>
    <ProductName>Acecare 2 mg/ml Solution for Injection for Dogs and Cats</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>15/07/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Acepromazine maleate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/004/001</DrugIDPK>
    <LicenceNumber>VPA10495/004/001</LicenceNumber>
    <ProductName>ACEGON 50 micrograms/ml solution for injection for cattle</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>28/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadorelin acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>HOVR10537/018/001</DrugIDPK>
    <LicenceNumber>HOVR10537/018/001</LicenceNumber>
    <ProductName>Acidum Silicicum</ProductName>
    <PAHolder>Galway Homeopathics (Manufacturing) Limited</PAHolder>
    <AuthorisedDate>08/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Registered homeopathic medicinal products (Article 17 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances xsi:nil="true" />
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Homeopathic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/024/001</DrugIDPK>
    <LicenceNumber>VPA22693/024/001</LicenceNumber>
    <ProductName>Acomec 10 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>26/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/042/001</DrugIDPK>
    <LicenceNumber>VPA10815/042/001</LicenceNumber>
    <ProductName>Adaxio Shampoo for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ATCs>
      <ATC>QD08AC52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine digluconate</ActiveSubstance>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/015/001</DrugIDPK>
    <LicenceNumber>VPA10980/015/001</LicenceNumber>
    <ProductName>Addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QA12AX</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate monohydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/015/002</DrugIDPK>
    <LicenceNumber>VPA10980/015/002</LicenceNumber>
    <ProductName>Addimag 240 mg/ml + 126 mg/ml solution for infusion for cattle</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QA12AX</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate monohydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23216/001/001</DrugIDPK>
    <LicenceNumber>VPA23216/001/001</LicenceNumber>
    <ProductName>Adequan 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Aniserve GmbH</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AX12</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Glycosaminoglycan polysulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/063/002</DrugIDPK>
    <LicenceNumber>VPA10774/063/002</LicenceNumber>
    <ProductName>Aderexa 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/063/001</DrugIDPK>
    <LicenceNumber>VPA10774/063/001</LicenceNumber>
    <ProductName>Aderexa 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/087/001</DrugIDPK>
    <LicenceNumber>VPA22664/087/001</LicenceNumber>
    <ProductName>Adrenacaine Solution for Injection for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01BA52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Adrenaline tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/046/002</DrugIDPK>
    <LicenceNumber>VPA22020/046/002</LicenceNumber>
    <ProductName>Advantage 100 mg spot-on solution for dogs (≥4 - &lt;10 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/046/003</DrugIDPK>
    <LicenceNumber>VPA22020/046/003</LicenceNumber>
    <ProductName>Advantage 250 mg spot-on solution for dogs (≥10 - &lt;25 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/045/001</DrugIDPK>
    <LicenceNumber>VPA22020/045/001</LicenceNumber>
    <ProductName>Advantage 40 mg spot-on solution for cats (&lt;4 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/052/001</DrugIDPK>
    <LicenceNumber>VPA22020/052/001</LicenceNumber>
    <ProductName>Advantage 40 mg spot-on solution for cats and pet rabbits (&lt;4 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/046/001</DrugIDPK>
    <LicenceNumber>VPA22020/046/001</LicenceNumber>
    <ProductName>Advantage 40 mg spot-on solution for dogs (&lt;4 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/047/001</DrugIDPK>
    <LicenceNumber>VPA22020/047/001</LicenceNumber>
    <ProductName>Advantage 400 mg spot-on solution for dogs (≥25 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/045/002</DrugIDPK>
    <LicenceNumber>VPA22020/045/002</LicenceNumber>
    <ProductName>Advantage 80 mg spot-on solution for cats (≥4 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/052/002</DrugIDPK>
    <LicenceNumber>VPA22020/052/002</LicenceNumber>
    <ProductName>Advantage 80 mg spot-on solution for cats and pet rabbits (≥4 kg)</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/048/003</DrugIDPK>
    <LicenceNumber>VPA22020/048/003</LicenceNumber>
    <ProductName>Advantix Spot-on solution for dogs over 10 kg up to 25 kg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>02/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/048/004</DrugIDPK>
    <LicenceNumber>VPA22020/048/004</LicenceNumber>
    <ProductName>Advantix Spot-on solution for dogs over 25 kg up to 40 kg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>02/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/048/002</DrugIDPK>
    <LicenceNumber>VPA22020/048/002</LicenceNumber>
    <ProductName>Advantix Spot-on solution for dogs over 4 kg up to 10 kg.</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>02/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/048/005</DrugIDPK>
    <LicenceNumber>VPA22020/048/005</LicenceNumber>
    <ProductName>Advantix Spot-on solution for dogs over 40 kg up to 60 kg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/048/001</DrugIDPK>
    <LicenceNumber>VPA22020/048/001</LicenceNumber>
    <ProductName>Advantix Spot-on solution for dogs up to 4 kg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>02/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10928/001/001</DrugIDPK>
    <LicenceNumber>VPA10928/001/001</LicenceNumber>
    <ProductName>Agrisept MC Tabs 2.5 g effervescent tablet for teat dip/spray solution</ProductName>
    <PAHolder>Medentech Ltd.</PAHolder>
    <AuthorisedDate>11/08/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QG52A</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium didichloroioscyanurate (anhydrous)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/014/001</DrugIDPK>
    <LicenceNumber>VPA22664/014/001</LicenceNumber>
    <ProductName>Alamycin Aerosol 3.2 %w/v Cutaneous Spray, solution</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QD06AA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/016/001</DrugIDPK>
    <LicenceNumber>VPA22664/016/001</LicenceNumber>
    <ProductName>Alamycin LA 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/039/001</DrugIDPK>
    <LicenceNumber>VPA22664/039/001</LicenceNumber>
    <ProductName>Alamycin LA 300 mg/ml Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>10/02/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/006/001</DrugIDPK>
    <LicenceNumber>VPA10915/006/001</LicenceNumber>
    <ProductName>Albencare with Selenium Oral Suspension</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/01/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/142/002</DrugIDPK>
    <LicenceNumber>VPA10987/142/002</LicenceNumber>
    <ProductName>Albex 100 mg/ml Oral Suspension</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/04/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/142/001</DrugIDPK>
    <LicenceNumber>VPA10987/142/001</LicenceNumber>
    <ProductName>Albex 25 mg/ml Oral Suspension</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/04/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/123/001</DrugIDPK>
    <LicenceNumber>VPA10987/123/001</LicenceNumber>
    <ProductName>Albex Gold 200 mg/ml oral suspension for cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>19/07/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/028/001</DrugIDPK>
    <LicenceNumber>VPA10782/028/001</LicenceNumber>
    <ProductName>Albiotic 330 mg/100 mg Intramammary Solution</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>31/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary solution</DosageForm>
    <ATCs>
      <ATC>QJ51RF03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride</ActiveSubstance>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10792/005/001</DrugIDPK>
    <LicenceNumber>VPA10792/005/001</LicenceNumber>
    <ProductName>Alcide UDDERgold Platinum</ProductName>
    <PAHolder>CID LINES N.V.</PAHolder>
    <AuthorisedDate>30/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip solution</DosageForm>
    <ATCs>
      <ATC>QG52A</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chlorite</ActiveSubstance>
      <ActiveSubstance>Lactic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/013/001</DrugIDPK>
    <LicenceNumber>VPA10980/013/001</LicenceNumber>
    <ProductName>Alfacef RTU, 50 mg/ml, suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10894/002/001</DrugIDPK>
    <LicenceNumber>VPA10894/002/001</LicenceNumber>
    <ProductName>Alfacycline LA Solution for Injection</ProductName>
    <PAHolder>Alfa Med  Limited</PAHolder>
    <AuthorisedDate>17/02/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/019/001</DrugIDPK>
    <LicenceNumber>VPA10980/019/001</LicenceNumber>
    <ProductName>Alfadexx 2 mg/ml solution for injection for horses, cattle, goats, pigs, dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>28/01/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Periarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/012/001</DrugIDPK>
    <LicenceNumber>VPA10980/012/001</LicenceNumber>
    <ProductName>ALFAGLANDIN C 0.250 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>29/06/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10894/004/001</DrugIDPK>
    <LicenceNumber>VPA10894/004/001</LicenceNumber>
    <ProductName>Alfamox LA 150 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Alfa Med Limited</PAHolder>
    <AuthorisedDate>22/01/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10894/003/001</DrugIDPK>
    <LicenceNumber>VPA10894/003/001</LicenceNumber>
    <ProductName>Alfapen-Strep Suspension for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Alfa Med  Limited</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulphate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10894/005/001</DrugIDPK>
    <LicenceNumber>VPA10894/005/001</LicenceNumber>
    <ProductName>Alfatrim 40/200 Solution for Injection</ProductName>
    <PAHolder>Alfa Med  Limited</PAHolder>
    <AuthorisedDate>12/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/103/001</DrugIDPK>
    <LicenceNumber>VPA10387/103/001</LicenceNumber>
    <ProductName>ALFAXAN 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Alfaxalone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/105/001</DrugIDPK>
    <LicenceNumber>VPA10387/105/001</LicenceNumber>
    <ProductName>Alfaxan Multidose 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>07/01/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Alfaxalone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/104/001</DrugIDPK>
    <LicenceNumber>VPA10387/104/001</LicenceNumber>
    <ProductName>Alfaxan Multidose 10 mg/ml solution for injection for dogs, cats and pet rabbits</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>27/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Alfaxalone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/066/001</DrugIDPK>
    <LicenceNumber>VPA10988/066/001</LicenceNumber>
    <ProductName>Alizin 30 mg/ml Solution for Injection</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>07/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03XB90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Aglepristone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10804/001/001</DrugIDPK>
    <LicenceNumber>VPA10804/001/001</LicenceNumber>
    <ProductName>ALPHA JECT 3000 Emulsion for injection for Atlantic salmon</ProductName>
    <PAHolder>PHARMAQ AS</PAHolder>
    <AuthorisedDate>01/10/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI10AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Aeromonas salmonicida subspecies Salmonicida; AL 2017</ActiveSubstance>
      <ActiveSubstance>Listonella anguillarum serotype O1; AL 112</ActiveSubstance>
      <ActiveSubstance>Listonella anguillarum serotype o2a; al 104</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10804/003/001</DrugIDPK>
    <LicenceNumber>VPA10804/003/001</LicenceNumber>
    <ProductName>ALPHA JECT micro 1 PD emulsion for injection for Atlantic salmon</ProductName>
    <PAHolder>PHARMAQ AS</PAHolder>
    <AuthorisedDate>04/12/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI10AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Formaldehyde inactivated culture of salmon pancreas disease virus inactivated strain al v405</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10804/005/001</DrugIDPK>
    <LicenceNumber>VPA10804/005/001</LicenceNumber>
    <ProductName>ALPHA JECT micro 6 emulsion for injection for atlantic salmon</ProductName>
    <PAHolder>PHARMAQ AS</PAHolder>
    <AuthorisedDate>15/03/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI10AL02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>infectious pancreatic necrosis virus, inactivated</ActiveSubstance>
      <ActiveSubstance>Listonella anguillarum serotype o2a; al 104</ActiveSubstance>
      <ActiveSubstance>Listonella anguillarum serotype O1; AL 112</ActiveSubstance>
      <ActiveSubstance>Aeromonas salmonicida subsp. salmonicida, al 2017</ActiveSubstance>
      <ActiveSubstance>Moritella viscosa, al 266</ActiveSubstance>
      <ActiveSubstance>Vibrio salmonicida al 1134 </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10391/001/001</DrugIDPK>
    <LicenceNumber>VPA10391/001/001</LicenceNumber>
    <ProductName>Alphalben 100 mg/ml Oral Suspension for Cattle and Sheep</ProductName>
    <PAHolder>Alphavet Zrt.</PAHolder>
    <AuthorisedDate>16/02/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/017/002</DrugIDPK>
    <LicenceNumber>VPA10980/017/002</LicenceNumber>
    <ProductName>Alpramil 12 mg/30 mg film-coated tablets for cats weighing at least 3 kg</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime for veterinary use </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/018/002</DrugIDPK>
    <LicenceNumber>VPA10980/018/002</LicenceNumber>
    <ProductName>Alpramil 12.5 mg/125 mg tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime for veterinary use </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/017/003</DrugIDPK>
    <LicenceNumber>VPA10980/017/003</LicenceNumber>
    <ProductName>Alpramil 16 mg/40 mg film-coated tablets for cats weighing at least 4 kg</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime for veterinary use </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/018/003</DrugIDPK>
    <LicenceNumber>VPA10980/018/003</LicenceNumber>
    <ProductName>Alpramil 20 mg/200 mg tablets for dogs weighing at least 8 kg</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime for veterinary use </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/017/001</DrugIDPK>
    <LicenceNumber>VPA10980/017/001</LicenceNumber>
    <ProductName>Alpramil 4 mg/10 mg film-coated tablets for cats weighing at least 0.5 kg</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime for veterinary use </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/018/001</DrugIDPK>
    <LicenceNumber>VPA10980/018/001</LicenceNumber>
    <ProductName>Alpramil 5 mg/50 mg tablets for dogs weighing at least 0.5 kg</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime for veterinary use </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/068/001</DrugIDPK>
    <LicenceNumber>VPA10989/068/001</LicenceNumber>
    <ProductName>Altidox 500 mg/g powder for use in drinking water for pigs, chickens and turkeys</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>21/10/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/010/001</DrugIDPK>
    <LicenceNumber>VPA10815/010/001</LicenceNumber>
    <ProductName>Altresyn 4 mg/ml oral solution for pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>06/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG03DX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Altrenogest</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/022/001</DrugIDPK>
    <LicenceNumber>VPA10521/022/001</LicenceNumber>
    <ProductName>Aluspray 4% w/w Cutaneous Spray, Powder</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, powder</DosageForm>
    <ATCs>
      <ATC>QD08AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA16142/003/001</DrugIDPK>
    <LicenceNumber>VPA16142/003/001</LicenceNumber>
    <ProductName>Alvebuton 100 mg/ml Solution for injection for cattle, pigs, horses, sheep, goats</ProductName>
    <PAHolder>V.M.D. n.v.,</PAHolder>
    <AuthorisedDate>24/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA05AX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Menbutone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA16142/002/001</DrugIDPK>
    <LicenceNumber>VPA16142/002/001</LicenceNumber>
    <ProductName>Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs and Cats</ProductName>
    <PAHolder>V.M.D. n.v.,</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/001/001</DrugIDPK>
    <LicenceNumber>VPA10495/001/001</LicenceNumber>
    <ProductName>Alzane 5 mg/ml, solution for injection for dogs and cats</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV03AB90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Atipamezole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/045/001</DrugIDPK>
    <LicenceNumber>VPA10774/045/001</LicenceNumber>
    <ProductName>Amatib 800 mg/g oral powder for pigs and chickens</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/059/002</DrugIDPK>
    <LicenceNumber>VPA10774/059/002</LicenceNumber>
    <ProductName>Amcofen 12.5/125.0 mg chewable tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/059/004</DrugIDPK>
    <LicenceNumber>VPA10774/059/004</LicenceNumber>
    <ProductName>Amcofen 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/060/002</DrugIDPK>
    <LicenceNumber>VPA10774/060/002</LicenceNumber>
    <ProductName>Amcofen 16 mg/40 mg chewable tablets for cats weighing at least 2 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/059/001</DrugIDPK>
    <LicenceNumber>VPA10774/059/001</LicenceNumber>
    <ProductName>Amcofen 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/059/003</DrugIDPK>
    <LicenceNumber>VPA10774/059/003</LicenceNumber>
    <ProductName>Amcofen 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/060/001</DrugIDPK>
    <LicenceNumber>VPA10774/060/001</LicenceNumber>
    <ProductName>Amcofen 4 mg/10 mg chewable tablets for small cats and kittens weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/022/001</DrugIDPK>
    <LicenceNumber>VPA10774/022/001</LicenceNumber>
    <ProductName>Amflee 2.5 mg/ml cutaneous spray, solution for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/051/002</DrugIDPK>
    <LicenceNumber>VPA10774/051/002</LicenceNumber>
    <ProductName>Amflee Combo 134 mg/120.6 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/051/003</DrugIDPK>
    <LicenceNumber>VPA10774/051/003</LicenceNumber>
    <ProductName>Amflee Combo 268 mg/241.2 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/051/004</DrugIDPK>
    <LicenceNumber>VPA10774/051/004</LicenceNumber>
    <ProductName>Amflee Combo 402 mg/361.8 mg spot-on solution for extra large dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/050/001</DrugIDPK>
    <LicenceNumber>VPA10774/050/001</LicenceNumber>
    <ProductName>Amflee Combo 50 mg/60 mg spot-on solution for cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/051/001</DrugIDPK>
    <LicenceNumber>VPA10774/051/001</LicenceNumber>
    <ProductName>Amflee Combo 67 mg/60.3 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/048/001</DrugIDPK>
    <LicenceNumber>VPA10815/048/001</LicenceNumber>
    <ProductName>Amodip 1.25 mg chewable tablets for cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>23/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC08CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/013/002</DrugIDPK>
    <LicenceNumber>VPA10475/013/002</LicenceNumber>
    <ProductName>Amoxibactin 250 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>16/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/013/001</DrugIDPK>
    <LicenceNumber>VPA10475/013/001</LicenceNumber>
    <ProductName>Amoxibactin 50 mg tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>16/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/013/003</DrugIDPK>
    <LicenceNumber>VPA10475/013/003</LicenceNumber>
    <ProductName>Amoxibactin 500 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>16/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10477/002/001</DrugIDPK>
    <LicenceNumber>VPA10477/002/001</LicenceNumber>
    <ProductName>AMOXICILLIN GLOBAL VET HEALTH 500 mg/g, powder for use in drinking water for chickens, turkeys, ducks and pigs</ProductName>
    <PAHolder>GLOBAL VET HEALTH SL</PAHolder>
    <AuthorisedDate>04/12/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/041/001</DrugIDPK>
    <LicenceNumber>VPA10983/041/001</LicenceNumber>
    <ProductName>Amoxinsol 50 % w/w powder for oral solution</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>11/07/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/005/001</DrugIDPK>
    <LicenceNumber>VPA10791/005/001</LicenceNumber>
    <ProductName>AMOXY ACTIVE, 697 mg/g, oral powder for pigs and chickens</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>22/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/034/001</DrugIDPK>
    <LicenceNumber>VPA10782/034/001</LicenceNumber>
    <ProductName>Amphen 200 mg/g granules for use in drinking water for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>29/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/044/001</DrugIDPK>
    <LicenceNumber>VPA10782/044/001</LicenceNumber>
    <ProductName>Amphen 200 mg/ml suspension for use in drinking water for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>12/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Drinking Water</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10793/002/001</DrugIDPK>
    <LicenceNumber>VPA10793/002/001</LicenceNumber>
    <ProductName>Ampisol 2g, powder for solution for injection</ProductName>
    <PAHolder>Acravet Limited</PAHolder>
    <AuthorisedDate>18/12/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10453/002/001</DrugIDPK>
    <LicenceNumber>VPA10453/002/001</LicenceNumber>
    <ProductName>AMPROLINE 400 mg/mL solution for use in drinking water for chickens and turkeys</ProductName>
    <PAHolder>HUVEPHARMA SA</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP51AX09</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amprolium hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10804/002/001</DrugIDPK>
    <LicenceNumber>VPA10804/002/001</LicenceNumber>
    <ProductName>AMX 10 mg/ml concentrate for solution for fish treatment</ProductName>
    <PAHolder>PHARMAQ AS</PAHolder>
    <AuthorisedDate>06/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for solution for fish treatment</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Topical use</RoutesOfAdministration>
      <RoutesOfAdministration>Water-borne use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
      <Species>Trout</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10900/010/001</DrugIDPK>
    <LicenceNumber>VPA10900/010/001</LicenceNumber>
    <ProductName>Anaemex 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Ark Animal Care Ltd.,</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC90</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Iron dextran</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/010/001</DrugIDPK>
    <LicenceNumber>VPA10475/010/001</LicenceNumber>
    <ProductName>Anaestamine 100 mg/ml solution for injection</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>14/11/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/025/001</DrugIDPK>
    <LicenceNumber>VPA10810/025/001</LicenceNumber>
    <ProductName>Analeptol 50 mg/ml + 50 mg/ml solution for injection for cattle, horses, pigs, dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>07/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>*** AWAITING VALUE ***</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QR03DA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Heptaminol hydrochloride</ActiveSubstance>
      <ActiveSubstance>Diprophylline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/070/001</DrugIDPK>
    <LicenceNumber>VPA10987/070/001</LicenceNumber>
    <ProductName>Animec 0.8 mg/ml Oral Solution for Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>29/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/147/001</DrugIDPK>
    <LicenceNumber>VPA10987/147/001</LicenceNumber>
    <ProductName>Animec 1 % Solution for Injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>12/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25460/001/001</DrugIDPK>
    <LicenceNumber>VPA25460/001/001</LicenceNumber>
    <ProductName>Animec 18.7 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Acme Drugs S.r.l.</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/152/001</DrugIDPK>
    <LicenceNumber>VPA10987/152/001</LicenceNumber>
    <ProductName>Animec 5 mg/ml Pour-on Solution for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/12/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/068/001</DrugIDPK>
    <LicenceNumber>VPA10987/068/001</LicenceNumber>
    <ProductName>Animec Super Solution for Injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/005/001</DrugIDPK>
    <LicenceNumber>VPA10826/005/001</LicenceNumber>
    <ProductName>Animedazon Spray, 2.45 % w/w cutaneous spray suspension for cattle, sheep and pigs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, suspension</DosageForm>
    <ATCs>
      <ATC>QD06AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/025/001</DrugIDPK>
    <LicenceNumber>VPA10826/025/001</LicenceNumber>
    <ProductName>Animeloxan, 20 mg/ml, solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>24/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/158/001</DrugIDPK>
    <LicenceNumber>VPA10987/158/001</LicenceNumber>
    <ProductName>Anisec 0.5 % w/v Pour-on Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/049/001</DrugIDPK>
    <LicenceNumber>VPA10774/049/001</LicenceNumber>
    <ProductName>Anthelmin 230 mg/20 mg film-coated tablets for cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>31/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/033/001</DrugIDPK>
    <LicenceNumber>VPA10774/033/001</LicenceNumber>
    <ProductName>Anthelmin Plus Flavour Tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/033/002</DrugIDPK>
    <LicenceNumber>VPA10774/033/002</LicenceNumber>
    <ProductName>Anthelmin Plus XL Tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10664/003/001</DrugIDPK>
    <LicenceNumber>VPA10664/003/001</LicenceNumber>
    <ProductName>Antisedan 5 mg/ml solution for injection</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>26/02/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV03AB90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Atipamezole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>HOVR23152/001/001</DrugIDPK>
    <LicenceNumber>HOVR23152/001/001</LicenceNumber>
    <ProductName>Anxt-F</ProductName>
    <PAHolder>HomeoPet Pet Products Limited</PAHolder>
    <AuthorisedDate>20/01/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Registered homeopathic medicinal products (Article 17 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Aconite (aconitum napellus)</ActiveSubstance>
      <ActiveSubstance>Avena sativa</ActiveSubstance>
      <ActiveSubstance>Belladonna (atropa belladonna)</ActiveSubstance>
      <ActiveSubstance>Borax (natrium tetraboracicum)</ActiveSubstance>
      <ActiveSubstance>Calcium phosphoricum</ActiveSubstance>
      <ActiveSubstance>Gelsemium sempervirens</ActiveSubstance>
      <ActiveSubstance>Lycopodium clavatum</ActiveSubstance>
      <ActiveSubstance>Natrium carbonicum</ActiveSubstance>
      <ActiveSubstance>Natrium chloratum (natrium mur)</ActiveSubstance>
      <ActiveSubstance>Passiflora incarnata</ActiveSubstance>
      <ActiveSubstance>Phosphorus</ActiveSubstance>
      <ActiveSubstance>Rhododendron</ActiveSubstance>
      <ActiveSubstance>Scutellaria lateriflora</ActiveSubstance>
      <ActiveSubstance>Silicea (acidum silicicum)</ActiveSubstance>
      <ActiveSubstance>Staphisagria (delphinium)</ActiveSubstance>
      <ActiveSubstance>Stramonium (datura stramonium)</ActiveSubstance>
      <ActiveSubstance>Valeriana officinalis</ActiveSubstance>
      <ActiveSubstance>Aconite (aconitum napellus)</ActiveSubstance>
      <ActiveSubstance>Avena sativa</ActiveSubstance>
      <ActiveSubstance>Borax (natrium tetraboracicum)</ActiveSubstance>
      <ActiveSubstance>Calcium phosphoricum</ActiveSubstance>
      <ActiveSubstance>Gelsemium sempervirens</ActiveSubstance>
      <ActiveSubstance>Gelsemium sempervirens</ActiveSubstance>
      <ActiveSubstance>Lycopodium clavatum</ActiveSubstance>
      <ActiveSubstance>Natrium carbonicum</ActiveSubstance>
      <ActiveSubstance>Passiflora incarnata</ActiveSubstance>
      <ActiveSubstance>Phosphorus</ActiveSubstance>
      <ActiveSubstance>Phosphorus</ActiveSubstance>
      <ActiveSubstance>Phosphorus</ActiveSubstance>
      <ActiveSubstance>Scutellaria lateriflora</ActiveSubstance>
      <ActiveSubstance>Valeriana officinalis</ActiveSubstance>
      <ActiveSubstance>Silicea (acidum silicicum)</ActiveSubstance>
      <ActiveSubstance>Staphisagria (delphinium)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Ornamental birds</Species>
    </VetSpecies>
    <VetTherapeuticClass>Homeopathic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10388/001/001</DrugIDPK>
    <LicenceNumber>VPA10388/001/001</LicenceNumber>
    <ProductName>Api-Bioxal 0.71 g/g bee-hive powder</ProductName>
    <PAHolder>Chemicals Laif S.P.A</PAHolder>
    <AuthorisedDate>07/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for bee-hive solution</DosageForm>
    <ATCs>
      <ATC>QP53AG03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxalic acid dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10388/001/002</DrugIDPK>
    <LicenceNumber>VPA10388/001/002</LicenceNumber>
    <ProductName>API-Bioxal 44.2 mg/ml bee-hive solution</ProductName>
    <PAHolder>Chemicals Laif S.P.A</PAHolder>
    <AuthorisedDate>10/12/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Bee-hive solution</DosageForm>
    <ATCs>
      <ATC>QP53AG03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxalic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22752/001/001</DrugIDPK>
    <LicenceNumber>VPA22752/001/001</LicenceNumber>
    <ProductName>APIGUARD gel 12.5 g for beehive use</ProductName>
    <PAHolder>Vita Bee Health Limited</PAHolder>
    <AuthorisedDate>21/03/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QP53AX22</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thymol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22752/001/002</DrugIDPK>
    <LicenceNumber>VPA22752/001/002</LicenceNumber>
    <ProductName>APIGUARD MULTIDOSE 0.25 g/g bee-hive gel</ProductName>
    <PAHolder>Vita Bee Health Limited</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Bee-hive gel</DosageForm>
    <ATCs>
      <ATC>QP53AX22</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thymol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22827/001/001</DrugIDPK>
    <LicenceNumber>VPA22827/001/001</LicenceNumber>
    <ProductName>Apivar 500 mg bee-hive strips for honey bees</ProductName>
    <PAHolder>Veto-Pharma</PAHolder>
    <AuthorisedDate>26/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Bee-hive strip</DosageForm>
    <ATCs>
      <ATC>QP53AD01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amitraz </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>PVPA10400/001/001</DrugIDPK>
    <LicenceNumber>PVPA10400/001/001</LicenceNumber>
    <ProductName>Apivar 500 mg Bee-hive strips for honey bees</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>24/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Bee-hive strip</DosageForm>
    <ATCs>
      <ATC>QP53AD01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amitraz </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/002/002</DrugIDPK>
    <LicenceNumber>VPA22622/002/002</LicenceNumber>
    <ProductName>Apovomin 1 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>16/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN04BC07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Apomorphine hydrochloride hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/002/001</DrugIDPK>
    <LicenceNumber>VPA22622/002/001</LicenceNumber>
    <ProductName>Apovomin 3 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>16/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN04BC07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Apomorphine hydrochloride hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/013/001</DrugIDPK>
    <LicenceNumber>VPA10782/013/001</LicenceNumber>
    <ProductName>Apravet 100 g/kg premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>29/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01GB</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Apramycin sulphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/024/001</DrugIDPK>
    <LicenceNumber>VPA10782/024/001</LicenceNumber>
    <ProductName>Apravet 552 IU/mg powder for use in drinking water/milk for pigs, calves, chickens and rabbits</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>14/09/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QA07AA92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water/milk use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Apramycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/024/001</DrugIDPK>
    <LicenceNumber>VPA10990/024/001</LicenceNumber>
    <ProductName>Aquaprim Solution for Injection</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/214/001</DrugIDPK>
    <LicenceNumber>VPA10996/214/001</LicenceNumber>
    <ProductName>AquaVac ERM. Concentrate for dip suspension for Rainbow trout</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>22/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip suspension</DosageForm>
    <ATCs>
      <ATC>QI10BB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Dipping</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Yersinia ruckeri cells inactivated (Hagerman type 1 stain)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Trout</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/274/001</DrugIDPK>
    <LicenceNumber>VPA10996/274/001</LicenceNumber>
    <ProductName>AquaVac PD3 emulsion for injection for Atlantic salmon</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>27/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI10AL</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated salmon pancreas disease virus</ActiveSubstance>
      <ActiveSubstance>Inactivated infectious pancreatic necrosis virus</ActiveSubstance>
      <ActiveSubstance>Inactivated aeromonas salmonicida subsp. salmonicida</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/290/001</DrugIDPK>
    <LicenceNumber>VPA10996/290/001</LicenceNumber>
    <ProductName>AquaVac S7 emulsion for injection for Atlantic salmon</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>20/03/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI10AL</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Infectious pancreatic necrosis virus, serotype Sp, strain SP.2005.009, Inactivated</ActiveSubstance>
      <ActiveSubstance>Aeromonas salmonicida, subsp. salmonicida, strain FT 449, Inactivated</ActiveSubstance>
      <ActiveSubstance>Aliivibrio salmonicida, strain NCMB 2262, Inactivated</ActiveSubstance>
      <ActiveSubstance>Vibrio anguillarum, serotype O1, strain FT 257, Inactivated</ActiveSubstance>
      <ActiveSubstance>Vibrio anguillarum, serotype O2a, strain FT 256, Inactivated</ActiveSubstance>
      <ActiveSubstance>Moritella viscosa, strain RO 1.0, Inactivated</ActiveSubstance>
      <ActiveSubstance>Yersinia ruckeri, serotype O1, biotype 1, strain Hagerman, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/010/001</DrugIDPK>
    <LicenceNumber>VPA10491/010/001</LicenceNumber>
    <ProductName>Aqupharm 1 (9 mg/ml) solution for injection/infusion</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/011/001</DrugIDPK>
    <LicenceNumber>VPA10491/011/001</LicenceNumber>
    <ProductName>Aqupharm 11 (Hartmann's) Solution for Infusion</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>16/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/050/001</DrugIDPK>
    <LicenceNumber>VPA10990/050/001</LicenceNumber>
    <ProductName>Arentor DC 250 mg Intramammary Suspension for Dry Cows</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>07/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DB90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalonium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/008/002</DrugIDPK>
    <LicenceNumber>VPA10509/008/002</LicenceNumber>
    <ProductName>ARIXIL vet 20 mg film-coated tablet for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>05/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/008/001</DrugIDPK>
    <LicenceNumber>VPA10509/008/001</LicenceNumber>
    <ProductName>ARIXIL vet 5 mg film-coated tablet for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>05/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/003/001</DrugIDPK>
    <LicenceNumber>VPA10915/003/001</LicenceNumber>
    <ProductName>Arrest Oral Suspension</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
      <ATC>QP52AE01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25433/002/001</DrugIDPK>
    <LicenceNumber>VPA25433/002/001</LicenceNumber>
    <ProductName>ASHIDOX 500 mg/g, powder for use in drinking water/milk for cattle (pre-ruminant), pigs and chickens</ProductName>
    <PAHolder>Ashish Life Science Holding B.V.</PAHolder>
    <AuthorisedDate>13/06/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/034/003</DrugIDPK>
    <LicenceNumber>VPA10774/034/003</LicenceNumber>
    <ProductName>Ataxxa 1250 mg/250 mg spot-on solution for dogs over 10 kg up to 25 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin</ActiveSubstance>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/034/001</DrugIDPK>
    <LicenceNumber>VPA10774/034/001</LicenceNumber>
    <ProductName>Ataxxa 200 mg/40 mg spot-on solution for dogs up to 4 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin</ActiveSubstance>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/034/004</DrugIDPK>
    <LicenceNumber>VPA10774/034/004</LicenceNumber>
    <ProductName>Ataxxa 2000 mg/400 mg spot-on solution for dogs over 25 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin</ActiveSubstance>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/034/002</DrugIDPK>
    <LicenceNumber>VPA10774/034/002</LicenceNumber>
    <ProductName>Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin</ActiveSubstance>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/055/001</DrugIDPK>
    <LicenceNumber>VPA10989/055/001</LicenceNumber>
    <ProductName>Atipam, 5.0 mg/ml, solution for injection for cats and dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>23/05/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV03AB90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Atipamezole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/016/001</DrugIDPK>
    <LicenceNumber>VPA22020/016/001</LicenceNumber>
    <ProductName>Atopica 10 mg soft capsules for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ATCs>
      <ATC>QL04AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/013/001</DrugIDPK>
    <LicenceNumber>VPA22020/013/001</LicenceNumber>
    <ProductName>Atopica 100 mg/ml oral solution for cats and dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>06/01/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QL04A</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/016/004</DrugIDPK>
    <LicenceNumber>VPA22020/016/004</LicenceNumber>
    <ProductName>Atopica 100 mg soft capsules for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ATCs>
      <ATC>QL04AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/016/002</DrugIDPK>
    <LicenceNumber>VPA22020/016/002</LicenceNumber>
    <ProductName>Atopica 25 mg soft capsules for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ATCs>
      <ATC>QL04AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/016/003</DrugIDPK>
    <LicenceNumber>VPA22020/016/003</LicenceNumber>
    <ProductName>Atopica 50 mg soft capsules for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ATCs>
      <ATC>QL04AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/005/001</DrugIDPK>
    <LicenceNumber>VPA23462/005/001</LicenceNumber>
    <ProductName>Aurimic ear drops and cutaneous suspension for dogs and cats</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>13/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
      <ActiveSubstance>Polymyxin b sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/027/001</DrugIDPK>
    <LicenceNumber>VPA10521/027/001</LicenceNumber>
    <ProductName>AURIZON ear drops, suspension</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>02/11/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA06</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Dexamethasone acetate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25497/001/001</DrugIDPK>
    <LicenceNumber>VPA25497/001/001</LicenceNumber>
    <ProductName>Aurofac Granular 250 mg/g Premix for medicated feedingstuff for pigs and chickens</ProductName>
    <PAHolder>Phibro Animal Health (Poland) Sp. z o.o.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/065/001</DrugIDPK>
    <LicenceNumber>VPA10987/065/001</LicenceNumber>
    <ProductName>Austiofen 20 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/027/001</DrugIDPK>
    <LicenceNumber>VPA10454/027/001</LicenceNumber>
    <ProductName>AVINEW NEO effervescent tablet for chickens and turkeys</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>13/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ATCs>
      <ATC>QI01AD06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live newcastle disease virus (VG/GA) component</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/068/001</DrugIDPK>
    <LicenceNumber>VPA22020/068/001</LicenceNumber>
    <ProductName>AviPro Thymovac Lyophilisate for use in drinking water</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ATCs>
      <ATC>QI01AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live chicken anaemia virus (CAV), strain cux-1</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25579/004/001</DrugIDPK>
    <LicenceNumber>VPA25579/004/001</LicenceNumber>
    <ProductName>Avishield IB GI-13, lyophilisate for oculonasal suspension/use in drinking water for chickens</ProductName>
    <PAHolder>Izo S.r.l.</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bronchitis virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25579/001/001</DrugIDPK>
    <LicenceNumber>VPA25579/001/001</LicenceNumber>
    <ProductName>Avishield IB H120, lyophilisate for oculonasal suspension/use in drinking water, for chickens</ProductName>
    <PAHolder>Izo S.r.l.</PAHolder>
    <AuthorisedDate>09/02/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for suspension for oculonasal or spray app</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious brochitis virus massachusetts serotype strain h-120</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25579/006/001</DrugIDPK>
    <LicenceNumber>VPA25579/006/001</LicenceNumber>
    <ProductName>Avishield IB QX</ProductName>
    <PAHolder>Izo S.r.l.</PAHolder>
    <AuthorisedDate>13/06/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application - new active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bronchitis virus, type QX, strain 1285, Live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25579/003/001</DrugIDPK>
    <LicenceNumber>VPA25579/003/001</LicenceNumber>
    <ProductName>Avishield IBD INT, lyophilisate for oculonasal suspension/use in drinking water, for chickens</ProductName>
    <PAHolder>Izo S.r.l.</PAHolder>
    <AuthorisedDate>07/01/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bursal disease virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25579/005/001</DrugIDPK>
    <LicenceNumber>VPA25579/005/001</LicenceNumber>
    <ProductName>Avishield IBD Plus,  lyophilisate for use in drinking water, for chickens</ProductName>
    <PAHolder>Izo S.r.l.</PAHolder>
    <AuthorisedDate>26/06/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bursal disease virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25579/002/001</DrugIDPK>
    <LicenceNumber>VPA25579/002/001</LicenceNumber>
    <ProductName>Avishield ND B1, lyophilisate for oculonasal suspension/use in drinking water for chickens.</ProductName>
    <PAHolder>Izo S.r.l.</PAHolder>
    <AuthorisedDate>18/05/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Newcastle disease virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA1136/002/001</DrugIDPK>
    <LicenceNumber>VPA1136/002/001</LicenceNumber>
    <ProductName>Azaporc 40 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Serumwerk Bernburg AG</PAHolder>
    <AuthorisedDate>05/03/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Azaperone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10465/003/001</DrugIDPK>
    <LicenceNumber>VPA10465/003/001</LicenceNumber>
    <ProductName>B. Braun Vet Care Hartmann's Lactated Ringers Solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats</ProductName>
    <PAHolder>B. Braun Melsungen AG.</PAHolder>
    <AuthorisedDate>17/08/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10956/007/001</DrugIDPK>
    <LicenceNumber>VPA10956/007/001</LicenceNumber>
    <ProductName>B.V.P. COPPER WITH VITAMIN B12 INJECTION</ProductName>
    <PAHolder>Ballinskelligs Vet. Products Ltd</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Copper methionate</ActiveSubstance>
      <ActiveSubstance>Vitamin B12</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10956/007/002</DrugIDPK>
    <LicenceNumber>VPA10956/007/002</LicenceNumber>
    <ProductName>B.V.P. COPPER WITH VITAMIN B12 INJECTION</ProductName>
    <PAHolder>Ballinskelligs Vet. Products Ltd</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Copper methionate</ActiveSubstance>
      <ActiveSubstance>Vitamin B12</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/018/001</DrugIDPK>
    <LicenceNumber>VPA10521/018/001</LicenceNumber>
    <ProductName>Bactidiaryl Oral Powder</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01RA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
      <ActiveSubstance>Tetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/011/002</DrugIDPK>
    <LicenceNumber>VPA10665/011/002</LicenceNumber>
    <ProductName>Banacep Vet 20 mg film-coated tablets for dogs</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>17/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/011/001</DrugIDPK>
    <LicenceNumber>VPA10665/011/001</LicenceNumber>
    <ProductName>Banacep Vet 5 mg film-coated tablets for dogs and cats</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>17/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/054/001</DrugIDPK>
    <LicenceNumber>VPA22020/054/001</LicenceNumber>
    <ProductName>Baycox 25 mg/ml, solution for use in drinking water for chickens and turkeys</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/055/001</DrugIDPK>
    <LicenceNumber>VPA22020/055/001</LicenceNumber>
    <ProductName>Baycox Multi 50 mg/ml oral suspension for Cattle, Pigs and Sheep</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51BC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/013/001</DrugIDPK>
    <LicenceNumber>VPA10521/013/001</LicenceNumber>
    <ProductName>Bayer Dog Tasty Bone 150/144/50 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/013/002</DrugIDPK>
    <LicenceNumber>VPA10521/013/002</LicenceNumber>
    <ProductName>Bayer Dog Tasty Bone XL 525/504/175 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/060/001</DrugIDPK>
    <LicenceNumber>VPA22020/060/001</LicenceNumber>
    <ProductName>Bayticol 10 mg/ml Pour-On Solution</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flumethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/043/001</DrugIDPK>
    <LicenceNumber>VPA22020/043/001</LicenceNumber>
    <ProductName>Baytril 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/063/001</DrugIDPK>
    <LicenceNumber>VPA22020/063/001</LicenceNumber>
    <ProductName>Baytril 100 mg/ml solution for use in drinking water for chickens, turkeys and rabbits</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Rabbits</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/062/001</DrugIDPK>
    <LicenceNumber>VPA22020/062/001</LicenceNumber>
    <ProductName>Baytril 25 mg/ml Oral Solution</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chinchilla</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/044/001</DrugIDPK>
    <LicenceNumber>VPA22020/044/001</LicenceNumber>
    <ProductName>Baytril 25 mg/ml solution for injection</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/061/001</DrugIDPK>
    <LicenceNumber>VPA22020/061/001</LicenceNumber>
    <ProductName>Baytril 50 mg/ml Solution for Injection</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/065/001</DrugIDPK>
    <LicenceNumber>VPA22020/065/001</LicenceNumber>
    <ProductName>Baytril Flavour Tablets 15 mg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/065/003</DrugIDPK>
    <LicenceNumber>VPA22020/065/003</LicenceNumber>
    <ProductName>Baytril Flavour Tablets 150 mg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/065/002</DrugIDPK>
    <LicenceNumber>VPA22020/065/002</LicenceNumber>
    <ProductName>Baytril Flavour Tablets 50 mg</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/053/001</DrugIDPK>
    <LicenceNumber>VPA22020/053/001</LicenceNumber>
    <ProductName>Baytril Max 100 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>23/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10455/004/001</DrugIDPK>
    <LicenceNumber>VPA10455/004/001</LicenceNumber>
    <ProductName>Beaphar Insecticidal Dog Shampoo, 0.2% w/w</ProductName>
    <PAHolder>Beaphar B.V.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ATCs>
      <ATC>QP53AC04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10455/005/001</DrugIDPK>
    <LicenceNumber>VPA10455/005/001</LicenceNumber>
    <ProductName>Beaphar Pump Action Flea Spray, Cutaneous Spray Solution</ProductName>
    <PAHolder>Beaphar B.V.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QP53AC51</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>25% Pyrethrum extract</ActiveSubstance>
      <ActiveSubstance>Piperonyl butoxide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/046/002</DrugIDPK>
    <LicenceNumber>VPA22622/046/002</LicenceNumber>
    <ProductName>Benakor 20 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/046/001</DrugIDPK>
    <LicenceNumber>VPA22622/046/001</LicenceNumber>
    <ProductName>Benakor 5 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/119/001</DrugIDPK>
    <LicenceNumber>VPA10988/119/001</LicenceNumber>
    <ProductName>Benamix 6.25 mg/g premix for medicated feeding stuff for cats.</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>28/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/006/002</DrugIDPK>
    <LicenceNumber>VPA10491/006/002</LicenceNumber>
    <ProductName>Benazecare Flavour 20 mg Tablets for Dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>24/08/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/006/001</DrugIDPK>
    <LicenceNumber>VPA10491/006/001</LicenceNumber>
    <ProductName>Benazecare Flavour 5 mg Tablets for Dogs and Cats</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>24/08/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10482/001/001</DrugIDPK>
    <LicenceNumber>VPA10482/001/001</LicenceNumber>
    <ProductName>Benefortin Flavour 2.5 mg tablets for cats and dogs</ProductName>
    <PAHolder>LAVET Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10482/001/003</DrugIDPK>
    <LicenceNumber>VPA10482/001/003</LicenceNumber>
    <ProductName>Benefortin Flavour 20 mg tablets for dogs</ProductName>
    <PAHolder>LAVET Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10482/001/002</DrugIDPK>
    <LicenceNumber>VPA10482/001/002</LicenceNumber>
    <ProductName>Benefortin Flavour 5 mg tablets for cats and dogs</ProductName>
    <PAHolder>LAVET Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/129/001</DrugIDPK>
    <LicenceNumber>VPA22664/129/001</LicenceNumber>
    <ProductName>Betafuse 1 mg/g + 5 mg/g gel for dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QD07CC01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
      <ActiveSubstance>Fusidic acid hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/004/001</DrugIDPK>
    <LicenceNumber>VPA22664/004/001</LicenceNumber>
    <ProductName>Betamox 150 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/010/001</DrugIDPK>
    <LicenceNumber>VPA22664/010/001</LicenceNumber>
    <ProductName>Betamox LA 150 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/074/001</DrugIDPK>
    <LicenceNumber>VPA10987/074/001</LicenceNumber>
    <ProductName>Bexepril 2.5 mg Film-coated tablet for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/074/003</DrugIDPK>
    <LicenceNumber>VPA10987/074/003</LicenceNumber>
    <ProductName>Bexepril 20 mg Film-coated tablet for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/074/002</DrugIDPK>
    <LicenceNumber>VPA10987/074/002</LicenceNumber>
    <ProductName>Bexepril 5 mg Film-coated tablet for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/010/001</DrugIDPK>
    <LicenceNumber>VPA10521/010/001</LicenceNumber>
    <ProductName>Big Cat Wormer Film-Coated Tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/055/001</DrugIDPK>
    <LicenceNumber>VPA22033/055/001</LicenceNumber>
    <ProductName>Bilovet 200 mg/ml Solution for Injection for cattle and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/083/001</DrugIDPK>
    <LicenceNumber>VPA22033/083/001</LicenceNumber>
    <ProductName>Bimacox 2.5 mg/ml Oral Suspension for Sheep and Cattle</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>16/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51BC03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diclazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/074/001</DrugIDPK>
    <LicenceNumber>VPA22033/074/001</LicenceNumber>
    <ProductName>Bimacure 500mg Intrauterine Suspension for Cattle</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>19/08/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intrauterine suspension</DosageForm>
    <ATCs>
      <ATC>QG51AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intrauterine use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefapirin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/037/001</DrugIDPK>
    <LicenceNumber>VPA22033/037/001</LicenceNumber>
    <ProductName>Bimadine Powder for Oral Suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ATCs>
      <ATC>QJ01EQ03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadimidine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/001/001</DrugIDPK>
    <LicenceNumber>VPA22033/001/001</LicenceNumber>
    <ProductName>Bimastat Oral Suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QJ01RA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulphate</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/056/001</DrugIDPK>
    <LicenceNumber>VPA22033/056/001</LicenceNumber>
    <ProductName>Bimectin 10 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>14/04/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/077/001</DrugIDPK>
    <LicenceNumber>VPA22033/077/001</LicenceNumber>
    <ProductName>Bimectin 5 mg/ml Pour-On solution for Cattle</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>10/12/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/049/001</DrugIDPK>
    <LicenceNumber>VPA22033/049/001</LicenceNumber>
    <ProductName>Bimectin Horse Oral Paste 18.7 mg/g</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>05/09/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/002/001</DrugIDPK>
    <LicenceNumber>VPA22033/002/001</LicenceNumber>
    <ProductName>Bimectin Plus Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/057/001</DrugIDPK>
    <LicenceNumber>VPA22033/057/001</LicenceNumber>
    <ProductName>Bimeprine 5 mg/ml pour-on solution for cattle</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>22/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/038/001</DrugIDPK>
    <LicenceNumber>VPA22033/038/001</LicenceNumber>
    <ProductName>Bimotrim Co Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadoxine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/039/001</DrugIDPK>
    <LicenceNumber>VPA22033/039/001</LicenceNumber>
    <ProductName>Bimoxyl LA 150 mg/ml Suspension for Injection for Cattle, Sheep, Pigs and Dogs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10436/002/001</DrugIDPK>
    <LicenceNumber>VPA10436/002/001</LicenceNumber>
    <ProductName>Bimoxyvet LA 150 mg/ml, Suspension for Injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Laboratorios Maymo S.A.U.</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/076/001</DrugIDPK>
    <LicenceNumber>VPA22033/076/001</LicenceNumber>
    <ProductName>Bimprocil 300 mg/ml suspension for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/002/003</DrugIDPK>
    <LicenceNumber>VPA22873/002/003</LicenceNumber>
    <ProductName>Biocefavet 375 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>13/12/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/002/001</DrugIDPK>
    <LicenceNumber>VPA22873/002/001</LicenceNumber>
    <ProductName>Biocefavet 50 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>13/12/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/002/002</DrugIDPK>
    <LicenceNumber>VPA22873/002/002</LicenceNumber>
    <ProductName>Biocefavet 75 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>13/12/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/002/004</DrugIDPK>
    <LicenceNumber>VPA22873/002/004</LicenceNumber>
    <ProductName>Biocefavet 750 mg chewable tablets for  dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>13/12/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/002/001</DrugIDPK>
    <LicenceNumber>VPA10445/002/001</LicenceNumber>
    <ProductName>Biocillin 1000 mg/g Powder for use in drinking water for chickens, ducks and turkeys</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>24/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/005/002</DrugIDPK>
    <LicenceNumber>VPA22873/005/002</LicenceNumber>
    <ProductName>Bioclanic 250 mg + 62.5 mg flavoured tablets for cats and dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>26/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/005/001</DrugIDPK>
    <LicenceNumber>VPA22873/005/001</LicenceNumber>
    <ProductName>Bioclanic 50 mg + 12.5 mg flavoured tablets for cats and dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>26/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/005/003</DrugIDPK>
    <LicenceNumber>VPA22873/005/003</LicenceNumber>
    <ProductName>Bioclanic 500 mg + 125 mg flavoured tablets for dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>26/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/003/001</DrugIDPK>
    <LicenceNumber>VPA22873/003/001</LicenceNumber>
    <ProductName>Bioclindavet 110 mg/ml oral solution for cats and dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>17/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/004/002</DrugIDPK>
    <LicenceNumber>VPA22873/004/002</LicenceNumber>
    <ProductName>Bioclindavet 275 mg chewable tablets for dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>17/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/004/001</DrugIDPK>
    <LicenceNumber>VPA22873/004/001</LicenceNumber>
    <ProductName>Bioclindavet 75 mg chewable tablet for dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>17/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/010/001</DrugIDPK>
    <LicenceNumber>VPA22028/010/001</LicenceNumber>
    <ProductName>BioEquin EHV, emulsion for injection for horses</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>05/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI05AA05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated equine herpes virus ehv msv bio 82S </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/008/001</DrugIDPK>
    <LicenceNumber>VPA22028/008/001</LicenceNumber>
    <ProductName>BioEquin F suspension for injection for horses</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>21/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI05AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine Influenza virus H3N8, A/Equine/Limerick/2010, Inactivated</ActiveSubstance>
      <ActiveSubstance>Equine influenza virus H3N8, A/Equine/Brno/08, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/009/001</DrugIDPK>
    <LicenceNumber>VPA22028/009/001</LicenceNumber>
    <ProductName>BioEquin FT suspension for injection for horses</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>21/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI05AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine Influenza virus H3N8, A/Equine/Limerick/2010, Inactivated</ActiveSubstance>
      <ActiveSubstance>Equine influenza virus H3N8, A/Equine/Brno/08, Inactivated</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/028/001</DrugIDPK>
    <LicenceNumber>VPA10521/028/001</LicenceNumber>
    <ProductName>Bioestrovet 0.250 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>28/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/063/001</DrugIDPK>
    <LicenceNumber>VPA10983/063/001</LicenceNumber>
    <ProductName>Bioestrovet Swine</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>08/07/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/003/001</DrugIDPK>
    <LicenceNumber>VPA22028/003/001</LicenceNumber>
    <ProductName>BIOSUIS ParvoEry suspension for injection for pigs</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>03/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine parvovirus inactivated</ActiveSubstance>
      <ActiveSubstance>erysipelothrix rhusiopathiae, inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/001/001</DrugIDPK>
    <LicenceNumber>VPA22028/001/001</LicenceNumber>
    <ProductName>BIOSUIS Salm emulsion for injection for pigs</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>11/10/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB14</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salmonella enterica subsp. enterica sv. Typhimurium (wild type, fagotype: DT104)</ActiveSubstance>
      <ActiveSubstance>Salmonella enterica subsp. enterica sv. Derby (wild type, PFGE type: De1)</ActiveSubstance>
      <ActiveSubstance>Salmonella enterica subsp. enterica sv. Infantis (wild type)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/002/001</DrugIDPK>
    <LicenceNumber>VPA10454/002/001</LicenceNumber>
    <ProductName>Bisolvon 10mg/g Oral Powder</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QR05CB02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bromhexine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/002/001</DrugIDPK>
    <LicenceNumber>VPA10387/002/001</LicenceNumber>
    <ProductName>Blackleg Vaccine</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>25/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB01</ATC>
      <ATC>QI04AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clostridium chauvoei, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10827/002/001</DrugIDPK>
    <LicenceNumber>VPA10827/002/001</LicenceNumber>
    <ProductName>Blockade 2.56 mg/ml teat dip solution</ProductName>
    <PAHolder>DeLaval NV</PAHolder>
    <AuthorisedDate>11/11/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Teat dip solution</DosageForm>
    <ATCs>
      <ATC>QD08AG03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Available iodine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/013/001</DrugIDPK>
    <LicenceNumber>VPA10509/013/001</LicenceNumber>
    <ProductName>Boflox flavour 20 mg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/013/002</DrugIDPK>
    <LicenceNumber>VPA10509/013/002</LicenceNumber>
    <ProductName>Boflox flavour 80 mg tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/003/001</DrugIDPK>
    <LicenceNumber>VPA10509/003/001</LicenceNumber>
    <ProductName>Boflox, 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22837/001/001</DrugIDPK>
    <LicenceNumber>VPA22837/001/001</LicenceNumber>
    <ProductName>BONHAREN IVN 10 mg/ml solution for injection for horses and dogs</ProductName>
    <PAHolder>Contipro a.s.,</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM09AX01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium hyaluronate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/082/001</DrugIDPK>
    <LicenceNumber>VPA10988/082/001</LicenceNumber>
    <ProductName>Borgal 200 mg/ml + 40 mg/ml solution for injection.</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>01/10/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadoxine</ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/005/001</DrugIDPK>
    <LicenceNumber>VPA22664/005/001</LicenceNumber>
    <ProductName>Bovaclox DC Intramammary Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RC</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/038/001</DrugIDPK>
    <LicenceNumber>VPA22664/038/001</LicenceNumber>
    <ProductName>Bovaclox DC Xtra Intramammary Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>11/06/1993</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CR50</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/029/001</DrugIDPK>
    <LicenceNumber>VPA10454/029/001</LicenceNumber>
    <ProductName>BOVALTO Respi 3 suspension for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated bovine respiratory syncytial virus, strain bio-24</ActiveSubstance>
      <ActiveSubstance>Inactivated bovine parainfluenza 3 virus, strain bio-23</ActiveSubstance>
      <ActiveSubstance>Inactivated mannheimia (pasteurella) haemolyica, a1 strain dsm 5283</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/029/002</DrugIDPK>
    <LicenceNumber>VPA10454/029/002</LicenceNumber>
    <ProductName>BOVALTO Respi 4 suspension for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated bovine respiratory syncytial virus, strain bio-24</ActiveSubstance>
      <ActiveSubstance>Inactivated bovine parainfluenza 3 virus, strain bio-23</ActiveSubstance>
      <ActiveSubstance>Inactivated mannheimia haemolytica serotype a1 strain dsm 5283</ActiveSubstance>
      <ActiveSubstance>Inactivated bovine viral diarrhoea virus, strain bio-25</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/029/003</DrugIDPK>
    <LicenceNumber>VPA10454/029/003</LicenceNumber>
    <ProductName>BOVALTO RESPI INTRANASAL, nasal spray, lyophilisate and solvent for suspension</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>13/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Nasal spray, lyophilisate and solvent for suspension</DosageForm>
    <ATCs>
      <ATC>QI02AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine respiratory syncytial virus, live</ActiveSubstance>
      <ActiveSubstance>Bovine parainfluenza virus 3 attenuated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/039/001</DrugIDPK>
    <LicenceNumber>VPA10987/039/001</LicenceNumber>
    <ProductName>Bovex 22.65 mg/ml Oral suspension for Cattle and Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>05/08/1992</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxfendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>HOVR10537/005/001</DrugIDPK>
    <LicenceNumber>HOVR10537/005/001</LicenceNumber>
    <ProductName>Bovi.BLI.Complex</ProductName>
    <PAHolder>Galway Homeopathics (Manufacturing) Limited</PAHolder>
    <AuthorisedDate>08/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Registered homeopathic medicinal products (Article 17 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances xsi:nil="true" />
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Homeopathic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>HOVR10537/004/001</DrugIDPK>
    <LicenceNumber>HOVR10537/004/001</LicenceNumber>
    <ProductName>Bovi.BLS.Complex</ProductName>
    <PAHolder>Galway Homeopathics (Manufacturing) Limited</PAHolder>
    <AuthorisedDate>08/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Registered homeopathic medicinal products (Article 17 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances xsi:nil="true" />
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Homeopathic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10954/011/001</DrugIDPK>
    <LicenceNumber>VPA10954/011/001</LicenceNumber>
    <ProductName>Bovicox 50 mg/ml oral suspension for cattle and sheep</ProductName>
    <PAHolder>J. &amp; M. Veterinary Services Ltd.</PAHolder>
    <AuthorisedDate>20/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10827/003/001</DrugIDPK>
    <LicenceNumber>VPA10827/003/001</LicenceNumber>
    <ProductName>Bovidip 20 mg/ml Concentrate for Teat Dip or Spray Solution</ProductName>
    <PAHolder>DeLaval NV</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Teat dip/spray solution</DosageForm>
    <ATCs>
      <ATC>QG52A</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Available iodine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10794/002/001</DrugIDPK>
    <LicenceNumber>VPA10794/002/001</LicenceNumber>
    <ProductName>Bovifer 200 mg/ml solution for injection, cattle (calves)</ProductName>
    <PAHolder>Pharmacosmos A/ S</PAHolder>
    <AuthorisedDate>25/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Iron dextran</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10806/004/001</DrugIDPK>
    <LicenceNumber>VPA10806/004/001</LicenceNumber>
    <ProductName>BOVIGEN SCOUR  Emulsion for injection for cattle</ProductName>
    <PAHolder>FORTE Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine coronavirus strain c-197 (inactivated)</ActiveSubstance>
      <ActiveSubstance>Bovine rotavirus strain TM-91, serotype G6P1 (inactivated). </ActiveSubstance>
      <ActiveSubstance>Escherichia coli strain EC/17, (inactivated) expressing F5(K99) adhesin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/152/001</DrugIDPK>
    <LicenceNumber>VPA10996/152/001</LicenceNumber>
    <ProductName>Bovilis Bovipast RSP suspension for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>06/06/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated bovine respiratory syncytial virus strain ev908</ActiveSubstance>
      <ActiveSubstance>Inactivated Parainfluenza-3-virus, strain SF-4 Reisinger</ActiveSubstance>
      <ActiveSubstance>Inactivated mannheimia (pasteurella) haemolyticaA1, strain M4/1</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/165/001</DrugIDPK>
    <LicenceNumber>VPA10996/165/001</LicenceNumber>
    <ProductName>Bovilis Bovivac S suspension for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>05/09/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salmonella dublin strain s342/70 formalin inactivated</ActiveSubstance>
      <ActiveSubstance>Salmonella typhimurium strain s341/70 formalin inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/271/001</DrugIDPK>
    <LicenceNumber>VPA10996/271/001</LicenceNumber>
    <ProductName>Bovilis BVD Suspension for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>30/08/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated antigen of cytopathogenic BVDV strain C-86</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/081/001</DrugIDPK>
    <LicenceNumber>VPA10996/081/001</LicenceNumber>
    <ProductName>Bovilis Huskvac oral suspension for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>22/12/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QI02AN01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated cells and equivalent toxoid of irradiated 3rd stage of dictyocaulus vivipatrous</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/200/001</DrugIDPK>
    <LicenceNumber>VPA10996/200/001</LicenceNumber>
    <ProductName>Bovilis IBR Marker inac suspension for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>05/07/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AA03</ATC>
    </ATCs>
    <LegalBasis>Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated antigen of BHV-1 (gE) strain GK/D</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/172/001</DrugIDPK>
    <LicenceNumber>VPA10996/172/001</LicenceNumber>
    <ProductName>Bovilis IBR marker live, lyophilisate and solvent for suspension for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>24/10/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intranasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Glycoprotein E deficient (gE-) Bovine Herpes Virus Type 1 (BHV-1), strain GK/D (gE-)1    </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/276/001</DrugIDPK>
    <LicenceNumber>VPA10996/276/001</LicenceNumber>
    <ProductName>Bovilis INtranasal RSP Live, nasal spray, lyophilisate and solvent for suspension for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>14/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for nasal administration</DosageForm>
    <ATCs>
      <ATC>QI02AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine respiratory syncytial virus (live) strain Jencine-2013</ActiveSubstance>
      <ActiveSubstance>Bovine parainfluenza virus type 3 (live) strain INT2-2013</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/235/001</DrugIDPK>
    <LicenceNumber>VPA10996/235/001</LicenceNumber>
    <ProductName>Bovilis Leptavoid-H Suspension for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>15/01/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Leptospira interrogans serovar hardjo 204 (inactivated)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/216/001</DrugIDPK>
    <LicenceNumber>VPA10996/216/001</LicenceNumber>
    <ProductName>Bovilis Rotavec Corona emulsion for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine rotavirus, strain UK-Compton, serotype G6 P5 (inactivated)</ActiveSubstance>
      <ActiveSubstance>Bovine coronavirus</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, strain O101:K99:F41, fimbrial adhesin F5 and F41, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/003/001</DrugIDPK>
    <LicenceNumber>VPA22033/003/001</LicenceNumber>
    <ProductName>Bovimast DC, 500 mg cloxacillin/syringe, Intramammary suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>08/07/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/162/001</DrugIDPK>
    <LicenceNumber>VPA10987/162/001</LicenceNumber>
    <ProductName>Bovipour 5 mg/ml Pour-on Solution for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/05/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/101/001</DrugIDPK>
    <LicenceNumber>VPA10387/101/001</LicenceNumber>
    <ProductName>Boviseal Dry cow intramammary suspension</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>20/11/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10793/003/001</DrugIDPK>
    <LicenceNumber>VPA10793/003/001</LicenceNumber>
    <ProductName>Bovitec Plus Oral Suspension</ProductName>
    <PAHolder>Acravet Limited</PAHolder>
    <AuthorisedDate>28/11/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10420/002/001</DrugIDPK>
    <LicenceNumber>VPA10420/002/001</LicenceNumber>
    <ProductName>Bromhex-Air forte 25 mg/g oral powder for cattle, pigs, chickens, turkeys and ducks</ProductName>
    <PAHolder>Pharmanovo Veterinärarzneimittel GmbH</PAHolder>
    <AuthorisedDate>03/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QR05CB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
      <RoutesOfAdministration>In-feed use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bromhexine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/083/001</DrugIDPK>
    <LicenceNumber>VPA10454/083/001</LicenceNumber>
    <ProductName>BULTAVO 3 suspension for injection for sheep and cattle</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>17/04/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI04AA02</ATC>
    </ATCs>
    <LegalBasis>Applications in exceptional circumstances (Article 25 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bluetongue virus, serotype 3, strain Bio-93:BTV3, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/003/001</DrugIDPK>
    <LicenceNumber>VPA23462/003/001</LicenceNumber>
    <ProductName>Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/004/001</DrugIDPK>
    <LicenceNumber>VPA10491/004/001</LicenceNumber>
    <ProductName>Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/004/002</DrugIDPK>
    <LicenceNumber>VPA10491/004/002</LicenceNumber>
    <ProductName>Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>16/12/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/009/001</DrugIDPK>
    <LicenceNumber>VPA10402/009/001</LicenceNumber>
    <ProductName>Buprecord 0.3 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>13/12/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/021/001</DrugIDPK>
    <LicenceNumber>VPA10475/021/001</LicenceNumber>
    <ProductName>Buprefelican Multidose 0.3 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>27/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/049/001</DrugIDPK>
    <LicenceNumber>VPA10980/049/001</LicenceNumber>
    <ProductName>Buproxan Multidose 0.3 mg/ml solution for injection for dogs, cats and horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>17/04/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/004/001</DrugIDPK>
    <LicenceNumber>VPA10454/004/001</LicenceNumber>
    <ProductName>Buscopan Compositum Solution for Injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03DB04</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Hyoscine butylbromide</ActiveSubstance>
      <ActiveSubstance>Metamizole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Spasmolytic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/027/001</DrugIDPK>
    <LicenceNumber>VPA10826/027/001</LicenceNumber>
    <ProductName>Busol 0.004 mg/ml solution for injection for cattle, horses, rabbits</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>05/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA90</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buserelin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/002/001</DrugIDPK>
    <LicenceNumber>VPA23462/002/001</LicenceNumber>
    <ProductName>Butador 10 mg/ml solution for injection for horses, dogs and cats</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>27/05/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22812/003/001</DrugIDPK>
    <LicenceNumber>VPA22812/003/001</LicenceNumber>
    <ProductName>Butasal 100 mg/ml + 0.05 mg/ml solution for injection for horses, cattle and dogs</ProductName>
    <PAHolder>Interchemie Werken De Adelaar Eesti AS.</PAHolder>
    <AuthorisedDate>23/07/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX99</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
      <ActiveSubstance>Butaphosphan (Butafosfan)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/178/001</DrugIDPK>
    <LicenceNumber>VPA10987/178/001</LicenceNumber>
    <ProductName>ButorVet 10 mg/ml solution for injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/103/001</DrugIDPK>
    <LicenceNumber>VPA10996/103/001</LicenceNumber>
    <ProductName>Butox 7.5 mg/ml Pour On Suspension</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on suspension</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/049/001</DrugIDPK>
    <LicenceNumber>VPA22020/049/001</LicenceNumber>
    <ProductName>ByeMite 500 mg/ml concentrate for spraying emulsion for laying hens</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for cutaneous spray, emulsion</DosageForm>
    <ATCs>
      <ATC>QP53AF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Coarse spray</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phoxim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/011/001</DrugIDPK>
    <LicenceNumber>VPA10509/011/001</LicenceNumber>
    <ProductName>Cadorex 300 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/003/001</DrugIDPK>
    <LicenceNumber>VPA10445/003/001</LicenceNumber>
    <ProductName>Calcibel 240/60/60 mg/ml solution for infusion for horses, cattle, sheep, goats and pigs</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QA12AX</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/007/001</DrugIDPK>
    <LicenceNumber>VPA10445/007/001</LicenceNumber>
    <ProductName>Calcibel Forte, 380/60/50 mg/ml solution for infusion for horses, cattle, sheep, goats and pigs</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>12/11/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QA12AX</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate for injection</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/032/001</DrugIDPK>
    <LicenceNumber>VPA22664/032/001</LicenceNumber>
    <ProductName>Calciject 40 + 3 Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate</ActiveSubstance>
      <ActiveSubstance>Magnesium hypophosphite hexahydrate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/031/001</DrugIDPK>
    <LicenceNumber>VPA22664/031/001</LicenceNumber>
    <ProductName>Calciject 40 Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12A</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium borogluconate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/015/001</DrugIDPK>
    <LicenceNumber>VPA10823/015/001</LicenceNumber>
    <ProductName>Calcipharm 40 Solution for Injection</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12AA</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium borogluconate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/001/001</DrugIDPK>
    <LicenceNumber>VPA10826/001/001</LicenceNumber>
    <ProductName>Calcitat 25, solution for infusion and injection in cattle</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ATCs>
      <ATC>QA12AA</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate monohydrate</ActiveSubstance>
      <ActiveSubstance>Calcium borogluconate</ActiveSubstance>
      <ActiveSubstance>Calcium hydroxide</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/001/002</DrugIDPK>
    <LicenceNumber>VPA10826/001/002</LicenceNumber>
    <ProductName>Calcitat 50, solution for infusion and injection in cattle</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ATCs>
      <ATC>QA12AA</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate monohydrate</ActiveSubstance>
      <ActiveSubstance>Calcium borogluconate</ActiveSubstance>
      <ActiveSubstance>Calcium hydroxide</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/054/001</DrugIDPK>
    <LicenceNumber>VPA22664/054/001</LicenceNumber>
    <ProductName>Calcivet Solution for Injection for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12A</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
      <ActiveSubstance>Magnesium hypophosphite hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22812/001/001</DrugIDPK>
    <LicenceNumber>VPA22812/001/001</LicenceNumber>
    <ProductName>Calmafusion, 380mg/60mg/50mg, solution for infusion for cattle, sheep and pigs</ProductName>
    <PAHolder>Interchemie Werken De Adelaar Eesti AS.</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QA12AX</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate for injection</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Boric acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10803/003/001</DrugIDPK>
    <LicenceNumber>VPA10803/003/001</LicenceNumber>
    <ProductName>Canaural ear drops, suspension for dogs and cats</ProductName>
    <PAHolder>Dechra Veterinary Products A/S</PAHolder>
    <AuthorisedDate>01/10/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diethanolamine Fusidate </ActiveSubstance>
      <ActiveSubstance>Framycetin sulphate </ActiveSubstance>
      <ActiveSubstance>Nystatin</ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/016/001</DrugIDPK>
    <LicenceNumber>VPA10475/016/001</LicenceNumber>
    <ProductName>Canergy 100 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propentofylline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/064/003</DrugIDPK>
    <LicenceNumber>VPA10987/064/003</LicenceNumber>
    <ProductName>Canidryl 100 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/064/001</DrugIDPK>
    <LicenceNumber>VPA10987/064/001</LicenceNumber>
    <ProductName>Canidryl 20 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/064/002</DrugIDPK>
    <LicenceNumber>VPA10987/064/002</LicenceNumber>
    <ProductName>Canidryl 50 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/048/001</DrugIDPK>
    <LicenceNumber>VPA10996/048/001</LicenceNumber>
    <ProductName>Caninsulin 40 IU/ml Suspension for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>10/01/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QA10AC03</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Insulin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10455/003/002</DrugIDPK>
    <LicenceNumber>VPA10455/003/002</LicenceNumber>
    <ProductName>Canishield 0.77 g medicated collar for small and medium sized dogs</ProductName>
    <PAHolder>Beaphar B.V.</PAHolder>
    <AuthorisedDate>22/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Medicated collar</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10455/003/001</DrugIDPK>
    <LicenceNumber>VPA10455/003/001</LicenceNumber>
    <ProductName>Canishield 1.04 g medicated collar for large sized dogs</ProductName>
    <PAHolder>Beaphar B.V.</PAHolder>
    <AuthorisedDate>21/09/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Medicated collar</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/101/002</DrugIDPK>
    <LicenceNumber>VPA10988/101/002</LicenceNumber>
    <ProductName>CANIXIN DHPPi/L lyophilisate suspension for injection for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>11/12/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and suspension for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AI02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine distemper virus </ActiveSubstance>
      <ActiveSubstance>Canine adenovirus type 2 </ActiveSubstance>
      <ActiveSubstance>Canine parvovirus</ActiveSubstance>
      <ActiveSubstance>Canine parainfluenza</ActiveSubstance>
      <ActiveSubstance>L.canicola</ActiveSubstance>
      <ActiveSubstance>L. icterohaemorrhagiae</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/101/001</DrugIDPK>
    <LicenceNumber>VPA10988/101/001</LicenceNumber>
    <ProductName>CANIXIN DHPPi lyophilisate and solvent for suspension for injection for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine distemper virus (lederle strain)</ActiveSubstance>
      <ActiveSubstance>Canine parvovirus (cpv 780916 strain)</ActiveSubstance>
      <ActiveSubstance>Canine adenovirus type 2 (manhattan strain)</ActiveSubstance>
      <ActiveSubstance>Canine parainfluenza (manhattan strain)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/102/001</DrugIDPK>
    <LicenceNumber>VPA10988/102/001</LicenceNumber>
    <ProductName>Canixin L suspension for injection for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>24/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Leptospira interrogans serogroup icterohaemorragiae, inactivated</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans serogroup canicola, inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/103/001</DrugIDPK>
    <LicenceNumber>VPA10988/103/001</LicenceNumber>
    <ProductName>CANIXIN Pi/L lyophilisate and suspension for suspension for injection for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and suspension for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AI08</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine Parainfluenza, live</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans serogroup canicola, inactivated</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans serogroup icterohaemorragiae, inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/024/001</DrugIDPK>
    <LicenceNumber>VPA10980/024/001</LicenceNumber>
    <ProductName>Cardisan 1.25 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/024/004</DrugIDPK>
    <LicenceNumber>VPA10980/024/004</LicenceNumber>
    <ProductName>Cardisan 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/024/005</DrugIDPK>
    <LicenceNumber>VPA10980/024/005</LicenceNumber>
    <ProductName>Cardisan 15 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/024/002</DrugIDPK>
    <LicenceNumber>VPA10980/024/002</LicenceNumber>
    <ProductName>Cardisan 2.5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/024/003</DrugIDPK>
    <LicenceNumber>VPA10980/024/003</LicenceNumber>
    <ProductName>Cardisan 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/059/003</DrugIDPK>
    <LicenceNumber>VPA10989/059/003</LicenceNumber>
    <ProductName>Cardisure  flavoured 5 mg Tablets For dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/026/001</DrugIDPK>
    <LicenceNumber>VPA22622/026/001</LicenceNumber>
    <ProductName>Cardisure 3.5 mg/ml Oral Solution for Dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>13/09/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/059/001</DrugIDPK>
    <LicenceNumber>VPA10989/059/001</LicenceNumber>
    <ProductName>Cardisure flavoured 1.25 mg Tablets For dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/059/004</DrugIDPK>
    <LicenceNumber>VPA10989/059/004</LicenceNumber>
    <ProductName>Cardisure flavoured 10 mg Tablets For dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/059/002</DrugIDPK>
    <LicenceNumber>VPA10989/059/002</LicenceNumber>
    <ProductName>Cardisure flavoured 2.5 mg Tablets For dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA16142/004/001</DrugIDPK>
    <LicenceNumber>VPA16142/004/001</LicenceNumber>
    <ProductName>Carofertin 10 mg/ml Emulsion for injection for cattle and pigs</ProductName>
    <PAHolder>V.M.D. n.v.,</PAHolder>
    <AuthorisedDate>12/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QA11CA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Betacarotene </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/047/002</DrugIDPK>
    <LicenceNumber>VPA10980/047/002</LicenceNumber>
    <ProductName>Carpcoat 20 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/047/003</DrugIDPK>
    <LicenceNumber>VPA10980/047/003</LicenceNumber>
    <ProductName>Carpcoat 40 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/047/001</DrugIDPK>
    <LicenceNumber>VPA10980/047/001</LicenceNumber>
    <ProductName>Carpcoat 8 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/047/004</DrugIDPK>
    <LicenceNumber>VPA10980/047/004</LicenceNumber>
    <ProductName>Carpcoat 80 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/019/002</DrugIDPK>
    <LicenceNumber>VPA10475/019/002</LicenceNumber>
    <ProductName>Carporal 160 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/019/001</DrugIDPK>
    <LicenceNumber>VPA10475/019/001</LicenceNumber>
    <ProductName>Carporal 40 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/071/003</DrugIDPK>
    <LicenceNumber>VPA22664/071/003</LicenceNumber>
    <ProductName>Carprieve 100 mg tablets for Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/071/001</DrugIDPK>
    <LicenceNumber>VPA22664/071/001</LicenceNumber>
    <ProductName>Carprieve 20 mg Tablets for Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/07/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/080/001</DrugIDPK>
    <LicenceNumber>VPA22664/080/001</LicenceNumber>
    <ProductName>Carprieve 50 mg/ml Solution for Injection for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>04/05/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/071/002</DrugIDPK>
    <LicenceNumber>VPA22664/071/002</LicenceNumber>
    <ProductName>Carprieve 50 mg Tablets for Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/07/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/065/003</DrugIDPK>
    <LicenceNumber>VPA10987/065/003</LicenceNumber>
    <ProductName>Carprochem 100 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/003/001</DrugIDPK>
    <LicenceNumber>VPA10475/003/001</LicenceNumber>
    <ProductName>Carprodolor 50 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>12/04/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/045/002</DrugIDPK>
    <LicenceNumber>VPA10815/045/002</LicenceNumber>
    <ProductName>Carprodyl Quadri 120 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>24/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/045/001</DrugIDPK>
    <LicenceNumber>VPA10815/045/001</LicenceNumber>
    <ProductName>Carprodyl Quadri 50 mg tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>24/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/007/001</DrugIDPK>
    <LicenceNumber>VPA10475/007/001</LicenceNumber>
    <ProductName>Carprofelican 50 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>09/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/019/001</DrugIDPK>
    <LicenceNumber>VPA10774/019/001</LicenceNumber>
    <ProductName>Carprofen KRKA 50 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/152/001</DrugIDPK>
    <LicenceNumber>VPA22664/152/001</LicenceNumber>
    <ProductName>Carprofen Norbrook 50 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>23/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/079/001</DrugIDPK>
    <LicenceNumber>VPA22664/079/001</LicenceNumber>
    <ProductName>Carprogesic 20 mg Tablets for dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/12/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/079/002</DrugIDPK>
    <LicenceNumber>VPA22664/079/002</LicenceNumber>
    <ProductName>Carprogesic 50 mg Tablets for dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/12/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/046/003</DrugIDPK>
    <LicenceNumber>VPA10980/046/003</LicenceNumber>
    <ProductName>Cartaxx 100 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/046/001</DrugIDPK>
    <LicenceNumber>VPA10980/046/001</LicenceNumber>
    <ProductName>Cartaxx 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/040/001</DrugIDPK>
    <LicenceNumber>VPA10980/040/001</LicenceNumber>
    <ProductName>Cartaxx 50 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/046/002</DrugIDPK>
    <LicenceNumber>VPA10980/046/002</LicenceNumber>
    <ProductName>Cartaxx 50 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22748/001/001</DrugIDPK>
    <LicenceNumber>VPA22748/001/001</LicenceNumber>
    <ProductName>Cartrophen Vet 100 mg/ml Solution for Injection.</ProductName>
    <PAHolder>Maperath Herbal Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AX90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentosan Polysulfate Sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/052/001</DrugIDPK>
    <LicenceNumber>VPA10774/052/001</LicenceNumber>
    <ProductName>Catobevit 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses, dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>07/01/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX99</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butaphosphan (Butafosfan)</ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/022/001</DrugIDPK>
    <LicenceNumber>VPA10810/022/001</LicenceNumber>
    <ProductName>Catophos 100 mg/ml + 0.05 mg/ml solution for injection for horses, cattle and dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>01/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX99</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butaphosphan (Butafosfan)</ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/102/001</DrugIDPK>
    <LicenceNumber>VPA10987/102/001</LicenceNumber>
    <ProductName>Cazitel 230/20 mg Flavoured Film-Coated Tablets for Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/077/001</DrugIDPK>
    <LicenceNumber>VPA10987/077/001</LicenceNumber>
    <ProductName>Cazitel Plus Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 10(3) of Directive No 2001/83/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/077/002</DrugIDPK>
    <LicenceNumber>VPA10987/077/002</LicenceNumber>
    <ProductName>Cazitel Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/024/004</DrugIDPK>
    <LicenceNumber>VPA10475/024/004</LicenceNumber>
    <ProductName>Cefabactin 1000 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>30/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/024/002</DrugIDPK>
    <LicenceNumber>VPA10475/024/002</LicenceNumber>
    <ProductName>Cefabactin 250 mg tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>30/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/024/001</DrugIDPK>
    <LicenceNumber>VPA10475/024/001</LicenceNumber>
    <ProductName>Cefabactin 50 mg tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>30/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/024/003</DrugIDPK>
    <LicenceNumber>VPA10475/024/003</LicenceNumber>
    <ProductName>Cefabactin 500 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>30/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/044/002</DrugIDPK>
    <LicenceNumber>VPA10983/044/002</LicenceNumber>
    <ProductName>Cefaseptin 300 mg tablets for dogs</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>15/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/044/001</DrugIDPK>
    <LicenceNumber>VPA10983/044/001</LicenceNumber>
    <ProductName>Cefaseptin 75 mg tablets for dogs and cats</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>15/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/044/003</DrugIDPK>
    <LicenceNumber>VPA10983/044/003</LicenceNumber>
    <ProductName>Cefaseptin 750 mg tablets for dogs</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>15/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/005/001</DrugIDPK>
    <LicenceNumber>VPA10790/005/001</LicenceNumber>
    <ProductName>Cefavex 50 mg/ml, suspension for injection for pigs and cattle</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>10/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/003/001</DrugIDPK>
    <LicenceNumber>VPA10534/003/001</LicenceNumber>
    <ProductName>Ceffect 25 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>07/12/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/005/001</DrugIDPK>
    <LicenceNumber>VPA10534/005/001</LicenceNumber>
    <ProductName>Ceffect LC, 75 mg, intramammary ointment for lactating cows</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>09/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary ointment</DosageForm>
    <ATCs>
      <ATC>QJ51DE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/015/001</DrugIDPK>
    <LicenceNumber>VPA10981/015/001</LicenceNumber>
    <ProductName>CEFOKEL 50 mg/ml, suspension for injection for pigs and cattle</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>14/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10436/001/001</DrugIDPK>
    <LicenceNumber>VPA10436/001/001</LicenceNumber>
    <ProductName>Cemay 50 mg/ml suspension for injection for pigs and cattle</ProductName>
    <PAHolder>Laboratorios Maymo S.A.U.</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23448/001/001</DrugIDPK>
    <LicenceNumber>VPA23448/001/001</LicenceNumber>
    <ProductName>Censulfatrim 200 mg/ml + 40 mg/ml solution for injection</ProductName>
    <PAHolder>Cenavisa S.L</PAHolder>
    <AuthorisedDate>07/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/035/001</DrugIDPK>
    <LicenceNumber>VPA10810/035/001</LicenceNumber>
    <ProductName>Cepfenicol 5 mg/ml eye drops, solution for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>02/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ATCs>
      <ATC>QS01AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chloramphenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/036/001</DrugIDPK>
    <LicenceNumber>VPA10810/036/001</LicenceNumber>
    <ProductName>Cepfenidex 2 mg/ml + 1 mg/ml eye drops, solution for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>30/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye drops, emulsion</DosageForm>
    <ATCs>
      <ATC>QS01CA01</ATC>
    </ATCs>
    <LegalBasis>Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chloramphenicol</ActiveSubstance>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/005/004</DrugIDPK>
    <LicenceNumber>VPA10491/005/004</LicenceNumber>
    <ProductName>Cephacare Flavour 1000 mg Tablets for Dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/005/002</DrugIDPK>
    <LicenceNumber>VPA10491/005/002</LicenceNumber>
    <ProductName>Cephacare flavour 250 mg tablets for dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>19/12/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/005/001</DrugIDPK>
    <LicenceNumber>VPA10491/005/001</LicenceNumber>
    <ProductName>Cephacare flavour 50 mg tablets for cats and dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>19/12/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/005/003</DrugIDPK>
    <LicenceNumber>VPA10491/005/003</LicenceNumber>
    <ProductName>Cephacare flavour 500 mg tablets for dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>19/12/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/083/001</DrugIDPK>
    <LicenceNumber>VPA10988/083/001</LicenceNumber>
    <ProductName>Cephaguard DC 150 mg intramammary ointment</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary ointment</DosageForm>
    <ATCs>
      <ATC>QJ51DA92</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/223/001</DrugIDPK>
    <LicenceNumber>VPA10996/223/001</LicenceNumber>
    <ProductName>Ceporex 180 mg/ml Suspension for Injection for cattle. cats, and dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin Sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/287/001</DrugIDPK>
    <LicenceNumber>VPA10996/287/001</LicenceNumber>
    <ProductName>Cepralock 2.6 g intramammary suspension for Dry Cows</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>22/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/282/001</DrugIDPK>
    <LicenceNumber>VPA10996/282/001</LicenceNumber>
    <ProductName>CepraShort 300 mg Intramammary Suspension for dairy cows at drying-off</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>11/02/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DB08</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefapirin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/224/001</DrugIDPK>
    <LicenceNumber>VPA10996/224/001</LicenceNumber>
    <ProductName>Cepravin Dry Cow 250 mg intramammary suspension for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalonium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/142/001</DrugIDPK>
    <LicenceNumber>VPA22664/142/001</LicenceNumber>
    <ProductName>Cepritect 250 mg Intramammary Suspension for Dry Cows</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/12/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DB90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalonium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/013/001</DrugIDPK>
    <LicenceNumber>VPA10836/013/001</LicenceNumber>
    <ProductName>Cetrimilk 250 mg intramammary suspension for cattle</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>31/07/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DB10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application - other (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefacetrile sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/020/001</DrugIDPK>
    <LicenceNumber>VPA10815/020/001</LicenceNumber>
    <ProductName>Cevac IBD 2512 L lyophilisate for oral suspension for chickens</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>14/12/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Similar biological application (Article 13(4) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live infectious bursal disease (ibd) virus strain, winterfield 2512, g-61</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/022/001</DrugIDPK>
    <LicenceNumber>VPA10815/022/001</LicenceNumber>
    <ProductName>CEVAC IBird lyophilisate for suspension for chickens</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>23/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Coarse spray</RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated infectious bronchitis (ib) virus, strain 1/96, variant subtype</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10463/004/001</DrugIDPK>
    <LicenceNumber>VPA10463/004/001</LicenceNumber>
    <ProductName>CEVAC MASS L lyophilisate for oculonasal suspension</ProductName>
    <PAHolder>CEVA-Phylaxia Veterinary Biologicals Co. Ltd</PAHolder>
    <AuthorisedDate>20/05/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nebulisation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated infectious bronchitis disease virus, Massachusetts type, strain B48</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10463/005/001</DrugIDPK>
    <LicenceNumber>VPA10463/005/001</LicenceNumber>
    <ProductName>Cevac MD HVT suspension and solvent for suspension for injection for chickens</ProductName>
    <PAHolder>CEVA-Phylaxia Veterinary Biologicals Co. Ltd</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In ovo</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Turkey herpesirus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10463/007/001</DrugIDPK>
    <LicenceNumber>VPA10463/007/001</LicenceNumber>
    <ProductName>Cevac MD Rispens concentrate and solvent for suspension for injection for chickens</ProductName>
    <PAHolder>CEVA-Phylaxia Veterinary Biologicals Co. Ltd</PAHolder>
    <AuthorisedDate>25/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marek's disease virus strain cvi 988 live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10463/003/001</DrugIDPK>
    <LicenceNumber>VPA10463/003/001</LicenceNumber>
    <ProductName>Cevac Meta L lyophilisate for oculonasal suspension for chickens</ProductName>
    <PAHolder>CEVA-Phylaxia Veterinary Biologicals Co. Ltd</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian metapneumovirus, subtype B, CRR126 strain</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/063/001</DrugIDPK>
    <LicenceNumber>VPA10815/063/001</LicenceNumber>
    <ProductName>Cevac Salmovac Lyophilisate for use in drinking water for chickens</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>05/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ATCs>
      <ATC>QI01AE01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salmonella enteritidis, strain no. 441/014</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/005/001</DrugIDPK>
    <LicenceNumber>VPA10815/005/001</LicenceNumber>
    <ProductName>CEVAC TRANSMUNE lyophilisate and solvent for suspension for injection</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>26/11/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In ovo</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live, attenuated infectious bursal disease (IBD) virus, strain winterfield 2512, G-61</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/016/001</DrugIDPK>
    <LicenceNumber>VPA10815/016/001</LicenceNumber>
    <ProductName>Cevaxel-RTU 50 mg/ml, suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/007/001</DrugIDPK>
    <LicenceNumber>VPA10815/007/001</LicenceNumber>
    <ProductName>Cevazuril 50 mg/ml, oral suspension for piglets and calves</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/054/001</DrugIDPK>
    <LicenceNumber>VPA10987/054/001</LicenceNumber>
    <ProductName>Chan Pen Strep Suspension for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulphate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/033/001</DrugIDPK>
    <LicenceNumber>VPA10987/033/001</LicenceNumber>
    <ProductName>Chanatol Oral Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QA16QA</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cobalt sulphate heptahydrate</ActiveSubstance>
      <ActiveSubstance>Propylene glycol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/008/001</DrugIDPK>
    <LicenceNumber>VPA10987/008/001</LicenceNumber>
    <ProductName>Chanaverm Plus Oral Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP52AE51</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/031/001</DrugIDPK>
    <LicenceNumber>VPA10987/031/001</LicenceNumber>
    <ProductName>Chanazine 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/030/001</DrugIDPK>
    <LicenceNumber>VPA10987/030/001</LicenceNumber>
    <ProductName>Chanazine 20 mg/ml Solution for Injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/169/001</DrugIDPK>
    <LicenceNumber>VPA10987/169/001</LicenceNumber>
    <ProductName>Chanear</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>23/02/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
      <ActiveSubstance>Polymyxin b sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/154/001</DrugIDPK>
    <LicenceNumber>VPA10987/154/001</LicenceNumber>
    <ProductName>Chanectin 0.5% w/v Pour-on Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/12/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/149/001</DrugIDPK>
    <LicenceNumber>VPA10987/149/001</LicenceNumber>
    <ProductName>Chanectin 1 % Solution for Injection for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/06/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/114/001</DrugIDPK>
    <LicenceNumber>VPA10987/114/001</LicenceNumber>
    <ProductName>Chanil 34 mg/ml oral suspension for cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>19/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxyclozanide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/155/001</DrugIDPK>
    <LicenceNumber>VPA10987/155/001</LicenceNumber>
    <ProductName>Chanimec 0.5% w/v Pour-on Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/12/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/081/001</DrugIDPK>
    <LicenceNumber>VPA10987/081/001</LicenceNumber>
    <ProductName>CHANIMEC 0.8 mg/ml Oral Solution for Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/145/001</DrugIDPK>
    <LicenceNumber>VPA10987/145/001</LicenceNumber>
    <ProductName>Chanimec 10 mg/ml solution for injection for Cattle, Pigs and Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/04/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/128/002</DrugIDPK>
    <LicenceNumber>VPA10987/128/002</LicenceNumber>
    <ProductName>Chanonil Combo 134 mg/120.6 mg Spot-on Solution for Medium Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/128/003</DrugIDPK>
    <LicenceNumber>VPA10987/128/003</LicenceNumber>
    <ProductName>Chanonil Combo 268 mg/241.2 mg Spot-on Solution for Large Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/128/004</DrugIDPK>
    <LicenceNumber>VPA10987/128/004</LicenceNumber>
    <ProductName>Chanonil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/127/001</DrugIDPK>
    <LicenceNumber>VPA10987/127/001</LicenceNumber>
    <ProductName>Chanonil Combo 50 mg/60 mg Spot-on Solution for Cats and Ferrets</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/128/001</DrugIDPK>
    <LicenceNumber>VPA10987/128/001</LicenceNumber>
    <ProductName>Chanonil Combo 67 mg/60.3 mg Spot-on Solution for Small Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/132/001</DrugIDPK>
    <LicenceNumber>VPA10987/132/001</LicenceNumber>
    <ProductName>Chanox Multi 50 mg/ml oral suspension for Piglets, Calves and Lambs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/041/001</DrugIDPK>
    <LicenceNumber>VPA10990/041/001</LicenceNumber>
    <ProductName>Chloromed 150 mg/g Oral Powder for Calves</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>11/12/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/042/001</DrugIDPK>
    <LicenceNumber>VPA10990/042/001</LicenceNumber>
    <ProductName>Chloromed 150 mg/g oral powder for pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/040/001</DrugIDPK>
    <LicenceNumber>VPA10990/040/001</LicenceNumber>
    <ProductName>Chloromed 150 mg/g premix for medicated feeding stuff for calves</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>11/12/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/043/001</DrugIDPK>
    <LicenceNumber>VPA10990/043/001</LicenceNumber>
    <ProductName>Chloromed 150 mg/g premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/053/001</DrugIDPK>
    <LicenceNumber>VPA10990/053/001</LicenceNumber>
    <ProductName>Chloromed 500 mg/g powder for oral solution for chickens and pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>22/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/021/001</DrugIDPK>
    <LicenceNumber>VPA10996/021/001</LicenceNumber>
    <ProductName>Chorulon 1500 IU lyophilisate and solvent for solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chorionic gonadotrophin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/011/001</DrugIDPK>
    <LicenceNumber>VPA10996/011/001</LicenceNumber>
    <ProductName>Chronogest CR 20 mg controlled release vaginal sponge for sheep</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Medicated sponge</DosageForm>
    <ATCs>
      <ATC>QG03D</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Vaginal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flugestone acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/006/001</DrugIDPK>
    <LicenceNumber>VPA10387/006/001</LicenceNumber>
    <ProductName>CIDR 1.38 g Vaginal Delivery System for Cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Vaginal delivery system</DosageForm>
    <ATCs>
      <ATC>QG03DA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Vaginal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/005/002</DrugIDPK>
    <LicenceNumber>VPA10786/005/002</LicenceNumber>
    <ProductName>Citramox 1000 mg/g powder for use in drinking water for chickens, ducks, turkeys and pigs</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>15/07/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/005/001</DrugIDPK>
    <LicenceNumber>VPA10786/005/001</LicenceNumber>
    <ProductName>Citramox 500 mg/g powder for use in drinking water for chickens, turkeys, ducks and pigs</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>29/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/006/001</DrugIDPK>
    <LicenceNumber>VPA10786/006/001</LicenceNumber>
    <ProductName>CITRAMOX L.A. 150 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>09/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/071/002</DrugIDPK>
    <LicenceNumber>VPA10774/071/002</LicenceNumber>
    <ProductName>Clamaden 200 mg/50 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/071/001</DrugIDPK>
    <LicenceNumber>VPA10774/071/001</LicenceNumber>
    <ProductName>Clamaden 40 mg/10 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/071/003</DrugIDPK>
    <LicenceNumber>VPA10774/071/003</LicenceNumber>
    <ProductName>Clamaden 400 mg/100 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/029/002</DrugIDPK>
    <LicenceNumber>VPA10521/029/002</LicenceNumber>
    <ProductName>Clavaseptin 250 mg palatable tablets for dogs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/029/001</DrugIDPK>
    <LicenceNumber>VPA10521/029/001</LicenceNumber>
    <ProductName>Clavaseptin 50 mg palatable tablets for dogs and cats</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/029/003</DrugIDPK>
    <LicenceNumber>VPA10521/029/003</LicenceNumber>
    <ProductName>Clavaseptin 500 mg palatable tablets for dogs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/029/004</DrugIDPK>
    <LicenceNumber>VPA10521/029/004</LicenceNumber>
    <ProductName>Clavaseptin 62.5 mg Palatable tablets for dogs and cats</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>26/04/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/029/005</DrugIDPK>
    <LicenceNumber>VPA10521/029/005</LicenceNumber>
    <ProductName>Clavaseptin 750 mg palatable tablets for dogs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>08/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10817/002/002</DrugIDPK>
    <LicenceNumber>VPA10817/002/002</LicenceNumber>
    <ProductName>Clavucill 200mg/50mg, tablets for dogs</ProductName>
    <PAHolder>V.M.D.</PAHolder>
    <AuthorisedDate>22/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10817/002/001</DrugIDPK>
    <LicenceNumber>VPA10817/002/001</LicenceNumber>
    <ProductName>Clavucill 40mg/10mg, tablets for dogs and cats</ProductName>
    <PAHolder>V.M.D.</PAHolder>
    <AuthorisedDate>22/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/005/002</DrugIDPK>
    <LicenceNumber>VPA22622/005/002</LicenceNumber>
    <ProductName>Clavudale 200 mg/50 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>15/04/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/005/001</DrugIDPK>
    <LicenceNumber>VPA22622/005/001</LicenceNumber>
    <ProductName>Clavudale 40 mg/10 mg tablets for cats and dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/005/003</DrugIDPK>
    <LicenceNumber>VPA22622/005/003</LicenceNumber>
    <ProductName>Clavudale 400 mg/100 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>15/04/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/026/002</DrugIDPK>
    <LicenceNumber>VPA10980/026/002</LicenceNumber>
    <ProductName>Clavusan 250 mg + 62.5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/026/001</DrugIDPK>
    <LicenceNumber>VPA10980/026/001</LicenceNumber>
    <ProductName>Clavusan 50 mg + 12.5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/026/003</DrugIDPK>
    <LicenceNumber>VPA10980/026/003</LicenceNumber>
    <ProductName>Clavusan 500 mg + 125 mg tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>14/04/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/021/001</DrugIDPK>
    <LicenceNumber>VPA22020/021/001</LicenceNumber>
    <ProductName>CLIK 50 mg/ml Pour-on Suspension for Sheep</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on suspension</DosageForm>
    <ATCs>
      <ATC>QP53AX24</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dicyclanil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/022/001</DrugIDPK>
    <LicenceNumber>VPA22020/022/001</LicenceNumber>
    <ProductName>CLiK Extra 65 mg/ml Pour-On Suspension for Sheep</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on suspension</DosageForm>
    <ATCs>
      <ATC>QP53AX24</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dicyclanil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/023/001</DrugIDPK>
    <LicenceNumber>VPA22020/023/001</LicenceNumber>
    <ProductName>CLiKZiN 12.5 mg/ml Pour-On Suspension for Sheep</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on suspension</DosageForm>
    <ATCs>
      <ATC>QP53AX24</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dicyclanil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/144/003</DrugIDPK>
    <LicenceNumber>VPA10987/144/003</LicenceNumber>
    <ProductName>Clinacin 150 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/144/002</DrugIDPK>
    <LicenceNumber>VPA10987/144/002</LicenceNumber>
    <ProductName>Clinacin 25 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/144/005</DrugIDPK>
    <LicenceNumber>VPA10987/144/005</LicenceNumber>
    <ProductName>Clinacin 300 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/144/001</DrugIDPK>
    <LicenceNumber>VPA10987/144/001</LicenceNumber>
    <ProductName>Clinacin 75 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/01/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/028/001</DrugIDPK>
    <LicenceNumber>VPA22622/028/001</LicenceNumber>
    <ProductName>Clindabactin 220 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>18/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/028/002</DrugIDPK>
    <LicenceNumber>VPA22622/028/002</LicenceNumber>
    <ProductName>Clindabactin 440 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>18/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/027/001</DrugIDPK>
    <LicenceNumber>VPA22622/027/001</LicenceNumber>
    <ProductName>Clindabactin 55 mg chewable tablets for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>18/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/031/001</DrugIDPK>
    <LicenceNumber>VPA22622/031/001</LicenceNumber>
    <ProductName>Clindacutin 10 mg/g ointment for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>16/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ATCs>
      <ATC>QD06AX</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/049/003</DrugIDPK>
    <LicenceNumber>VPA10983/049/003</LicenceNumber>
    <ProductName>Clindacyl 150 mg Tablets for Dogs</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>01/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/049/001</DrugIDPK>
    <LicenceNumber>VPA10983/049/001</LicenceNumber>
    <ProductName>Clindacyl 25 mg Tablets for dogs and cats</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>01/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/161/001</DrugIDPK>
    <LicenceNumber>VPA10987/161/001</LicenceNumber>
    <ProductName>Clindacyl 300 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>30/07/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin (as clindamycin hydrochloride)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/049/002</DrugIDPK>
    <LicenceNumber>VPA10983/049/002</LicenceNumber>
    <ProductName>Clindacyl 75 mg Tablets for dogs</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>01/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/163/003</DrugIDPK>
    <LicenceNumber>VPA10987/163/003</LicenceNumber>
    <ProductName>Clindaseptin 150 mg capsules for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/097/001</DrugIDPK>
    <LicenceNumber>VPA10987/097/001</LicenceNumber>
    <ProductName>Clindaseptin 25 mg/ml oral solution for cats and dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/163/001</DrugIDPK>
    <LicenceNumber>VPA10987/163/001</LicenceNumber>
    <ProductName>Clindaseptin 25 mg capsules for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>18/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/163/004</DrugIDPK>
    <LicenceNumber>VPA10987/163/004</LicenceNumber>
    <ProductName>Clindaseptin 300 mg capsules for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/163/002</DrugIDPK>
    <LicenceNumber>VPA10987/163/002</LicenceNumber>
    <ProductName>Clindaseptin 75 mg capsules for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/084/001</DrugIDPK>
    <LicenceNumber>VPA22664/084/001</LicenceNumber>
    <ProductName>Closamectin 5 mg/ml/125 mg/ml Solution for Injection for Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/088/001</DrugIDPK>
    <LicenceNumber>VPA22664/088/001</LicenceNumber>
    <ProductName>Closamectin 5 mg/ml + 200 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>07/08/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Closantel sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/083/001</DrugIDPK>
    <LicenceNumber>VPA22664/083/001</LicenceNumber>
    <ProductName>Closamectin Solution for Injection for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>09/11/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/102/001</DrugIDPK>
    <LicenceNumber>VPA22664/102/001</LicenceNumber>
    <ProductName>Closivet 5 mg/ml + 200 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/001/001</DrugIDPK>
    <LicenceNumber>VPA10981/001/001</LicenceNumber>
    <ProductName>Co-Trimoxazole 240 mg/ml solution for injection for cattle.</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW11</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfamethoxazole</ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/104/001</DrugIDPK>
    <LicenceNumber>VPA10996/104/001</LicenceNumber>
    <ProductName>Cobactan 25 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>20/09/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DE90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/105/001</DrugIDPK>
    <LicenceNumber>VPA10996/105/001</LicenceNumber>
    <ProductName>Cobactan LC, 75 mg, intramammary ointment for lactating cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>29/05/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary ointment</DosageForm>
    <ATCs>
      <ATC>QJ51DE90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/032/001</DrugIDPK>
    <LicenceNumber>VPA10987/032/001</LicenceNumber>
    <ProductName>Cobalt Super 2.1 mg/ml oral solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QV06D</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cobalt sulphate heptahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/012/002</DrugIDPK>
    <LicenceNumber>VPA10790/012/002</LicenceNumber>
    <ProductName>Coccibal 400 mg/ml  solution for use in drinking water  for chickens and turkeys</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>26/02/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP51BX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amprolium hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/012/001</DrugIDPK>
    <LicenceNumber>VPA10790/012/001</LicenceNumber>
    <ProductName>Coccibal, 200 mg/ml solution for use in drinking water for chickens and turkeys</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>16/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP51AX09</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amprolium hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/047/001</DrugIDPK>
    <LicenceNumber>VPA10782/047/001</LicenceNumber>
    <ProductName>Cocciril 2.5 mg/ml oral suspension for cattle and sheep</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>30/05/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51BC03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diclazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/030/001</DrugIDPK>
    <LicenceNumber>VPA10815/030/001</LicenceNumber>
    <ProductName>Coglapix suspension for injection for pigs.</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>23/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Actinobacillus pleuropneumoniae strain nt3</ActiveSubstance>
      <ActiveSubstance>Actinobacillus pleurpneumoniae strain szii</ActiveSubstance>
      <ActiveSubstance>Actinobacillus pleuropneumoniae strain po</ActiveSubstance>
      <ActiveSubstance>Actinobacillus pleuropneumoniae strain u3</ActiveSubstance>
      <ActiveSubstance>Actinobacillus pleuropneumoniae strain b4</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/007/001</DrugIDPK>
    <LicenceNumber>VPA10387/007/001</LicenceNumber>
    <ProductName>Colombovac PMV suspension for injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>24/11/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01EA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated newcastle disease virus strain la sota</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Pigeons</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/028/001</DrugIDPK>
    <LicenceNumber>VPA22664/028/001</LicenceNumber>
    <ProductName>Colvasone 2 mg/ml Solution for injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/143/001</DrugIDPK>
    <LicenceNumber>VPA22664/143/001</LicenceNumber>
    <ProductName>Combiclav Intramammary Suspension for Lactating Cows</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>23/11/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RV01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/069/001</DrugIDPK>
    <LicenceNumber>VPA10989/069/001</LicenceNumber>
    <ProductName>Comfortan 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>14/10/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AC90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Methadone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/008/001</DrugIDPK>
    <LicenceNumber>VPA10836/008/001</LicenceNumber>
    <ProductName>CONTINENCE 40 mg/ml syrup for dogs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>11/10/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ATCs>
      <ATC>QG04BX91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylpropanolamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10956/005/002</DrugIDPK>
    <LicenceNumber>VPA10956/005/002</LicenceNumber>
    <ProductName>Copper 20 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Ballinskelligs Vet. Products Ltd</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Copper methionate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/005/001</DrugIDPK>
    <LicenceNumber>VPA10495/005/001</LicenceNumber>
    <ProductName>CORTEXONAVET 2 mg/ml solution for injection for cattle, horses, pigs, dogs and cats</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>05/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/006/001</DrugIDPK>
    <LicenceNumber>VPA10539/006/001</LicenceNumber>
    <ProductName>Cortico Veyxin 10 mg/ml suspension for injection for cattle, horses, dogs and cats</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>21/09/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/117/001</DrugIDPK>
    <LicenceNumber>VPA10988/117/001</LicenceNumber>
    <ProductName>Cortotic 0.584 mg/ml ear spray, solution for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>17/02/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear spray, solution</DosageForm>
    <ATCs>
      <ATC>QS02BA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone Aceponate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/001/001</DrugIDPK>
    <LicenceNumber>VPA22622/001/001</LicenceNumber>
    <ProductName>Cosacthen 0.25 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>14/02/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01AA02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tetracosactide hexaacetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/054/001</DrugIDPK>
    <LicenceNumber>VPA22033/054/001</LicenceNumber>
    <ProductName>Cosecure Cattle Bolus Continuous Release Intraruminal Device</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>27/04/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Continuous-release intraruminal device</DosageForm>
    <ATCs>
      <ATC>QA12CE99</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Copper</ActiveSubstance>
      <ActiveSubstance>Cobalt</ActiveSubstance>
      <ActiveSubstance>Sodium selenate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/008/001</DrugIDPK>
    <LicenceNumber>VPA10387/008/001</LicenceNumber>
    <ProductName>Covexin 10 Suspension for injection for sheep and cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB01</ATC>
      <ATC>QI04AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>C. haemolyticum toxoid (strain cn 3629)</ActiveSubstance>
      <ActiveSubstance>C. sordellii toxoid (strain 831)</ActiveSubstance>
      <ActiveSubstance>C. tetani toxoid (strain cn 3911)</ActiveSubstance>
      <ActiveSubstance>C. septicum toxoid (strain cn 368)</ActiveSubstance>
      <ActiveSubstance>C. novyi type b toxoid (strain cn 6120)</ActiveSubstance>
      <ActiveSubstance>C. chauvoei whole culture (strain cn 3796)</ActiveSubstance>
      <ActiveSubstance>C. perfringens type a toxoid (strain cn 1491)</ActiveSubstance>
      <ActiveSubstance>C. perfringens type b toxoid (strain cn 1240)</ActiveSubstance>
      <ActiveSubstance>C. perfringens type c toxoid (strain cn 883)</ActiveSubstance>
      <ActiveSubstance>C. perfringens type d toxoid (strain cn 3688)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/009/001</DrugIDPK>
    <LicenceNumber>VPA10387/009/001</LicenceNumber>
    <ProductName>Covexin 8 suspension for injection for sheep and cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>11/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB01</ATC>
      <ATC>QI04AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>C. perfringens type b &amp; c ß toxoid</ActiveSubstance>
      <ActiveSubstance>C. perfringens type d (e) toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei, strain 3796, Inactivated</ActiveSubstance>
      <ActiveSubstance>C. novyi type B anaculture</ActiveSubstance>
      <ActiveSubstance>C. septicum toxoid </ActiveSubstance>
      <ActiveSubstance>C. tetani toxoid </ActiveSubstance>
      <ActiveSubstance>C. haemolyticum anaculture</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/008/001</DrugIDPK>
    <LicenceNumber>VPA10774/008/001</LicenceNumber>
    <ProductName>Coxaclear 50 mg/ml oral suspension for pigs, cattle and sheep</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10483/002/001</DrugIDPK>
    <LicenceNumber>VPA10483/002/001</LicenceNumber>
    <ProductName>Coxx-Kure 50 mg/ml oral suspension for piglets and calves</ProductName>
    <PAHolder>LAPROVET</PAHolder>
    <AuthorisedDate>05/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/034/001</DrugIDPK>
    <LicenceNumber>VPA22033/034/001</LicenceNumber>
    <ProductName>Cronyxin 50 mg/g Oral paste for horses</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>16/11/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/040/001</DrugIDPK>
    <LicenceNumber>VPA22033/040/001</LicenceNumber>
    <ProductName>Cronyxin Injection 50 mg/ml Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>20/02/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/023/001</DrugIDPK>
    <LicenceNumber>VPA10509/023/001</LicenceNumber>
    <ProductName>Cryptisel 0.5 mg/ml oral solution for calves</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>13/11/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP51AX08</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Halofuginone Lactate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/018/001</DrugIDPK>
    <LicenceNumber>VPA10990/018/001</LicenceNumber>
    <ProductName>CTC 10 %w/w Oral Powder</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/039/001</DrugIDPK>
    <LicenceNumber>VPA10990/039/001</LicenceNumber>
    <ProductName>CTC 10 %w/w Premix for Medicated Feed</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>23/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/039/002</DrugIDPK>
    <LicenceNumber>VPA10990/039/002</LicenceNumber>
    <ProductName>CTC 15 %w/w Premix for Medicated Feed</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>23/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/034/001</DrugIDPK>
    <LicenceNumber>VPA10990/034/001</LicenceNumber>
    <ProductName>CTC 15% w/w Oral Powder</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>19/02/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/024/001</DrugIDPK>
    <LicenceNumber>VPA10791/024/001</LicenceNumber>
    <ProductName>Cubarmix Equi 400 mg/g and 80 mg/g oral powder for horses</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>23/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/092/001</DrugIDPK>
    <LicenceNumber>VPA10988/092/001</LicenceNumber>
    <ProductName>Curacef duo, 50 mg/ml/150 mg/ml, Suspension for Injection for Cattle</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>01/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/032/002</DrugIDPK>
    <LicenceNumber>VPA10990/032/002</LicenceNumber>
    <ProductName>Curafluke 10% w/v Oral Drench</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>15/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC30</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/032/001</DrugIDPK>
    <LicenceNumber>VPA10990/032/001</LicenceNumber>
    <ProductName>Curafluke 50 mg/ml oral drench for cattle and sheep</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC30</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/015/001</DrugIDPK>
    <LicenceNumber>VPA10990/015/001</LicenceNumber>
    <ProductName>Curazole 100 mg/ml oral drench for cattle</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>07/05/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/015/004</DrugIDPK>
    <LicenceNumber>VPA10990/015/004</LicenceNumber>
    <ProductName>Curazole 100 mg/ml oral suspension for horses</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>23/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/015/002</DrugIDPK>
    <LicenceNumber>VPA10990/015/002</LicenceNumber>
    <ProductName>Curazole 25 mg/ml oral drench for sheep</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>14/05/1992</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/030/001</DrugIDPK>
    <LicenceNumber>VPA10990/030/001</LicenceNumber>
    <ProductName>Curazole 5% w/w Premix for Medicated Feed</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>26/06/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/044/001</DrugIDPK>
    <LicenceNumber>VPA10990/044/001</LicenceNumber>
    <ProductName>Curazole 50 mg/g oral powder for pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>29/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/015/003</DrugIDPK>
    <LicenceNumber>VPA10990/015/003</LicenceNumber>
    <ProductName>Curazole 50 mg/ml oral drench for cattle and sheep</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>12/03/1992</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/045/001</DrugIDPK>
    <LicenceNumber>VPA10990/045/001</LicenceNumber>
    <ProductName>Curofen 50 mg/g oral powder for pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>06/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/046/001</DrugIDPK>
    <LicenceNumber>VPA10990/046/001</LicenceNumber>
    <ProductName>Curofen 50 mg/g Premix for Medicated Feeding Stuff for Pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/094/001</DrugIDPK>
    <LicenceNumber>VPA10988/094/001</LicenceNumber>
    <ProductName>Cyclavance 100 mg/ml oral solution for dogs and cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>14/03/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QL04A</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/061/001</DrugIDPK>
    <LicenceNumber>VPA10988/061/001</LicenceNumber>
    <ProductName>Cyclio 12 mg Spot-on Solution For Small Dogs</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>15/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX23</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/061/002</DrugIDPK>
    <LicenceNumber>VPA10988/061/002</LicenceNumber>
    <ProductName>Cyclio 30 mg Spot-on Solution for Medium Sized Dogs</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>15/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX23</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/061/003</DrugIDPK>
    <LicenceNumber>VPA10988/061/003</LicenceNumber>
    <ProductName>Cyclio 60 mg Spot-on Solution for Large Dogs</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>15/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX23</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/079/001</DrugIDPK>
    <LicenceNumber>VPA10988/079/001</LicenceNumber>
    <ProductName>Cyclix 250 microgram/ml solution for injection for cattle</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/080/001</DrugIDPK>
    <LicenceNumber>VPA10988/080/001</LicenceNumber>
    <ProductName>Cyclix porcine 87.5 microgram/ml solution for injection</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/040/001</DrugIDPK>
    <LicenceNumber>VPA22622/040/001</LicenceNumber>
    <ProductName>Cyclofin 300 mg/ml + 20 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>15/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA56</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline</ActiveSubstance>
      <ActiveSubstance>Flunixin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/026/001</DrugIDPK>
    <LicenceNumber>VPA10989/026/001</LicenceNumber>
    <ProductName>Cyclosol LA 200 mg/ml solution for injection for cattle and pigs.</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/049/001</DrugIDPK>
    <LicenceNumber>VPA10989/049/001</LicenceNumber>
    <ProductName>Cyclospray, 2.45 % w/w cutaneous spray, suspension for cattle, sheep and pigs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, suspension</DosageForm>
    <ATCs>
      <ATC>QD06A</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Topical use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/011/001</DrugIDPK>
    <LicenceNumber>VPA10387/011/001</LicenceNumber>
    <ProductName>Cydectin 0.1% w/v oral solution for sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/012/001</DrugIDPK>
    <LicenceNumber>VPA10387/012/001</LicenceNumber>
    <ProductName>CYDECTIN 0.5% w/v Pour-On for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/013/001</DrugIDPK>
    <LicenceNumber>VPA10387/013/001</LicenceNumber>
    <ProductName>Cydectin 1 % w/v Solution for injection for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/014/001</DrugIDPK>
    <LicenceNumber>VPA10387/014/001</LicenceNumber>
    <ProductName>Cydectin 1% w/v Injectable Solution for Sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/015/001</DrugIDPK>
    <LicenceNumber>VPA10387/015/001</LicenceNumber>
    <ProductName>Cydectin 10 % LA Solution for Injection for Cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/095/001</DrugIDPK>
    <LicenceNumber>VPA10387/095/001</LicenceNumber>
    <ProductName>Cydectin LA 20 mg/ml Solution for Injection for Sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>24/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/016/001</DrugIDPK>
    <LicenceNumber>VPA10387/016/001</LicenceNumber>
    <ProductName>Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/017/001</DrugIDPK>
    <LicenceNumber>VPA10387/017/001</LicenceNumber>
    <ProductName>Cydectin TriclaMox 5 mg/ml + 200 mg/ml Pour-on Solution for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/025/002</DrugIDPK>
    <LicenceNumber>VPA10509/025/002</LicenceNumber>
    <ProductName>Cylanic 250 mg + 62.5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>28/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/025/001</DrugIDPK>
    <LicenceNumber>VPA10509/025/001</LicenceNumber>
    <ProductName>Cylanic 50 mg + 12.5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>28/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/025/003</DrugIDPK>
    <LicenceNumber>VPA10509/025/003</LicenceNumber>
    <ProductName>Cylanic 500  mg + 125 mg tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>28/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/081/001</DrugIDPK>
    <LicenceNumber>VPA22033/081/001</LicenceNumber>
    <ProductName>Cypercare 2.5%w/v Pour-on Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>14/06/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin technical (93%) (cis: trans 50:50)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/007/001</DrugIDPK>
    <LicenceNumber>VPA22033/007/001</LicenceNumber>
    <ProductName>Cyperguard Concentrate for Dip Emulsion</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>15/05/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip emulsion</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin (Cis:Trans 80:20)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10784/001/001</DrugIDPK>
    <LicenceNumber>VPA10784/001/001</LicenceNumber>
    <ProductName>CZV Avian Tuberculin PPD</ProductName>
    <PAHolder>CZ Vaccines S.A.U.</PAHolder>
    <AuthorisedDate>06/07/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI02AR02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Purified protein derivative from culture of Mycobacterium avium, subsp. avium strain D4 ER   </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10784/002/001</DrugIDPK>
    <LicenceNumber>VPA10784/002/001</LicenceNumber>
    <ProductName>CZV BOVINE TUBERCULIN PPD, solution for injection</ProductName>
    <PAHolder>CZ Vaccines S.A.U.</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI02AR01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Purified protein derivative from culture of mycobacterium bovis, strain an-5</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/074/003</DrugIDPK>
    <LicenceNumber>VPA10774/074/003</LicenceNumber>
    <ProductName>DACLOTRIX 1250 mg/250 mg spot-on solution for dogs over 10 kg up to 25 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/074/001</DrugIDPK>
    <LicenceNumber>VPA10774/074/001</LicenceNumber>
    <ProductName>DACLOTRIX 200 mg/40 mg spot-on solution for dogs up to 4 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/074/004</DrugIDPK>
    <LicenceNumber>VPA10774/074/004</LicenceNumber>
    <ProductName>DACLOTRIX 2000 mg/400 mg spot-on solution for dogs over 25 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/074/002</DrugIDPK>
    <LicenceNumber>VPA10774/074/002</LicenceNumber>
    <ProductName>DACLOTRIX 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/009/001</DrugIDPK>
    <LicenceNumber>VPA10836/009/001</LicenceNumber>
    <ProductName>Dalmaprost 0.075 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>13/09/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>D-cloprostenol sodium salt</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/002/001</DrugIDPK>
    <LicenceNumber>VPA10836/002/001</LicenceNumber>
    <ProductName>Dalmarelin 25 micrograms/ml solution for injection for cattle and rabbits</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>19/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA92</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lecirelin acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/001/001</DrugIDPK>
    <LicenceNumber>VPA10836/001/001</LicenceNumber>
    <ProductName>Dalmazin, 75 micrograms/ml, solution for injection for cattle, buffaloes and pigs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>13/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>*** AWAITING VALUE ***</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>D-cloprostenol sodium salt</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Buffalo</Species>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/073/003</DrugIDPK>
    <LicenceNumber>VPA10774/073/003</LicenceNumber>
    <ProductName>Damtix 1250 mg/250 mg spot-on solution for dogs over 10 kg up to 25 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/073/001</DrugIDPK>
    <LicenceNumber>VPA10774/073/001</LicenceNumber>
    <ProductName>Damtix 200 mg/40 mg spot-on solution for dogs up to 4 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/073/004</DrugIDPK>
    <LicenceNumber>VPA10774/073/004</LicenceNumber>
    <ProductName>Damtix 2000 mg/400 mg spot-on solution for dogs over 25 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/073/002</DrugIDPK>
    <LicenceNumber>VPA10774/073/002</LicenceNumber>
    <ProductName>Damtix 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid for veterinary use</ActiveSubstance>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/014/001</DrugIDPK>
    <LicenceNumber>VPA10491/014/001</LicenceNumber>
    <ProductName>Danilon Equidos NF 1.5 g/sachet granules in sachet for horses and ponies</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>10/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules in sachet</DosageForm>
    <ATCs>
      <ATC>QM01AA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Suxibuzone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25497/002/001</DrugIDPK>
    <LicenceNumber>VPA25497/002/001</LicenceNumber>
    <ProductName>Deccox 60.6 g/kg Premix for Medicated Feeding Stuff</ProductName>
    <PAHolder>Phibro Animal Health (Poland) Sp. z o.o.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP51AX14</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Decoquinate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/019/001</DrugIDPK>
    <LicenceNumber>VPA10387/019/001</LicenceNumber>
    <ProductName>DECTOMAX 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doramectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/020/001</DrugIDPK>
    <LicenceNumber>VPA10387/020/001</LicenceNumber>
    <ProductName>Dectomax 5 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doramectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/058/001</DrugIDPK>
    <LicenceNumber>VPA22033/058/001</LicenceNumber>
    <ProductName>Dectospot 10 mg/ml Pour-on Solution for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>12/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/053/001</DrugIDPK>
    <LicenceNumber>VPA10988/053/001</LicenceNumber>
    <ProductName>Defendog Cutaneous solution</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>13/06/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ATCs>
      <ATC>QP53AC04</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (Cis:Trans 40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/008/001</DrugIDPK>
    <LicenceNumber>VPA22033/008/001</LicenceNumber>
    <ProductName>Deltadot 10 mg/ml Pour-on Solution for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>23/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/087/001</DrugIDPK>
    <LicenceNumber>VPA10988/087/001</LicenceNumber>
    <ProductName>Deltanil 10 mg/ml Pour-on Solution for cattle and sheep</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/021/001</DrugIDPK>
    <LicenceNumber>VPA10387/021/001</LicenceNumber>
    <ProductName>Depo-Medrone V 40 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>06/01/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Methylprednisolone acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/068/001</DrugIDPK>
    <LicenceNumber>VPA10996/068/001</LicenceNumber>
    <ProductName>Depocillin 300 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/026/001</DrugIDPK>
    <LicenceNumber>VPA10475/026/001</LicenceNumber>
    <ProductName>Dermanolon 1.77 mg/ml + 17.7 mg/ml cutaneous spray, solution for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QD07XB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/029/002</DrugIDPK>
    <LicenceNumber>VPA10815/029/002</LicenceNumber>
    <ProductName>Dermipred 10 mg tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/029/003</DrugIDPK>
    <LicenceNumber>VPA10815/029/003</LicenceNumber>
    <ProductName>Dermipred 20 mg tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/029/001</DrugIDPK>
    <LicenceNumber>VPA10815/029/001</LicenceNumber>
    <ProductName>Dermipred 5 mg tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10789/001/001</DrugIDPK>
    <LicenceNumber>VPA10789/001/001</LicenceNumber>
    <ProductName>DETOGESIC 10 mg/ml Solution for Injection for Horses</ProductName>
    <PAHolder>Vetcare Limited,</PAHolder>
    <AuthorisedDate>22/08/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/010/001</DrugIDPK>
    <LicenceNumber>VPA10816/010/001</LicenceNumber>
    <ProductName>Detonervin 10 mg/ml, solution for injection for Horses and Cattle</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/004/001</DrugIDPK>
    <LicenceNumber>VPA10791/004/001</LicenceNumber>
    <ProductName>Dexa-ject 2 mg/ml solution for injection for cattle, horses, pigs, dogs and cats</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>05/10/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/035/001</DrugIDPK>
    <LicenceNumber>VPA10475/035/001</LicenceNumber>
    <ProductName>Dexacortone 0.5 mg chewable tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>05/01/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/035/002</DrugIDPK>
    <LicenceNumber>VPA10475/035/002</LicenceNumber>
    <ProductName>Dexacortone 2.0 mg chewable tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>05/01/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/027/001</DrugIDPK>
    <LicenceNumber>VPA10996/027/001</LicenceNumber>
    <ProductName>Dexadreson 2 mg/ml solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/017/001</DrugIDPK>
    <LicenceNumber>VPA10509/017/001</LicenceNumber>
    <ProductName>Dexafast 2 mg/ml solution for injection for horses, cattle, goats, pigs, dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>25/01/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Periarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/028/001</DrugIDPK>
    <LicenceNumber>VPA10996/028/001</LicenceNumber>
    <ProductName>Dexafort Suspension for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
      <ActiveSubstance>Dexamethasone phenylpropionate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/013/001</DrugIDPK>
    <LicenceNumber>VPA10823/013/001</LicenceNumber>
    <ProductName>Dexameth 2 mg/ml solution for injection</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/002/001</DrugIDPK>
    <LicenceNumber>VPA10980/002/001</LicenceNumber>
    <ProductName>Dexamethasone 2 mg/ml solution for injection for dogs, cats, cattle and horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/003/001</DrugIDPK>
    <LicenceNumber>VPA20742/003/001</LicenceNumber>
    <ProductName>DEXASHOT 2 mg/ml solution for injection for cattle, horses, pigs, dogs and cats</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>21/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/002/001</DrugIDPK>
    <LicenceNumber>VPA10826/002/001</LicenceNumber>
    <ProductName>Dexatat 2 mg/ml solution for Injection</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/034/001</DrugIDPK>
    <LicenceNumber>VPA10980/034/001</LicenceNumber>
    <ProductName>Dexdormostart</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>13/10/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM18</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexmedetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/001/001</DrugIDPK>
    <LicenceNumber>VPA25237/001/001</LicenceNumber>
    <ProductName>Dexmedocord 0.5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>15/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM18</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexmedetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/013/001</DrugIDPK>
    <LicenceNumber>VPA10516/013/001</LicenceNumber>
    <ProductName>DEXMOPET 0.5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>26/08/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM18</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexmedetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/016/001</DrugIDPK>
    <LicenceNumber>VPA23462/016/001</LicenceNumber>
    <ProductName>Dexrapid 2 mg/ml solution for injection</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>30/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10505/001/001</DrugIDPK>
    <LicenceNumber>VPA10505/001/001</LicenceNumber>
    <ProductName>DFV DOXIVET 200 mg/ml, solution for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Divasa-Farmavic S.A.,</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10505/002/001</DrugIDPK>
    <LicenceNumber>VPA10505/002/001</LicenceNumber>
    <ProductName>DFV DOXIVET 500 mg/g, powder for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Divasa-Farmavic S.A.,</PAHolder>
    <AuthorisedDate>17/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10806/007/001</DrugIDPK>
    <LicenceNumber>VPA10806/007/001</LicenceNumber>
    <ProductName>DiarrVac RCE Emulsion for injection for cattle.</ProductName>
    <PAHolder>FORTE Healthcare Ltd</PAHolder>
    <AuthorisedDate>08/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine rotavirus, Inactivated</ActiveSubstance>
      <ActiveSubstance>Bovine coronavirus, Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia Coli (Inactivated) </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/070/001</DrugIDPK>
    <LicenceNumber>VPA10989/070/001</LicenceNumber>
    <ProductName>Diatrim 200 mg/ml + 40 mg/ml solution for injection</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>09/02/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/008/001</DrugIDPK>
    <LicenceNumber>VPA23462/008/001</LicenceNumber>
    <ProductName>Diazedor 5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05BA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23174/003/001</DrugIDPK>
    <LicenceNumber>VPA23174/003/001</LicenceNumber>
    <ProductName>DIB 1.0 g Vaginal Delivery System for Cattle</ProductName>
    <PAHolder>Syn Vet-Pharma Ireland Limited</PAHolder>
    <AuthorisedDate>04/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Vaginal delivery system</DosageForm>
    <ATCs>
      <ATC>QG03DA04</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Vaginal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/010/001</DrugIDPK>
    <LicenceNumber>VPA10786/010/001</LicenceNumber>
    <ProductName>Diclacare 2.5 mg/ml Oral Suspension for lambs and calves</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>28/03/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51BC03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diclazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/004/001</DrugIDPK>
    <LicenceNumber>VPA10980/004/001</LicenceNumber>
    <ProductName>Dihydrostreptomycin 25% Solution for Injection</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01GA90</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrostreptomycin sulphate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/002/001</DrugIDPK>
    <LicenceNumber>VPA10475/002/001</LicenceNumber>
    <ProductName>Dilaterol 25 micrograms/ml syrup for horses</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>16/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ATCs>
      <ATC>QR03CC13</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/109/001</DrugIDPK>
    <LicenceNumber>VPA10996/109/001</LicenceNumber>
    <ProductName>Dimazon 50 mg/ml Solution for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QC03CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Furosemide Monoethanolamine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10389/001/001</DrugIDPK>
    <LicenceNumber>VPA10389/001/001</LicenceNumber>
    <ProductName>DINALGEN  300 mg/ml oral solution for use in drinking water for cattle and pigs</ProductName>
    <PAHolder>Ecuphar Veterinaria S.L.U.</PAHolder>
    <AuthorisedDate>08/04/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10389/002/001</DrugIDPK>
    <LicenceNumber>VPA10389/002/001</LicenceNumber>
    <ProductName>DINALGEN 150 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Ecuphar Veterinaria S.L.U.</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/009/001</DrugIDPK>
    <LicenceNumber>VPA22033/009/001</LicenceNumber>
    <ProductName>Dipen 100ml Suspension for Injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/013/001</DrugIDPK>
    <LicenceNumber>VPA10791/013/001</LicenceNumber>
    <ProductName>Distocur 34 mg/ml Oral suspension for cattle and sheep</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>13/01/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxyclozanide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/019/001</DrugIDPK>
    <LicenceNumber>VPA10521/019/001</LicenceNumber>
    <ProductName>Diurizone Injectable</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QC03AX01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
      <ActiveSubstance>Dexamethasone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/020/001</DrugIDPK>
    <LicenceNumber>VPA10846/020/001</LicenceNumber>
    <ProductName>DIVENCE TRI</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>24/01/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AH</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine respiratory syncytial virus, strain LYM-56, Live</ActiveSubstance>
      <ActiveSubstance>Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live</ActiveSubstance>
      <ActiveSubstance>Bovine parainfluenza virus 3, strain SF-4 Reisinger, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Mixed Vaccine (L &amp; A)</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/021/001</DrugIDPK>
    <LicenceNumber>VPA10521/021/001</LicenceNumber>
    <ProductName>Dolethal 200 mg/ml Solution for Injection for dogs and cats</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentobarbital sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/014/003</DrugIDPK>
    <LicenceNumber>VPA10826/014/003</LicenceNumber>
    <ProductName>Dolocarp flavour, 100 mg, chewable tablet for dogs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/014/001</DrugIDPK>
    <LicenceNumber>VPA10826/014/001</LicenceNumber>
    <ProductName>Dolocarp flavour, 20 mg, chewable tablets for dogs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/014/002</DrugIDPK>
    <LicenceNumber>VPA10826/014/002</LicenceNumber>
    <ProductName>Dolocarp flavour, 50 mg, chewable tablet for dogs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/053/001</DrugIDPK>
    <LicenceNumber>VPA10989/053/001</LicenceNumber>
    <ProductName>Domidine 10 mg/ml solution for injection, for horses and cattle</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>27/09/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10664/005/001</DrugIDPK>
    <LicenceNumber>VPA10664/005/001</LicenceNumber>
    <ProductName>Domitor 1 mg/ml solution for injection</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>12/03/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10664/004/001</DrugIDPK>
    <LicenceNumber>VPA10664/004/001</LicenceNumber>
    <ProductName>Domosedan 10 mg/ml solution for injection for horses and cattle</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>12/03/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10664/001/001</DrugIDPK>
    <LicenceNumber>VPA10664/001/001</LicenceNumber>
    <ProductName>DOMOSEDAN GEL 7.6 mg/ml oromucosal gel</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oromucosal gel</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Sublingual use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/018/001</DrugIDPK>
    <LicenceNumber>VPA10791/018/001</LicenceNumber>
    <ProductName>DOPHACYL 1000 mg/g powder for use in drinking water for turkeys</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>24/06/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QN02BA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium salicylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/019/001</DrugIDPK>
    <LicenceNumber>VPA10791/019/001</LicenceNumber>
    <ProductName>Dophacyl 1000 mg/g, powder for use in drinking water/milk for cattle and pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>14/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QN02BA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium salicylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/023/001</DrugIDPK>
    <LicenceNumber>VPA10791/023/001</LicenceNumber>
    <ProductName>Dophacyl Avi, 1000 mg/g powder for use in drinking water for chickens</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QN02BA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium salicylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/022/001</DrugIDPK>
    <LicenceNumber>VPA10791/022/001</LicenceNumber>
    <ProductName>Dophatyl-ject 200 000 IU/ml solution for injection for cattle, sheep, goats and pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>12/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/011/001</DrugIDPK>
    <LicenceNumber>VPA10791/011/001</LicenceNumber>
    <ProductName>DOPHEXINE 20 mg/g powder for use in drinking water/milk</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>02/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QR05CB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water/milk use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bromhexine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/009/001</DrugIDPK>
    <LicenceNumber>VPA10791/009/001</LicenceNumber>
    <ProductName>DORAFLOX 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>10/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/170/001</DrugIDPK>
    <LicenceNumber>VPA10987/170/001</LicenceNumber>
    <ProductName>Doramax 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>26/08/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doramectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/166/001</DrugIDPK>
    <LicenceNumber>VPA10987/166/001</LicenceNumber>
    <ProductName>Doramax 5 mg/ml Pour-on Solution for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>09/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doramectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/015/001</DrugIDPK>
    <LicenceNumber>VPA10791/015/001</LicenceNumber>
    <ProductName>DORAXX 25 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>07/01/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/002/001</DrugIDPK>
    <LicenceNumber>VPA10495/002/001</LicenceNumber>
    <ProductName>Dorbene vet 1 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/048/001</DrugIDPK>
    <LicenceNumber>VPA22622/048/001</LicenceNumber>
    <ProductName>Dormazolam 5 mg/ml solution for injection for horses</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>05/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CD08</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Midazolam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/033/001</DrugIDPK>
    <LicenceNumber>VPA10980/033/001</LicenceNumber>
    <ProductName>Dormostart 1 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>13/10/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/031/001</DrugIDPK>
    <LicenceNumber>VPA10980/031/001</LicenceNumber>
    <ProductName>Dormostop 5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>18/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV03AB90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Atipamezole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/046/001</DrugIDPK>
    <LicenceNumber>VPA10774/046/001</LicenceNumber>
    <ProductName>Doxatib 500 mg/g powder for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>09/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/008/001</DrugIDPK>
    <LicenceNumber>VPA10790/008/001</LicenceNumber>
    <ProductName>Doxipulvis 500 mg/g powder for use in drinking water/milk</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>30/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/002/001</DrugIDPK>
    <LicenceNumber>VPA10400/002/001</LicenceNumber>
    <ProductName>Doxivex, 100 mg/ml concentrate for oral solution for chickens and pigs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>03/08/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/017/001</DrugIDPK>
    <LicenceNumber>VPA10782/017/001</LicenceNumber>
    <ProductName>Doxx-Sol 500 mg/g powder for use in drinking water/milk replacer for pre-ruminant calves, pigs and chickens</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/044/002</DrugIDPK>
    <LicenceNumber>VPA22622/044/002</LicenceNumber>
    <ProductName>Doxybactin 200 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycyline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/044/003</DrugIDPK>
    <LicenceNumber>VPA22622/044/003</LicenceNumber>
    <ProductName>Doxybactin 400 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycyline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/044/001</DrugIDPK>
    <LicenceNumber>VPA22622/044/001</LicenceNumber>
    <ProductName>Doxybactin 50 mg tablets for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycyline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/013/002</DrugIDPK>
    <LicenceNumber>VPA10491/013/002</LicenceNumber>
    <ProductName>Doxycare Flavour 200 mg Tablets for Cats and Dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>25/10/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/013/001</DrugIDPK>
    <LicenceNumber>VPA10491/013/001</LicenceNumber>
    <ProductName>Doxycare Flavour 40 mg Tablets for Cats and Dogs</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>25/10/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/021/001</DrugIDPK>
    <LicenceNumber>VPA10791/021/001</LicenceNumber>
    <ProductName>Doxylin 500 mg/g, powder for use in drinking water/milk for pre-ruminant calves, pigs and chickens</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>14/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/007/001</DrugIDPK>
    <LicenceNumber>VPA10791/007/001</LicenceNumber>
    <ProductName>Doxylin, 433 mg/g, powder for use in drinking water for chickens and turkeys</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/020/001</DrugIDPK>
    <LicenceNumber>VPA10810/020/001</LicenceNumber>
    <ProductName>Doxytab vet. 15 mg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/020/003</DrugIDPK>
    <LicenceNumber>VPA10810/020/003</LicenceNumber>
    <ProductName>Doxytab vet. 200 mg Tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/020/004</DrugIDPK>
    <LicenceNumber>VPA10810/020/004</LicenceNumber>
    <ProductName>Doxytab vet. 400 mg Tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/020/002</DrugIDPK>
    <LicenceNumber>VPA10810/020/002</LicenceNumber>
    <ProductName>Doxytab vet. 50 mg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/002/001</DrugIDPK>
    <LicenceNumber>VPA10791/002/001</LicenceNumber>
    <ProductName>Dozuril 25 mg/ml solution for use in drinking water for chickens</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/016/001</DrugIDPK>
    <LicenceNumber>VPA10791/016/001</LicenceNumber>
    <ProductName>Dozuril 50 mg/ml oral suspension for pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>27/05/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/099/001</DrugIDPK>
    <LicenceNumber>VPA10387/099/001</LicenceNumber>
    <ProductName>Draxxin Plus 100 mg/ml + 120 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>25/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/005/001</DrugIDPK>
    <LicenceNumber>VPA10521/005/001</LicenceNumber>
    <ProductName>Droncit Tablets 50 mg</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/007/001</DrugIDPK>
    <LicenceNumber>VPA10521/007/001</LicenceNumber>
    <ProductName>Drontal Cat Tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>22/09/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/007/002</DrugIDPK>
    <LicenceNumber>VPA10521/007/002</LicenceNumber>
    <ProductName>Drontal Cat XL film-coated tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>06/08/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/012/001</DrugIDPK>
    <LicenceNumber>VPA10521/012/001</LicenceNumber>
    <ProductName>Drontal Dog Tasty Bone 150/144/50 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/012/002</DrugIDPK>
    <LicenceNumber>VPA10521/012/002</LicenceNumber>
    <ProductName>Drontal Dog Tasty Bone XL 525/504/175 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>27/10/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/008/001</DrugIDPK>
    <LicenceNumber>VPA10521/008/001</LicenceNumber>
    <ProductName>Drontal Oral Suspension for Puppies 15/5 mg/ml</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>23/05/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AF02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/006/003</DrugIDPK>
    <LicenceNumber>VPA10521/006/003</LicenceNumber>
    <ProductName>Drontal Plus Flavour Bone Shaped Tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/011/001</DrugIDPK>
    <LicenceNumber>VPA10521/011/001</LicenceNumber>
    <ProductName>Drontal Plus Flavour Tablets for Dogs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>25/01/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AF30</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/006/001</DrugIDPK>
    <LicenceNumber>VPA10521/006/001</LicenceNumber>
    <ProductName>Drontal Plus Tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>12/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/009/001</DrugIDPK>
    <LicenceNumber>VPA10521/009/001</LicenceNumber>
    <ProductName>Drontal Plus XL Flavour Tablets for Dogs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AF30</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/006/002</DrugIDPK>
    <LicenceNumber>VPA10521/006/002</LicenceNumber>
    <ProductName>Drontal Plus XL Tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>17/10/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/014/001</DrugIDPK>
    <LicenceNumber>VPA10521/014/001</LicenceNumber>
    <ProductName>Drontal Tasty Bone Multi-worm 150/144/50 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/014/002</DrugIDPK>
    <LicenceNumber>VPA10521/014/002</LicenceNumber>
    <ProductName>Drontal Tasty Bone Multi-worm XL 525/504/175 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/015/001</DrugIDPK>
    <LicenceNumber>VPA10521/015/001</LicenceNumber>
    <ProductName>Drontal Tasty Bone Wormer 150/144/50 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/015/002</DrugIDPK>
    <LicenceNumber>VPA10521/015/002</LicenceNumber>
    <ProductName>Drontal Tasty Bone Wormer XL 525/504/175 mg tablets</ProductName>
    <PAHolder>Vetoquinol SA</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/069/001</DrugIDPK>
    <LicenceNumber>VPA22020/069/001</LicenceNumber>
    <ProductName>DrySeal intramammary suspension</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>27/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Teat Dip/Seal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25460/003/001</DrugIDPK>
    <LicenceNumber>VPA25460/003/001</LicenceNumber>
    <ProductName>Dugmectin 18.7 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Acme Drugs S.r.l.</PAHolder>
    <AuthorisedDate>05/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10477/004/001</DrugIDPK>
    <LicenceNumber>VPA10477/004/001</LicenceNumber>
    <ProductName>Dugnixon 50 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Global Vet Health S.L.</PAHolder>
    <AuthorisedDate>15/12/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/009/001</DrugIDPK>
    <LicenceNumber>VPA10990/009/001</LicenceNumber>
    <ProductName>Duocycline 10% Solution for Injection</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/016/001</DrugIDPK>
    <LicenceNumber>VPA10990/016/001</LicenceNumber>
    <ProductName>Duocycline LA 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/003/001</DrugIDPK>
    <LicenceNumber>VPA22664/003/001</LicenceNumber>
    <ProductName>Duofast Intramammary Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>05/02/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulphadiazine</ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/007/001</DrugIDPK>
    <LicenceNumber>VPA23340/007/001</LicenceNumber>
    <ProductName>DUOMYXIN, 3 400 IU/ml/10 000 IU/ml, Eye drops, powder and solvent for solution for dogs and cats</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>09/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye drops, powder and solvent for solution</DosageForm>
    <ATCs>
      <ATC>QS01AA30</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
      <ActiveSubstance>Polymyxin b sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/057/001</DrugIDPK>
    <LicenceNumber>VPA22664/057/001</LicenceNumber>
    <ProductName>Duotech Oral Suspension for Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>04/05/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC30</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxfendazole</ActiveSubstance>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/004/001</DrugIDPK>
    <LicenceNumber>VPA10400/004/001</LicenceNumber>
    <ProductName>DV8FLEA COMBO 50 mg/60 mg spot-on solution for cats and ferrets</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>12/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/005/003</DrugIDPK>
    <LicenceNumber>VPA10400/005/003</LicenceNumber>
    <ProductName>DV8FLEA COMBO L 268 mg/241.2 mg spot-on solution for dogs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>12/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/005/002</DrugIDPK>
    <LicenceNumber>VPA10400/005/002</LicenceNumber>
    <ProductName>DV8FLEA COMBO M 134 mg/120.6  mg spot-on solution for dogs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>12/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/005/001</DrugIDPK>
    <LicenceNumber>VPA10400/005/001</LicenceNumber>
    <ProductName>DV8FLEA COMBO S 67 mg/60.3 mg spot-on solution for dogs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>12/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/005/004</DrugIDPK>
    <LicenceNumber>VPA10400/005/004</LicenceNumber>
    <ProductName>DV8FLEA COMBO XL 402 mg/361.8 mg spot-on solution for dogs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>12/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/001/001</DrugIDPK>
    <LicenceNumber>VPA10400/001/001</LicenceNumber>
    <ProductName>DV8WORM 50 mg/144 mg/200 mg Tablets for dogs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>27/05/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/122/001</DrugIDPK>
    <LicenceNumber>VPA10987/122/001</LicenceNumber>
    <ProductName>Dycoxan 2.5 mg/ml Oral Suspension for sheep and cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/05/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diclazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/012/001</DrugIDPK>
    <LicenceNumber>VPA22033/012/001</LicenceNumber>
    <ProductName>Ecofleece 100 mg/g Concentrate for dip emulsion for sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>11/09/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip emulsion</DosageForm>
    <ATCs>
      <ATC>QP53AC</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin (Cis:Trans 80:20)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/001/001</DrugIDPK>
    <LicenceNumber>VPA22693/001/001</LicenceNumber>
    <ProductName>Ecomectin 10 mg/ml Solution for Injection</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>01/01/1900</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25460/002/001</DrugIDPK>
    <LicenceNumber>VPA25460/002/001</LicenceNumber>
    <ProductName>Ecomectin 18.7 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Acme Drugs S.r.l.</PAHolder>
    <AuthorisedDate>05/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/013/001</DrugIDPK>
    <LicenceNumber>VPA22693/013/001</LicenceNumber>
    <ProductName>Ecomectin 6 mg/g Oral Powder for pigs</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>22/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/011/001</DrugIDPK>
    <LicenceNumber>VPA22693/011/001</LicenceNumber>
    <ProductName>Ecomectin 6 mg/g Premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-feed use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/013/001</DrugIDPK>
    <LicenceNumber>VPA22033/013/001</LicenceNumber>
    <ProductName>Ectoflits Summer and Winter Sheep Dip 600 mg/g Concentrate for Dip Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>03/11/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip solution</DosageForm>
    <ATCs>
      <ATC>QP53AF</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dimpylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/059/001</DrugIDPK>
    <LicenceNumber>VPA22033/059/001</LicenceNumber>
    <ProductName>Ectofly 12.5 mg/ml Pour-On Solution for Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin high:cis (80:20)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/014/001</DrugIDPK>
    <LicenceNumber>VPA22033/014/001</LicenceNumber>
    <ProductName>Ectospec 2.5% w/v Pour-On Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin technical (93%) (cis: trans 50:50)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/036/001</DrugIDPK>
    <LicenceNumber>VPA10815/036/001</LicenceNumber>
    <ProductName>Efex 10 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/036/003</DrugIDPK>
    <LicenceNumber>VPA10815/036/003</LicenceNumber>
    <ProductName>Efex 100 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/036/002</DrugIDPK>
    <LicenceNumber>VPA10815/036/002</LicenceNumber>
    <ProductName>Efex 40 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/076/002</DrugIDPK>
    <LicenceNumber>VPA10988/076/002</LicenceNumber>
    <ProductName>EFFIPRO 134 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/072/001</DrugIDPK>
    <LicenceNumber>VPA10988/072/001</LicenceNumber>
    <ProductName>EFFIPRO 2.5 mg/ml cutaneous spray, solution for cats and dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/076/003</DrugIDPK>
    <LicenceNumber>VPA10988/076/003</LicenceNumber>
    <ProductName>EFFIPRO 268 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/076/004</DrugIDPK>
    <LicenceNumber>VPA10988/076/004</LicenceNumber>
    <ProductName>EFFIPRO 402 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/075/001</DrugIDPK>
    <LicenceNumber>VPA10988/075/001</LicenceNumber>
    <ProductName>EFFIPRO 50 mg spot-on solution for cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/076/001</DrugIDPK>
    <LicenceNumber>VPA10988/076/001</LicenceNumber>
    <ProductName>EFFIPRO 67 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/100/006</DrugIDPK>
    <LicenceNumber>VPA10988/100/006</LicenceNumber>
    <ProductName>Effipro duo 100 mg/120 mg spot-on solution for very large cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/100/002</DrugIDPK>
    <LicenceNumber>VPA10988/100/002</LicenceNumber>
    <ProductName>Effipro duo 134 mg/40 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/100/003</DrugIDPK>
    <LicenceNumber>VPA10988/100/003</LicenceNumber>
    <ProductName>Effipro duo 268 mg/80 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/100/004</DrugIDPK>
    <LicenceNumber>VPA10988/100/004</LicenceNumber>
    <ProductName>Effipro duo 402 mg/120 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/100/005</DrugIDPK>
    <LicenceNumber>VPA10988/100/005</LicenceNumber>
    <ProductName>Effipro duo 50 mg/60 mg spot-on solution for cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/100/001</DrugIDPK>
    <LicenceNumber>VPA10988/100/001</LicenceNumber>
    <ProductName>Effipro duo 67 mg/20 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Pyriproxyfen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/097/003</DrugIDPK>
    <LicenceNumber>VPA10988/097/003</LicenceNumber>
    <ProductName>Effitix 134 mg/1200 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/097/001</DrugIDPK>
    <LicenceNumber>VPA10988/097/001</LicenceNumber>
    <ProductName>Effitix 26.8 mg/240 mg spot-on solution for very small dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/097/004</DrugIDPK>
    <LicenceNumber>VPA10988/097/004</LicenceNumber>
    <ProductName>Effitix 268 mg/2400 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/097/005</DrugIDPK>
    <LicenceNumber>VPA10988/097/005</LicenceNumber>
    <ProductName>Effitix 402 mg/3600 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/097/002</DrugIDPK>
    <LicenceNumber>VPA10988/097/002</LicenceNumber>
    <ProductName>Effitix 67 mg/600 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/006/001</DrugIDPK>
    <LicenceNumber>VPA10846/006/001</LicenceNumber>
    <ProductName>EFICUR 50 mg/ml suspension for injection for pigs and cattle</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>28/05/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ceftiofur hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10481/002/001</DrugIDPK>
    <LicenceNumber>VPA10481/002/001</LicenceNumber>
    <ProductName>EKYFLOGYL 1.8mg/ml + 8.7mg/ml GEL FOR HORSES</ProductName>
    <PAHolder>Audevard</PAHolder>
    <AuthorisedDate>11/10/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QM02AX</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
      <ActiveSubstance>Lidocaine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/014/001</DrugIDPK>
    <LicenceNumber>VPA10509/014/001</LicenceNumber>
    <ProductName>Elivec 5 mg/ml pour-on solution for cattle, sheep and goats.</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>25/05/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/015/001</DrugIDPK>
    <LicenceNumber>VPA22033/015/001</LicenceNumber>
    <ProductName>Embotape 400 mg/g Oral Paste for Horses and Ponies</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>09/01/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP52AF02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/008/001</DrugIDPK>
    <LicenceNumber>VPA10534/008/001</LicenceNumber>
    <ProductName>Emdofluxin 50 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>07/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/008/001</DrugIDPK>
    <LicenceNumber>VPA23340/008/001</LicenceNumber>
    <ProductName>Emedog 1 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>21/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN04BC07</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Apomorphine hydrochloride hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/017/001</DrugIDPK>
    <LicenceNumber>VPA10815/017/001</LicenceNumber>
    <ProductName>Emeprid 1 mg/ml oral solution for dogs and cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QA03FA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metoclopramide hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/018/001</DrugIDPK>
    <LicenceNumber>VPA10815/018/001</LicenceNumber>
    <ProductName>Emeprid 5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03FA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metoclopramide hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/060/001</DrugIDPK>
    <LicenceNumber>VPA22033/060/001</LicenceNumber>
    <ProductName>Endofluke 100 mg/ml Oral Suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/08/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/004/001</DrugIDPK>
    <LicenceNumber>VPA10774/004/001</LicenceNumber>
    <ProductName>Endogard Plus Flavour Tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/004/002</DrugIDPK>
    <LicenceNumber>VPA10774/004/002</LicenceNumber>
    <ProductName>Endogard Plus XL Tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AC55</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/016/001</DrugIDPK>
    <LicenceNumber>VPA22033/016/001</LicenceNumber>
    <ProductName>Endospec 100 mg/ml SC Oral Suspension for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>23/09/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/017/001</DrugIDPK>
    <LicenceNumber>VPA22033/017/001</LicenceNumber>
    <ProductName>Endospec 25 mg/ml SC Oral Suspension for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>23/09/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/071/001</DrugIDPK>
    <LicenceNumber>VPA10996/071/001</LicenceNumber>
    <ProductName>Engemycin DD 100 mg/ml Solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/212/001</DrugIDPK>
    <LicenceNumber>VPA10996/212/001</LicenceNumber>
    <ProductName>Engemycin Spray, 25 mg/mL, cutaneous spray, suspension for cattle, sheep and pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>02/10/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, suspension</DosageForm>
    <ATCs>
      <ATC>QD06AA03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/055/001</DrugIDPK>
    <LicenceNumber>VPA22664/055/001</LicenceNumber>
    <ProductName>Enovex 10 mg/ml Solution for Injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/056/001</DrugIDPK>
    <LicenceNumber>VPA22664/056/001</LicenceNumber>
    <ProductName>Enovex 5 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/001/001</DrugIDPK>
    <LicenceNumber>VPA10786/001/001</LicenceNumber>
    <ProductName>ENRO-K 100 mg/ml Solution for use in drinking water for chickens and turkeys.</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/020/001</DrugIDPK>
    <LicenceNumber>VPA10475/020/001</LicenceNumber>
    <ProductName>Enrobactin 25 mg/ml concentrate for oral solution for pet rabbits, rodents, ornamental birds and reptiles</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>15/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chinchilla</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Rabbit (non-food-producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/007/003</DrugIDPK>
    <LicenceNumber>VPA10534/007/003</LicenceNumber>
    <ProductName>Enrocare 100 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/007/004</DrugIDPK>
    <LicenceNumber>VPA10491/007/004</LicenceNumber>
    <ProductName>Enrocare 25 mg/ml Oral Solution for Pet Rabbits, Rodents, Ornamental Birds and Reptiles</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chinchilla</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Rabbit (non-food-producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/007/001</DrugIDPK>
    <LicenceNumber>VPA10534/007/001</LicenceNumber>
    <ProductName>Enrocare 25 mg/ml Solution for Injection for Dogs, Cats, Rabbits, Rodents, Reptiles and Ornamental birds</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rabbits</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/007/002</DrugIDPK>
    <LicenceNumber>VPA10534/007/002</LicenceNumber>
    <ProductName>Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/019/001</DrugIDPK>
    <LicenceNumber>VPA10509/019/001</LicenceNumber>
    <ProductName>Enrocat flavour 25 mg/ml oral suspension for cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>08/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/004/001</DrugIDPK>
    <LicenceNumber>VPA10509/004/001</LicenceNumber>
    <ProductName>ENRODEXIL 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>28/06/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/026/003</DrugIDPK>
    <LicenceNumber>VPA10826/026/003</LicenceNumber>
    <ProductName>Enrotron 100 mg/ml Solution for injection for cattle, sheep, goats and pigs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/018/001</DrugIDPK>
    <LicenceNumber>VPA10826/018/001</LicenceNumber>
    <ProductName>Enrotron 100 mg/ml solution for use in drinking water for chicken, turkeys and rabbits</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Rabbits</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/026/001</DrugIDPK>
    <LicenceNumber>VPA10826/026/001</LicenceNumber>
    <ProductName>Enrotron 25 mg/ml Solution for injection for dogs, cats, rodents, reptiles and ornamental birds</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/016/001</DrugIDPK>
    <LicenceNumber>VPA10826/016/001</LicenceNumber>
    <ProductName>Enrotron 5 mg/ml oral solution for pigs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/026/002</DrugIDPK>
    <LicenceNumber>VPA10826/026/002</LicenceNumber>
    <ProductName>Enrotron 50 mg/ml Solution for injection for cattle, sheep, goats, pigs, dogs and cats</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/011/002</DrugIDPK>
    <LicenceNumber>VPA10826/011/002</LicenceNumber>
    <ProductName>Enrotron Flavour 150 mg Tablets for dogs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/011/001</DrugIDPK>
    <LicenceNumber>VPA10826/011/001</LicenceNumber>
    <ProductName>Enrotron Flavour 50 mg Tablets for dogs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/001/001</DrugIDPK>
    <LicenceNumber>VPA10774/001/001</LicenceNumber>
    <ProductName>Enrox Flavour 15 mg Tablets for dogs and cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>12/06/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/001/003</DrugIDPK>
    <LicenceNumber>VPA10774/001/003</LicenceNumber>
    <ProductName>Enrox Flavour 150 mg Tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>12/06/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/001/002</DrugIDPK>
    <LicenceNumber>VPA10774/001/002</LicenceNumber>
    <ProductName>Enrox Flavour 50 mg Tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>12/06/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/002/003</DrugIDPK>
    <LicenceNumber>VPA10774/002/003</LicenceNumber>
    <ProductName>Enroxil 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/002/002</DrugIDPK>
    <LicenceNumber>VPA10774/002/002</LicenceNumber>
    <ProductName>ENROXIL 50 mg/ml solution for injection for calves, pigs and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/002/001</DrugIDPK>
    <LicenceNumber>VPA10774/002/001</LicenceNumber>
    <ProductName>Enroxil Max 100 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>19/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10784/003/001</DrugIDPK>
    <LicenceNumber>VPA10784/003/001</LicenceNumber>
    <ProductName>Entericolix, emulsion for injection for pig</ProductName>
    <PAHolder>CZ Vaccines S.A.U.</PAHolder>
    <AuthorisedDate>16/03/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB08</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>E.coli strain p4 (f6 adhesins), inactivated</ActiveSubstance>
      <ActiveSubstance>E.coli strain p5 (f18 adhesins), inactivated</ActiveSubstance>
      <ActiveSubstance>E. coli strain p6 (f4ac adhesins), inactivated</ActiveSubstance>
      <ActiveSubstance>E. coli strain P9 (F18ac adhesins), inactivated</ActiveSubstance>
      <ActiveSubstance>E.coli strain p10 (f5 + f41 adhesins), inactivated</ActiveSubstance>
      <ActiveSubstance>ß toxoid of C. perfringens type C</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/005/001</DrugIDPK>
    <LicenceNumber>VPA10454/005/001</LicenceNumber>
    <ProductName>Enterisol Ileitis lyophilisate and solvent for oral suspension for pigs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>07/07/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for oral suspension</DosageForm>
    <ATCs>
      <ATC>QI09AE04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Attenuated live bacteria lawsonia intracellularis (ms b3903)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/002/001</DrugIDPK>
    <LicenceNumber>VPA10815/002/001</LicenceNumber>
    <ProductName>Enzaprost 5 mg/ml Solution for injection for cattle and pig</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>30/07/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dinoprost trometamol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/079/001</DrugIDPK>
    <LicenceNumber>VPA10996/079/001</LicenceNumber>
    <ProductName>Enzovax lyophilisate and solvent for suspension for injection for sheep</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>15/11/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI04AE01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlamydophila abortus live attenuated strain ts 1b</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/100/001</DrugIDPK>
    <LicenceNumber>VPA10987/100/001</LicenceNumber>
    <ProductName>Epityl 60mg Flavoured Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/024/001</DrugIDPK>
    <LicenceNumber>VPA10815/024/001</LicenceNumber>
    <ProductName>Eprecis 20 mg/ml solution for injection for cattle, sheep and goats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>11/09/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/025/001</DrugIDPK>
    <LicenceNumber>VPA10815/025/001</LicenceNumber>
    <ProductName>Eprecis 5 mg/ml pour-on solution for cattle, sheep and goats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/033/001</DrugIDPK>
    <LicenceNumber>VPA10454/033/001</LicenceNumber>
    <ProductName>Eprinex 5 mg/ml Pour-on Solution for Beef and Dairy Cattle</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>14/08/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/034/001</DrugIDPK>
    <LicenceNumber>VPA10454/034/001</LicenceNumber>
    <ProductName>Eprinex Multi 5 mg/ml pour-on solution for cattle, sheep and goats</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>09/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/035/001</DrugIDPK>
    <LicenceNumber>VPA10454/035/001</LicenceNumber>
    <ProductName>Eprivalan 5 mg/ml pour-on solution for cattle</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>30/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/103/001</DrugIDPK>
    <LicenceNumber>VPA22664/103/001</LicenceNumber>
    <ProductName>Eprizero 5 mg/ml Pour-On Solution for Beef and Dairy Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/03/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/107/001</DrugIDPK>
    <LicenceNumber>VPA10987/107/001</LicenceNumber>
    <ProductName>Epromec 5 mg/ml Pour-on Solution for beef and dairy cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/025/001</DrugIDPK>
    <LicenceNumber>VPA10387/025/001</LicenceNumber>
    <ProductName>EQUEST ORAL GEL, 18.92 mg/g, oral gel for horses and ponies</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral gel</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/026/001</DrugIDPK>
    <LicenceNumber>VPA10387/026/001</LicenceNumber>
    <ProductName>Equest Pramox 19.5 mg/g + 121.7 mg/g oral gel</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral gel</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/037/001</DrugIDPK>
    <LicenceNumber>VPA10475/037/001</LicenceNumber>
    <ProductName>Equibactin 250 mg/g + 50 mg/g oral powder for horses</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>05/07/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/004/001</DrugIDPK>
    <LicenceNumber>VPA10816/004/001</LicenceNumber>
    <ProductName>Equibactin vet. (333 mg/g + 67 mg/g) Oral Paste for horses</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>21/07/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/007/001</DrugIDPK>
    <LicenceNumber>VPA10400/007/001</LicenceNumber>
    <ProductName>EquiDaz Forte 100 mg/ml oral suspension for horses</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>04/07/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed Consent application (Article 21 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/091/001</DrugIDPK>
    <LicenceNumber>VPA10988/091/001</LicenceNumber>
    <ProductName>Equimax oral gel for horses</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral gel</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/114/001</DrugIDPK>
    <LicenceNumber>VPA22664/114/001</LicenceNumber>
    <ProductName>Equinor 370 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/027/001</DrugIDPK>
    <LicenceNumber>VPA10387/027/001</LicenceNumber>
    <ProductName>Equip Artervac emulsion for injection for horses and ponies</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI05AA07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine arteritis virus inactivated, strain bucyrus</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/028/001</DrugIDPK>
    <LicenceNumber>VPA10387/028/001</LicenceNumber>
    <ProductName>Equip EHV 1,4 Suspension for injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>26/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI05AA05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine herpes virus 4, strain 405/76 inactivated</ActiveSubstance>
      <ActiveSubstance>Equine herpes virus 1, strain 438/77 inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/029/001</DrugIDPK>
    <LicenceNumber>VPA10387/029/001</LicenceNumber>
    <ProductName>Equip F solution for injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>30/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI05AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated equine influenza a newmarket 77 (H7 N7) </ActiveSubstance>
      <ActiveSubstance>Inactivated equine influenza a borlonge 91 (H3 N8) </ActiveSubstance>
      <ActiveSubstance>Inactivated equine influenza a Kentucky 98 (H3 N8) </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/030/001</DrugIDPK>
    <LicenceNumber>VPA10387/030/001</LicenceNumber>
    <ProductName>Equip FT</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>04/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI05AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated equine influenza a newmarket 77 (H7 N7) </ActiveSubstance>
      <ActiveSubstance>Inactivated equine influenza a borlonge 91 (H3 N8) </ActiveSubstance>
      <ActiveSubstance>Inactivated equine influenza a Kentucky 98 (H3 N8) </ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/031/001</DrugIDPK>
    <LicenceNumber>VPA10387/031/001</LicenceNumber>
    <ProductName>Equip Rotavirus emulsion for injection for horses</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI05AA09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine rotavirus H2 strain</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/032/001</DrugIDPK>
    <LicenceNumber>VPA10387/032/001</LicenceNumber>
    <ProductName>Equip T</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>04/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI05AB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/007/001</DrugIDPK>
    <LicenceNumber>VPA22622/007/001</LicenceNumber>
    <ProductName>Equipalazone 1 g Oral Paste</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QM01AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylbutazone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/006/001</DrugIDPK>
    <LicenceNumber>VPA22622/006/001</LicenceNumber>
    <ProductName>Equipalazone 1 g Oral Powder</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/10/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QM01AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylbutazone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/006/001</DrugIDPK>
    <LicenceNumber>VPA10826/006/001</LicenceNumber>
    <ProductName>Equiparin 5,000 IU/100 g gel for horses</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>24/01/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QM02AC99</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Heparin sodium </ActiveSubstance>
      <ActiveSubstance>Hydroxyethyl Salicylate </ActiveSubstance>
      <ActiveSubstance>Levomenthol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/006/002</DrugIDPK>
    <LicenceNumber>VPA10826/006/002</LicenceNumber>
    <ProductName>Equiparin 50,000 IU/100 g gel for horses</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>24/01/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QM02AC99</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Heparin sodium </ActiveSubstance>
      <ActiveSubstance>Hydroxyethyl Salicylate </ActiveSubstance>
      <ActiveSubstance>Levomenthol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/017/001</DrugIDPK>
    <LicenceNumber>VPA10810/017/001</LicenceNumber>
    <ProductName>Equipred 50 mg tablets for horses</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>15/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/014/001</DrugIDPK>
    <LicenceNumber>VPA10810/014/001</LicenceNumber>
    <ProductName>Equizol 400 mg gastro-resistant granules for horses</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>20/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gastro-resistant granules</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/036/001</DrugIDPK>
    <LicenceNumber>VPA10454/036/001</LicenceNumber>
    <ProductName>EQVALAN DUO, oral paste</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/037/001</DrugIDPK>
    <LicenceNumber>VPA10454/037/001</LicenceNumber>
    <ProductName>EQVALAN Oral Paste for Horses 18.7 mg/g</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/109/001</DrugIDPK>
    <LicenceNumber>VPA10988/109/001</LicenceNumber>
    <ProductName>ERADIA 125 mg/ml oral suspension for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>13/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/104/001</DrugIDPK>
    <LicenceNumber>VPA10988/104/001</LicenceNumber>
    <ProductName>ERAQUELL 18.7 mg/g  Oral Paste</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/005/001</DrugIDPK>
    <LicenceNumber>VPA10509/005/001</LicenceNumber>
    <ProductName>Espacox 50 mg/ml oral suspension for pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>04/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51BC01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/227/001</DrugIDPK>
    <LicenceNumber>VPA10996/227/001</LicenceNumber>
    <ProductName>Estrumate 250 micrograms/ml Solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>14/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Donkey</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/038/001</DrugIDPK>
    <LicenceNumber>VPA10454/038/001</LicenceNumber>
    <ProductName>Eurican DAP lyophilisate and solvent for suspension for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>15/07/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Attenuated canine distemper virus, strain ba5</ActiveSubstance>
      <ActiveSubstance>Attenuated canine adenovirus type 2, strain dk13</ActiveSubstance>
      <ActiveSubstance>Attenuated canine parvovirus, strain cgf</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/039/001</DrugIDPK>
    <LicenceNumber>VPA10454/039/001</LicenceNumber>
    <ProductName>Eurican DAPPi lyophilisate and solvent for suspension for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>22/07/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Attenuated canine distemper virus, strain ba5</ActiveSubstance>
      <ActiveSubstance>Attenuated canine adenovirus type 2, strain dk13</ActiveSubstance>
      <ActiveSubstance>Attenuated canine parvovirus, strain cag2</ActiveSubstance>
      <ActiveSubstance>Attenuated canine parainfluenza virus type 2, strain cgf 2004/75</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/040/001</DrugIDPK>
    <LicenceNumber>VPA10454/040/001</LicenceNumber>
    <ProductName>Eurican DHPPi lyophilisate for suspension for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>28/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Attenuated canine distemper virus, strain ba5</ActiveSubstance>
      <ActiveSubstance>Attenuated canine adenovirus type 2, strain dk13</ActiveSubstance>
      <ActiveSubstance>Attenuated canine parvovirus, strain cag2</ActiveSubstance>
      <ActiveSubstance>Attenuated canine parainfluenza virus type 2, strain cgf 2004/75</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/117/003</DrugIDPK>
    <LicenceNumber>VPA10987/117/003</LicenceNumber>
    <ProductName>Eurofen 100 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/08/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/117/001</DrugIDPK>
    <LicenceNumber>VPA10987/117/001</LicenceNumber>
    <ProductName>Eurofen 20 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/08/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/117/002</DrugIDPK>
    <LicenceNumber>VPA10987/117/002</LicenceNumber>
    <ProductName>Eurofen 50 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/08/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/014/001</DrugIDPK>
    <LicenceNumber>VPA10980/014/001</LicenceNumber>
    <ProductName>Euthanimal 200 mg/ml, solution for injection</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>29/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium pentobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
      <Species>Horse (non-food producing)</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Frog</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Pigeons</Species>
      <Species>Rabbit (non-food-producing)</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Snake</Species>
      <Species>Turtle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/014/002</DrugIDPK>
    <LicenceNumber>VPA10980/014/002</LicenceNumber>
    <ProductName>Euthanimal 400 mg/ml, solution for injection</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>29/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium pentobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
      <Species>Horse (non-food producing)</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Frog</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Pigeons</Species>
      <Species>Rabbit (non-food-producing)</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Snake</Species>
      <Species>Turtle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/011/001</DrugIDPK>
    <LicenceNumber>VPA10816/011/001</LicenceNumber>
    <ProductName>Euthasol vet. 400 mg/ml, solution for injection</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>16/12/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentobarbital sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mink</Species>
      <Species>Mouse</Species>
      <Species>Rat</Species>
      <Species>Sheep</Species>
      <Species>Horse (non-food producing)</Species>
      <Species>Rabbit (non-food-producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/008/001</DrugIDPK>
    <LicenceNumber>VPA10400/008/001</LicenceNumber>
    <ProductName>EUTHATAL solution for injection 200 mg in 1 ml</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>01/10/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentobarbital sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/115/001</DrugIDPK>
    <LicenceNumber>VPA10987/115/001</LicenceNumber>
    <ProductName>Euthoxin 500 mg/ml solution for injection.</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intrapulmonary use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentobarbital sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Hare</Species>
      <Species>Mink</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Pigeons</Species>
      <Species>Pigs</Species>
      <Species>Polecat</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Horse (non-food producing)</Species>
      <Species>Rabbit (non-food-producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA1717/001/001</DrugIDPK>
    <LicenceNumber>VPA1717/001/001</LicenceNumber>
    <ProductName>Evoctin 10 mg/ml solution for injection for cattle, sheep, pigs</ProductName>
    <PAHolder>ADOH B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA1717/003/001</DrugIDPK>
    <LicenceNumber>VPA1717/003/001</LicenceNumber>
    <ProductName>Evoctin Plus</ProductName>
    <PAHolder>ADOH B.V.</PAHolder>
    <AuthorisedDate>14/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/138/003</DrugIDPK>
    <LicenceNumber>VPA10987/138/003</LicenceNumber>
    <ProductName>Exidot 100 mg Spot-on solution for Medium Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/138/004</DrugIDPK>
    <LicenceNumber>VPA10987/138/004</LicenceNumber>
    <ProductName>Exidot 250 mg Spot-on solution for Large Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/138/001</DrugIDPK>
    <LicenceNumber>VPA10987/138/001</LicenceNumber>
    <ProductName>Exidot 40 mg Spot-on solution for Small Cats, Small Pet Rabbits &amp; Small Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/138/005</DrugIDPK>
    <LicenceNumber>VPA10987/138/005</LicenceNumber>
    <ProductName>Exidot 400 mg Spot-on solution for Extra Large Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/138/002</DrugIDPK>
    <LicenceNumber>VPA10987/138/002</LicenceNumber>
    <ProductName>Exidot 80 mg Spot-on solution for Large Cats and Large Pet Rabbits</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX17</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/103/001</DrugIDPK>
    <LicenceNumber>VPA10987/103/001</LicenceNumber>
    <ProductName>Exitel 230/20 mg Flavoured Film-Coated Tablets for Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/078/001</DrugIDPK>
    <LicenceNumber>VPA10987/078/001</LicenceNumber>
    <ProductName>Exitel Plus Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 10(3) of Directive No 2001/83/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/078/002</DrugIDPK>
    <LicenceNumber>VPA10987/078/002</LicenceNumber>
    <ProductName>Exitel Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/018/001</DrugIDPK>
    <LicenceNumber>VPA22033/018/001</LicenceNumber>
    <ProductName>Exodus Oral Paste</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>03/10/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP52AF02</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/019/001</DrugIDPK>
    <LicenceNumber>VPA22033/019/001</LicenceNumber>
    <ProductName>Ezeepour 2.5% w/v Pour on Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin technical (93%) (cis: trans 50:50)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/020/001</DrugIDPK>
    <LicenceNumber>VPA22033/020/001</LicenceNumber>
    <ProductName>Fasifree 100 mg/ml Oral Suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>22/02/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/003/001</DrugIDPK>
    <LicenceNumber>VPA22020/003/001</LicenceNumber>
    <ProductName>Fasinex 240 mg/ml oral suspension for cattle</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/011/001</DrugIDPK>
    <LicenceNumber>VPA10836/011/001</LicenceNumber>
    <ProductName>Fatrobendan 1.25 mg, chewable tablets for dogs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>19/03/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/011/003</DrugIDPK>
    <LicenceNumber>VPA10836/011/003</LicenceNumber>
    <ProductName>Fatrobendan 10 mg, chewable tablets for dogs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>19/03/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/011/002</DrugIDPK>
    <LicenceNumber>VPA10836/011/002</LicenceNumber>
    <ProductName>Fatrobendan 5 mg, chewable tablets for dogs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>19/03/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/012/001</DrugIDPK>
    <LicenceNumber>VPA10836/012/001</LicenceNumber>
    <ProductName>Fatroseal 2.6 g intramammary suspension for dry cows</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/009/003</DrugIDPK>
    <LicenceNumber>VPA22622/009/003</LicenceNumber>
    <ProductName>Felimazole 1.25 mg Coated tablets for cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/009/001</DrugIDPK>
    <LicenceNumber>VPA22622/009/001</LicenceNumber>
    <ProductName>Felimazole 2.5 mg Coated Tablets for Cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/009/004</DrugIDPK>
    <LicenceNumber>VPA22622/009/004</LicenceNumber>
    <ProductName>Felimazole 5 mg/ml oral solution for cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>06/10/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/009/002</DrugIDPK>
    <LicenceNumber>VPA22622/009/002</LicenceNumber>
    <ProductName>Felimazole 5 mg Coated Tablets for Cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/186/001</DrugIDPK>
    <LicenceNumber>VPA10987/186/001</LicenceNumber>
    <ProductName>Felipex 5 mg/ml oral solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>17/07/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in pharmaceutical form (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10462/003/001</DrugIDPK>
    <LicenceNumber>VPA10462/003/001</LicenceNumber>
    <ProductName>Fenafluke 5% w/v Oral Suspension</ProductName>
    <PAHolder>Pharvet (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/09/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
      <ATC>QP52AX</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/002/001</DrugIDPK>
    <LicenceNumber>VPA10915/002/001</LicenceNumber>
    <ProductName>Fenben 10 Oral Suspension</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/02/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10462/002/001</DrugIDPK>
    <LicenceNumber>VPA10462/002/001</LicenceNumber>
    <ProductName>Fenbenor 100 mg/ml oral drench for cattle</ProductName>
    <PAHolder>Pharvet (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/07/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10462/002/002</DrugIDPK>
    <LicenceNumber>VPA10462/002/002</LicenceNumber>
    <ProductName>Fenbenor 25 mg/ml oral drench for sheep</ProductName>
    <PAHolder>Pharvet (Ireland) Limited</PAHolder>
    <AuthorisedDate>04/08/1992</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/080/001</DrugIDPK>
    <LicenceNumber>VPA10454/080/001</LicenceNumber>
    <ProductName>Fencovis</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>19/08/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Escherichia coli, strain 08:K35, fimbrial adhesin F5, Inactivated</ActiveSubstance>
      <ActiveSubstance>Bovine rotavirus, strain TM-91, Inactivated</ActiveSubstance>
      <ActiveSubstance>Bovine coronavirus strain c-197 (inactivated)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/010/001</DrugIDPK>
    <LicenceNumber>VPA10774/010/001</LicenceNumber>
    <ProductName>Fenflor 300 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>03/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/009/001</DrugIDPK>
    <LicenceNumber>VPA10774/009/001</LicenceNumber>
    <ProductName>Fenflor 300 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>26/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/072/002</DrugIDPK>
    <LicenceNumber>VPA10987/072/002</LicenceNumber>
    <ProductName>Fenoflox 100 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/05/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/072/001</DrugIDPK>
    <LicenceNumber>VPA10987/072/001</LicenceNumber>
    <ProductName>Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/05/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/148/001</DrugIDPK>
    <LicenceNumber>VPA10987/148/001</LicenceNumber>
    <ProductName>Fermectin 1 % Solution for Injection for Pigs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/06/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/016/001</DrugIDPK>
    <LicenceNumber>VPA10516/016/001</LicenceNumber>
    <ProductName>Fertigest 0.004 mg/ml Solution for Injection</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>01/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buserelin acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/024/002</DrugIDPK>
    <LicenceNumber>VPA10509/024/002</LicenceNumber>
    <ProductName>Ficoxil 227 mg chewable tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Firocoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/024/001</DrugIDPK>
    <LicenceNumber>VPA10509/024/001</LicenceNumber>
    <ProductName>Ficoxil 57 mg chewable tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Firocoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/228/001</DrugIDPK>
    <LicenceNumber>VPA10996/228/001</LicenceNumber>
    <ProductName>Finadyne, 50 mg/ml, solution for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/015/001</DrugIDPK>
    <LicenceNumber>VPA10475/015/001</LicenceNumber>
    <ProductName>Finilac 50 microgram/ml oral solution for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG02CB03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/095/002</DrugIDPK>
    <LicenceNumber>VPA10987/095/002</LicenceNumber>
    <ProductName>Fipnil 134 mg Spot-on Solution for medium dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/095/003</DrugIDPK>
    <LicenceNumber>VPA10987/095/003</LicenceNumber>
    <ProductName>Fipnil 268 mg Spot-on Solution for large dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/095/004</DrugIDPK>
    <LicenceNumber>VPA10987/095/004</LicenceNumber>
    <ProductName>Fipnil 402 mg Spot-on Solution for extra large dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/096/001</DrugIDPK>
    <LicenceNumber>VPA10987/096/001</LicenceNumber>
    <ProductName>Fipnil 50 mg Spot-on solution for Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/095/001</DrugIDPK>
    <LicenceNumber>VPA10987/095/001</LicenceNumber>
    <ProductName>Fipnil 67 mg Spot-on Solution for small dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/005/001</DrugIDPK>
    <LicenceNumber>VPA20742/005/001</LicenceNumber>
    <ProductName>FIPREX DUO 50 mg+ 60 mg spot-on solution for cats and ferrets</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/004/003</DrugIDPK>
    <LicenceNumber>VPA20742/004/003</LicenceNumber>
    <ProductName>Fiprex Duo L 268 mg + 241.2 mg spot-on solution for dogs</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/004/002</DrugIDPK>
    <LicenceNumber>VPA20742/004/002</LicenceNumber>
    <ProductName>Fiprex Duo M 134 mg + 120.6 mg spot-on solution for dogs</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/004/001</DrugIDPK>
    <LicenceNumber>VPA20742/004/001</LicenceNumber>
    <ProductName>FIPREX DUO S 67 mg + 60.3 mg spot-on solution for dogs</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/004/004</DrugIDPK>
    <LicenceNumber>VPA20742/004/004</LicenceNumber>
    <ProductName>Fiprex Duo XL 402 mg + 361.8 mg spot-on solution for dogs</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/107/002</DrugIDPK>
    <LicenceNumber>VPA22664/107/002</LicenceNumber>
    <ProductName>Fiproclear 134 mg Spot-On Solution for Medium Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/107/003</DrugIDPK>
    <LicenceNumber>VPA22664/107/003</LicenceNumber>
    <ProductName>Fiproclear 268 mg Spot-On Solution for Large Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/107/004</DrugIDPK>
    <LicenceNumber>VPA22664/107/004</LicenceNumber>
    <ProductName>Fiproclear 402 mg Spot-On Solution for Very Large Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/108/001</DrugIDPK>
    <LicenceNumber>VPA22664/108/001</LicenceNumber>
    <ProductName>Fiproclear 50 mg Spot-On Solution for Cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/107/001</DrugIDPK>
    <LicenceNumber>VPA22664/107/001</LicenceNumber>
    <ProductName>Fiproclear 67 mg Spot-On Solution for Small Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/137/002</DrugIDPK>
    <LicenceNumber>VPA22664/137/002</LicenceNumber>
    <ProductName>Fiproclear Combo 134 mg/120.6 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/137/003</DrugIDPK>
    <LicenceNumber>VPA22664/137/003</LicenceNumber>
    <ProductName>Fiproclear Combo 268 mg/241.2 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/137/004</DrugIDPK>
    <LicenceNumber>VPA22664/137/004</LicenceNumber>
    <ProductName>Fiproclear Combo 402 mg/361.8 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/134/001</DrugIDPK>
    <LicenceNumber>VPA22664/134/001</LicenceNumber>
    <ProductName>Fiproclear Combo 50 mg/60 mg spot-on solution for cats and ferrets</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/137/001</DrugIDPK>
    <LicenceNumber>VPA22664/137/001</LicenceNumber>
    <ProductName>Fiproclear Combo 67 mg/60.3 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/057/002</DrugIDPK>
    <LicenceNumber>VPA10815/057/002</LicenceNumber>
    <ProductName>Firodyl 250 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Firocoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/057/001</DrugIDPK>
    <LicenceNumber>VPA10815/057/001</LicenceNumber>
    <ProductName>Firodyl 62.5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Firocoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23174/002/001</DrugIDPK>
    <LicenceNumber>VPA23174/002/001</LicenceNumber>
    <ProductName>Fixplan 200 IU/ml lyophilisate and solvent for solution for injection</ProductName>
    <PAHolder>Syn Vet-Pharma Ireland Limited</PAHolder>
    <AuthorisedDate>05/03/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadotrophin, Equine Serum, For Veterinary Use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/136/002</DrugIDPK>
    <LicenceNumber>VPA22664/136/002</LicenceNumber>
    <ProductName>Fleanil Combo 134 mg/120.6 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>S-methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/136/003</DrugIDPK>
    <LicenceNumber>VPA22664/136/003</LicenceNumber>
    <ProductName>Fleanil Combo 268 mg/241.2 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-methopene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/136/004</DrugIDPK>
    <LicenceNumber>VPA22664/136/004</LicenceNumber>
    <ProductName>Fleanil Combo 402 mg/361.8 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>S-methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/132/001</DrugIDPK>
    <LicenceNumber>VPA22664/132/001</LicenceNumber>
    <ProductName>Fleanil Combo 50 mg/60 mg spot-on solution for cats and ferrets</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/136/001</DrugIDPK>
    <LicenceNumber>VPA22664/136/001</LicenceNumber>
    <ProductName>Fleanil Combo 67 mg/60.3 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/002</DrugIDPK>
    <LicenceNumber>VPA10987/106/002</LicenceNumber>
    <ProductName>Fleaway 134 mg Spot-on Solution for medium dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/003</DrugIDPK>
    <LicenceNumber>VPA10987/106/003</LicenceNumber>
    <ProductName>Fleaway 268 mg Spot-on Solution for large dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/004</DrugIDPK>
    <LicenceNumber>VPA10987/106/004</LicenceNumber>
    <ProductName>Fleaway 402 mg Spot-on Solution for extra large dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/105/001</DrugIDPK>
    <LicenceNumber>VPA10987/105/001</LicenceNumber>
    <ProductName>Fleaway 50 mg Spot on solution for cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/001</DrugIDPK>
    <LicenceNumber>VPA10987/106/001</LicenceNumber>
    <ProductName>Fleaway 67 mg Spot-on Solution for small dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/008</DrugIDPK>
    <LicenceNumber>VPA10987/106/008</LicenceNumber>
    <ProductName>Fleaway Plus 134 mg/120.6 mg Spot-on Solution for Medium Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>10/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/007</DrugIDPK>
    <LicenceNumber>VPA10987/106/007</LicenceNumber>
    <ProductName>Fleaway Plus 268 mg/241.2 mg Spot-on Solution for Large Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>10/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/006</DrugIDPK>
    <LicenceNumber>VPA10987/106/006</LicenceNumber>
    <ProductName>Fleaway Plus 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>10/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/009</DrugIDPK>
    <LicenceNumber>VPA10987/106/009</LicenceNumber>
    <ProductName>Fleaway Plus 50 mg/60 mg Spot-on Solution for Cats and Ferrets</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>10/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/106/005</DrugIDPK>
    <LicenceNumber>VPA10987/106/005</LicenceNumber>
    <ProductName>Fleaway Plus 67 mg/60.3 mg Spot-on Solution for Small Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>10/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/034/001</DrugIDPK>
    <LicenceNumber>VPA10387/034/001</LicenceNumber>
    <ProductName>Flectron Fly Tags 935 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear tag</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/021/001</DrugIDPK>
    <LicenceNumber>VPA22033/021/001</LicenceNumber>
    <ProductName>Flexiben 100 mg/ml SC Oral Suspension for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>27/06/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/015/001</DrugIDPK>
    <LicenceNumber>VPA10774/015/001</LicenceNumber>
    <ProductName>FLIMABEND 100 mg/g suspension for use in drinking water for chickens and pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/03/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC12</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flubendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/006/001</DrugIDPK>
    <LicenceNumber>VPA10791/006/001</LicenceNumber>
    <ProductName>Flordofen 300 mg/ml Solution for injection for cattle and pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/013/001</DrugIDPK>
    <LicenceNumber>VPA10981/013/001</LicenceNumber>
    <ProductName>FLORFENIKEL 300 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/007/001</DrugIDPK>
    <LicenceNumber>VPA10495/007/001</LicenceNumber>
    <ProductName>FLORFENIS 300 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>12/02/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/001/001</DrugIDPK>
    <LicenceNumber>VPA10534/001/001</LicenceNumber>
    <ProductName>Florgane 300 mg/ml Suspension for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>13/08/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/006/001</DrugIDPK>
    <LicenceNumber>VPA10665/006/001</LicenceNumber>
    <ProductName>FLORINJECT 300 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/008/001</DrugIDPK>
    <LicenceNumber>VPA10815/008/001</LicenceNumber>
    <ProductName>Florkem 300 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/003/001</DrugIDPK>
    <LicenceNumber>VPA10402/003/001</LicenceNumber>
    <ProductName>FLOROLAB 100 mg/ml solution for use in drinking water for pigs</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>23/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/009/001</DrugIDPK>
    <LicenceNumber>VPA10786/009/001</LicenceNumber>
    <ProductName>Flortekxin 300 mg/ml + 16.5 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>28/03/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA99</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
      <ActiveSubstance>Flunixin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/006/001</DrugIDPK>
    <LicenceNumber>VPA10816/006/001</LicenceNumber>
    <ProductName>Floxabactin 15 mg tablets for cats and dogs</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>03/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/006/003</DrugIDPK>
    <LicenceNumber>VPA10816/006/003</LicenceNumber>
    <ProductName>Floxabactin 150 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>03/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/006/002</DrugIDPK>
    <LicenceNumber>VPA10816/006/002</LicenceNumber>
    <ProductName>Floxabactin 50 mg tablets for dogs</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>03/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/002/001</DrugIDPK>
    <LicenceNumber>VPA10790/002/001</LicenceNumber>
    <ProductName>Floxamax 100 mg/ml concentrate for oral solution for chickens and turkeys</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/071/002</DrugIDPK>
    <LicenceNumber>VPA10987/071/002</LicenceNumber>
    <ProductName>Floxibac 100 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/071/001</DrugIDPK>
    <LicenceNumber>VPA10987/071/001</LicenceNumber>
    <ProductName>Floxibac 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/037/001</DrugIDPK>
    <LicenceNumber>VPA22020/037/001</LicenceNumber>
    <ProductName>Flubendazole Elanco 50 mg/g oral powder for pigs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QP52AC12</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flubendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/028/001</DrugIDPK>
    <LicenceNumber>VPA22020/028/001</LicenceNumber>
    <ProductName>Flubenol 50 mg/g Oral Powder</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QP52AC12</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flubendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/006/001</DrugIDPK>
    <LicenceNumber>VPA22020/006/001</LicenceNumber>
    <ProductName>Flubenol 50 mg/g Premix for Medicated Feeding Stuff</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP52AC12</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flubendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Goose</Species>
      <Species>Partridge</Species>
      <Species>Pheasants</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/036/001</DrugIDPK>
    <LicenceNumber>VPA22622/036/001</LicenceNumber>
    <ProductName>Fluboral 200 mg/ml, suspension for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>05/05/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP52AC12</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flubendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/017/001</DrugIDPK>
    <LicenceNumber>VPA10791/017/001</LicenceNumber>
    <ProductName>Fludosol 200 mg/ml Suspension for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>30/06/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP52AC12</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flubendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/001/001</DrugIDPK>
    <LicenceNumber>VPA22020/001/001</LicenceNumber>
    <ProductName>Flukiver 50 mg/ml Oral Suspension for sheep and lambs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG09</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Closantel sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/039/001</DrugIDPK>
    <LicenceNumber>VPA22020/039/001</LicenceNumber>
    <ProductName>Flukiver Combi 50 mg/ml + 75 mg/ml oral suspension</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52A</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
      <ActiveSubstance>Mebendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/061/001</DrugIDPK>
    <LicenceNumber>VPA22033/061/001</LicenceNumber>
    <ProductName>Flunazine 50 mg/ml Solution for Injection for cattle, horses and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>27/07/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/009/001</DrugIDPK>
    <LicenceNumber>VPA10509/009/001</LicenceNumber>
    <ProductName>Flunex 50 mg/ml solution for injection for cattle, horses and pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>19/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/046/001</DrugIDPK>
    <LicenceNumber>VPA22664/046/001</LicenceNumber>
    <ProductName>Flunixin Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>23/04/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/009/001</DrugIDPK>
    <LicenceNumber>VPA23340/009/001</LicenceNumber>
    <ProductName>Fluoxevet 32 mg, tablets for dogs</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>02/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN06AB03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/048/001</DrugIDPK>
    <LicenceNumber>VPA10387/048/001</LicenceNumber>
    <ProductName>Fly and Lice Spot On Insecticide 10 mg/ml spot-on solution for cattle and sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>04/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/055/001</DrugIDPK>
    <LicenceNumber>VPA10996/055/001</LicenceNumber>
    <ProductName>Folligon PMSG 200 IU/ml lyophilisate and solvent for solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>19/09/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadotropin, equine, serum </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/050/001</DrugIDPK>
    <LicenceNumber>VPA10983/050/001</LicenceNumber>
    <ProductName>Folltropin 700 IU Powder and Solvent for solution for injection</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>06/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine follicle stimulating hormone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/232/001</DrugIDPK>
    <LicenceNumber>VPA10996/232/001</LicenceNumber>
    <ProductName>Footvax Emulsion for Injection for Sheep</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>20/02/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI04AB03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dichelobacter nodosus serotype I</ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype H</ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype G</ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosusserotype F </ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype E</ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype D </ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype C </ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype B2</ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype B1</ActiveSubstance>
      <ActiveSubstance>Dichelobacter nodosus serotype A</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/030/001</DrugIDPK>
    <LicenceNumber>VPA10521/030/001</LicenceNumber>
    <ProductName>Forcyl 160 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/052/001</DrugIDPK>
    <LicenceNumber>VPA10983/052/001</LicenceNumber>
    <ProductName>FORCYL swine 160 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/006/001</DrugIDPK>
    <LicenceNumber>VPA20742/006/001</LicenceNumber>
    <ProductName>Forespix 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>22/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22670/002/001</DrugIDPK>
    <LicenceNumber>VPA22670/002/001</LicenceNumber>
    <ProductName>Formicpro 68.2g Beehive Strips for Honey Bees</ProductName>
    <PAHolder>NOD Apiary Ireland Limited</PAHolder>
    <AuthorisedDate>04/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Bee-hive strip</DosageForm>
    <ATCs>
      <ATC>QP53AG01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Inhalation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Formic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/017/001</DrugIDPK>
    <LicenceNumber>VPA22020/017/001</LicenceNumber>
    <ProductName>Fortekor 2.5 mg tablets for cats and dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/018/002</DrugIDPK>
    <LicenceNumber>VPA22020/018/002</LicenceNumber>
    <ProductName>Fortekor Flavour 20 mg Tablets for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/018/001</DrugIDPK>
    <LicenceNumber>VPA22020/018/001</LicenceNumber>
    <ProductName>Fortekor Flavour 5 mg Tablets for cats and dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/011/001</DrugIDPK>
    <LicenceNumber>VPA10915/011/001</LicenceNumber>
    <ProductName>Fortemec 1 % w/v Pour On Solution</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA02</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/046/001</DrugIDPK>
    <LicenceNumber>VPA10454/046/001</LicenceNumber>
    <ProductName>Frontline Combo Spot-on Cat</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>14/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/047/003</DrugIDPK>
    <LicenceNumber>VPA10454/047/003</LicenceNumber>
    <ProductName>Frontline Combo Spot-on Dog L</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>14/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/047/002</DrugIDPK>
    <LicenceNumber>VPA10454/047/002</LicenceNumber>
    <ProductName>Frontline Combo Spot-on Dog M</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>14/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/047/001</DrugIDPK>
    <LicenceNumber>VPA10454/047/001</LicenceNumber>
    <ProductName>Frontline Combo Spot-on Dog S</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>14/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/047/004</DrugIDPK>
    <LicenceNumber>VPA10454/047/004</LicenceNumber>
    <ProductName>Frontline Combo Spot-on Dog XL</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>14/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/048/001</DrugIDPK>
    <LicenceNumber>VPA10454/048/001</LicenceNumber>
    <ProductName>Frontline Spot On Cat</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>12/06/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/049/001</DrugIDPK>
    <LicenceNumber>VPA10454/049/001</LicenceNumber>
    <ProductName>Frontline Spot On Dog</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>12/06/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/050/001</DrugIDPK>
    <LicenceNumber>VPA10454/050/001</LicenceNumber>
    <ProductName>Frontline Spray 0.25 w/v</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>07/07/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/024/001</DrugIDPK>
    <LicenceNumber>VPA10810/024/001</LicenceNumber>
    <ProductName>Fugasol 10 mg/ml oral solution for cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>16/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ02AC02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Itraconazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/047/001</DrugIDPK>
    <LicenceNumber>VPA22622/047/001</LicenceNumber>
    <ProductName>Fungiconazol 200 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>14/11/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoconazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/047/002</DrugIDPK>
    <LicenceNumber>VPA22622/047/002</LicenceNumber>
    <ProductName>Fungiconazol 400 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>14/11/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoconazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/017/001</DrugIDPK>
    <LicenceNumber>VPA10475/017/001</LicenceNumber>
    <ProductName>Furosoral 10 mg tablets for cats and dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>20/02/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC03CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Furosemide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/017/002</DrugIDPK>
    <LicenceNumber>VPA10475/017/002</LicenceNumber>
    <ProductName>Furosoral 40 mg tablets for cats and dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>20/02/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC03CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Furosemide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/147/001</DrugIDPK>
    <LicenceNumber>VPA22664/147/001</LicenceNumber>
    <ProductName>Fuselieve 1 mg/g + 5 mg/g Gel for Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/03/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QD07CC01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
      <ActiveSubstance>Fusidic acid hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/050/001</DrugIDPK>
    <LicenceNumber>VPA10815/050/001</LicenceNumber>
    <ProductName>Gabbrovet 140 mg/ml solution for use in drinking water, milk or milk replacer for pre-ruminant cattle and pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>13/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QA07AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paromomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/066/001</DrugIDPK>
    <LicenceNumber>VPA10815/066/001</LicenceNumber>
    <ProductName>Gabbrovet Multi 140 mg/ml solution for use in drinking water/milk</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>02/09/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QA07AA06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paromomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/010/001</DrugIDPK>
    <LicenceNumber>VPA10509/010/001</LicenceNumber>
    <ProductName>Galapan 75 micrograms/ml solution for injection for cattle, horses and pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>01/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Informed Consent application (Article 21 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>D-cloprostenol sodium salt</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/030/001</DrugIDPK>
    <LicenceNumber>VPA10782/030/001</LicenceNumber>
    <ProductName>Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>29/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pheasants</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/022/001</DrugIDPK>
    <LicenceNumber>VPA10782/022/001</LicenceNumber>
    <ProductName>Gallifen 40 mg/g premix for medicated feeding stuff for chickens and pheasants</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>20/01/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-feed use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pheasants</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/053/001</DrugIDPK>
    <LicenceNumber>VPA10454/053/001</LicenceNumber>
    <ProductName>GALLIMUNE 407 ND+IB+EDS+ART Emulsion for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>25/11/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01AA18</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated newcastle disease virus, ulser 2C strain, at least </ActiveSubstance>
      <ActiveSubstance>Inactivated infectious bronchitis virus, mass41 strain, at least</ActiveSubstance>
      <ActiveSubstance>Inactivated egg drop syndrome virus (EDS76), V127 strain, at least</ActiveSubstance>
      <ActiveSubstance>Inactivated avian rhinotracheitis virus (swollen head syndrome), vc03 strain, at least</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/054/001</DrugIDPK>
    <LicenceNumber>VPA10454/054/001</LicenceNumber>
    <ProductName>Gallimune Se + St, water-in-oil emulsion for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>22/06/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated Salmonella Enteritidis PT4</ActiveSubstance>
      <ActiveSubstance>Inactivated Salmonella Typhimurium DT 104</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/056/001</DrugIDPK>
    <LicenceNumber>VPA10454/056/001</LicenceNumber>
    <ProductName>GALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>19/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nebulisation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated coronavirus, CR88121 strain</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/079/001</DrugIDPK>
    <LicenceNumber>VPA10454/079/001</LicenceNumber>
    <ProductName>Gallivac IBD S706 NEO Effervescent tablet for use in drinking water for chickens</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>08/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Infectious bursal disease virus, attenuated strain S706</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/023/001</DrugIDPK>
    <LicenceNumber>VPA10782/023/001</LicenceNumber>
    <ProductName>GalluDoxx 500 mg/g powder for use in drinking water/milk replacer for calves, chickens and turkeys</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/084/001</DrugIDPK>
    <LicenceNumber>VPA22033/084/001</LicenceNumber>
    <ProductName>Gamrozyne 150 mg/ml Solution for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>13/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA95</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gamithromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/124/001</DrugIDPK>
    <LicenceNumber>VPA10987/124/001</LicenceNumber>
    <ProductName>Gastazole 370 mg/g oral paste for horses</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/072/001</DrugIDPK>
    <LicenceNumber>VPA22033/072/001</LicenceNumber>
    <ProductName>Gastrobim 370 mg/g oral paste for horses</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>09/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/058/001</DrugIDPK>
    <LicenceNumber>VPA10454/058/001</LicenceNumber>
    <ProductName>GastroGard 370 mg/g oral paste</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>19/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10664/009/001</DrugIDPK>
    <LicenceNumber>VPA10664/009/001</LicenceNumber>
    <ProductName>Geepenil vet 6.36 g powder for solution for injection</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>17/04/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin Sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10391/003/001</DrugIDPK>
    <LicenceNumber>VPA10391/003/001</LicenceNumber>
    <ProductName>GEFRIDERM cutaneous spray solution for dogs</ProductName>
    <PAHolder>Alphavet Zrt.</PAHolder>
    <AuthorisedDate>23/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QD07CA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
      <ActiveSubstance>Ketoconazole </ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/007/001</DrugIDPK>
    <LicenceNumber>VPA10915/007/001</LicenceNumber>
    <ProductName>Genesis 1% Pour-on Solution</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>20/12/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/009/001</DrugIDPK>
    <LicenceNumber>VPA10915/009/001</LicenceNumber>
    <ProductName>Genesis Sheep Drench 0.8 mg/ml abamectin oral solution</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/010/001</DrugIDPK>
    <LicenceNumber>VPA10826/010/001</LicenceNumber>
    <ProductName>Genestran 75 micrograms/ml solution for injection for cattle, horses and pigs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>D-cloprostenol sodium salt</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/011/001</DrugIDPK>
    <LicenceNumber>VPA10981/011/001</LicenceNumber>
    <ProductName>Genta 50 mg/ml solution for injection</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>01/10/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01GB03</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/008/001</DrugIDPK>
    <LicenceNumber>VPA10445/008/001</LicenceNumber>
    <ProductName>GentaDug 85 mg/ml solution for injection for horses, cattle, pigs, dogs and cats</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>04/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01GB03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10976/002/001</DrugIDPK>
    <LicenceNumber>VPA10976/002/001</LicenceNumber>
    <ProductName>Gentaject 10% Solution for Injection for Horses</ProductName>
    <PAHolder>Franklin Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01GB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23501/001/001</DrugIDPK>
    <LicenceNumber>VPA23501/001/001</LicenceNumber>
    <ProductName>GESTAVET OXYTOCIN 10 IU/ml Synthetic Oxytocin, solution for injection</ProductName>
    <PAHolder>Biogenesis Global S.L.</PAHolder>
    <AuthorisedDate>01/09/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB02</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytocin synthetic</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/001/001</DrugIDPK>
    <LicenceNumber>VPA10402/001/001</LicenceNumber>
    <ProductName>Gleptoferron Labiana 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>23/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gleptoferron</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/006/001</DrugIDPK>
    <LicenceNumber>VPA10402/006/001</LicenceNumber>
    <ProductName>Gleptolab 200 mg/ml Solution for Injection for pigs</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>14/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Iron (as gleptoferron)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/027/001</DrugIDPK>
    <LicenceNumber>VPA10815/027/001</LicenceNumber>
    <ProductName>Gleptosil 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC91</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gleptoferron</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/010/001</DrugIDPK>
    <LicenceNumber>VPA10790/010/001</LicenceNumber>
    <ProductName>GLEPTOVEX 200 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gleptoferron</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/035/001</DrugIDPK>
    <LicenceNumber>VPA10387/035/001</LicenceNumber>
    <ProductName>GLETVAX 6</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>29/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB08</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Purified toxoids of Cl. perfringens</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, fimbrial adhesin F4ac</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, fimbrial adhesin F4ab</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, fimbrial adhesin F5</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, fimbrial adhesin F6</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22633/001/001</DrugIDPK>
    <LicenceNumber>VPA22633/001/001</LicenceNumber>
    <ProductName>Glucadex 2 mg/ml solution for injection for horses, cattle, goats, pigs, dogs and cats</ProductName>
    <PAHolder>Kepro B.V.</PAHolder>
    <AuthorisedDate>14/02/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Periarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/009/001</DrugIDPK>
    <LicenceNumber>VPA10445/009/001</LicenceNumber>
    <ProductName>Glucobel 40 g/100 ml solution for infusion for horses, cattle, sheep, goats, pigs, dogs and cats</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>25/11/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BA03</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10465/001/001</DrugIDPK>
    <LicenceNumber>VPA10465/001/001</LicenceNumber>
    <ProductName>Glucose B. Braun Vet Care 50 mg/ml solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats</ProductName>
    <PAHolder>B. Braun Melsungen AG.</PAHolder>
    <AuthorisedDate>27/04/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BA03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/023/001</DrugIDPK>
    <LicenceNumber>VPA22033/023/001</LicenceNumber>
    <ProductName>Gold Fleece Sheep Dip 600 mg/g Concentrate for Dip Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip solution</DosageForm>
    <ATCs>
      <ATC>QP53AF03</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dimpylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/004/001</DrugIDPK>
    <LicenceNumber>VPA10539/004/001</LicenceNumber>
    <ProductName>Gonavet Veyx 50 micrograms/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>20/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadorelin (6-D-phenylalanine) acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/021/001</DrugIDPK>
    <LicenceNumber>VPA10846/021/001</LicenceNumber>
    <ProductName>GRIPORK emulsion for injection for pigs</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>14/11/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AA03</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Influenza A virus, subtype H1N1, strain OLL (swine), Inactivated</ActiveSubstance>
      <ActiveSubstance>Influenza A virus, subtype H3N2, strain G (swine), Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/007/001</DrugIDPK>
    <LicenceNumber>VPA10786/007/001</LicenceNumber>
    <ProductName>Halofusol 0.5 mg/ml oral solution for calves</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>18/12/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP51AX08</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Halofuginone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/061/001</DrugIDPK>
    <LicenceNumber>VPA10454/061/001</LicenceNumber>
    <ProductName>HATCHPAK IB H120 NEO effervescent tablet for nebuliser suspension for chickens</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nebulisation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live avian infectious bronchitis virus (strain h120)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/018/002</DrugIDPK>
    <LicenceNumber>VPA10509/018/002</LicenceNumber>
    <ProductName>Hedylon 25 mg tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>15/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/018/001</DrugIDPK>
    <LicenceNumber>VPA10509/018/001</LicenceNumber>
    <ProductName>Hedylon 5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>15/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10389/004/001</DrugIDPK>
    <LicenceNumber>VPA10389/004/001</LicenceNumber>
    <ProductName>HEMOSILATE 125 mg/ml Solution for injection</ProductName>
    <PAHolder>Ecuphar Veterinaria S.L.U.</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB02BX01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Etamsylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/146/001</DrugIDPK>
    <LicenceNumber>VPA10996/146/001</LicenceNumber>
    <ProductName>Heptavac P Plus</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>21/03/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI04AB05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clostridium perfringens beta toxoid (strains 554 and 578)</ActiveSubstance>
      <ActiveSubstance>Clostridium perfringens epsilon toxoid (strain 603)</ActiveSubstance>
      <ActiveSubstance>Clostridium septicum toxoid (strain 505)</ActiveSubstance>
      <ActiveSubstance>Clostridium tetani toxoid (strain s1123/91)</ActiveSubstance>
      <ActiveSubstance>Clostridium novyi toxoid (strain 754)</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei cells and equivalent toxoid of strain 655</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei cells and equivalent toxoid of strain 656</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei cells and equivalent toxoid of strain 657</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei cells and equivalent toxoid of strain 658</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei cells and equivalent toxoid of strain 1048</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella haemolytica strain a1 (s1006/77)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella haemolytica strain a2 (s1126/92)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella haemolytica strain a6 (s1084/81)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella haemolytica strain a7 (s1078/81)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella haemolytica strain a9 (s994/77)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella trehalosi strain t3 (s1109/84)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella trehalosi strain t4 (s1085/81)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella trehalosi strain t10 (s1075/81)</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella trehalosi strain t15 (s1105/84)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/049/001</DrugIDPK>
    <LicenceNumber>VPA22664/049/001</LicenceNumber>
    <ProductName>Hexasol LA Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>05/02/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA56</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/009/001</DrugIDPK>
    <LicenceNumber>VPA10790/009/001</LicenceNumber>
    <ProductName>HIDROCOL, 4000000 IU/ml solution for use in drinking water/milk</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>15/07/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QA07AA10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Colistin   </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/005/001</DrugIDPK>
    <LicenceNumber>VPA10846/005/001</LicenceNumber>
    <ProductName>HIPRABOVIS SOMNI/Lkt emulsion for injection for cattle</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>27/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Haemophilus somnus bailie strain, inactivated</ActiveSubstance>
      <ActiveSubstance>Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/003/001</DrugIDPK>
    <LicenceNumber>VPA10846/003/001</LicenceNumber>
    <ProductName>HIPRABOVIS-4</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>06/06/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AH</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated infectious bovine rhinotracheitis virus strain LA</ActiveSubstance>
      <ActiveSubstance>Inactivated parainfluenza-3 virus, strain SF4</ActiveSubstance>
      <ActiveSubstance>Inactivated bovine diarrhoea virus strain NADL</ActiveSubstance>
      <ActiveSubstance>Live bovine respiratory strain lym-56 </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Mixed Vaccine (L &amp; A)</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/009/001</DrugIDPK>
    <LicenceNumber>VPA10846/009/001</LicenceNumber>
    <ProductName>Hipracox Broilers Oral suspension for chicken</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>31/10/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QI01AN01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eimeria acervulina, strain 003</ActiveSubstance>
      <ActiveSubstance>Eimeria maxima, strain 013</ActiveSubstance>
      <ActiveSubstance>Eimeria mitis, strain 006</ActiveSubstance>
      <ActiveSubstance>Eimeria praecox, strain 007</ActiveSubstance>
      <ActiveSubstance>Eimeria tenella, strain 004</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/017/001</DrugIDPK>
    <LicenceNumber>VPA10846/017/001</LicenceNumber>
    <ProductName>Hipragumboro CW Lyophilisate for use in drinking water</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>07/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bursal disease virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/014/001</DrugIDPK>
    <LicenceNumber>VPA10846/014/001</LicenceNumber>
    <ProductName>HIPRAGUMBORO-G97</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live Infectious Bursal Disease Virus, strain GM97</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/029/001</DrugIDPK>
    <LicenceNumber>VPA10475/029/001</LicenceNumber>
    <ProductName>Histodine 10 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QR06AB04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlorphenamine maleate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/039/001</DrugIDPK>
    <LicenceNumber>VPA10782/039/001</LicenceNumber>
    <ProductName>Huvacillin 800 mg/g Powder for use in drinking water for chickens and pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>05/08/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Drinking Water</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/038/001</DrugIDPK>
    <LicenceNumber>VPA10782/038/001</LicenceNumber>
    <ProductName>Huvamox 800 mg/g powder for use in drinking water for chickens, turkeys, ducks and pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>16/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/037/001</DrugIDPK>
    <LicenceNumber>VPA10782/037/001</LicenceNumber>
    <ProductName>Huvebiotic 330 mg/100 mg Intramammary solution</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>29/10/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary solution</DosageForm>
    <ATCs>
      <ATC>QJ51RF03</ATC>
      <ATC>QJ51RG01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
      <ActiveSubstance>Lincomycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/027/001</DrugIDPK>
    <LicenceNumber>VPA10782/027/001</LicenceNumber>
    <ProductName>HuveGuard MMAT suspension for oral suspension for chickens</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QI01AN</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eimeria acervulina </ActiveSubstance>
      <ActiveSubstance>Eimeria maxima </ActiveSubstance>
      <ActiveSubstance>Eimeria mitis </ActiveSubstance>
      <ActiveSubstance>Eimeria tenella </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/025/001</DrugIDPK>
    <LicenceNumber>VPA10782/025/001</LicenceNumber>
    <ProductName>HuveGuard NB suspension for oral suspension for chickens</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>19/08/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QI01AN01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eimeria brunetti strain roybru 3+28</ActiveSubstance>
      <ActiveSubstance>Eimeria necatrix strain mednec 3+8</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/040/002</DrugIDPK>
    <LicenceNumber>VPA10782/040/002</LicenceNumber>
    <ProductName>Huvexxin 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>03/02/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/040/001</DrugIDPK>
    <LicenceNumber>VPA10782/040/001</LicenceNumber>
    <ProductName>Huvexxin 25 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>03/02/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/010/001</DrugIDPK>
    <LicenceNumber>VPA22622/010/001</LicenceNumber>
    <ProductName>HY-50 Vet. 17 mg/ml solution for injection for horses</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>22/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM09AX01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium hyaluronate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/007/001</DrugIDPK>
    <LicenceNumber>VPA10782/007/001</LicenceNumber>
    <ProductName>HydroDoxx 500 mg/g Powder for use in drinking water for chickens and pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/043/001</DrugIDPK>
    <LicenceNumber>VPA10782/043/001</LicenceNumber>
    <ProductName>Hydrotrim 500 mg/g + 100 mg/g powder for use in drinking water/milk for cattle, sheep, pigs and chickens</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>14/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine sodium</ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/001/001</DrugIDPK>
    <LicenceNumber>VPA10509/001/001</LicenceNumber>
    <ProductName>Hymatil 300 mg/ml solution for injection for cattle and sheep</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>17/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/026/001</DrugIDPK>
    <LicenceNumber>VPA10815/026/001</LicenceNumber>
    <ProductName>Hyogen emulsion for injection for pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated bacterin of mycoplasma hyopneumoniae strain 2940</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/062/001</DrugIDPK>
    <LicenceNumber>VPA10454/062/001</LicenceNumber>
    <ProductName>Hyonate 10 mg/ml solution for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM09AX01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium hyaluronate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/011/001</DrugIDPK>
    <LicenceNumber>VPA22622/011/001</LicenceNumber>
    <ProductName>HyperCard 10 mg Coated Tablets for Cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>10/11/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ATCs>
      <ATC>QC08DB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10453/001/001</DrugIDPK>
    <LicenceNumber>VPA10453/001/001</LicenceNumber>
    <ProductName>Hypersol 500 mg/g Powder for use in Drinking water</ProductName>
    <PAHolder>HUVEPHARMA SA</PAHolder>
    <AuthorisedDate>31/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/003/001</DrugIDPK>
    <LicenceNumber>VPA10539/003/001</LicenceNumber>
    <ProductName>Hypophysin LA 35 microgram/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>22/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carbetocin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/003/002</DrugIDPK>
    <LicenceNumber>VPA10539/003/002</LicenceNumber>
    <ProductName>Hypophysin LA 70 microgram/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>22/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carbetocin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10481/001/001</DrugIDPK>
    <LicenceNumber>VPA10481/001/001</LicenceNumber>
    <ProductName>Imaverol 100 mg/ml Concentrate for Cutaneous Emulsion</ProductName>
    <PAHolder>Audevard</PAHolder>
    <AuthorisedDate>30/09/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous emulsion</DosageForm>
    <ATCs>
      <ATC>QD01AC90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enilconazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/007/001</DrugIDPK>
    <LicenceNumber>VPA22693/007/001</LicenceNumber>
    <ProductName>Imec 10 mg/ml Solution for Injection</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>26/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/009/001</DrugIDPK>
    <LicenceNumber>VPA20742/009/001</LicenceNumber>
    <ProductName>Imidokal 85 mg/ml solution for injection for cattle and dogs</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>29/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP51E</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidocarb dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/234/001</DrugIDPK>
    <LicenceNumber>VPA10996/234/001</LicenceNumber>
    <ProductName>Imizol 85 mg/ml Solution for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP51EX01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidocarb dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/067/002</DrugIDPK>
    <LicenceNumber>VPA10774/067/002</LicenceNumber>
    <ProductName>Imoxicate 100 mg/25 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/067/003</DrugIDPK>
    <LicenceNumber>VPA10774/067/003</LicenceNumber>
    <ProductName>Imoxicate 250 mg/62.5 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/067/001</DrugIDPK>
    <LicenceNumber>VPA10774/067/001</LicenceNumber>
    <ProductName>Imoxicate 40 mg/10 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/065/001</DrugIDPK>
    <LicenceNumber>VPA10774/065/001</LicenceNumber>
    <ProductName>Imoxicate 40 mg/4 mg spot-on solution for small cats and ferrets</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/067/004</DrugIDPK>
    <LicenceNumber>VPA10774/067/004</LicenceNumber>
    <ProductName>Imoxicate 400 mg/100 mg spot-on solution for extra-large dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/066/001</DrugIDPK>
    <LicenceNumber>VPA10774/066/001</LicenceNumber>
    <ProductName>Imoxicate 80 mg/8 mg spot-on solution for large cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/010/001</DrugIDPK>
    <LicenceNumber>VPA10516/010/001</LicenceNumber>
    <ProductName>INDUPART 75 micrograms /mL solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>D-cloprostenol sodium salt</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/012/001</DrugIDPK>
    <LicenceNumber>VPA10495/012/001</LicenceNumber>
    <ProductName>Ingelvac Ery emulsion for injection for pigs</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>18/02/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Erysipelothrix rhusiopathiae, serotype 2, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/007/001</DrugIDPK>
    <LicenceNumber>VPA10454/007/001</LicenceNumber>
    <ProductName>Ingelvac MycoFLEX suspension for injection for pigs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated mycoplasma hyopneumoniae, j strain isolate b-3745</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/008/001</DrugIDPK>
    <LicenceNumber>VPA10454/008/001</LicenceNumber>
    <ProductName>Ingelvac PRRSFLEX EU lyophilisate and solvent for suspension for injection for pigs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>02/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Attenuated prrs 94881 virus</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/011/001</DrugIDPK>
    <LicenceNumber>VPA20742/011/001</LicenceNumber>
    <ProductName>Iniram 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>23/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Maropitant</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/018/001</DrugIDPK>
    <LicenceNumber>VPA10846/018/001</LicenceNumber>
    <ProductName>INMEVA, suspension for injection for sheep</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>14/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI04AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlamydophila abortus strain A22 inactivated</ActiveSubstance>
      <ActiveSubstance>Salmonella enterica subsp. enterica serovar Abortusovis strain Sao</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/119/001</DrugIDPK>
    <LicenceNumber>VPA22664/119/001</LicenceNumber>
    <ProductName>Insecinor 10 mg/ml Spot-on Solution for cattle and sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>05/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/009/001</DrugIDPK>
    <LicenceNumber>VPA23462/009/001</LicenceNumber>
    <ProductName>Insistor 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>20/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AC90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Methadone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23184/001/001</DrugIDPK>
    <LicenceNumber>VPA23184/001/001</LicenceNumber>
    <ProductName>Intercam 0.5 mg/ml oral suspension for cats</ProductName>
    <PAHolder>C&amp;H Generics Limited</PAHolder>
    <AuthorisedDate>15/07/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23184/002/001</DrugIDPK>
    <LicenceNumber>VPA23184/002/001</LicenceNumber>
    <ProductName>Intercam 1.5 mg/ml Oral Suspension for Dogs</ProductName>
    <PAHolder>C&amp;H Generics Limited</PAHolder>
    <AuthorisedDate>13/03/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23184/003/001</DrugIDPK>
    <LicenceNumber>VPA23184/003/001</LicenceNumber>
    <ProductName>Intercam 20 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>C&amp;H Generics Limited</PAHolder>
    <AuthorisedDate>06/03/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/011/001</DrugIDPK>
    <LicenceNumber>VPA10823/011/001</LicenceNumber>
    <ProductName>Interclox DC Intramammary Suspension</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RC</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/006/001</DrugIDPK>
    <LicenceNumber>VPA10555/006/001</LicenceNumber>
    <ProductName>Interject 15% solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>21/03/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/005/001</DrugIDPK>
    <LicenceNumber>VPA10823/005/001</LicenceNumber>
    <ProductName>Intertrim Solution for Injection</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/185/001</DrugIDPK>
    <LicenceNumber>VPA10987/185/001</LicenceNumber>
    <ProductName>Interzuril 50 mg/ml oral suspension for Piglets, Calves and Lambs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>31/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10409/001/001</DrugIDPK>
    <LicenceNumber>VPA10409/001/001</LicenceNumber>
    <ProductName>INTRA DYSOVINOL 499 mg/ml solution for use in drinking water for pigs</ProductName>
    <PAHolder>Intracare B.V.</PAHolder>
    <AuthorisedDate>06/09/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QA07XA</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Disodium zinc edetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/013/001</DrugIDPK>
    <LicenceNumber>VPA22622/013/001</LicenceNumber>
    <ProductName>Intra-Epicaine 20 mg/ml solution for injection for horses</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/12/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01BB03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Epidural use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intrabursal use</RoutesOfAdministration>
      <RoutesOfAdministration>Perineural use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Mepivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22812/005/001</DrugIDPK>
    <LicenceNumber>VPA22812/005/001</LicenceNumber>
    <ProductName>Introflor Vet 300 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Interchemie Werken De Adelaar Eesti AS.</PAHolder>
    <AuthorisedDate>05/12/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/014/001</DrugIDPK>
    <LicenceNumber>VPA22622/014/001</LicenceNumber>
    <ProductName>Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>07/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Laryngopharyngeal spray, solution</DosageForm>
    <ATCs>
      <ATC>QR02AD02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Laryngopharyngeal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine Hydrochloride Monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10803/006/001</DrugIDPK>
    <LicenceNumber>VPA10803/006/001</LicenceNumber>
    <ProductName>Isaderm 5 mg/g + 1 mg/g gel for dogs</ProductName>
    <PAHolder>Dechra Veterinary Products A/S</PAHolder>
    <AuthorisedDate>14/03/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QD07CC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fusidic acid</ActiveSubstance>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10803/004/001</DrugIDPK>
    <LicenceNumber>VPA10803/004/001</LicenceNumber>
    <ProductName>Isathal 10 mg/g eye drops, suspension for dogs, cats and rabbits</ProductName>
    <PAHolder>Dechra Veterinary Products A/S</PAHolder>
    <AuthorisedDate>15/11/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS01AA13</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fusidic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22583/001/001</DrugIDPK>
    <LicenceNumber>VPA22583/001/001</LicenceNumber>
    <ProductName>Iso-Vet 1000 mg/g Inhalation Vapour, liquid</ProductName>
    <PAHolder>Piramal Critical Care B.V.</PAHolder>
    <AuthorisedDate>25/11/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Inhalation vapour, liquid</DosageForm>
    <ATCs>
      <ATC>QN01AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Inhalation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Isoflurane </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Ferrets</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Pigs</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/012/001</DrugIDPK>
    <LicenceNumber>VPA10516/012/001</LicenceNumber>
    <ProductName>ISOFLURIN 1000 mg/g Inhalation Vapour, Liquid</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>15/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Inhalation vapour, liquid</DosageForm>
    <ATCs>
      <ATC>QN01AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Inhalation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Isoflurane </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Ferrets</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22583/002/001</DrugIDPK>
    <LicenceNumber>VPA22583/002/001</LicenceNumber>
    <ProductName>Isothesia 1000 mg/g inhalation vapour, liquid</ProductName>
    <PAHolder>Piramal Critical Care B.V.</PAHolder>
    <AuthorisedDate>09/04/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Inhalation vapour, liquid</DosageForm>
    <ATCs>
      <ATC>QN01AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Inhalation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Isoflurane </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Ferrets</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/116/001</DrugIDPK>
    <LicenceNumber>VPA10988/116/001</LicenceNumber>
    <ProductName>Itrafungol 10 mg/ml Oral Solution</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ02AC02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Itraconazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/148/001</DrugIDPK>
    <LicenceNumber>VPA22664/148/001</LicenceNumber>
    <ProductName>Iverpraz, 18.7 mg/g + 140.3 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/064/001</DrugIDPK>
    <LicenceNumber>VPA10454/064/001</LicenceNumber>
    <ProductName>Ivomec Classic Injection for Cattle and Sheep 10 mg/ml</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/065/001</DrugIDPK>
    <LicenceNumber>VPA10454/065/001</LicenceNumber>
    <ProductName>Ivomec Classic Pour-On for Cattle 5 mg/ml</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>30/03/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/068/001</DrugIDPK>
    <LicenceNumber>VPA10454/068/001</LicenceNumber>
    <ProductName>Ivomec Super Injection for Cattle</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/007/001</DrugIDPK>
    <LicenceNumber>VPA20742/007/001</LicenceNumber>
    <ProductName>Kabergovet 50 microgram/ml oral solution for dogs and cats</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>05/02/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG02CB03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>HOVR10537/011/001</DrugIDPK>
    <LicenceNumber>HOVR10537/011/001</LicenceNumber>
    <ProductName>Kali Sulphuricum 200c</ProductName>
    <PAHolder>Galway Homeopathics (Manufacturing) Limited</PAHolder>
    <AuthorisedDate>18/10/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Registered homeopathic medicinal products (Article 17 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Kali sulphuricum</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Homeopathic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/001/001</DrugIDPK>
    <LicenceNumber>VPA10555/001/001</LicenceNumber>
    <ProductName>Kanacef M.C. Intramammary Suspension</ProductName>
    <PAHolder>Interchem (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RD01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
      <ActiveSubstance>Kanamycin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/002/001</DrugIDPK>
    <LicenceNumber>VPA10786/002/001</LicenceNumber>
    <ProductName>KARIFLOX 100 mg/ml Oral Solution for Chickens and Turkeys</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>12/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/004/001</DrugIDPK>
    <LicenceNumber>VPA10786/004/001</LicenceNumber>
    <ProductName>KARIFLOX 25 mg/ml oral solution for calves</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>10/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/003/001</DrugIDPK>
    <LicenceNumber>VPA10786/003/001</LicenceNumber>
    <ProductName>KARIFLOX 5 mg/ml oral solution for piglets</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>10/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/006/003</DrugIDPK>
    <LicenceNumber>VPA10774/006/003</LicenceNumber>
    <ProductName>Karprovet 100 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/006/001</DrugIDPK>
    <LicenceNumber>VPA10774/006/001</LicenceNumber>
    <ProductName>Karprovet 20 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/005/001</DrugIDPK>
    <LicenceNumber>VPA10774/005/001</LicenceNumber>
    <ProductName>Karprovet 50 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/006/002</DrugIDPK>
    <LicenceNumber>VPA10774/006/002</LicenceNumber>
    <ProductName>Karprovet 50 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/025/001</DrugIDPK>
    <LicenceNumber>VPA22033/025/001</LicenceNumber>
    <ProductName>Keelogane SC 25 mg/ml Oral suspension for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>30/06/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/041/001</DrugIDPK>
    <LicenceNumber>VPA22033/041/001</LicenceNumber>
    <ProductName>KEFAMAST Dry Cow Intramammary Suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RD01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/016/001</DrugIDPK>
    <LicenceNumber>VPA10981/016/001</LicenceNumber>
    <ProductName>Kelamoxil LA 150 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>25/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/012/001</DrugIDPK>
    <LicenceNumber>VPA10981/012/001</LicenceNumber>
    <ProductName>Kelaprofen 100 mg/ml, solution for injection for cattle, horses and pigs</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/026/001</DrugIDPK>
    <LicenceNumber>VPA10509/026/001</LicenceNumber>
    <ProductName>Kelevo 200 µg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/026/002</DrugIDPK>
    <LicenceNumber>VPA10509/026/002</LicenceNumber>
    <ProductName>Kelevo 400 µg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/026/003</DrugIDPK>
    <LicenceNumber>VPA10509/026/003</LicenceNumber>
    <ProductName>Kelevo 800 µg tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10792/003/001</DrugIDPK>
    <LicenceNumber>VPA10792/003/001</LicenceNumber>
    <ProductName>Kenocidin Chlorhexidine digluconate 5 mg/ml, Teat dip solution for cattle (dairy)</ProductName>
    <PAHolder>CID LINES N.V.</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QD08AC02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine digluconate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10792/004/001</DrugIDPK>
    <LicenceNumber>VPA10792/004/001</LicenceNumber>
    <ProductName>Kenocidin SPRAY AND DIPChlorhexidine digluconate 5 mg/ml, Teat Dip/Teat Spray solution for cattle (dairy)</ProductName>
    <PAHolder>CID LINES N.V.</PAHolder>
    <AuthorisedDate>15/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Teat dip/spray solution</DosageForm>
    <ATCs>
      <ATC>QD08AC02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine digluconate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10792/001/001</DrugIDPK>
    <LicenceNumber>VPA10792/001/001</LicenceNumber>
    <ProductName>Kenostart 3 mg/g teat dip solution for cattle (dairy).</ProductName>
    <PAHolder>CID LINES N.V.</PAHolder>
    <AuthorisedDate>19/01/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Teat dip solution</DosageForm>
    <ATCs>
      <ATC>QD08AG03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Iodine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10792/002/001</DrugIDPK>
    <LicenceNumber>VPA10792/002/001</LicenceNumber>
    <ProductName>KENOSTART SPRAY AND DIP 3 mg/g Teat Dip or Spray Solution for cattle (dairy)</ProductName>
    <PAHolder>CID LINES N.V.</PAHolder>
    <AuthorisedDate>14/03/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Teat dip solution</DosageForm>
    <ATCs>
      <ATC>QD08AG03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Topical use</RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Iodine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/034/003</DrugIDPK>
    <LicenceNumber>VPA10815/034/003</LicenceNumber>
    <ProductName>Kesium 200 mg/50 mg Chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/034/001</DrugIDPK>
    <LicenceNumber>VPA10815/034/001</LicenceNumber>
    <ProductName>Kesium 40 mg/10 mg Chewable tablets for cats and dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/034/004</DrugIDPK>
    <LicenceNumber>VPA10815/034/004</LicenceNumber>
    <ProductName>Kesium 400 mg/100 mg Chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/034/002</DrugIDPK>
    <LicenceNumber>VPA10815/034/002</LicenceNumber>
    <ProductName>Kesium 50 mg/12.5 mg Chewable tablets for cats and dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/034/005</DrugIDPK>
    <LicenceNumber>VPA10815/034/005</LicenceNumber>
    <ProductName>Kesium 500 mg/125 mg Chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/005/001</DrugIDPK>
    <LicenceNumber>VPA10445/005/001</LicenceNumber>
    <ProductName>Ketabel 100 mg/ml solution for injection</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>03/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mouse</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Rat</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/004/001</DrugIDPK>
    <LicenceNumber>VPA23462/004/001</LicenceNumber>
    <ProductName>Ketamidor 100 mg/ml solution for injection</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>08/02/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/036/001</DrugIDPK>
    <LicenceNumber>VPA10387/036/001</LicenceNumber>
    <ProductName>Ketavet 100 mg/ml solution for injection for dogs, cats and horses</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>20/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/016/001</DrugIDPK>
    <LicenceNumber>VPA10980/016/001</LicenceNumber>
    <ProductName>Ketexx 100 mg/ml solution for injection</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>20/05/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mouse</Species>
      <Species>Rabbits</Species>
      <Species>Rat</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/002/001</DrugIDPK>
    <LicenceNumber>VPA10509/002/001</LicenceNumber>
    <ProductName>Ketink 100 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>10/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/019/001</DrugIDPK>
    <LicenceNumber>VPA23462/019/001</LicenceNumber>
    <ProductName>Ketiva 150 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>27/02/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in therapeutic indication(s) (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/008/001</DrugIDPK>
    <LicenceNumber>VPA10475/008/001</LicenceNumber>
    <ProductName>Ketodolor 100 mg/ml solution for injection for horses, cattle, pigs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/051/001</DrugIDPK>
    <LicenceNumber>VPA10815/051/001</LicenceNumber>
    <ProductName>Ketofen 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>15/03/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23448/002/001</DrugIDPK>
    <LicenceNumber>VPA23448/002/001</LicenceNumber>
    <ProductName>Ketoprocen 150 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Cenavisa S.L</PAHolder>
    <AuthorisedDate>10/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22812/004/001</DrugIDPK>
    <LicenceNumber>VPA22812/004/001</LicenceNumber>
    <ProductName>Ketosol 100 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Interchemie Werken De Adelaar Eesti AS.</PAHolder>
    <AuthorisedDate>29/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/020/001</DrugIDPK>
    <LicenceNumber>VPA22693/020/001</LicenceNumber>
    <ProductName>Kilo-mec 1% Solution for Injection</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23349/002/003</DrugIDPK>
    <LicenceNumber>VPA23349/002/003</LicenceNumber>
    <ProductName>KUIVET 134 mg/1200 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Quimica De Munguia S.A. (Quimunsa)</PAHolder>
    <AuthorisedDate>14/08/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin (40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23349/002/001</DrugIDPK>
    <LicenceNumber>VPA23349/002/001</LicenceNumber>
    <ProductName>KUIVET 26.8 mg/240 mg spot-on solution for very small dogs</ProductName>
    <PAHolder>Quimica De Munguia S.A. (Quimunsa)</PAHolder>
    <AuthorisedDate>14/08/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin (40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23349/002/004</DrugIDPK>
    <LicenceNumber>VPA23349/002/004</LicenceNumber>
    <ProductName>KUIVET 268 mg/2400 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Quimica De Munguia S.A. (Quimunsa)</PAHolder>
    <AuthorisedDate>14/08/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin (40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23349/002/002</DrugIDPK>
    <LicenceNumber>VPA23349/002/002</LicenceNumber>
    <ProductName>KUIVET 67 mg/600 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Quimica De Munguia S.A. (Quimunsa)</PAHolder>
    <AuthorisedDate>14/08/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>Permethrin (40:60)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/008/001</DrugIDPK>
    <LicenceNumber>VPA10402/008/001</LicenceNumber>
    <ProductName>Labimycin LA 300 mg/ml solution for injection</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>23/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/005/001</DrugIDPK>
    <LicenceNumber>VPA10402/005/001</LicenceNumber>
    <ProductName>Labiprofen 150 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>12/11/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/042/001</DrugIDPK>
    <LicenceNumber>VPA22664/042/001</LicenceNumber>
    <ProductName>Lactatrim MC Lactating Cow Intramammary Suspension.</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/10/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51E</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulphadiazine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/032/001</DrugIDPK>
    <LicenceNumber>VPA10980/032/001</LicenceNumber>
    <ProductName>Lamoxsan 150 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>21/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22009/002/001</DrugIDPK>
    <LicenceNumber>VPA22009/002/001</LicenceNumber>
    <ProductName>Latroxin 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>MEVET S.A.U.</PAHolder>
    <AuthorisedDate>30/05/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/002/001</DrugIDPK>
    <LicenceNumber>VPA10996/002/001</LicenceNumber>
    <ProductName>Laurabolin 25 mg/ml solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA14AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Nandrolone laurate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/048/001</DrugIDPK>
    <LicenceNumber>VPA10980/048/001</LicenceNumber>
    <ProductName>Laxasan 667 mg/ml syrup for dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>31/07/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ATCs>
      <ATC>QA06AD11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lactulose, liquid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/041/001</DrugIDPK>
    <LicenceNumber>VPA10475/041/001</LicenceNumber>
    <ProductName>Laxatract 667mg/ml syrup for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>11/01/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ATCs>
      <ATC>QA06AD11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lactulose, liquid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/030/001</DrugIDPK>
    <LicenceNumber>VPA22020/030/001</LicenceNumber>
    <ProductName>LECTADE Plus Powder for Oral Solution</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>21/03/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QA07CQ02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Potassium dihydrogen phosphate</ActiveSubstance>
      <ActiveSubstance>Sodium acid citrate</ActiveSubstance>
      <ActiveSubstance>Potassium citrate</ActiveSubstance>
      <ActiveSubstance>Sodium citrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/082/001</DrugIDPK>
    <LicenceNumber>VPA10454/082/001</LicenceNumber>
    <ProductName>Lenzelta suspension for injection</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>05/12/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB17</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Escherichia Coli (Inactivated) </ActiveSubstance>
      <ActiveSubstance>Staphylococcus aureus inactivated bacteria</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/025/001</DrugIDPK>
    <LicenceNumber>VPA22664/025/001</LicenceNumber>
    <ProductName>Levacide Injection 75 mg/ml</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP52AE01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/026/001</DrugIDPK>
    <LicenceNumber>VPA22664/026/001</LicenceNumber>
    <ProductName>Levacide Low Volume Worm Drench 75 mg/ml</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP52AE01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/047/001</DrugIDPK>
    <LicenceNumber>VPA22664/047/001</LicenceNumber>
    <ProductName>Levacide Pour-on 200 mg/ml</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/12/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP52AE01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
      <RoutesOfAdministration>Topical use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/024/001</DrugIDPK>
    <LicenceNumber>VPA22664/024/001</LicenceNumber>
    <ProductName>Levafas Diamond Fluke and Worm Drench</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AE51</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
      <ActiveSubstance>Oxyclozanide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/010/001</DrugIDPK>
    <LicenceNumber>VPA10823/010/001</LicenceNumber>
    <ProductName>Levapharm Injection 75 mg/ml</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP52AE01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/199/001</DrugIDPK>
    <LicenceNumber>VPA10996/199/001</LicenceNumber>
    <ProductName>Leventa 1 mg/ml oral solution for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>29/06/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/004/001</DrugIDPK>
    <LicenceNumber>VPA10915/004/001</LicenceNumber>
    <ProductName>Levicare Hi-Mineral Oral Solution</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>31/03/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP52AE01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/037/001</DrugIDPK>
    <LicenceNumber>VPA10815/037/001</LicenceNumber>
    <ProductName>Libeo 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC03CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Furosemide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/037/002</DrugIDPK>
    <LicenceNumber>VPA10815/037/002</LicenceNumber>
    <ProductName>Libeo 40 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC03CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Furosemide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/015/001</DrugIDPK>
    <LicenceNumber>VPA22622/015/001</LicenceNumber>
    <ProductName>Libromide 325 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>18/11/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN05CM11</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Potassium bromide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/026/001</DrugIDPK>
    <LicenceNumber>VPA22033/026/001</LicenceNumber>
    <ProductName>Liceban 2.5% w/v Pour on Solution</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>12/12/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin technical (93%) (cis: trans 50:50)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/004/001</DrugIDPK>
    <LicenceNumber>VPA10445/004/001</LicenceNumber>
    <ProductName>LidoBel 20 mg/ml solution for injection for horses, dogs, and cats.</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01BB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Perineural use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
      <RoutesOfAdministration>Submucosal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25497/004/001</DrugIDPK>
    <LicenceNumber>VPA25497/004/001</LicenceNumber>
    <ProductName>Linco-Spectin 100, 222/444.7 mg/g Powder for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Phibro Animal Health (Poland) Sp. z o.o.</PAHolder>
    <AuthorisedDate>01/10/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FF52</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spectinomycin</ActiveSubstance>
      <ActiveSubstance>Lincomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/041/001</DrugIDPK>
    <LicenceNumber>VPA10387/041/001</LicenceNumber>
    <ProductName>Linco-Spectin Sterile Solution for injection for pigs, non-ruminating calves, dogs and cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FF52</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride</ActiveSubstance>
      <ActiveSubstance>Spectinomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/039/001</DrugIDPK>
    <LicenceNumber>VPA10387/039/001</LicenceNumber>
    <ProductName>Lincocin 100 mg/ml Sterile Solution for injection for dogs, cats and pigs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>10/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FF02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25497/003/001</DrugIDPK>
    <LicenceNumber>VPA25497/003/001</LicenceNumber>
    <ProductName>Lincocin Soluble Powder, 400 mg/g powder for use in drinking water</ProductName>
    <PAHolder>Phibro Animal Health (Poland) Sp. z o.o.</PAHolder>
    <AuthorisedDate>26/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FF02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/041/001</DrugIDPK>
    <LicenceNumber>VPA10782/041/001</LicenceNumber>
    <ProductName>Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>08/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FF52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride monohydrate</ActiveSubstance>
      <ActiveSubstance>Spectinomycin sulfate tetrahydrate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/015/001</DrugIDPK>
    <LicenceNumber>VPA10790/015/001</LicenceNumber>
    <ProductName>Lincovex 100 mg/ml solution for injection for pigs, cats and dogs</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>23/02/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FF02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/023/001</DrugIDPK>
    <LicenceNumber>VPA22664/023/001</LicenceNumber>
    <ProductName>Liquid Life Aid Concentrate for Oral Solution for Cattle, Pigs and Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QA07CQ02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium propionate</ActiveSubstance>
      <ActiveSubstance>Potassium dihydrogen orthophosphate</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10436/004/001</DrugIDPK>
    <LicenceNumber>VPA10436/004/001</LicenceNumber>
    <ProductName>Lismay 444.7 mg/g + 222.0 mg/g powder for use in drinking water for pigs</ProductName>
    <PAHolder>Laboratorios Maymo S.A.U.</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FF52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spectinomycin</ActiveSubstance>
      <ActiveSubstance>Lincomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/032/001</DrugIDPK>
    <LicenceNumber>VPA22622/032/001</LicenceNumber>
    <ProductName>Lodisure 1 mg tablets for cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>05/02/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC08CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/023/001</DrugIDPK>
    <LicenceNumber>VPA10815/023/001</LicenceNumber>
    <ProductName>Longocilline 150 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/002/001</DrugIDPK>
    <LicenceNumber>VPA25237/002/001</LicenceNumber>
    <ProductName>Lozenord 5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>07/02/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/042/001</DrugIDPK>
    <LicenceNumber>VPA10387/042/001</LicenceNumber>
    <ProductName>Lutalyse</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>18/10/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dinoprost trometamol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/042/002</DrugIDPK>
    <LicenceNumber>VPA10387/042/002</LicenceNumber>
    <ProductName>Lutalyse High Concentration 12.5 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>23/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dinoprost trometamol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23174/004/001</DrugIDPK>
    <LicenceNumber>VPA23174/004/001</LicenceNumber>
    <ProductName>Luteoplan 250 micrograms/ml solution for injection for cattle and horses</ProductName>
    <PAHolder>Syn Vet-Pharma Ireland Limited</PAHolder>
    <AuthorisedDate>13/10/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25365/001/001</DrugIDPK>
    <LicenceNumber>VPA25365/001/001</LicenceNumber>
    <ProductName>Lyncoo 400 mg/g powder for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Endectovet EOOD</PAHolder>
    <AuthorisedDate>19/09/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FF02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/236/001</DrugIDPK>
    <LicenceNumber>VPA10996/236/001</LicenceNumber>
    <ProductName>M+PAC</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>12/09/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated mycoplasma hyopneumoniae</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/075/001</DrugIDPK>
    <LicenceNumber>VPA22664/075/001</LicenceNumber>
    <ProductName>Macromectin 0.8 mg/ml oral solution for sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/09/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/076/001</DrugIDPK>
    <LicenceNumber>VPA22664/076/001</LicenceNumber>
    <ProductName>Macromectin 5 mg/ml Pour-On Solution</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/11/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/073/001</DrugIDPK>
    <LicenceNumber>VPA22033/073/001</LicenceNumber>
    <ProductName>Macrosyn 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>11/09/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/037/001</DrugIDPK>
    <LicenceNumber>VPA10987/037/001</LicenceNumber>
    <ProductName>Magnesium Sulphate 25% Solution for Injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CC02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Magnesium sulphate heptahydrate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/030/001</DrugIDPK>
    <LicenceNumber>VPA22664/030/001</LicenceNumber>
    <ProductName>Magniject 250 mg/ml Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CC02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Magnesium sulphate heptahydrate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10803/005/001</DrugIDPK>
    <LicenceNumber>VPA10803/005/001</LicenceNumber>
    <ProductName>Malaseb shampoo for dogs and cats</ProductName>
    <PAHolder>Dechra Veterinary Products A/S</PAHolder>
    <AuthorisedDate>16/01/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ATCs>
      <ATC>QD01AC52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine digluconate</ActiveSubstance>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/009/001</DrugIDPK>
    <LicenceNumber>VPA10454/009/001</LicenceNumber>
    <ProductName>Mamyzin 269.5 mg/ml Powder and Solvent for Suspension for Injection for cattle</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>03/03/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/001/001</DrugIDPK>
    <LicenceNumber>VPA10539/001/001</LicenceNumber>
    <ProductName>Maprelin 75 microgram/ml solution for injection for pigs</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Peforelin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/029/001</DrugIDPK>
    <LicenceNumber>VPA10990/029/001</LicenceNumber>
    <ProductName>Maracycline 500 mg/g Premix for Medicated Feeding</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>25/07/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/031/001</DrugIDPK>
    <LicenceNumber>VPA10990/031/001</LicenceNumber>
    <ProductName>Maracycline Powder 100 % w/w Premix for Medicated Feed</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/004/002</DrugIDPK>
    <LicenceNumber>VPA10534/004/002</LicenceNumber>
    <ProductName>Marbocare flavour 20 mg tablets for dogs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>20/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/004/001</DrugIDPK>
    <LicenceNumber>VPA10534/004/001</LicenceNumber>
    <ProductName>Marbocare flavour 5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>20/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/004/003</DrugIDPK>
    <LicenceNumber>VPA10534/004/003</LicenceNumber>
    <ProductName>Marbocare flavour 80 mg tablets for dogs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>20/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/025/001</DrugIDPK>
    <LicenceNumber>VPA10521/025/001</LicenceNumber>
    <ProductName>Marbocyl 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>31/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/024/001</DrugIDPK>
    <LicenceNumber>VPA10521/024/001</LicenceNumber>
    <ProductName>Marbocyl 20 mg/ml Solution for Injection</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>18/09/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/037/001</DrugIDPK>
    <LicenceNumber>VPA10983/037/001</LicenceNumber>
    <ProductName>MARBOCYL FD, powder and solvent for solution for injection</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>18/02/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/031/002</DrugIDPK>
    <LicenceNumber>VPA10521/031/002</LicenceNumber>
    <ProductName>Marbocyl P 20 mg Tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>19/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/031/001</DrugIDPK>
    <LicenceNumber>VPA10521/031/001</LicenceNumber>
    <ProductName>Marbocyl P 5 mg Tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>19/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/031/003</DrugIDPK>
    <LicenceNumber>VPA10521/031/003</LicenceNumber>
    <ProductName>Marbocyl P 80 mg Tablets</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>19/04/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/006/002</DrugIDPK>
    <LicenceNumber>VPA10534/006/002</LicenceNumber>
    <ProductName>Marbodug 100 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/006/001</DrugIDPK>
    <LicenceNumber>VPA10534/006/001</LicenceNumber>
    <ProductName>Marbodug 20 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/100/001</DrugIDPK>
    <LicenceNumber>VPA22664/100/001</LicenceNumber>
    <ProductName>Marbonor 100 mg/ml Solution for Injection for cattle and pig</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/003/001</DrugIDPK>
    <LicenceNumber>VPA10495/003/001</LicenceNumber>
    <ProductName>Marbosyva 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>23/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA20742/010/001</DrugIDPK>
    <LicenceNumber>VPA20742/010/001</LicenceNumber>
    <ProductName>Marbotis 3mg/ml + 10mg/ml + 1mg/ml ear drops, suspension for dogs</ProductName>
    <PAHolder>Vet-Agro Multi-Trade Company Sp z o.o.</PAHolder>
    <AuthorisedDate>15/03/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – differences in raw materials or in manufacturing processes of biological VMPs (Article 19(1)(c) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Dexamethasone acetate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/014/001</DrugIDPK>
    <LicenceNumber>VPA10815/014/001</LicenceNumber>
    <ProductName>Marbox 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/014/002</DrugIDPK>
    <LicenceNumber>VPA10774/014/002</LicenceNumber>
    <ProductName>Marfloxin 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/016/002</DrugIDPK>
    <LicenceNumber>VPA10774/016/002</LicenceNumber>
    <ProductName>Marfloxin 20 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/016/001</DrugIDPK>
    <LicenceNumber>VPA10774/016/001</LicenceNumber>
    <ProductName>Marfloxin 5 mg tablets for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/016/003</DrugIDPK>
    <LicenceNumber>VPA10774/016/003</LicenceNumber>
    <ProductName>Marfloxin 80 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/005/001</DrugIDPK>
    <LicenceNumber>VPA25237/005/001</LicenceNumber>
    <ProductName>Maropicord 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>27/03/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Maropitant citrate monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/120/001</DrugIDPK>
    <LicenceNumber>VPA10988/120/001</LicenceNumber>
    <ProductName>Mastavance 20 mg intramammary suspension for cattle (lactating cow)</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>09/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone Aceponate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/003/001</DrugIDPK>
    <LicenceNumber>VPA10836/003/001</LicenceNumber>
    <ProductName>MASTERFLOX 40 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>24/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA93</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/021/001</DrugIDPK>
    <LicenceNumber>VPA22693/021/001</LicenceNumber>
    <ProductName>Mastermectin 10 mg/ml Solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/012/001</DrugIDPK>
    <LicenceNumber>VPA22028/012/001</LicenceNumber>
    <ProductName>MASTIC DRY COW 600 mg intramammary suspension for cattle</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>22/05/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/005/001</DrugIDPK>
    <LicenceNumber>VPA22028/005/001</LicenceNumber>
    <ProductName>MASTIC Lacto 200 mg + 50 mg + 10 mg intramammary suspension for cattle</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>10/01/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RV01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/006/001</DrugIDPK>
    <LicenceNumber>VPA22028/006/001</LicenceNumber>
    <ProductName>Mastic Seal 2.6 g intramammary suspension for cattle</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>05/04/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Teat Dip/Seal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/205/001</DrugIDPK>
    <LicenceNumber>VPA10996/205/001</LicenceNumber>
    <ProductName>Mastiplan LC, 300mg/20mg (Cefapirin/Prednisolone), intramammary suspension for lactating cows</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RV01</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefapirin</ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/028/001</DrugIDPK>
    <LicenceNumber>VPA22033/028/001</LicenceNumber>
    <ProductName>Maximec Horse Oral Paste 18.7 mg/g</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>05/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/007/001</DrugIDPK>
    <LicenceNumber>VPA10823/007/001</LicenceNumber>
    <ProductName>Maxoject LA 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/011/002</DrugIDPK>
    <LicenceNumber>VPA10786/011/002</LicenceNumber>
    <ProductName>Maxpramil 12.5 mg/125 mg tablets for dogs</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>19/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10786/011/001</DrugIDPK>
    <LicenceNumber>VPA10786/011/001</LicenceNumber>
    <ProductName>Maxpramil 2.5 mg/25 mg tablets for small dogs and puppies</ProductName>
    <PAHolder>Laboratorios Karizoo S.A.</PAHolder>
    <AuthorisedDate>19/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/011/001</DrugIDPK>
    <LicenceNumber>VPA10516/011/001</LicenceNumber>
    <ProductName>MAXYL 500 mg/g POWDER FOR USE IN DRINKING WATER FOR CHICKENS, TURKEYS, DUCKS AND PIGS</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/064/001</DrugIDPK>
    <LicenceNumber>VPA22033/064/001</LicenceNumber>
    <ProductName>Mectaject 10 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>20/12/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/029/001</DrugIDPK>
    <LicenceNumber>VPA22033/029/001</LicenceNumber>
    <ProductName>Mectaject Plus Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/003/001</DrugIDPK>
    <LicenceNumber>VPA10810/003/001</LicenceNumber>
    <ProductName>Medesedan 10 mg/ml solution for injection for horses and cattle</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>15/02/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/002/001</DrugIDPK>
    <LicenceNumber>VPA10810/002/001</LicenceNumber>
    <ProductName>Medetor 1 mg/ml Solution for Injection for Dog and Cat</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>27/07/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/153/001</DrugIDPK>
    <LicenceNumber>VPA10987/153/001</LicenceNumber>
    <ProductName>Medimec 0.5 %w/v Pour-on Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>03/12/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10956/001/001</DrugIDPK>
    <LicenceNumber>VPA10956/001/001</LicenceNumber>
    <ProductName>Megacal-M Injection</ProductName>
    <PAHolder>Ballinskelligs Vet. Products Ltd</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12A</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Calcium</ActiveSubstance>
      <ActiveSubstance>Phosphorous</ActiveSubstance>
      <ActiveSubstance>Magnesium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10976/008/001</DrugIDPK>
    <LicenceNumber>VPA10976/008/001</LicenceNumber>
    <ProductName>Megapen - Strep Injection</ProductName>
    <PAHolder>Franklin Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulphate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/061/002</DrugIDPK>
    <LicenceNumber>VPA10774/061/002</LicenceNumber>
    <ProductName>Mektix 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/061/004</DrugIDPK>
    <LicenceNumber>VPA10774/061/004</LicenceNumber>
    <ProductName>Mektix 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/062/002</DrugIDPK>
    <LicenceNumber>VPA10774/062/002</LicenceNumber>
    <ProductName>Mektix 16 mg/40 mg chewable tablets for cats weighing at least 2 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/061/001</DrugIDPK>
    <LicenceNumber>VPA10774/061/001</LicenceNumber>
    <ProductName>Mektix 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/061/003</DrugIDPK>
    <LicenceNumber>VPA10774/061/003</LicenceNumber>
    <ProductName>Mektix 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/062/001</DrugIDPK>
    <LicenceNumber>VPA10774/062/001</LicenceNumber>
    <ProductName>Mektix 4 mg/10 mg chewable tablets for small cats and kittens weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/023/001</DrugIDPK>
    <LicenceNumber>VPA10826/023/001</LicenceNumber>
    <ProductName>Menbutil 100 mg/ml solution for injection for cattle, pigs, horses, sheep and goats</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>14/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA05AX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Menbutone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/012/001</DrugIDPK>
    <LicenceNumber>VPA22622/012/001</LicenceNumber>
    <ProductName>Mepiblock 20 mg/ml solution for injection for horses</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>15/12/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01BB03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Epidural use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Mepivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/007/001</DrugIDPK>
    <LicenceNumber>VPA23462/007/001</LicenceNumber>
    <ProductName>Mepidor 20 mg/ml solution for injection for horses</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>05/01/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01BB03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Epidural use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Mepivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/066/001</DrugIDPK>
    <LicenceNumber>VPA10989/066/001</LicenceNumber>
    <ProductName>Metaxol 20/100 mg/ml solution for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>08/07/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01EW11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfamethoxazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/025/001</DrugIDPK>
    <LicenceNumber>VPA10980/025/001</LicenceNumber>
    <ProductName>Metaxx 0.25 mg chewable tablets for cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>23/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/036/001</DrugIDPK>
    <LicenceNumber>VPA10980/036/001</LicenceNumber>
    <ProductName>Metaxx 0.5 mg/ml oral suspension for cats and guinea pigs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>28/03/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Guinea pig</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/035/001</DrugIDPK>
    <LicenceNumber>VPA10980/035/001</LicenceNumber>
    <ProductName>Metaxx 1.5 mg/ml oral suspension for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>28/03/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/023/001</DrugIDPK>
    <LicenceNumber>VPA10980/023/001</LicenceNumber>
    <ProductName>Metaxx 15 mg/ml oral suspension for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>03/02/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/021/001</DrugIDPK>
    <LicenceNumber>VPA10980/021/001</LicenceNumber>
    <ProductName>Metaxx 20 mg/ml solution for injection for cattle, pigs and horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>25/11/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/022/001</DrugIDPK>
    <LicenceNumber>VPA10980/022/001</LicenceNumber>
    <ProductName>Metaxx 5 mg/ml solution for injection for cattle, pigs, dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>25/11/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/106/001</DrugIDPK>
    <LicenceNumber>VPA10387/106/001</LicenceNumber>
    <ProductName>Methadyne 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>08/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AC90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Methadone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/009/001</DrugIDPK>
    <LicenceNumber>VPA10475/009/001</LicenceNumber>
    <ProductName>Metomotyl 2.5 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03FA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metoclopramide hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/009/002</DrugIDPK>
    <LicenceNumber>VPA10475/009/002</LicenceNumber>
    <ProductName>Metomotyl 5 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03FA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metoclopramide hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/053/001</DrugIDPK>
    <LicenceNumber>VPA10996/053/001</LicenceNumber>
    <ProductName>Metricure 500 mg Intrauterine Suspension</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>02/11/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intrauterine suspension</DosageForm>
    <ATCs>
      <ATC>QG51AA05</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intrauterine use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cephapirin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/037/001</DrugIDPK>
    <LicenceNumber>VPA22622/037/001</LicenceNumber>
    <ProductName>Metrobactin 250 mg tablets for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>18/12/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/037/002</DrugIDPK>
    <LicenceNumber>VPA22622/037/002</LicenceNumber>
    <ProductName>Metrobactin 500 mg tablets for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>18/12/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/012/001</DrugIDPK>
    <LicenceNumber>VPA10491/012/001</LicenceNumber>
    <ProductName>Metrocare Flavour 250 mg tablets for dogs and cats</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>13/09/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10491/012/002</DrugIDPK>
    <LicenceNumber>VPA10491/012/002</LicenceNumber>
    <ProductName>Metrocare Flavour 500 mg tablets for dogs and cats</ProductName>
    <PAHolder>Ecuphar N.V.</PAHolder>
    <AuthorisedDate>13/09/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/021/003</DrugIDPK>
    <LicenceNumber>VPA10810/021/003</LicenceNumber>
    <ProductName>Metrotab vet. Flavoured 1000 mg tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/021/001</DrugIDPK>
    <LicenceNumber>VPA10810/021/001</LicenceNumber>
    <ProductName>Metrotab vet. Flavoured 250 mg tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/021/002</DrugIDPK>
    <LicenceNumber>VPA10810/021/002</LicenceNumber>
    <ProductName>Metrotab vet. Flavoured 500 mg tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/020/001</DrugIDPK>
    <LicenceNumber>VPA10509/020/001</LicenceNumber>
    <ProductName>Metrovis 100 mg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>13/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/020/002</DrugIDPK>
    <LicenceNumber>VPA10509/020/002</LicenceNumber>
    <ProductName>Metrovis 250 mg tablets for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>13/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/020/003</DrugIDPK>
    <LicenceNumber>VPA10509/020/003</LicenceNumber>
    <ProductName>Metrovis 750 mg tablets for dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>13/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01XD01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/019/001</DrugIDPK>
    <LicenceNumber>VPA22020/019/001</LicenceNumber>
    <ProductName>Micotil 300 mg/ml Solution for Injection</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>26/09/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/083/001</DrugIDPK>
    <LicenceNumber>VPA10987/083/001</LicenceNumber>
    <ProductName>Milaxyn Plus Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>18/12/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/083/002</DrugIDPK>
    <LicenceNumber>VPA10987/083/002</LicenceNumber>
    <ProductName>Milaxyn Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>12/04/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/030/002</DrugIDPK>
    <LicenceNumber>VPA10774/030/002</LicenceNumber>
    <ProductName>Milbactor 12.5 mg/125 mg tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/032/002</DrugIDPK>
    <LicenceNumber>VPA10774/032/002</LicenceNumber>
    <ProductName>Milbactor 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/02/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/030/001</DrugIDPK>
    <LicenceNumber>VPA10774/030/001</LicenceNumber>
    <ProductName>Milbactor 2.5 mg/25 mg tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/032/001</DrugIDPK>
    <LicenceNumber>VPA10774/032/001</LicenceNumber>
    <ProductName>Milbactor 4 mg/10 mg film-coated tablets for small cats and kittens weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/072/002</DrugIDPK>
    <LicenceNumber>VPA10815/072/002</LicenceNumber>
    <ProductName>Milbacyl 12.5 mg/125 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/073/002</DrugIDPK>
    <LicenceNumber>VPA10815/073/002</LicenceNumber>
    <ProductName>Milbacyl 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/072/001</DrugIDPK>
    <LicenceNumber>VPA10815/072/001</LicenceNumber>
    <ProductName>Milbacyl 2.5 mg/25 mg chewable tablets for small dogs and puppies</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/072/003</DrugIDPK>
    <LicenceNumber>VPA10815/072/003</LicenceNumber>
    <ProductName>Milbacyl 25 mg/250 mg chewable tablets for large dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/073/001</DrugIDPK>
    <LicenceNumber>VPA10815/073/001</LicenceNumber>
    <ProductName>Milbacyl 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/067/002</DrugIDPK>
    <LicenceNumber>VPA10815/067/002</LicenceNumber>
    <ProductName>Milbeguard Duo 12.5 mg/125 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/068/002</DrugIDPK>
    <LicenceNumber>VPA10815/068/002</LicenceNumber>
    <ProductName>Milbeguard Duo 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/067/001</DrugIDPK>
    <LicenceNumber>VPA10815/067/001</LicenceNumber>
    <ProductName>Milbeguard Duo 2.5 mg/25 mg chewable tablets for small dogs and puppies</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/067/003</DrugIDPK>
    <LicenceNumber>VPA10815/067/003</LicenceNumber>
    <ProductName>Milbeguard Duo 25 mg/250 mg chewable tablets for large dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/068/001</DrugIDPK>
    <LicenceNumber>VPA10815/068/001</LicenceNumber>
    <ProductName>Milbeguard Duo 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/009/002</DrugIDPK>
    <LicenceNumber>VPA22020/009/002</LicenceNumber>
    <ProductName>MILBEMAX 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/009/001</DrugIDPK>
    <LicenceNumber>VPA22020/009/001</LicenceNumber>
    <ProductName>MILBEMAX 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/008/004</DrugIDPK>
    <LicenceNumber>VPA22020/008/004</LicenceNumber>
    <ProductName>MILBEMAX chewable tablets for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/008/003</DrugIDPK>
    <LicenceNumber>VPA22020/008/003</LicenceNumber>
    <ProductName>MILBEMAX chewable tablets for small dogs and puppies</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/008/001</DrugIDPK>
    <LicenceNumber>VPA22020/008/001</LicenceNumber>
    <ProductName>MILBEMAX tablets for small dogs and puppies</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/008/002</DrugIDPK>
    <LicenceNumber>VPA22020/008/002</LicenceNumber>
    <ProductName>MILBEMAX® tablets for dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/003/002</DrugIDPK>
    <LicenceNumber>VPA25201/003/002</LicenceNumber>
    <ProductName>Milbemycin oxime/Praziquantel Alfamed 12.5 mg/125 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>16/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/002/002</DrugIDPK>
    <LicenceNumber>VPA25201/002/002</LicenceNumber>
    <ProductName>Milbemycin oxime/Praziquantel Alfamed 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>16/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/003/001</DrugIDPK>
    <LicenceNumber>VPA25201/003/001</LicenceNumber>
    <ProductName>Milbemycin oxime/Praziquantel Alfamed 2.5 mg/25 mg film-coated tablet for small dogs and puppies</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>16/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/002/001</DrugIDPK>
    <LicenceNumber>VPA25201/002/001</LicenceNumber>
    <ProductName>Milbemycin oxime/Praziquantel Alfamed 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>16/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/001/002</DrugIDPK>
    <LicenceNumber>VPA25201/001/002</LicenceNumber>
    <ProductName>Milbemycin oxime Praziquantel Chew Alfamed 12.5 mg/125.0 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>10/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/001/001</DrugIDPK>
    <LicenceNumber>VPA25201/001/001</LicenceNumber>
    <ProductName>Milbemycin oxime Praziquantel Chew Alfamed 2.5 mg/25.0 mg chewable tablets for small dogs and puppies</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>10/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25201/001/003</DrugIDPK>
    <LicenceNumber>VPA25201/001/003</LicenceNumber>
    <ProductName>Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg/250.0 mg chewable tablets for large dogs</ProductName>
    <PAHolder>Alfamed</PAHolder>
    <AuthorisedDate>10/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/069/002</DrugIDPK>
    <LicenceNumber>VPA10815/069/002</LicenceNumber>
    <ProductName>Milbepar 12.5 mg/125 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/071/002</DrugIDPK>
    <LicenceNumber>VPA10815/071/002</LicenceNumber>
    <ProductName>Milbepar 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/069/001</DrugIDPK>
    <LicenceNumber>VPA10815/069/001</LicenceNumber>
    <ProductName>Milbepar 2.5 mg/25 mg chewable tablets for small dogs and puppies</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/069/003</DrugIDPK>
    <LicenceNumber>VPA10815/069/003</LicenceNumber>
    <ProductName>Milbepar 25 mg/250 mg chewable tablets for large dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/071/001</DrugIDPK>
    <LicenceNumber>VPA10815/071/001</LicenceNumber>
    <ProductName>Milbepar 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>12/07/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/181/001</DrugIDPK>
    <LicenceNumber>VPA10987/181/001</LicenceNumber>
    <ProductName>Milbetab 12.5 mg/125 mg Chewable Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/135/001</DrugIDPK>
    <LicenceNumber>VPA10987/135/001</LicenceNumber>
    <ProductName>Milbetab 12.5 mg/125 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/173/001</DrugIDPK>
    <LicenceNumber>VPA10987/173/001</LicenceNumber>
    <ProductName>Milbetab 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>08/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/181/002</DrugIDPK>
    <LicenceNumber>VPA10987/181/002</LicenceNumber>
    <ProductName>Milbetab 2.5 mg/25 mg Chewable Tablets for small dogs and puppies</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/179/001</DrugIDPK>
    <LicenceNumber>VPA10987/179/001</LicenceNumber>
    <ProductName>Milbetab 2.5 mg/25 mg Tablets for small dogs and puppies</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>11/04/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/173/002</DrugIDPK>
    <LicenceNumber>VPA10987/173/002</LicenceNumber>
    <ProductName>Milbetab 4 mg/10 mg  film coated tablets for small cats and kittens</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>08/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/075/001</DrugIDPK>
    <LicenceNumber>VPA10987/075/001</LicenceNumber>
    <ProductName>Milbotyl 300 mg/ml solution for injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/11/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/063/004</DrugIDPK>
    <LicenceNumber>VPA10774/063/004</LicenceNumber>
    <ProductName>Milgusto 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/064/002</DrugIDPK>
    <LicenceNumber>VPA10774/064/002</LicenceNumber>
    <ProductName>Milgusto 16 mg/40 mg chewable tablets for cats weighing at least 2 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/063/003</DrugIDPK>
    <LicenceNumber>VPA10774/063/003</LicenceNumber>
    <ProductName>Milgusto 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/064/001</DrugIDPK>
    <LicenceNumber>VPA10774/064/001</LicenceNumber>
    <ProductName>Milgusto 4 mg/10 mg chewable tablets for small cats and kittens weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/182/001</DrugIDPK>
    <LicenceNumber>VPA10987/182/001</LicenceNumber>
    <ProductName>Milipraz 12.5 mg/125 mg Chewable Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/136/001</DrugIDPK>
    <LicenceNumber>VPA10987/136/001</LicenceNumber>
    <ProductName>Milipraz 12.5 mg/125 mg Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/174/001</DrugIDPK>
    <LicenceNumber>VPA10987/174/001</LicenceNumber>
    <ProductName>Milipraz 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>08/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/182/002</DrugIDPK>
    <LicenceNumber>VPA10987/182/002</LicenceNumber>
    <ProductName>Milipraz 2.5 mg/25 mg Chewable Tablets for small dogs and puppies</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/180/001</DrugIDPK>
    <LicenceNumber>VPA10987/180/001</LicenceNumber>
    <ProductName>Milipraz 2.5 mg/25 mg Tablets for small dogs and puppies</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>11/04/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/174/002</DrugIDPK>
    <LicenceNumber>VPA10987/174/002</LicenceNumber>
    <ProductName>Milipraz 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>08/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/029/002</DrugIDPK>
    <LicenceNumber>VPA10774/029/002</LicenceNumber>
    <ProductName>Milprazon 12.5 mg/125 mg tablets for dogs weighing at least 5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/031/002</DrugIDPK>
    <LicenceNumber>VPA10774/031/002</LicenceNumber>
    <ProductName>Milprazon 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/029/001</DrugIDPK>
    <LicenceNumber>VPA10774/029/001</LicenceNumber>
    <ProductName>Milprazon 2.5 mg/25 mg tablets for small dogs and puppies weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/031/001</DrugIDPK>
    <LicenceNumber>VPA10774/031/001</LicenceNumber>
    <ProductName>Milprazon 4 mg/10 mg film-coated tablets for small cats and kittens weighing at least 0.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>24/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/095/002</DrugIDPK>
    <LicenceNumber>VPA10988/095/002</LicenceNumber>
    <ProductName>Milpro 12.5 mg/125 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>18/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/096/002</DrugIDPK>
    <LicenceNumber>VPA10988/096/002</LicenceNumber>
    <ProductName>Milpro 16 mg/40 mg film-coated tablets for cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/095/001</DrugIDPK>
    <LicenceNumber>VPA10988/095/001</LicenceNumber>
    <ProductName>Milpro 2.5 mg/25 mg film-coated tablets for small dogs and puppies</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>18/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/096/001</DrugIDPK>
    <LicenceNumber>VPA10988/096/001</LicenceNumber>
    <ProductName>Milpro 4 mg/10 mg film-coated tablets for small cats and kittens</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/118/002</DrugIDPK>
    <LicenceNumber>VPA10988/118/002</LicenceNumber>
    <ProductName>Milpro Chewy 12.5 mg/125.0 mg chewable tablets for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>17/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/118/001</DrugIDPK>
    <LicenceNumber>VPA10988/118/001</LicenceNumber>
    <ProductName>Milpro Chewy 2.5 mg/25.0 mg chewable tablets for small dogs and puppies</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>17/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/118/003</DrugIDPK>
    <LicenceNumber>VPA10988/118/003</LicenceNumber>
    <ProductName>Milpro Chewy 25.0 mg/250.0 mg chewable tablets for large dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>17/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP54AB51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Milbemycin oxime</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/043/001</DrugIDPK>
    <LicenceNumber>VPA10815/043/001</LicenceNumber>
    <ProductName>Modulis 100 mg/ml oral solution for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QL04AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10396/001/001</DrugIDPK>
    <LicenceNumber>VPA10396/001/001</LicenceNumber>
    <ProductName>Morlam Intravaginal Sponge</ProductName>
    <PAHolder>Laboratorios Ovejero S.A.U.</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Medicated sponge</DosageForm>
    <ATCs>
      <ATC>QG03DA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Vaginal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medroxyprogesterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/007/001</DrugIDPK>
    <LicenceNumber>VPA10826/007/001</LicenceNumber>
    <ProductName>Morphasol 4 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>18/12/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10817/003/001</DrugIDPK>
    <LicenceNumber>VPA10817/003/001</LicenceNumber>
    <ProductName>MOXAPULVIS 500 mg/g powder for use in drinking water</ProductName>
    <PAHolder>V.M.D.</PAHolder>
    <AuthorisedDate>16/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/140/002</DrugIDPK>
    <LicenceNumber>VPA22664/140/002</LicenceNumber>
    <ProductName>Moxiclear 100 mg + 25 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/140/003</DrugIDPK>
    <LicenceNumber>VPA22664/140/003</LicenceNumber>
    <ProductName>Moxiclear 250 mg + 62.5 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/140/001</DrugIDPK>
    <LicenceNumber>VPA22664/140/001</LicenceNumber>
    <ProductName>Moxiclear 40 mg + 10 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/139/001</DrugIDPK>
    <LicenceNumber>VPA22664/139/001</LicenceNumber>
    <ProductName>Moxiclear 40 mg + 4 mg spot-on solution for small cats and ferrets</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/140/004</DrugIDPK>
    <LicenceNumber>VPA22664/140/004</LicenceNumber>
    <ProductName>Moxiclear 400 mg + 100 mg spot-on solution for very-large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/139/002</DrugIDPK>
    <LicenceNumber>VPA22664/139/002</LicenceNumber>
    <ProductName>Moxiclear 80 mg + 8 mg spot-on solution for large cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/079/001</DrugIDPK>
    <LicenceNumber>VPA22033/079/001</LicenceNumber>
    <ProductName>Moxisolv LA 100 mg/ml Solution for Injection for Cattle</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>31/03/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/111/001</DrugIDPK>
    <LicenceNumber>VPA10987/111/001</LicenceNumber>
    <ProductName>Moxodex 1 mg/ml oral solution for sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/08/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/129/001</DrugIDPK>
    <LicenceNumber>VPA10987/129/001</LicenceNumber>
    <ProductName>Moxodex 5 mg/ml Pour-on solution for cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>24/01/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/171/001</DrugIDPK>
    <LicenceNumber>VPA10987/171/001</LicenceNumber>
    <ProductName>Moxodex LA 100 mg/ml Solution for Injection for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>17/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/030/001</DrugIDPK>
    <LicenceNumber>VPA22033/030/001</LicenceNumber>
    <ProductName>Multimast Dry Cow Intramammary Suspension</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RC</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulphate</ActiveSubstance>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10431/001/001</DrugIDPK>
    <LicenceNumber>VPA10431/001/001</LicenceNumber>
    <ProductName>Multimin Solution for Injection for Cattle</ProductName>
    <PAHolder>Warburton Technology Limited</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX99</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
      <ActiveSubstance>Manganese carbonate</ActiveSubstance>
      <ActiveSubstance>Copper(II) carbonate</ActiveSubstance>
      <ActiveSubstance>Sodium selenite</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/065/001</DrugIDPK>
    <LicenceNumber>VPA22033/065/001</LicenceNumber>
    <ProductName>Multishield DC Intramammary Suspension for Cows</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>25/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RC22</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulphate</ActiveSubstance>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/113/001</DrugIDPK>
    <LicenceNumber>VPA10988/113/001</LicenceNumber>
    <ProductName>MUSTELIGEN D lyophilisate and solvent for suspension for injection for ferrets</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>26/06/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI20DD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine Distemper Virus, Strain Lederle, Live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/007/001</DrugIDPK>
    <LicenceNumber>VPA10790/007/001</LicenceNumber>
    <ProductName>MYCOFLOR 200 mg/ml solution for use in drinking water for pigs</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>29/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/004/001</DrugIDPK>
    <LicenceNumber>VPA10790/004/001</LicenceNumber>
    <ProductName>MYCOFLOR 300 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>21/12/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/047/001</DrugIDPK>
    <LicenceNumber>VPA10990/047/001</LicenceNumber>
    <ProductName>Mycomas 100 mg/ml Solution for use in drinking water</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>28/10/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/027/001</DrugIDPK>
    <LicenceNumber>VPA10475/027/001</LicenceNumber>
    <ProductName>Myodine 25 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>28/07/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA14AB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Nandrolone laurate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/042/001</DrugIDPK>
    <LicenceNumber>VPA10475/042/001</LicenceNumber>
    <ProductName>Myolone 25 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA14AB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Nandrolone laurate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/004/001</DrugIDPK>
    <LicenceNumber>VPA10846/004/001</LicenceNumber>
    <ProductName>MYPRAVAC SUISSuspension for injection</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>02/05/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB13</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated Mycoplasma hyopneumoniae strain J</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/015/001</DrugIDPK>
    <LicenceNumber>VPA10810/015/001</LicenceNumber>
    <ProductName>Nandrosol 25 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>27/09/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA14AB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Nandrolone laurate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/046/001</DrugIDPK>
    <LicenceNumber>VPA10782/046/001</LicenceNumber>
    <ProductName>Nanotrim 464.2 mg/g + 100 mg/g powder for use in drinking water/milk for chickens, turkeys, pigs and cattle</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>10/01/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QJ01EW12</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfachlorpyridazine sodium</ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/032/001</DrugIDPK>
    <LicenceNumber>VPA10521/032/001</LicenceNumber>
    <ProductName>Narketan-10 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/005/001</DrugIDPK>
    <LicenceNumber>VPA10516/005/001</LicenceNumber>
    <ProductName>NEFOTEK 100 mg/ml solution for injection for cattle, horses and pigs</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>10/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/031/002</DrugIDPK>
    <LicenceNumber>VPA10815/031/002</LicenceNumber>
    <ProductName>Nelio 2.5 mg Tablet for Cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/032/002</DrugIDPK>
    <LicenceNumber>VPA10815/032/002</LicenceNumber>
    <ProductName>Nelio 20 mg Tablet for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>25/09/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/031/001</DrugIDPK>
    <LicenceNumber>VPA10815/031/001</LicenceNumber>
    <ProductName>Nelio 5 mg tablet for cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>03/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/032/001</DrugIDPK>
    <LicenceNumber>VPA10815/032/001</LicenceNumber>
    <ProductName>Nelio 5 mg Tablet for Dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>25/09/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC09AA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/005/001</DrugIDPK>
    <LicenceNumber>VPA10475/005/001</LicenceNumber>
    <ProductName>Nematel-P 439 mg/g oral paste for horses</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>04/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP52AF02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/070/001</DrugIDPK>
    <LicenceNumber>VPA10454/070/001</LicenceNumber>
    <ProductName>NEMOVAC</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>08/06/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live pneumovirus, PL21 strain</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10436/003/001</DrugIDPK>
    <LicenceNumber>VPA10436/003/001</LicenceNumber>
    <ProductName>NEOMAY 500 000 IU/g powder for use in drinking water/milk replacer</ProductName>
    <PAHolder>Laboratorios Maymo S.A.U.</PAHolder>
    <AuthorisedDate>23/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QA07AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Goose</Species>
      <Species>Partridge</Species>
      <Species>Pigs</Species>
      <Species>Quail</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/006/002</DrugIDPK>
    <LicenceNumber>VPA10996/006/002</LicenceNumber>
    <ProductName>Neopen Suspension for Injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulphate</ActiveSubstance>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/090/001</DrugIDPK>
    <LicenceNumber>VPA10988/090/001</LicenceNumber>
    <ProductName>NEOPRINIL POUR-ON 5 mg/ml pour-on solution for cattle</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/004/001</DrugIDPK>
    <LicenceNumber>VPA10402/004/001</LicenceNumber>
    <ProductName>NEOSKILAB 1.5 mg/ml solution for injection for cattle, sheep, goats and horses</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN07AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neostigmine Metilsulfate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/013/002</DrugIDPK>
    <LicenceNumber>VPA10816/013/002</LicenceNumber>
    <ProductName>Nerfasin 100 mg/ml, solution for injection for cattle and horses</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>18/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/013/001</DrugIDPK>
    <LicenceNumber>VPA10816/013/001</LicenceNumber>
    <ProductName>Nerfasin 20 mg/ml, solution for injection for cattle, horses, dogs and cats</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>18/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25460/004/001</DrugIDPK>
    <LicenceNumber>VPA25460/004/001</LicenceNumber>
    <ProductName>Nexmectin 18.7 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Acme Drugs S.r.l.</PAHolder>
    <AuthorisedDate>21/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/011/001</DrugIDPK>
    <LicenceNumber>VPA22028/011/001</LicenceNumber>
    <ProductName>NEXPRAZ DUO 18.7 mg/g + 140.3 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>27/02/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10463/009/001</DrugIDPK>
    <LicenceNumber>VPA10463/009/001</LicenceNumber>
    <ProductName>Nextmune concentrate and solvent for suspension for injection for chickens</ProductName>
    <PAHolder>CEVA-Phylaxia Veterinary Biologicals Co. Ltd</PAHolder>
    <AuthorisedDate>07/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In ovo</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated IBD virus, serotype 1, strain G-61 </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/007/001</DrugIDPK>
    <LicenceNumber>VPA10516/007/001</LicenceNumber>
    <ProductName>Nifencol 300 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>18/10/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/062/001</DrugIDPK>
    <LicenceNumber>VPA10989/062/001</LicenceNumber>
    <ProductName>NIMATEK 100 mg/ml, Solution for injection for dogs, cats and horses</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>09/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX03</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/131/001</DrugIDPK>
    <LicenceNumber>VPA10996/131/001</LicenceNumber>
    <ProductName>Nobilis CAV P4</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>28/10/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chick anaemia agent virus strain 26p4</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/083/001</DrugIDPK>
    <LicenceNumber>VPA10996/083/001</LicenceNumber>
    <ProductName>Nobilis E.coli inac emulsion for injection for chickens</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>06/06/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01AB05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>F11-antigen (E. coli fimbrial antigen)</ActiveSubstance>
      <ActiveSubstance>FT-antigen (E. coli flagellar toxin antigen)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/134/001</DrugIDPK>
    <LicenceNumber>VPA10996/134/001</LicenceNumber>
    <ProductName>Nobilis Gumboro 228E lyophilisate for use in drinking water for chickens</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>12/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gumboro disease virus strain 228e</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/133/001</DrugIDPK>
    <LicenceNumber>VPA10996/133/001</LicenceNumber>
    <ProductName>Nobilis Gumboro D78 lyophilisate for use in drinking water for chickens</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>04/04/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gumboro disease virus strain D78</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/136/001</DrugIDPK>
    <LicenceNumber>VPA10996/136/001</LicenceNumber>
    <ProductName>Nobilis IB Ma5</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>19/02/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oculonasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated IB virus strain Ma5</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/094/001</DrugIDPK>
    <LicenceNumber>VPA10996/094/001</LicenceNumber>
    <ProductName>Nobilis IB+ND+EDS emulsion for injection for chickens</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>28/10/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01AA13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Infectious bronchitis virus strain m41 inactivated</ActiveSubstance>
      <ActiveSubstance>Inactivated ND virus strain clone 30 inducing</ActiveSubstance>
      <ActiveSubstance>Inactivated egg drop syndrome’76 inducing</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/091/001</DrugIDPK>
    <LicenceNumber>VPA10996/091/001</LicenceNumber>
    <ProductName>Nobilis ND Clone 30 live lyophilisate for oculonasal suspension/use in drinking water for chickens and turkeys.</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>31/08/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live newcastle disease virus clone 30</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/190/001</DrugIDPK>
    <LicenceNumber>VPA10996/190/001</LicenceNumber>
    <ProductName>Nobilis Rhino CV</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>17/06/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension</DosageForm>
    <ATCs>
      <ATC>QI01AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated avian rhinotracheitis virus strain trt 11/94</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/087/001</DrugIDPK>
    <LicenceNumber>VPA10996/087/001</LicenceNumber>
    <ProductName>Nobilis RT+IBmulti+G+ND</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>24/08/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01AA18</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Infectious bronchitis virus strain M41</ActiveSubstance>
      <ActiveSubstance>Infectious bronchitis virus strain 249g </ActiveSubstance>
      <ActiveSubstance>Avian rhinotracheitis virus strain But1 #8544 (subgroup A)</ActiveSubstance>
      <ActiveSubstance>Infectious bursal disease virus strain D78</ActiveSubstance>
      <ActiveSubstance>Newcastle disease virus strain clone 30 </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/181/001</DrugIDPK>
    <LicenceNumber>VPA10996/181/001</LicenceNumber>
    <ProductName>Nobilis RT+IBmulti+ND+EDS</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>03/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01AA18</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Infectious bronchitis virus strain M41 (pre-inactivation)</ActiveSubstance>
      <ActiveSubstance>Infectious bronchitis virus strain 249g </ActiveSubstance>
      <ActiveSubstance>Avian rhinotracheitis strain But1 #8544 </ActiveSubstance>
      <ActiveSubstance>Egg drop syndrome 76 strain bc14</ActiveSubstance>
      <ActiveSubstance>Newcastle disease virus strain clone 30 </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/174/001</DrugIDPK>
    <LicenceNumber>VPA10996/174/001</LicenceNumber>
    <ProductName>Nobivac DHP lyophilisate and solvent for suspension for injection for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>12/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine distemper virus, strain onderstepoort</ActiveSubstance>
      <ActiveSubstance>Canine adenovirus type 2 strain manhattan lpv3 (live)</ActiveSubstance>
      <ActiveSubstance>Canine parvovirus strain 154 (live)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/166/001</DrugIDPK>
    <LicenceNumber>VPA10996/166/001</LicenceNumber>
    <ProductName>Nobivac DHPPi</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>03/06/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for solution for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine distemper virus strain ondertespoort (live)</ActiveSubstance>
      <ActiveSubstance>Canine adenovirus type 2 strain manhattan lpv3 (live)</ActiveSubstance>
      <ActiveSubstance>Canine parvovirus strain 154 (live)</ActiveSubstance>
      <ActiveSubstance>Canine parainfluenza virus strain Cornell (Live)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/182/001</DrugIDPK>
    <LicenceNumber>VPA10996/182/001</LicenceNumber>
    <ProductName>Nobivac Ducat lyophilisate and solvent for suspension for injection, for cats</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>14/01/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI06AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live feline calicivirus, strain F9</ActiveSubstance>
      <ActiveSubstance>Live feline rhinotracheitis virus strain G2620A</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/129/001</DrugIDPK>
    <LicenceNumber>VPA10996/129/001</LicenceNumber>
    <ProductName>Nobivac KC nasal drops, lyophilisate and solvent for suspension for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>22/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Nasal drops, lyophilisate and solvent for suspension</DosageForm>
    <ATCs>
      <ATC>QI07AF</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intranasal use</RoutesOfAdministration>
      <RoutesOfAdministration>Nasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bordetella bronchiseptica</ActiveSubstance>
      <ActiveSubstance>Canine parainfluenza</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/169/001</DrugIDPK>
    <LicenceNumber>VPA10996/169/001</LicenceNumber>
    <ProductName>Nobivac Lepto 2 Suspension for Injection for Dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>03/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Leptospira interrogans serogroup Canicola; serovar portland-vere, strain Ca-12-000</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans serogroup icterohaemorrhagiae strain 820k</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/167/001</DrugIDPK>
    <LicenceNumber>VPA10996/167/001</LicenceNumber>
    <ProductName>Nobivac Parvo-C</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>05/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine parvovirus attenuated strain 154</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/289/001</DrugIDPK>
    <LicenceNumber>VPA10996/289/001</LicenceNumber>
    <ProductName>Nobivac Pi lyophilisate and solvent for suspension for injection for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>14/04/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD08</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine parainfluenza virus strain Cornell (Live)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/170/001</DrugIDPK>
    <LicenceNumber>VPA10996/170/001</LicenceNumber>
    <ProductName>Nobivac Rabies suspension for injection for dogs and cats</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>10/08/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated rabies virus antigen suspension</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/277/002</DrugIDPK>
    <LicenceNumber>VPA10996/277/002</LicenceNumber>
    <ProductName>Nobivac Respira Bb suspension for injection for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>25/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bordetella Bronchiseptica Fimbriae</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/277/001</DrugIDPK>
    <LicenceNumber>VPA10996/277/001</LicenceNumber>
    <ProductName>Nobivac Respira Bb suspension for injection in pre-filled syringe for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>25/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection in pre-filled syringe</DosageForm>
    <ATCs>
      <ATC>QI07AB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bordetella Bronchiseptica Fimbriae</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/177/001</DrugIDPK>
    <LicenceNumber>VPA10996/177/001</LicenceNumber>
    <ProductName>Nobivac Solvent</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>03/10/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ATCs>
      <ATC>QV07AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances xsi:nil="true" />
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Diluent</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/204/001</DrugIDPK>
    <LicenceNumber>VPA10996/204/001</LicenceNumber>
    <ProductName>Nobivac Tricat Trio, lyophilisate and solvent for suspension for injection, for cats</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>28/02/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI06AD04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Feline calicivrus, strain f9 live attenuated</ActiveSubstance>
      <ActiveSubstance>Feline herpes virus type 1, strain g2620a live attenuated</ActiveSubstance>
      <ActiveSubstance>Feline panleucopenia virus, strain mw-1 live attenuated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/097/002</DrugIDPK>
    <LicenceNumber>VPA22664/097/002</LicenceNumber>
    <ProductName>Norbrook Fipronil 134 mg Spot-On Solution for Medium Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/097/003</DrugIDPK>
    <LicenceNumber>VPA22664/097/003</LicenceNumber>
    <ProductName>Norbrook Fipronil 268 mg Spot-On Solution for Large Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/097/004</DrugIDPK>
    <LicenceNumber>VPA22664/097/004</LicenceNumber>
    <ProductName>Norbrook Fipronil 402 mg Spot-On Solution for Very Large Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/096/001</DrugIDPK>
    <LicenceNumber>VPA22664/096/001</LicenceNumber>
    <ProductName>Norbrook Fipronil 50 mg Spot-On Solution for cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/097/001</DrugIDPK>
    <LicenceNumber>VPA22664/097/001</LicenceNumber>
    <ProductName>Norbrook Fipronil 67 mg Spot-On Solution for Small Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/138/002</DrugIDPK>
    <LicenceNumber>VPA22664/138/002</LicenceNumber>
    <ProductName>Norbrook Fipronil and (S)-Methoprene 134 mg/120.6 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/138/003</DrugIDPK>
    <LicenceNumber>VPA22664/138/003</LicenceNumber>
    <ProductName>Norbrook Fipronil and (S)-Methoprene 268 mg/241.2 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/138/004</DrugIDPK>
    <LicenceNumber>VPA22664/138/004</LicenceNumber>
    <ProductName>Norbrook Fipronil and (S)-Methoprene 402 mg/361.8 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/133/001</DrugIDPK>
    <LicenceNumber>VPA22664/133/001</LicenceNumber>
    <ProductName>Norbrook Fipronil and (S)-Methoprene 50 mg/60 mg spot-on solution for cats and ferrets</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/138/001</DrugIDPK>
    <LicenceNumber>VPA22664/138/001</LicenceNumber>
    <ProductName>Norbrook Fipronil and (S)-Methoprene 67 mg/60.3 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/093/001</DrugIDPK>
    <LicenceNumber>VPA22664/093/001</LicenceNumber>
    <ProductName>Norfenicol 300 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/145/001</DrugIDPK>
    <LicenceNumber>VPA22664/145/001</LicenceNumber>
    <ProductName>Normazole 5 mg/ml Oral Solution for Cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/11/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/073/001</DrugIDPK>
    <LicenceNumber>VPA22664/073/001</LicenceNumber>
    <ProductName>Norocarp 50 mg/ml Solution for Injection for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/012/001</DrugIDPK>
    <LicenceNumber>VPA22664/012/001</LicenceNumber>
    <ProductName>Norocillin 300 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/072/002</DrugIDPK>
    <LicenceNumber>VPA22664/072/002</LicenceNumber>
    <ProductName>Noroclav 250 mg Tablets for dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/072/001</DrugIDPK>
    <LicenceNumber>VPA22664/072/001</LicenceNumber>
    <ProductName>Noroclav 50 mg Tablets for Dogs and Cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/05/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/082/001</DrugIDPK>
    <LicenceNumber>VPA22664/082/001</LicenceNumber>
    <ProductName>Noroclav 500 mg Palatable Tablets for Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>05/10/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/058/001</DrugIDPK>
    <LicenceNumber>VPA22664/058/001</LicenceNumber>
    <ProductName>Noroclav Injection for Cattle, Dogs and Cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>27/09/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/090/001</DrugIDPK>
    <LicenceNumber>VPA22664/090/001</LicenceNumber>
    <ProductName>Noroclav Intramammary Suspension for Lactating Cows</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/11/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RV01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/011/001</DrugIDPK>
    <LicenceNumber>VPA22664/011/001</LicenceNumber>
    <ProductName>Noroclox DC Intramammary Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/043/001</DrugIDPK>
    <LicenceNumber>VPA22664/043/001</LicenceNumber>
    <ProductName>Noroclox DC Xtra Intramammary Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/05/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/021/001</DrugIDPK>
    <LicenceNumber>VPA22664/021/001</LicenceNumber>
    <ProductName>Norodine 240 mg/ml Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/019/001</DrugIDPK>
    <LicenceNumber>VPA22664/019/001</LicenceNumber>
    <ProductName>Norodine Equine Oral Paste</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/051/001</DrugIDPK>
    <LicenceNumber>VPA22664/051/001</LicenceNumber>
    <ProductName>Noromectin 10 mg/ml Solution for Injection for Cattle and Pigs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/03/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/059/001</DrugIDPK>
    <LicenceNumber>VPA22664/059/001</LicenceNumber>
    <ProductName>Noromectin 10 mg/ml Solution for Injection for sheep.</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/06/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/062/001</DrugIDPK>
    <LicenceNumber>VPA22664/062/001</LicenceNumber>
    <ProductName>Noromectin 18.7 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/04/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/052/001</DrugIDPK>
    <LicenceNumber>VPA22664/052/001</LicenceNumber>
    <ProductName>Noromectin 5 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/03/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/053/001</DrugIDPK>
    <LicenceNumber>VPA22664/053/001</LicenceNumber>
    <ProductName>Noromectin Drench 0.8 mg/ml Oral Solution for Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/068/001</DrugIDPK>
    <LicenceNumber>VPA22664/068/001</LicenceNumber>
    <ProductName>Noromectin Multi Injection Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>22/02/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/117/001</DrugIDPK>
    <LicenceNumber>VPA22664/117/001</LicenceNumber>
    <ProductName>Noropraz, 18.7 mg/g + 140.3 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/115/001</DrugIDPK>
    <LicenceNumber>VPA22664/115/001</LicenceNumber>
    <ProductName>Noroseal 2.6 g Intramammary Suspension for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10660/005/001</DrugIDPK>
    <LicenceNumber>VPA10660/005/001</LicenceNumber>
    <ProductName>Novaderma 660 mg/g + 7.7 mg/g cutaneous paste for horses, cattle and sheep</ProductName>
    <PAHolder>WDT - Wirtschaftsgenossenschaft deutscher Tierarzte eG,</PAHolder>
    <AuthorisedDate>17/04/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous paste</DosageForm>
    <ATCs>
      <ATC>QD02AF</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 19(1) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
      <ActiveSubstance>Methyl salicylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10463/006/001</DrugIDPK>
    <LicenceNumber>VPA10463/006/001</LicenceNumber>
    <ProductName>Novamune concentrate and solvent for suspension for injection for chickens</ProductName>
    <PAHolder>CEVA-Phylaxia Veterinary Biologicals Co. Ltd</PAHolder>
    <AuthorisedDate>31/08/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bursal disease virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10420/003/001</DrugIDPK>
    <LicenceNumber>VPA10420/003/001</LicenceNumber>
    <ProductName>Novocillin LC 1000 mg intramammary suspension for lactating cows</ProductName>
    <PAHolder>Pharmanovo Veterinärarzneimittel GmbH</PAHolder>
    <AuthorisedDate>15/10/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ01CF04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxacillin sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22931/001/001</DrugIDPK>
    <LicenceNumber>VPA22931/001/001</LicenceNumber>
    <ProductName>Novomate 277.8 mg/ml powder and solvent for suspension for injection for cattle</ProductName>
    <PAHolder>Lohmann Pharma Herstellung GmbH</PAHolder>
    <AuthorisedDate>04/12/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/048/001</DrugIDPK>
    <LicenceNumber>VPA10782/048/001</LicenceNumber>
    <ProductName>Novosol 500 000 IU/g powder for use in drinking water/milk for cattle, chickens, pigs, ducks, turkeys, geese, quail and partridges</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>18/07/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QA07AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Goose</Species>
      <Species>Partridge</Species>
      <Species>Pigs</Species>
      <Species>Quail</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/268/001</DrugIDPK>
    <LicenceNumber>VPA10996/268/001</LicenceNumber>
    <ProductName>NUFLOR 300 mg/ml solution for injection for cattle and sheep</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>23/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/207/001</DrugIDPK>
    <LicenceNumber>VPA10996/207/001</LicenceNumber>
    <ProductName>Nuflor Minidose 450 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>12/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/066/001</DrugIDPK>
    <LicenceNumber>VPA22033/066/001</LicenceNumber>
    <ProductName>Nullamec 5 mg/ml pour-on solution for cattle</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>14/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/026/001</DrugIDPK>
    <LicenceNumber>VPA10516/026/001</LicenceNumber>
    <ProductName>Oapent 100 mg/ml Solution for injection for dogs</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>05/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentosan Polysulfate Sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/015/001</DrugIDPK>
    <LicenceNumber>VPA10516/015/001</LicenceNumber>
    <ProductName>OCNIL 400 mg/g powder for use in drinking water</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>28/07/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FF02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lincomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/051/001</DrugIDPK>
    <LicenceNumber>VPA10989/051/001</LicenceNumber>
    <ProductName>Octacillin 697 mg/g powder for use in drinking water for chickens</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>21/12/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/073/001</DrugIDPK>
    <LicenceNumber>VPA10989/073/001</LicenceNumber>
    <ProductName>Octacillin 800 mg/g powder for use in drinking water for pigs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>12/06/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/003/001</DrugIDPK>
    <LicenceNumber>VPA10521/003/001</LicenceNumber>
    <ProductName>Oestracton 52.4  microgram/ml solution for injection for cattle, horses, pigs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>08/11/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadorelin (6-D-phenylalanine) acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10892/001/001</DrugIDPK>
    <LicenceNumber>VPA10892/001/001</LicenceNumber>
    <ProductName>Olab Sultrim 21% premix for medicated feed</ProductName>
    <PAHolder>Old Castle Laboratories Limited</PAHolder>
    <AuthorisedDate>24/04/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/071/001</DrugIDPK>
    <LicenceNumber>VPA10454/071/001</LicenceNumber>
    <ProductName>Omeproshield 370 mg/g oral paste for horses</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>13/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/010/001</DrugIDPK>
    <LicenceNumber>VPA23340/010/001</LicenceNumber>
    <ProductName>Ophtalon vet 10 mg/g eye ointment for dogs and cats</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>26/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ATCs>
      <ATC>QS01AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application - other (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chloramphenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/028/001</DrugIDPK>
    <LicenceNumber>VPA10475/028/001</LicenceNumber>
    <ProductName>Ophtocycline 10 mg/g eye ointment for dogs, cats and horses</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>01/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ATCs>
      <ATC>QS01AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/007/001</DrugIDPK>
    <LicenceNumber>VPA22664/007/001</LicenceNumber>
    <ProductName>Opticlox Eye Ointment 167 mg/g</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ATCs>
      <ATC>QS01AA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Conjunctival use</RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/242/001</DrugIDPK>
    <LicenceNumber>VPA10996/242/001</LicenceNumber>
    <ProductName>Optimmune 2 mg/g Eye ointment for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>19/04/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ATCs>
      <ATC>QS01XA90</ATC>
      <ATC>QS01XA18</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Eye Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22827/002/001</DrugIDPK>
    <LicenceNumber>VPA22827/002/001</LicenceNumber>
    <ProductName>Optivar 500 mg beehive strips for honey bees</ProductName>
    <PAHolder>Veto-Pharma</PAHolder>
    <AuthorisedDate>17/04/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Bee-hive strip</DosageForm>
    <ATCs>
      <ATC>QP53AD01</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-hive use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amitraz </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Honey bees</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/114/001</DrugIDPK>
    <LicenceNumber>VPA10988/114/001</LicenceNumber>
    <ProductName>Optomease Vet 200 mg/ml concentrate for solution for fish treatment</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>12/06/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for solution for fish treatment</DosageForm>
    <ATCs>
      <ATC>QN01AX92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Water-borne use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
      <Species>Trout</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/003/002</DrugIDPK>
    <LicenceNumber>VPA10555/003/002</LicenceNumber>
    <ProductName>Orafluke 10 % w/v Oral Suspension</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>18/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/003/001</DrugIDPK>
    <LicenceNumber>VPA10555/003/001</LicenceNumber>
    <ProductName>Orafluke 5 % w/v Oral Suspension</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>18/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
      <ATC>QP52AG05</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/072/001</DrugIDPK>
    <LicenceNumber>VPA10454/072/001</LicenceNumber>
    <ProductName>ORAMEC Drench for Sheep 0.8 mg/ml</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10484/012/001</DrugIDPK>
    <LicenceNumber>VPA10484/012/001</LicenceNumber>
    <ProductName>Orazole 100 mg/ml Oral Drench</ProductName>
    <PAHolder>Foran Healthcare Unlimited Company</PAHolder>
    <AuthorisedDate>13/08/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/045/001</DrugIDPK>
    <LicenceNumber>VPA10387/045/001</LicenceNumber>
    <ProductName>Orbenin Dry Cow 500 mg Intramammary Suspension</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>01/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/046/001</DrugIDPK>
    <LicenceNumber>VPA10387/046/001</LicenceNumber>
    <ProductName>Orbenin Extra Dry Cow 600 mg intramammary suspension</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/026/001</DrugIDPK>
    <LicenceNumber>VPA10521/026/001</LicenceNumber>
    <ProductName>Oridermyl ear gel</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>13/06/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QS02CA04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulphate</ActiveSubstance>
      <ActiveSubstance>Nystatin</ActiveSubstance>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
      <ActiveSubstance>Permethrin (25:75) technical</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10442/001/001</DrugIDPK>
    <LicenceNumber>VPA10442/001/001</LicenceNumber>
    <ProductName>Orniflox 25 mg/ml concentrate for oral solution for pet rabbits, rodents, ornamental birds and reptiles</ProductName>
    <PAHolder>Avimedical B.V.</PAHolder>
    <AuthorisedDate>27/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chinchilla</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Rabbit (non-food-producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/016/001</DrugIDPK>
    <LicenceNumber>VPA22622/016/001</LicenceNumber>
    <ProductName>Osphos 51 mg/ml solution for injection for horses</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>03/09/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM05BA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clodronate disodium tetrahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/131/001</DrugIDPK>
    <LicenceNumber>VPA10987/131/001</LicenceNumber>
    <ProductName>Osteopen 100 mg/ml Solution for injection for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentosan Polysulfate Sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/168/001</DrugIDPK>
    <LicenceNumber>VPA10987/168/001</LicenceNumber>
    <ProductName>Otisur</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>23/02/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
      <ActiveSubstance>Polymyxin b sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/244/001</DrugIDPK>
    <LicenceNumber>VPA10996/244/001</LicenceNumber>
    <ProductName>Otomax Ear Drops Suspension</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>07/09/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA90</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin</ActiveSubstance>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/077/001</DrugIDPK>
    <LicenceNumber>VPA10774/077/001</LicenceNumber>
    <ProductName>Otomicol ear drops and cutaneous suspension for dogs, cats and guinea pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>10/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
      <ActiveSubstance>Polymyxin B sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Guinea pig</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/047/001</DrugIDPK>
    <LicenceNumber>VPA10774/047/001</LicenceNumber>
    <ProductName>Otoxolan ear drops, suspension for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>20/01/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, suspension</DosageForm>
    <ATCs>
      <ATC>QS02CA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Marbofloxacin</ActiveSubstance>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Dexamethasone acetate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/004/001</DrugIDPK>
    <LicenceNumber>VPA10815/004/001</LicenceNumber>
    <ProductName>Ovarelin 50 ug/ml, solution for injection for cattle</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>07/12/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadorelin Diacetate Tetrahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/081/002</DrugIDPK>
    <LicenceNumber>VPA10988/081/002</LicenceNumber>
    <ProductName>Ovarid Tablets 20 mg</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>01/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QG03AC05</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Megestrol acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/081/001</DrugIDPK>
    <LicenceNumber>VPA10988/081/001</LicenceNumber>
    <ProductName>Ovarid Tablets 5 mg</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>01/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QG03AC05</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Megestrol acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/012/001</DrugIDPK>
    <LicenceNumber>VPA10915/012/001</LicenceNumber>
    <ProductName>Ovimec 0.8 mg/ml Oral Solution for Sheep</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>03/06/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA02</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/067/001</DrugIDPK>
    <LicenceNumber>VPA22033/067/001</LicenceNumber>
    <ProductName>Ovimectin 10 mg/ml Solution for Injection for Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>26/05/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/027/001</DrugIDPK>
    <LicenceNumber>VPA10516/027/001</LicenceNumber>
    <ProductName>Ovimel 18 mg implantation tablets for sheep</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>16/05/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Implantation tablet</DosageForm>
    <ATCs>
      <ATC>QN05CH01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Melatonin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/078/001</DrugIDPK>
    <LicenceNumber>VPA22033/078/001</LicenceNumber>
    <ProductName>Ovisect 12.5 mg/ml Pour-On Solution for Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>04/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC08</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin technical high-cis (80:20)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/149/001</DrugIDPK>
    <LicenceNumber>VPA10996/149/001</LicenceNumber>
    <ProductName>OVIVAC P PLUS</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>21/03/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI04AB05</ATC>
    </ATCs>
    <LegalBasis>Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clostridium perfringens type d, strain 603 epsilon toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium septicum s1110/85 toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei strain no. 655</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei strain no. 656</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei strain no. 657</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei strain no. 658</ActiveSubstance>
      <ActiveSubstance>Clostridium chauvoei strain no. 1048</ActiveSubstance>
      <ActiveSubstance>Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated</ActiveSubstance>
      <ActiveSubstance>Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated</ActiveSubstance>
      <ActiveSubstance>Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated</ActiveSubstance>
      <ActiveSubstance>Formalin killed cells of mannheimia haemolytica serotypes a7</ActiveSubstance>
      <ActiveSubstance>Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated</ActiveSubstance>
      <ActiveSubstance>Formalin killed cells of pasteurella trehalosi serotypes t3</ActiveSubstance>
      <ActiveSubstance>Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated</ActiveSubstance>
      <ActiveSubstance>Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated</ActiveSubstance>
      <ActiveSubstance>Formalin pasteurella trehalosi strain t15 (s1105/84)</ActiveSubstance>
      <ActiveSubstance>Clostridium tetani strain no. s1123/91</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/007/001</DrugIDPK>
    <LicenceNumber>VPA22028/007/001</LicenceNumber>
    <ProductName>OVIVERM 25 mg/ml Oral Suspension for Sheep</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>11/07/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10915/001/001</DrugIDPK>
    <LicenceNumber>VPA10915/001/001</LicenceNumber>
    <ProductName>Oxfencare Oral Suspension</ProductName>
    <PAHolder>Ancare Ireland Ltd.</PAHolder>
    <AuthorisedDate>09/06/1992</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxfendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/010/001</DrugIDPK>
    <LicenceNumber>VPA10836/010/001</LicenceNumber>
    <ProductName>OXTRA DD 100 mg/ml solution for injection for cattle, sheep, pigs, horses, dogs and cats</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>18/09/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/042/001</DrugIDPK>
    <LicenceNumber>VPA22033/042/001</LicenceNumber>
    <ProductName>Oxycomplex NS Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>10/06/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA56</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/141/001</DrugIDPK>
    <LicenceNumber>VPA22664/141/001</LicenceNumber>
    <ProductName>Oxyfluke 34 mg/ml Oral Suspension for Cattle and Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxyclozanide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/005/001</DrugIDPK>
    <LicenceNumber>VPA10981/005/001</LicenceNumber>
    <ProductName>Oxytetracycline 200 mg/ml L.A. solution for injection for cattle</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/001/001</DrugIDPK>
    <LicenceNumber>VPA10980/001/001</LicenceNumber>
    <ProductName>Oxytetracycline Injection 10%</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10445/001/001</DrugIDPK>
    <LicenceNumber>VPA10445/001/001</LicenceNumber>
    <ProductName>Oxytobel 10 IU/ml solution for injection for Horses, Cattle, Pigs, Sheep, Goats, Dogs and Cats</ProductName>
    <PAHolder>Bela-Pharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>21/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytocin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/004/001</DrugIDPK>
    <LicenceNumber>VPA10826/004/001</LicenceNumber>
    <ProductName>Oxytocin aniMedica, solution for injection</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytocin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/044/001</DrugIDPK>
    <LicenceNumber>VPA10989/044/001</LicenceNumber>
    <ProductName>Oxytocin Solution for Injection</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>01/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytocin synthetic</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/111/001</DrugIDPK>
    <LicenceNumber>VPA10996/111/001</LicenceNumber>
    <ProductName>Panacur 100 mg/ml oral suspension for cattle and horses</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/118/001</DrugIDPK>
    <LicenceNumber>VPA10996/118/001</LicenceNumber>
    <ProductName>Panacur Equine 187.5 mg/g Oral Paste</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/188/001</DrugIDPK>
    <LicenceNumber>VPA10996/188/001</LicenceNumber>
    <ProductName>Panacur PetPaste 187.5 mg/g oral paste for dogs and cats</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>23/09/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/073/001</DrugIDPK>
    <LicenceNumber>VPA10454/073/001</LicenceNumber>
    <ProductName>Panomec 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>19/12/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Veterinary medicinal products intended for animals exclusively kept as pets (article 5(6) of Reg 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/215/001</DrugIDPK>
    <LicenceNumber>VPA10996/215/001</LicenceNumber>
    <ProductName>Paracox-5, suspension for oral suspension for chickens</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>23/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for oral suspension</DosageForm>
    <ATCs>
      <ATC>QI01AN01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eimeria acervulina hp</ActiveSubstance>
      <ActiveSubstance>Eimeria maxima cp</ActiveSubstance>
      <ActiveSubstance>Eimeria maxima mfp</ActiveSubstance>
      <ActiveSubstance>Eimeria mitis hp</ActiveSubstance>
      <ActiveSubstance>Eimeria tenella hp</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/245/001</DrugIDPK>
    <LicenceNumber>VPA10996/245/001</LicenceNumber>
    <ProductName>Paracox-8, suspension for oral suspension for chickens</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>19/10/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for oral suspension</DosageForm>
    <ATCs>
      <ATC>QI01AN01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eimeria acervulina hp</ActiveSubstance>
      <ActiveSubstance>Eimeria brunetti hp</ActiveSubstance>
      <ActiveSubstance>Eimeria maxima cp</ActiveSubstance>
      <ActiveSubstance>Eimeria maxima mfp</ActiveSubstance>
      <ActiveSubstance>Eimeria mitis hp</ActiveSubstance>
      <ActiveSubstance>Eimeria necatrix hp</ActiveSubstance>
      <ActiveSubstance>Eimeria praecox hp</ActiveSubstance>
      <ActiveSubstance>Eimeria tenella hp</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/040/001</DrugIDPK>
    <LicenceNumber>VPA22664/040/001</LicenceNumber>
    <ProductName>Parafend 2.265 % Oral Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>10/02/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC02</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxfendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/070/001</DrugIDPK>
    <LicenceNumber>VPA22664/070/001</LicenceNumber>
    <ProductName>Parafend Plus Oral Suspension</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/06/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC52</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxfendazole</ActiveSubstance>
      <ActiveSubstance>Closantel </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/061/001</DrugIDPK>
    <LicenceNumber>VPA22664/061/001</LicenceNumber>
    <ProductName>Paramectin 0.8 mg/ml Drench for Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/065/001</DrugIDPK>
    <LicenceNumber>VPA22664/065/001</LicenceNumber>
    <ProductName>Paramectin 10 mg/ml Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/06/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/066/001</DrugIDPK>
    <LicenceNumber>VPA22664/066/001</LicenceNumber>
    <ProductName>Paramectin 5 mg/ml Pour-On Solution for cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/06/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10484/021/001</DrugIDPK>
    <LicenceNumber>VPA10484/021/001</LicenceNumber>
    <ProductName>Parazole 10% w/v Oral Suspension</ProductName>
    <PAHolder>Foran Healthcare Unlimited Company</PAHolder>
    <AuthorisedDate>01/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10484/022/001</DrugIDPK>
    <LicenceNumber>VPA10484/022/001</LicenceNumber>
    <ProductName>Parazole Dog/Cat 100 mg/ml Oral Suspension</ProductName>
    <PAHolder>Foran Healthcare Unlimited Company</PAHolder>
    <AuthorisedDate>21/09/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/026/001</DrugIDPK>
    <LicenceNumber>VPA10782/026/001</LicenceNumber>
    <ProductName>Parofor 140 mg/ml solution for use in drinking water/milk for cattle (pre-ruminant) and pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>04/08/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QA07AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paromomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/014/001</DrugIDPK>
    <LicenceNumber>VPA10782/014/001</LicenceNumber>
    <ProductName>Parofor 70000 IU/g powder for use in drinking water/ milk for cattle (pre-ruminant) and pigs.</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QA07AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paromomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/035/001</DrugIDPK>
    <LicenceNumber>VPA10782/035/001</LicenceNumber>
    <ProductName>Parofor crypto 140 000 IU/ml oral solution for pre-ruminant cattle</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>07/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QA07AA06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paromomycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/033/001</DrugIDPK>
    <LicenceNumber>VPA10782/033/001</LicenceNumber>
    <ProductName>Parofor crypto 140 000 IU/ml oral solution for sheep and goats</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>05/07/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QA07AA06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paromomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/052/001</DrugIDPK>
    <LicenceNumber>VPA10815/052/001</LicenceNumber>
    <ProductName>Parvoruvax suspension for injection for pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>01/05/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine parvovirus inactivated k-22 strain</ActiveSubstance>
      <ActiveSubstance>Erysipelothrix rhusiopathiae, serotype 2, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10823/002/001</DrugIDPK>
    <LicenceNumber>VPA10823/002/001</LicenceNumber>
    <ProductName>PEN/STREP Injection</ProductName>
    <PAHolder>Chem-Pharm Limited</PAHolder>
    <AuthorisedDate>01/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/009/001</DrugIDPK>
    <LicenceNumber>VPA22664/009/001</LicenceNumber>
    <ProductName>Pen &amp; Strep Suspension for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/009/001</DrugIDPK>
    <LicenceNumber>VPA10980/009/001</LicenceNumber>
    <ProductName>Pen-Strep 20/20 Suspension for Injection</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
      <ActiveSubstance>Streptomycin sulphate</ActiveSubstance>
      <ActiveSubstance>Procaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10505/004/001</DrugIDPK>
    <LicenceNumber>VPA10505/004/001</LicenceNumber>
    <ProductName>Penethaone 236.3 mg/ml powder and solvent for suspension for injection for cattle</ProductName>
    <PAHolder>Divasa-Farmavic S.A.,</PAHolder>
    <AuthorisedDate>03/09/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/005/001</DrugIDPK>
    <LicenceNumber>VPA10990/005/001</LicenceNumber>
    <ProductName>Pentomycin Suspension for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulphate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/149/001</DrugIDPK>
    <LicenceNumber>VPA22664/149/001</LicenceNumber>
    <ProductName>Peptaleve 370 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/113/001</DrugIDPK>
    <LicenceNumber>VPA22664/113/001</LicenceNumber>
    <ProductName>Peptizole 370 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QA02BC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/049/001</DrugIDPK>
    <LicenceNumber>VPA10782/049/001</LicenceNumber>
    <ProductName>Pereprin 5 mg/ml pour on solution for cattle, sheep and goats</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>30/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/042/004</DrugIDPK>
    <LicenceNumber>VPA10980/042/004</LicenceNumber>
    <ProductName>Pergocoat 0.25 mg film-coated tablets for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>28/10/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/042/001</DrugIDPK>
    <LicenceNumber>VPA10980/042/001</LicenceNumber>
    <ProductName>Pergocoat 0.5 mg film-coated tablets for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>18/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/042/002</DrugIDPK>
    <LicenceNumber>VPA10980/042/002</LicenceNumber>
    <ProductName>Pergocoat 1 mg film-coated tablets for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>18/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/042/003</DrugIDPK>
    <LicenceNumber>VPA10980/042/003</LicenceNumber>
    <ProductName>Pergocoat 2 mg film-coated tablets for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>18/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/014/001</DrugIDPK>
    <LicenceNumber>VPA23462/014/001</LicenceNumber>
    <ProductName>Pergoquin 1 mg tablets for horses</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>21/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10505/005/001</DrugIDPK>
    <LicenceNumber>VPA10505/005/001</LicenceNumber>
    <ProductName>Permacyl 236.3 mg/ml powder and solvent for suspension for injection for cattle</ProductName>
    <PAHolder>Divasa-Farmavic S.A.,</PAHolder>
    <AuthorisedDate>09/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/062/001</DrugIDPK>
    <LicenceNumber>VPA10983/062/001</LicenceNumber>
    <ProductName>PERMAWAY 600 mg intramammary suspension for cattle</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>23/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CF02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloxacillin Benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/095/002</DrugIDPK>
    <LicenceNumber>VPA22664/095/002</LicenceNumber>
    <ProductName>Pestigon 134 mg Spot-On Solution for Medium Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/095/003</DrugIDPK>
    <LicenceNumber>VPA22664/095/003</LicenceNumber>
    <ProductName>Pestigon 268 mg Spot-On Solution for large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/095/004</DrugIDPK>
    <LicenceNumber>VPA22664/095/004</LicenceNumber>
    <ProductName>Pestigon 402 mg Spot-On Solution for very large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/098/001</DrugIDPK>
    <LicenceNumber>VPA22664/098/001</LicenceNumber>
    <ProductName>Pestigon 50 mg Spot-On Solution for Cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/095/001</DrugIDPK>
    <LicenceNumber>VPA22664/095/001</LicenceNumber>
    <ProductName>Pestigon 67 mg Spot-On Solution for Small Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/135/002</DrugIDPK>
    <LicenceNumber>VPA22664/135/002</LicenceNumber>
    <ProductName>PestiGon Combo 134 mg/120.6 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/135/003</DrugIDPK>
    <LicenceNumber>VPA22664/135/003</LicenceNumber>
    <ProductName>PestiGon Combo 268 mg/241.2 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/135/004</DrugIDPK>
    <LicenceNumber>VPA22664/135/004</LicenceNumber>
    <ProductName>PestiGon Combo 402 mg/361.8 mg spot-on solution for very large dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/131/001</DrugIDPK>
    <LicenceNumber>VPA22664/131/001</LicenceNumber>
    <ProductName>PestiGon Combo 50 mg/60 mg spot-on solution for cats and ferrets</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/135/001</DrugIDPK>
    <LicenceNumber>VPA22664/135/001</LicenceNumber>
    <ProductName>PestiGon Combo 67 mg/60.3 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/025/001</DrugIDPK>
    <LicenceNumber>VPA10996/025/001</LicenceNumber>
    <ProductName>PG 600 Powder and solvent for solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA99</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadotrophin equine serum</ActiveSubstance>
      <ActiveSubstance>Gonadotrophin chorionic</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/002/001</DrugIDPK>
    <LicenceNumber>VPA10539/002/001</LicenceNumber>
    <ProductName>PGF Veyx 0.0875 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>19/10/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/002/002</DrugIDPK>
    <LicenceNumber>VPA10539/002/002</LicenceNumber>
    <ProductName>PGF Veyx forte 0.250 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>19/10/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/012/001</DrugIDPK>
    <LicenceNumber>VPA10782/012/001</LicenceNumber>
    <ProductName>Pharmasin 1 g/g Granules for Use in Drinking Water for Pigs, Chickens, Turkeys and Calves</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>08/04/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/006/002</DrugIDPK>
    <LicenceNumber>VPA10782/006/002</LicenceNumber>
    <ProductName>Pharmasin 100 000 IU/g Premix for medicated feeding stuff for pigs, broilers and pullets</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>21/08/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/001/002</DrugIDPK>
    <LicenceNumber>VPA10782/001/002</LicenceNumber>
    <ProductName>Pharmasin 20 000 IU/g Oral Granules for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>21/08/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/015/001</DrugIDPK>
    <LicenceNumber>VPA10782/015/001</LicenceNumber>
    <ProductName>Pharmasin 200 mg/ml solution for injection for cattle, sheep, goats and pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>07/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/006/003</DrugIDPK>
    <LicenceNumber>VPA10782/006/003</LicenceNumber>
    <ProductName>Pharmasin 250 000 IU/g Premix for medicated feeding stuff for pigs, broilers and pullets</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>21/08/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin (base)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/065/001</DrugIDPK>
    <LicenceNumber>VPA10989/065/001</LicenceNumber>
    <ProductName>Phenocillin 800 mg/g powder for use in drinking water for chickens</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CE02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenoxymethylpenicillin potassium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/044/002</DrugIDPK>
    <LicenceNumber>VPA10980/044/002</LicenceNumber>
    <ProductName>Phenocoat 12.5 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/044/003</DrugIDPK>
    <LicenceNumber>VPA10980/044/003</LicenceNumber>
    <ProductName>Phenocoat 25 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/044/001</DrugIDPK>
    <LicenceNumber>VPA10980/044/001</LicenceNumber>
    <ProductName>Phenocoat 5 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/044/004</DrugIDPK>
    <LicenceNumber>VPA10980/044/004</LicenceNumber>
    <ProductName>Phenocoat 50 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/045/004</DrugIDPK>
    <LicenceNumber>VPA22622/045/004</LicenceNumber>
    <ProductName>Phenoleptil 100 mg Tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>15/02/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/045/001</DrugIDPK>
    <LicenceNumber>VPA22622/045/001</LicenceNumber>
    <ProductName>Phenoleptil 12.5 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>17/06/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/045/003</DrugIDPK>
    <LicenceNumber>VPA22622/045/003</LicenceNumber>
    <ProductName>Phenoleptil 25 mg Tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>15/02/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/045/002</DrugIDPK>
    <LicenceNumber>VPA22622/045/002</LicenceNumber>
    <ProductName>Phenoleptil 50 mg tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>17/06/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/043/003</DrugIDPK>
    <LicenceNumber>VPA10980/043/003</LicenceNumber>
    <ProductName>Phenosan 100 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/043/001</DrugIDPK>
    <LicenceNumber>VPA10980/043/001</LicenceNumber>
    <ProductName>Phenosan 12.5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/043/002</DrugIDPK>
    <LicenceNumber>VPA10980/043/002</LicenceNumber>
    <ProductName>Phenosan 50 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/019/003</DrugIDPK>
    <LicenceNumber>VPA10810/019/003</LicenceNumber>
    <ProductName>Phenotab Flavoured 100 mg Tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>11/09/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/019/001</DrugIDPK>
    <LicenceNumber>VPA10810/019/001</LicenceNumber>
    <ProductName>Phenotab Flavoured 25 mg Tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>11/09/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/019/002</DrugIDPK>
    <LicenceNumber>VPA10810/019/002</LicenceNumber>
    <ProductName>Phenotab Flavoured 60 mg Tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>11/09/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenobarbital</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/001/001</DrugIDPK>
    <LicenceNumber>VPA10791/001/001</LicenceNumber>
    <ProductName>Phenoxypen Water Soluble Powder, 325 mg/g powder for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>25/10/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01CE02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenoxymethylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/020/001</DrugIDPK>
    <LicenceNumber>VPA10521/020/001</LicenceNumber>
    <ProductName>Phenylarthrite solution for injection</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylbutazone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/029/001</DrugIDPK>
    <LicenceNumber>VPA10782/029/001</LicenceNumber>
    <ProductName>Pigfen 200 mg/ml suspension for use in drinking water for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>29/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/019/001</DrugIDPK>
    <LicenceNumber>VPA10782/019/001</LicenceNumber>
    <ProductName>Pigfen 40 mg/g granules for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>11/09/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/021/001</DrugIDPK>
    <LicenceNumber>VPA10782/021/001</LicenceNumber>
    <ProductName>Pigfen 40 mg/g premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>09/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-feed use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/067/001</DrugIDPK>
    <LicenceNumber>VPA10989/067/001</LicenceNumber>
    <ProductName>Pimocard 1.25 mg flavoured tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/067/004</DrugIDPK>
    <LicenceNumber>VPA10989/067/004</LicenceNumber>
    <ProductName>Pimocard 10 mg flavoured tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/067/002</DrugIDPK>
    <LicenceNumber>VPA10989/067/002</LicenceNumber>
    <ProductName>Pimocard 2.5 mg flavoured tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/067/003</DrugIDPK>
    <LicenceNumber>VPA10989/067/003</LicenceNumber>
    <ProductName>Pimocard 5 mg flavoured tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>22/01/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/153/001</DrugIDPK>
    <LicenceNumber>VPA22664/153/001</LicenceNumber>
    <ProductName>Pimodine 5 mg/ml Oral Suspension for Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/07/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in pharmaceutical form (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/018/001</DrugIDPK>
    <LicenceNumber>VPA10810/018/001</LicenceNumber>
    <ProductName>Pimotab 1.25 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/018/004</DrugIDPK>
    <LicenceNumber>VPA10810/018/004</LicenceNumber>
    <ProductName>Pimotab 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/018/005</DrugIDPK>
    <LicenceNumber>VPA10810/018/005</LicenceNumber>
    <ProductName>Pimotab 15 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/018/002</DrugIDPK>
    <LicenceNumber>VPA10810/018/002</LicenceNumber>
    <ProductName>Pimotab 2.5 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/018/003</DrugIDPK>
    <LicenceNumber>VPA10810/018/003</LicenceNumber>
    <ProductName>Pimotab 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/014/001</DrugIDPK>
    <LicenceNumber>VPA10790/014/001</LicenceNumber>
    <ProductName>PIRESOL 300 mg/ml solution for use in drinking water for pigs</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>02/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QN02BE01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/246/001</DrugIDPK>
    <LicenceNumber>VPA10996/246/001</LicenceNumber>
    <ProductName>Planate 87.5 micrograms/ml, solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/017/001</DrugIDPK>
    <LicenceNumber>VPA10454/017/001</LicenceNumber>
    <ProductName>Planipart Solution for Injection 30 microgram/ml</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02CA91</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/001/001</DrugIDPK>
    <LicenceNumber>VPA10665/001/001</LicenceNumber>
    <ProductName>Pluset 500 IU/ml + 500 IU/ml powder and solvent for solution for injection for cattle</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>26/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Follicle stimulating hormone (fshp)</ActiveSubstance>
      <ActiveSubstance>Luteinizing hormone (lhp)</ActiveSubstance>
      <ActiveSubstance>Follicle stimulating hormone (fshp)</ActiveSubstance>
      <ActiveSubstance>Luteinizing hormone (lhp)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22715/002/001</DrugIDPK>
    <LicenceNumber>VPA22715/002/001</LicenceNumber>
    <ProductName>Pneumovac Plus suspension for injection for cattle</ProductName>
    <PAHolder>Animal Health Distributors Limited</PAHolder>
    <AuthorisedDate>08/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine respiratory syncytial virus, strain bio-24, inactivated</ActiveSubstance>
      <ActiveSubstance>Bovine parainfluenza 3 virus, strain bio-23, inactivated</ActiveSubstance>
      <ActiveSubstance>Mannheimia Haemolytica, serotype A1 strain dsm 5283, inactivated</ActiveSubstance>
      <ActiveSubstance>Bovine Viral Diarrhoea Virus, Strain Bio-25, Inactavited</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22715/001/001</DrugIDPK>
    <LicenceNumber>VPA22715/001/001</LicenceNumber>
    <ProductName>Pneumovac suspension for injection for cattle</ProductName>
    <PAHolder>Animal Health Distributors Limited</PAHolder>
    <AuthorisedDate>08/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AL04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine Respiratory Syncytial Virus, Strain Bio-24 Inactivated</ActiveSubstance>
      <ActiveSubstance>Bovine parainfluenza 3 virus, strain bio-23, inactivated</ActiveSubstance>
      <ActiveSubstance>Mannheimia Haemolytica, serotype A1 strain dsm 5283, inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/100/001</DrugIDPK>
    <LicenceNumber>VPA10996/100/001</LicenceNumber>
    <ProductName>Porcilis APP suspension for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>31/01/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Concentrate of actinobacillus pleuropneumoniae antigens containing</ActiveSubstance>
      <ActiveSubstance>Omp (outer membrane protein)</ActiveSubstance>
      <ActiveSubstance>Apxi (105 kilodalton type i toxoid)</ActiveSubstance>
      <ActiveSubstance>Apxii (105 kilodalton type ii toxoid)</ActiveSubstance>
      <ActiveSubstance>Apxiii (120 kilodalton macrophage toxoid)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/097/001</DrugIDPK>
    <LicenceNumber>VPA10996/097/001</LicenceNumber>
    <ProductName>Porcilis Ery + Parvo suspension for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>04/05/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL01</ATC>
    </ATCs>
    <LegalBasis>Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated porcine parvovirus strain 014</ActiveSubstance>
      <ActiveSubstance>Inactivated erysipelothrix rhusiopathiae strain M2 (Serotype 2)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/096/001</DrugIDPK>
    <LicenceNumber>VPA10996/096/001</LicenceNumber>
    <ProductName>Porcilis ERY suspension for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>10/04/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Erysipelothrix rhusiopathiae strain m2 (serotype 2)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/279/001</DrugIDPK>
    <LicenceNumber>VPA10996/279/001</LicenceNumber>
    <ProductName>Porcilis Ery+Parvo+Lepto suspension for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>16/12/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>E.rhusiopathiae strain m2</ActiveSubstance>
      <ActiveSubstance>Porcine parvo virus</ActiveSubstance>
      <ActiveSubstance>Leptospira canicola</ActiveSubstance>
      <ActiveSubstance>Leptospira icterohaemorrhagiae</ActiveSubstance>
      <ActiveSubstance>Leptospira australis</ActiveSubstance>
      <ActiveSubstance>Leptospira grippotyphosa</ActiveSubstance>
      <ActiveSubstance>Leptospira pomona</ActiveSubstance>
      <ActiveSubstance>Leptospira tarassovi</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/179/001</DrugIDPK>
    <LicenceNumber>VPA10996/179/001</LicenceNumber>
    <ProductName>Porcilis Glässer</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>04/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Haemophilus parasuis, serotype 5, strain 4800, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/280/001</DrugIDPK>
    <LicenceNumber>VPA10996/280/001</LicenceNumber>
    <ProductName>Porcilis Lawsonia ID lyophilisate and solvent for emulsion for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>08/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Lawsonia intracellularis strain spah-08 inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/278/001</DrugIDPK>
    <LicenceNumber>VPA10996/278/001</LicenceNumber>
    <ProductName>Porcilis Lawsonia lyophilisate and solvent for emulsion for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>08/11/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated Lawsonia intracellularis strain SPAH-08</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/264/001</DrugIDPK>
    <LicenceNumber>VPA10996/264/001</LicenceNumber>
    <ProductName>Porcilis M Hyo ID ONCE emulsion for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>20/01/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated whole cell concentrate of m. hyopneumoniae strain 11</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/128/001</DrugIDPK>
    <LicenceNumber>VPA10996/128/001</LicenceNumber>
    <ProductName>Porcilis PRRS lyophilisate and solvent for suspension for injection for pigs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>06/06/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine reproductive respiratory syndrome (prrs) virus strain dv live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/049/001</DrugIDPK>
    <LicenceNumber>VPA10387/049/001</LicenceNumber>
    <ProductName>Poulvac Bursa Plus Lyophilisate for suspension in drinking water for chickens</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live infectious bursal disease virus, strain V877</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/091/001</DrugIDPK>
    <LicenceNumber>VPA10387/091/001</LicenceNumber>
    <ProductName>Poulvac Bursine 2 lyophilisate for suspension for spray vaccination or for use in drinking water for chickens</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>18/09/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oculonasal suspension/use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AD09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Coarse spray</RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Infectious bursal disease virus strain lukert</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/051/001</DrugIDPK>
    <LicenceNumber>VPA10387/051/001</LicenceNumber>
    <ProductName>Poulvac IB QX lyophilisate for oculonasal suspension for chickens</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>06/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for suspension for spray administration</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Coarse spray</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated avian infectious bronchitis virus strain L1148</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/053/001</DrugIDPK>
    <LicenceNumber>VPA10387/053/001</LicenceNumber>
    <ProductName>POULVAC IBMM + ARK Lyophilisate for suspension for spray administration for chickens</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for suspension for spray administration</DosageForm>
    <ATCs>
      <ATC>QI01AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Avian infectious bronchitis virus strain massachusetts 1263</ActiveSubstance>
      <ActiveSubstance>Avian infectious bronchitis virus strain arkansas 3168</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/011/001</DrugIDPK>
    <LicenceNumber>VPA10454/011/001</LicenceNumber>
    <ProductName>Prascend 1 mg tablets for horses</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>21/05/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/030/001</DrugIDPK>
    <LicenceNumber>VPA10810/030/001</LicenceNumber>
    <ProductName>Prasequine 1 mg tablets for horses</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN04BC02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/101/001</DrugIDPK>
    <LicenceNumber>VPA10987/101/001</LicenceNumber>
    <ProductName>Prazitel 230/20 mg Flavoured Film-Coated Tablets for Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>12/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/076/001</DrugIDPK>
    <LicenceNumber>VPA10987/076/001</LicenceNumber>
    <ProductName>Prazitel Plus Tablets for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 10(3) of Directive No 2001/83/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/076/002</DrugIDPK>
    <LicenceNumber>VPA10987/076/002</LicenceNumber>
    <ProductName>Prazitel Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA01</ATC>
      <ATC>QP52AC05</ATC>
      <ATC>QP52AF02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/038/002</DrugIDPK>
    <LicenceNumber>VPA22622/038/002</LicenceNumber>
    <ProductName>Prednicortone 20 mg tablets for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>23/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/038/001</DrugIDPK>
    <LicenceNumber>VPA22622/038/001</LicenceNumber>
    <ProductName>Prednicortone 5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>23/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/003/002</DrugIDPK>
    <LicenceNumber>VPA25237/003/002</LicenceNumber>
    <ProductName>Preglukord  5 mg tablets for dogs and cats</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>16/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/003/001</DrugIDPK>
    <LicenceNumber>VPA25237/003/001</LicenceNumber>
    <ProductName>Preglukord 1 mg tablets for dogs and cats</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>16/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/003/003</DrugIDPK>
    <LicenceNumber>VPA25237/003/003</LicenceNumber>
    <ProductName>Preglukord 25 mg tablets for dogs</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>16/01/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH02AB06</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/030/001</DrugIDPK>
    <LicenceNumber>VPA10980/030/001</LicenceNumber>
    <ProductName>Presedine 10 mg/ml solution for injection for horses and cattle</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>04/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/013/001</DrugIDPK>
    <LicenceNumber>VPA10815/013/001</LicenceNumber>
    <ProductName>Prid delta 1.55 g vaginal delivery system for cattle</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Vaginal delivery system</DosageForm>
    <ATCs>
      <ATC>QG03DA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Vaginal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10483/001/001</DrugIDPK>
    <LicenceNumber>VPA10483/001/001</LicenceNumber>
    <ProductName>PRID E 1.55 g vaginal delivery system for cattle</ProductName>
    <PAHolder>LAPROVET</PAHolder>
    <AuthorisedDate>24/08/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Vaginal delivery system</DosageForm>
    <ATCs>
      <ATC>QG03DA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Vaginal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/035/001</DrugIDPK>
    <LicenceNumber>VPA10815/035/001</LicenceNumber>
    <ProductName>Prilactone Next 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC03DA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/035/003</DrugIDPK>
    <LicenceNumber>VPA10815/035/003</LicenceNumber>
    <ProductName>Prilactone Next 100 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC03DA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/035/002</DrugIDPK>
    <LicenceNumber>VPA10815/035/002</LicenceNumber>
    <ProductName>Prilactone Next 50 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC03DA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/078/001</DrugIDPK>
    <LicenceNumber>VPA22664/078/001</LicenceNumber>
    <ProductName>Primectin 5 mg/ml Pour-On Solution</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/12/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/022/001</DrugIDPK>
    <LicenceNumber>VPA22664/022/001</LicenceNumber>
    <ProductName>Primidoxine Solution for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadoxine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/007/001</DrugIDPK>
    <LicenceNumber>VPA10836/007/001</LicenceNumber>
    <ProductName>PRIMOPEN 300 mg/ml suspension for injection for cattle, pigs and horses</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>18/09/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/009/001</DrugIDPK>
    <LicenceNumber>VPA10665/009/001</LicenceNumber>
    <ProductName>Primun salmonella E Lyophilisate for use in drinking water for chickens</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>16/08/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QI01AE01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salmonella enterica, subsp. enterica, serovar Enteritidis, strain CAL10 Sm+/Rif+/Ssq-, Live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/070/002</DrugIDPK>
    <LicenceNumber>VPA10774/070/002</LicenceNumber>
    <ProductName>Prinocate 100 mg/25 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/070/003</DrugIDPK>
    <LicenceNumber>VPA10774/070/003</LicenceNumber>
    <ProductName>Prinocate 250 mg/62.5 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/070/001</DrugIDPK>
    <LicenceNumber>VPA10774/070/001</LicenceNumber>
    <ProductName>Prinocate 40 mg/10 mg spot-on solution for small dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/068/001</DrugIDPK>
    <LicenceNumber>VPA10774/068/001</LicenceNumber>
    <ProductName>Prinocate 40 mg/4 mg spot-on solution for small cats and ferrets</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/070/004</DrugIDPK>
    <LicenceNumber>VPA10774/070/004</LicenceNumber>
    <ProductName>Prinocate 400 mg/100 mg spot-on solution for extra-large dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/069/001</DrugIDPK>
    <LicenceNumber>VPA10774/069/001</LicenceNumber>
    <ProductName>Prinocate 80 mg/8 mg spot-on solution for large cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/057/002</DrugIDPK>
    <LicenceNumber>VPA22020/057/002</LicenceNumber>
    <ProductName>Prinovox 100 mg + 25 mg spot-on solution for medium dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/057/003</DrugIDPK>
    <LicenceNumber>VPA22020/057/003</LicenceNumber>
    <ProductName>Prinovox 250 mg + 62.5 mg spot-on solution for large dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/057/001</DrugIDPK>
    <LicenceNumber>VPA22020/057/001</LicenceNumber>
    <ProductName>Prinovox 40 mg + 10 mg spot-on solution for small dogs.</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/056/001</DrugIDPK>
    <LicenceNumber>VPA22020/056/001</LicenceNumber>
    <ProductName>Prinovox 40 mg + 4 mg spot-on solution for small cats and ferrets</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/057/004</DrugIDPK>
    <LicenceNumber>VPA22020/057/004</LicenceNumber>
    <ProductName>Prinovox 400 mg + 100 mg spot-on solution for extra-large dogs</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/056/002</DrugIDPK>
    <LicenceNumber>VPA22020/056/002</LicenceNumber>
    <ProductName>Prinovox 80 mg + 8 mg spot-on solution for large cats</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/007/001</DrugIDPK>
    <LicenceNumber>VPA10555/007/001</LicenceNumber>
    <ProductName>Pro Penstrep Suspension for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>10/02/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01RA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
      <ActiveSubstance>Dihydrostreptomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10803/001/001</DrugIDPK>
    <LicenceNumber>VPA10803/001/001</LicenceNumber>
    <ProductName>Pro-Dynam Oral Powder 1 g phenylbutazone per sachet</ProductName>
    <PAHolder>Dechra Veterinary Products A/S</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QM01AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylbutazone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10827/001/001</DrugIDPK>
    <LicenceNumber>VPA10827/001/001</LicenceNumber>
    <ProductName>Proactive 1.52 mg/mL Teat Dip/Spray Solution</ProductName>
    <PAHolder>DeLaval NV</PAHolder>
    <AuthorisedDate>11/01/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Teat dip/spray solution</DosageForm>
    <ATCs>
      <ATC>QD08AG03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Coarse spray</RoutesOfAdministration>
      <RoutesOfAdministration>Dipping</RoutesOfAdministration>
      <RoutesOfAdministration>Teat use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Available iodine, ph. eur. (as iodine/sodium iodide/poloxamer complex 0.86)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antiseptics</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22009/001/001</DrugIDPK>
    <LicenceNumber>VPA22009/001/001</LicenceNumber>
    <ProductName>PROBENCIL 300 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>MEVET S.A.U.</PAHolder>
    <AuthorisedDate>03/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/006/001</DrugIDPK>
    <LicenceNumber>VPA10495/006/001</LicenceNumber>
    <ProductName>Procactive 300 mg/ml Suspension for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>03/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/011/001</DrugIDPK>
    <LicenceNumber>VPA23462/011/001</LicenceNumber>
    <ProductName>Procamidor Duo 40 mg/ml + 0.036 mg/ml solution for injection</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for haemofiltration</DosageForm>
    <ATCs>
      <ATC>QN01BA52</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Perineural use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Epinephrine bitartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/019/001</DrugIDPK>
    <LicenceNumber>VPA10826/019/001</LicenceNumber>
    <ProductName>Procapen Injector 3 g intramammary suspension for cattle</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>27/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CE09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/075/001</DrugIDPK>
    <LicenceNumber>VPA22033/075/001</LicenceNumber>
    <ProductName>Procipen 300 mg/ml suspension for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/008/001</DrugIDPK>
    <LicenceNumber>VPA10555/008/001</LicenceNumber>
    <ProductName>Procycline LA 200 mg/ml solution for injection</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>16/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/012/001</DrugIDPK>
    <LicenceNumber>VPA10555/012/001</LicenceNumber>
    <ProductName>Profen Equine 100 mg/ml oral suspension for horses.</ProductName>
    <PAHolder>Interchem (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/06/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed Consent application (Article 21 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/039/001</DrugIDPK>
    <LicenceNumber>VPA10980/039/001</LicenceNumber>
    <ProductName>Profexx 50 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/054/001</DrugIDPK>
    <LicenceNumber>VPA10815/054/001</LicenceNumber>
    <ProductName>Progressis Emulsion for injection for pigs (sows and gilts)</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>06/06/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AA05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated porcine reproductive and respiratory syndrome (prrs) virus, p120 strain</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22713/001/001</DrugIDPK>
    <LicenceNumber>VPA22713/001/001</LicenceNumber>
    <ProductName>Proin 15 mg chewable tablets for dogs</ProductName>
    <PAHolder>Pegasus Laboratories Ireland Limited</PAHolder>
    <AuthorisedDate>23/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QG04BX91</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylpropanolamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22713/001/002</DrugIDPK>
    <LicenceNumber>VPA22713/001/002</LicenceNumber>
    <ProductName>Proin 50 mg chewable tablets for dogs</ProductName>
    <PAHolder>Pegasus Laboratories Ireland Limited</PAHolder>
    <AuthorisedDate>23/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QG04BX91</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylpropanolamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23174/001/001</DrugIDPK>
    <LicenceNumber>VPA23174/001/001</LicenceNumber>
    <ProductName>Prolusyn 50 micrograms/ml solution for injection for cattle</ProductName>
    <PAHolder>Syn Vet-Pharma Ireland Limited</PAHolder>
    <AuthorisedDate>15/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadorelin acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25460/005/001</DrugIDPK>
    <LicenceNumber>VPA25460/005/001</LicenceNumber>
    <ProductName>Promec 18.7 mg/g Oral Paste for Horses</ProductName>
    <PAHolder>Acme Drugs S.r.l.</PAHolder>
    <AuthorisedDate>21/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/010/001</DrugIDPK>
    <LicenceNumber>VPA10555/010/001</LicenceNumber>
    <ProductName>Promox LA 150 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Interchem (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/004/001</DrugIDPK>
    <LicenceNumber>VPA10836/004/001</LicenceNumber>
    <ProductName>Pronestesic 40 mg/ml + 0.036 mg/ml solution for injection for horses, cattle, pigs and sheep</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01BA52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Perineural use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Epinephrine bitartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/033/001</DrugIDPK>
    <LicenceNumber>VPA10521/033/001</LicenceNumber>
    <ProductName>Propalin Syrup</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ATCs>
      <ATC>QG04BX91</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylpropanolamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/009/001</DrugIDPK>
    <LicenceNumber>VPA10555/009/001</LicenceNumber>
    <ProductName>Propen 300 mg/ml Suspension for Injection for Cattle, Sheep and Pigs</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>30/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/034/001</DrugIDPK>
    <LicenceNumber>VPA22622/034/001</LicenceNumber>
    <ProductName>Propodine 10 mg/ml emulsion for injection/infusion for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ATCs>
      <ATC>QN01AX10</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/056/001</DrugIDPK>
    <LicenceNumber>VPA10387/056/001</LicenceNumber>
    <ProductName>PropoFlo Plus 10 mg/ml, Emulsion for injection for dogs and cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>06/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX10</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10664/008/001</DrugIDPK>
    <LicenceNumber>VPA10664/008/001</LicenceNumber>
    <ProductName>Propomitor 10 mg/ml emulsion for injection/infusion for dogs and cats</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>24/04/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ATCs>
      <ATC>QN01AX10</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/001/001</DrugIDPK>
    <LicenceNumber>VPA22873/001/001</LicenceNumber>
    <ProductName>Proposure 10 mg/ml emulsion for injection for dogs and cats</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX10</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/078/001</DrugIDPK>
    <LicenceNumber>VPA10988/078/001</LicenceNumber>
    <ProductName>Prosolvin 7.5 mg/ml Solution for Injection</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD91</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Luprostiol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23471/001/001</DrugIDPK>
    <LicenceNumber>VPA23471/001/001</LicenceNumber>
    <ProductName>Protect Oral Suspension for New Born Calves</ProductName>
    <PAHolder>Provita Eurotech Ireland Limited</PAHolder>
    <AuthorisedDate>30/10/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QA07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enterococcus faecium SF 101</ActiveSubstance>
      <ActiveSubstance>Lactobacillus acidophilus, strain LA101, Live</ActiveSubstance>
      <ActiveSubstance>Lactobacillus acidophilus, strain LA107, Live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/102/001</DrugIDPK>
    <LicenceNumber>VPA10387/102/001</LicenceNumber>
    <ProductName>Protivity lyophilisate and solvent for suspension for injection for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AE</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Mycoplasma bovis, strain N2805-1, Live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/062/001</DrugIDPK>
    <LicenceNumber>VPA10988/062/001</LicenceNumber>
    <ProductName>PULMODOX 5 % PREMIX</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>12/01/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycyline </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/012/001</DrugIDPK>
    <LicenceNumber>VPA22020/012/001</LicenceNumber>
    <ProductName>Pulmotil G100 Premix for medicated feedingstuff</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>24/01/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/012/002</DrugIDPK>
    <LicenceNumber>VPA22020/012/002</LicenceNumber>
    <ProductName>Pulmotil G200 Premix for medicated feedingstuff</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>24/01/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/010/001</DrugIDPK>
    <LicenceNumber>VPA10791/010/001</LicenceNumber>
    <ProductName>Pulmovet 250 mg/ml solution for use in drinking water or milk replacer for cattle, pigs, chickens and turkeys</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>04/05/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water/milk use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23263/001/002</DrugIDPK>
    <LicenceNumber>VPA23263/001/002</LicenceNumber>
    <ProductName>PULSIX 100 mg/500 mg spot-on solution for dogs over 4 kg up to 10 kg</ProductName>
    <PAHolder>Ab7 Sante</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23263/001/003</DrugIDPK>
    <LicenceNumber>VPA23263/001/003</LicenceNumber>
    <ProductName>PULSIX 250 mg/1250 mg spot-on solution for dogs over 10 kg up to 25 kg</ProductName>
    <PAHolder>Ab7 Sante</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23263/001/001</DrugIDPK>
    <LicenceNumber>VPA23263/001/001</LicenceNumber>
    <ProductName>PULSIX 40 mg/200 mg spot-on solution for dogs over 1.5 kg up to 4 kg</ProductName>
    <PAHolder>Ab7 Sante</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23263/001/004</DrugIDPK>
    <LicenceNumber>VPA23263/001/004</LicenceNumber>
    <ProductName>PULSIX 400 mg/2000 mg spot-on solution for dogs over 25 kg up to 40 kg</ProductName>
    <PAHolder>Ab7 Sante</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23263/001/005</DrugIDPK>
    <LicenceNumber>VPA23263/001/005</LicenceNumber>
    <ProductName>PULSIX 600 mg/3000 mg spot-on solution for dogs over 40 kg up to 60 kg</ProductName>
    <PAHolder>Ab7 Sante</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/042/001</DrugIDPK>
    <LicenceNumber>VPA10782/042/001</LicenceNumber>
    <ProductName>Pyrocam 15 mg/ml oral suspension for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>18/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/045/001</DrugIDPK>
    <LicenceNumber>VPA10782/045/001</LicenceNumber>
    <ProductName>Pyrocam 20 mg/ml solution for injection</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>17/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AC06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Meloxicam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/012/001</DrugIDPK>
    <LicenceNumber>VPA10509/012/001</LicenceNumber>
    <ProductName>Qivitan 25 mg/ml suspension for injection for cattle and pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>27/01/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/015/001</DrugIDPK>
    <LicenceNumber>VPA10509/015/001</LicenceNumber>
    <ProductName>Qivitan LC 75 mg intramammary ointment for lactating cows</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary ointment</DosageForm>
    <ATCs>
      <ATC>QJ51DE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefquinome sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/002/001</DrugIDPK>
    <LicenceNumber>VPA22693/002/001</LicenceNumber>
    <ProductName>Qualimec 10 mg/ml Solution for Injection.</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>01/01/1900</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/063/001</DrugIDPK>
    <LicenceNumber>VPA10987/063/001</LicenceNumber>
    <ProductName>Quanifen (50 mg Praziquantel/500 mg Fenbendazole) Tablets for Cats and Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/062/001</DrugIDPK>
    <LicenceNumber>VPA10987/062/001</LicenceNumber>
    <ProductName>Quenazole (50 mg praziquantel/500 mg Fenbendazole) Tablets for Cats and Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10477/001/001</DrugIDPK>
    <LicenceNumber>VPA10477/001/001</LicenceNumber>
    <ProductName>Quinoflox 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>GLOBAL VET HEALTH SL</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/051/001</DrugIDPK>
    <LicenceNumber>VPA10782/051/001</LicenceNumber>
    <ProductName>Quinox 6 mg/g oral powder for cattle and sheep</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>26/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QP51BX04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Decoquinate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/052/001</DrugIDPK>
    <LicenceNumber>VPA10782/052/001</LicenceNumber>
    <ProductName>Quinox 60.6 mg/g Premix for Medicated Feeding Stuff for Cattle and Sheep</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>26/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP51BX04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Decoquinate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/074/001</DrugIDPK>
    <LicenceNumber>VPA10454/074/001</LicenceNumber>
    <ProductName>Rabisin</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>10/08/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Rabies virus glycoprotein</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Ferrets</Species>
      <Species>Horses</Species>
      <Species>Mink</Species>
      <Species>Polecat</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/027/001</DrugIDPK>
    <LicenceNumber>VPA10990/027/001</LicenceNumber>
    <ProductName>Ranide 30 mg/ml Oral Drench</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>17/02/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG05</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/056/001</DrugIDPK>
    <LicenceNumber>VPA10989/056/001</LicenceNumber>
    <ProductName>Rapidexon 2 mg/ml solution for injection</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>04/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intrabursal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/123/001</DrugIDPK>
    <LicenceNumber>VPA10996/123/001</LicenceNumber>
    <ProductName>Receptal 4 microgram/ml solution for injection</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buserelin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Trout</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/025/001</DrugIDPK>
    <LicenceNumber>VPA10475/025/001</LicenceNumber>
    <ProductName>Recicort 1.77 mg/ml + 17.7 mg/ml ear drops, solution for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ATCs>
      <ATC>QD07XB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/027/001</DrugIDPK>
    <LicenceNumber>VPA10980/027/001</LicenceNumber>
    <ProductName>Recudon 2.5 mg/ml + 0.125 mg/ml solution for injection for horses and dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>17/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AC52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levomethadone hydrochloride</ActiveSubstance>
      <ActiveSubstance>Fenpipramide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/027/002</DrugIDPK>
    <LicenceNumber>VPA10980/027/002</LicenceNumber>
    <ProductName>Recudon 5.0 mg/ml + 0.25 mg/ml solution for injection for horses and dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>17/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AC52</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levomethadone hydrochloride</ActiveSubstance>
      <ActiveSubstance>Fenpipramide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/054/001</DrugIDPK>
    <LicenceNumber>VPA10990/054/001</LicenceNumber>
    <ProductName>Redymox 150 mg/ml suspension for injection for cattle, sheep, pigs, dogs and cats</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>15/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/025/002</DrugIDPK>
    <LicenceNumber>VPA10516/025/002</LicenceNumber>
    <ProductName>REFORDOG 100 mg/500 mg spot-on solution for dogs over 4 kg up to 10 kg</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/025/003</DrugIDPK>
    <LicenceNumber>VPA10516/025/003</LicenceNumber>
    <ProductName>REFORDOG 250 mg/1250 mg spot-on solution for dogs over 10 kg up to 25 kg</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/025/001</DrugIDPK>
    <LicenceNumber>VPA10516/025/001</LicenceNumber>
    <ProductName>REFORDOG 40 mg/200 mg spot-on solution for dogs over 1.5 kg up to 4 kg</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/025/004</DrugIDPK>
    <LicenceNumber>VPA10516/025/004</LicenceNumber>
    <ProductName>REFORDOG 400 mg/2000 mg spot-on solution for dogs over 25 kg up to 40 kg</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/025/005</DrugIDPK>
    <LicenceNumber>VPA10516/025/005</LicenceNumber>
    <ProductName>REFORDOG 600 mg/3000 mg spot-on solution for dogs over 40 kg up to 60 kg</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>20/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC54</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Imidacloprid</ActiveSubstance>
      <ActiveSubstance>Permethrin cis:trans/40:60</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/124/001</DrugIDPK>
    <LicenceNumber>VPA10996/124/001</LicenceNumber>
    <ProductName>Regumate Equine 2.2 mg/ml oral solution for horses</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG03DX90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Altrenogest</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22969/004/001</DrugIDPK>
    <LicenceNumber>VPA22969/004/001</LicenceNumber>
    <ProductName>Relaquine 35 mg/ml Oral Gel for Horses</ProductName>
    <PAHolder>Floris Holding BV</PAHolder>
    <AuthorisedDate>05/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral gel</DosageForm>
    <ATCs>
      <ATC>QN05AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Acepromazine maleate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10660/001/001</DrugIDPK>
    <LicenceNumber>VPA10660/001/001</LicenceNumber>
    <ProductName>Release 300 mg/ml, solution for injection</ProductName>
    <PAHolder>WDT - Wirtschaftsgenossenschaft deutscher Tierarzte eG,</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intrapulmonary use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentobarbital sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Hare</Species>
      <Species>Mink</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Pigeons</Species>
      <Species>Polecat</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
      <Species>Horse (non-food producing)</Species>
      <Species>Rabbit (non-food-producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/254/001</DrugIDPK>
    <LicenceNumber>VPA10996/254/001</LicenceNumber>
    <ProductName>Repidose Ready Pulse</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pulsatile-release intraruminal device</DosageForm>
    <ATCs>
      <ATC>QP52AC02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxfendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/030/001</DrugIDPK>
    <LicenceNumber>VPA10475/030/001</LicenceNumber>
    <ProductName>Repose 500 mg/ml solution for injection</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN51AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intracardiac use</RoutesOfAdministration>
      <RoutesOfAdministration>Intraperitoneal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pentobarbital sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Gerbil</Species>
      <Species>Goats</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mink</Species>
      <Species>Mouse</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Rat</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/002/001</DrugIDPK>
    <LicenceNumber>VPA10521/002/001</LicenceNumber>
    <ProductName>Reprocine 0.07 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>05/11/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01BB03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carbetocin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/012/001</DrugIDPK>
    <LicenceNumber>VPA10454/012/001</LicenceNumber>
    <ProductName>ReproCyc PRRS EU lyophilisate and solvent for suspension for injection for pigs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>02/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated prrs 94881 virus</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/085/001</DrugIDPK>
    <LicenceNumber>VPA22664/085/001</LicenceNumber>
    <ProductName>Resflam 300/20 mg/ml Solution for Injection for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/09/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA56</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/255/001</DrugIDPK>
    <LicenceNumber>VPA10996/255/001</LicenceNumber>
    <ProductName>RESFLOR 300/16.5 mg/mL Solution for Injection for Cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA99</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Flunixin meglumine</ActiveSubstance>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/004/001</DrugIDPK>
    <LicenceNumber>VPA10555/004/001</LicenceNumber>
    <ProductName>RESPICHLOR 15% w/w Oral Powder</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>29/06/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/004/001</DrugIDPK>
    <LicenceNumber>VPA10810/004/001</LicenceNumber>
    <ProductName>Revertor 5 mg/ml Solution for Injection for Dogs and Cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>25/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV03AB90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Atipamezole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/071/001</DrugIDPK>
    <LicenceNumber>VPA10989/071/001</LicenceNumber>
    <ProductName>Revozyn RTU 400 mg/ml suspension for injection for cattle</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>23/02/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/006/001</DrugIDPK>
    <LicenceNumber>VPA10509/006/001</LicenceNumber>
    <ProductName>Rhemox 500 mg/g powder for use in drinking water for pigs, chicken broilers, duck broilers and turkeys for meat production</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>16/10/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22715/004/001</DrugIDPK>
    <LicenceNumber>VPA22715/004/001</LicenceNumber>
    <ProductName>Rhinovac IBR Marker live Lyophilisate and solvent for suspension for injection or nasal spray for cattle.</ProductName>
    <PAHolder>Animal Health Distributors Limited</PAHolder>
    <AuthorisedDate>10/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Nasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine herpesvirus 1, strain bio-27 live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10954/012/001</DrugIDPK>
    <LicenceNumber>VPA10954/012/001</LicenceNumber>
    <ProductName>Ridacox 50 mg/ml oral suspension for cattle and sheep</ProductName>
    <PAHolder>J &amp; M Veterinary Services Limited</PAHolder>
    <AuthorisedDate>17/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 10(1) of Directive No 2001/83/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/112/001</DrugIDPK>
    <LicenceNumber>VPA10987/112/001</LicenceNumber>
    <ProductName>Ridamec 1 mg/ml oral solution for sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/08/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>HOVR10537/019/001</DrugIDPK>
    <LicenceNumber>HOVR10537/019/001</LicenceNumber>
    <ProductName>Ridomast</ProductName>
    <PAHolder>Galway Homeopathics (Manufacturing) Limited</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral liquid</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bryonia</ActiveSubstance>
      <ActiveSubstance>Carbo vegetabilis</ActiveSubstance>
      <ActiveSubstance>Phytolacca americana</ActiveSubstance>
      <ActiveSubstance>Acidum silicicum</ActiveSubstance>
      <ActiveSubstance>Sulfur</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Camel</Species>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Homeopathic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/001/001</DrugIDPK>
    <LicenceNumber>VPA23462/001/001</LicenceNumber>
    <ProductName>Rifen 100 mg/ml solution for injection for horses, cattle and pigs</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>23/04/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketoprofen </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/018/002</DrugIDPK>
    <LicenceNumber>VPA10988/018/002</LicenceNumber>
    <ProductName>Rilexine 300 mg Tablets for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/018/003</DrugIDPK>
    <LicenceNumber>VPA10988/018/003</LicenceNumber>
    <ProductName>Rilexine 600 mg Tablets for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>21/09/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/018/001</DrugIDPK>
    <LicenceNumber>VPA10988/018/001</LicenceNumber>
    <ProductName>Rilexine 75 mg Tablets for dogs and cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/115/001</DrugIDPK>
    <LicenceNumber>VPA10988/115/001</LicenceNumber>
    <ProductName>Rilexine DC 375 mg intramammary suspension for dry cows</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>08/07/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cephalexin benzathine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/058/001</DrugIDPK>
    <LicenceNumber>VPA10387/058/001</LicenceNumber>
    <ProductName>RIMADYL Cattle 50 mg/ml Solution for Injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>28/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/059/003</DrugIDPK>
    <LicenceNumber>VPA10387/059/003</LicenceNumber>
    <ProductName>Rimadyl Palatable Tablets 100 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/059/001</DrugIDPK>
    <LicenceNumber>VPA10387/059/001</LicenceNumber>
    <ProductName>Rimadyl Palatable Tablets 20 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/059/002</DrugIDPK>
    <LicenceNumber>VPA10387/059/002</LicenceNumber>
    <ProductName>Rimadyl Palatable Tablets 50 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/066/003</DrugIDPK>
    <LicenceNumber>VPA10987/066/003</LicenceNumber>
    <ProductName>Rimifin 100 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/066/001</DrugIDPK>
    <LicenceNumber>VPA10987/066/001</LicenceNumber>
    <ProductName>Rimifin 20 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/066/002</DrugIDPK>
    <LicenceNumber>VPA10987/066/002</LicenceNumber>
    <ProductName>Rimifin 50 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/100/001</DrugIDPK>
    <LicenceNumber>VPA10387/100/001</LicenceNumber>
    <ProductName>Rispoval 2/BRSV + Pi3 Lyophilisate and solvent for suspension for injection for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>19/02/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine Para Influenza 3 Virus, live</ActiveSubstance>
      <ActiveSubstance>Bovine respiratory syncytial virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/060/001</DrugIDPK>
    <LicenceNumber>VPA10387/060/001</LicenceNumber>
    <ProductName>Rispoval 3 BRSV Pi3 BVD Lyophilisate and suspension for suspension for injection for cattle</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and suspension for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AH</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Parainfluenza 3 virus, modified live, strain rlb103</ActiveSubstance>
      <ActiveSubstance>Bovine respiratory syncytial virus, modified live, strain 375</ActiveSubstance>
      <ActiveSubstance>Inactivated bovine viral diarrhoea virus 1, strain 5960 (cytopathic)</ActiveSubstance>
      <ActiveSubstance>Inactivated bovine viral diarrhoea virus type 1 strain 6309 (non cytopathic)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Mixed Vaccine (L &amp; A)</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/061/001</DrugIDPK>
    <LicenceNumber>VPA10387/061/001</LicenceNumber>
    <ProductName>Rispoval IBR-Marker Inactivated</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine herpes virus type 1 (BHV-1), strain difivac </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/062/001</DrugIDPK>
    <LicenceNumber>VPA10387/062/001</LicenceNumber>
    <ProductName>Rispoval IBR-Marker Live</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intranasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine herpes virus type 1 (BHV-1), strain difivac (gE-negative), modified live (attenuated) virus</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/064/001</DrugIDPK>
    <LicenceNumber>VPA10387/064/001</LicenceNumber>
    <ProductName>Rispoval RS+PI3 IntraNasal</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>pdr and diluent for intra-nasal soln</DosageForm>
    <ATCs>
      <ATC>QI02AD07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intranasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine parainfluenza 3 virus (pi3v), rlb 103, attenuated</ActiveSubstance>
      <ActiveSubstance>Bovine respiratory syncytial virus (brsv), strain 375 attenuated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25237/004/001</DrugIDPK>
    <LicenceNumber>VPA25237/004/001</LicenceNumber>
    <ProductName>Robenord 20 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Accord Healthcare B.V.</PAHolder>
    <AuthorisedDate>20/03/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/183/002</DrugIDPK>
    <LicenceNumber>VPA10987/183/002</LicenceNumber>
    <ProductName>Robentrol 10 mg tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/183/003</DrugIDPK>
    <LicenceNumber>VPA10987/183/003</LicenceNumber>
    <ProductName>Robentrol 20 mg tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/183/004</DrugIDPK>
    <LicenceNumber>VPA10987/183/004</LicenceNumber>
    <ProductName>Robentrol 40 mg tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/183/001</DrugIDPK>
    <LicenceNumber>VPA10987/183/001</LicenceNumber>
    <ProductName>Robentrol 5 mg tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/184/001</DrugIDPK>
    <LicenceNumber>VPA10987/184/001</LicenceNumber>
    <ProductName>Robentrol 6 mg tablets for cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>30/05/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/075/002</DrugIDPK>
    <LicenceNumber>VPA10774/075/002</LicenceNumber>
    <ProductName>Robexera 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/078/001</DrugIDPK>
    <LicenceNumber>VPA10774/078/001</LicenceNumber>
    <ProductName>Robexera 20 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>01/08/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/075/003</DrugIDPK>
    <LicenceNumber>VPA10774/075/003</LicenceNumber>
    <ProductName>Robexera 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/075/004</DrugIDPK>
    <LicenceNumber>VPA10774/075/004</LicenceNumber>
    <ProductName>Robexera 40 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/075/001</DrugIDPK>
    <LicenceNumber>VPA10774/075/001</LicenceNumber>
    <ProductName>Robexera 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/075/005</DrugIDPK>
    <LicenceNumber>VPA10774/075/005</LicenceNumber>
    <ProductName>Robexera 6 mg chewable tablets for cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>08/12/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/104/001</DrugIDPK>
    <LicenceNumber>VPA22664/104/001</LicenceNumber>
    <ProductName>Robonex 5 mg/ml Pour-On Solution for Beef and Dairy Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/03/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/067/003</DrugIDPK>
    <LicenceNumber>VPA10987/067/003</LicenceNumber>
    <ProductName>Rofeniflex 100 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/067/001</DrugIDPK>
    <LicenceNumber>VPA10987/067/001</LicenceNumber>
    <ProductName>Rofeniflex 20 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/067/002</DrugIDPK>
    <LicenceNumber>VPA10987/067/002</LicenceNumber>
    <ProductName>Rofeniflex 50 mg Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/076/002</DrugIDPK>
    <LicenceNumber>VPA10774/076/002</LicenceNumber>
    <ProductName>Rogiola 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/076/003</DrugIDPK>
    <LicenceNumber>VPA10774/076/003</LicenceNumber>
    <ProductName>Rogiola 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/076/004</DrugIDPK>
    <LicenceNumber>VPA10774/076/004</LicenceNumber>
    <ProductName>Rogiola 40 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/076/001</DrugIDPK>
    <LicenceNumber>VPA10774/076/001</LicenceNumber>
    <ProductName>Rogiola 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/076/005</DrugIDPK>
    <LicenceNumber>VPA10774/076/005</LicenceNumber>
    <ProductName>Rogiola 6 mg chewable tablets for cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>08/12/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QM01AH91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Robenacoxib</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22028/004/001</DrugIDPK>
    <LicenceNumber>VPA22028/004/001</LicenceNumber>
    <ProductName>Rokopig Entero emulsion for injection for pigs</ProductName>
    <PAHolder>Bioveta, a.s.</PAHolder>
    <AuthorisedDate>28/03/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 8(3) of Directive No 2001/83/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine rotavirus, strain OSU 6, inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, strain O149:K88, fimbrial adhesin F4, Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, strain K85:987P, fimbrial adhesin F6, Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli O101:K99, fimbrial adhesin F5 and F41, Inactivated</ActiveSubstance>
      <ActiveSubstance>Clostridium Perfringens Type C, Beta Toxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22715/005/001</DrugIDPK>
    <LicenceNumber>VPA22715/005/001</LicenceNumber>
    <ProductName>Rokopig, emulsion for injection for pigs</ProductName>
    <PAHolder>Animal Health Distributors Limited</PAHolder>
    <AuthorisedDate>30/06/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL02</ATC>
    </ATCs>
    <LegalBasis>Similar biological application (Article 13(4) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine rotavirus, strain OSU 6, inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia Coli 0149:K91,K88 (F4), Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia Coli 0147:K88(F4), Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia Coli K85:987P (F6), Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli O101:K99, fimbrial adhesin F5 and F41, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/040/001</DrugIDPK>
    <LicenceNumber>VPA10475/040/001</LicenceNumber>
    <ProductName>Rominervin 10 mg/ml solution for injection for horses</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Romifidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/075/002</DrugIDPK>
    <LicenceNumber>VPA10454/075/002</LicenceNumber>
    <ProductName>Ronaxan 100 mg tablets for dogs and cats</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>12/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/075/001</DrugIDPK>
    <LicenceNumber>VPA10454/075/001</LicenceNumber>
    <ProductName>Ronaxan 20 mg tablets for dogs and cats</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>12/10/1995</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>PVPA10400/002/001</DrugIDPK>
    <LicenceNumber>PVPA10400/002/001</LicenceNumber>
    <ProductName>Rotacoli Suis emulsion for injection for pigs</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>05/12/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs xsi:nil="true" />
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Not Currently Available</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine rotavirus, strain OSU 6, inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, strain O149:K88, fimbrial adhesin F4, Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli O101:K99, fimbrial adhesin F5 and F41, Inactivated</ActiveSubstance>
      <ActiveSubstance>Escherichia coli, strain K85:987P, fimbrial adhesin F6, Inactivated</ActiveSubstance>
      <ActiveSubstance>Clostridium Perfringens Type C, Beta Toxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Not applicable</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/002/001</DrugIDPK>
    <LicenceNumber>VPA10665/002/001</LicenceNumber>
    <ProductName>ROXACIN 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>15/07/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/113/001</DrugIDPK>
    <LicenceNumber>VPA10987/113/001</LicenceNumber>
    <ProductName>Rumenil 34 mg/ml oral suspension for cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>19/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxyclozanide </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/027/003</DrugIDPK>
    <LicenceNumber>VPA10774/027/003</LicenceNumber>
    <ProductName>Rycarfa 100 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/027/001</DrugIDPK>
    <LicenceNumber>VPA10774/027/001</LicenceNumber>
    <ProductName>Rycarfa 20 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/028/001</DrugIDPK>
    <LicenceNumber>VPA10774/028/001</LicenceNumber>
    <ProductName>Rycarfa 50 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>11/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/027/002</DrugIDPK>
    <LicenceNumber>VPA10774/027/002</LicenceNumber>
    <ProductName>Rycarfa 50 mg tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AE91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carprofen</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/064/001</DrugIDPK>
    <LicenceNumber>VPA10815/064/001</LicenceNumber>
    <ProductName>Salmoporc lyophilisate and solvent for suspension for injection for pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>18/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AE02</ATC>
    </ATCs>
    <LegalBasis>Similar biological application (Article 13(4) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salmonella typhimurium mutant, strain 421/125</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/064/002</DrugIDPK>
    <LicenceNumber>VPA10815/064/002</LicenceNumber>
    <ProductName>Salmoporc lyophilisate for oral suspension for pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>18/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate for oral suspension</DosageForm>
    <ATCs>
      <ATC>QI09AE02</ATC>
    </ATCs>
    <LegalBasis>Similar biological application (Article 13(4) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Salmonella typhimurium mutant, strain 421/125</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/057/001</DrugIDPK>
    <LicenceNumber>VPA10983/057/001</LicenceNumber>
    <ProductName>Sedalin Oral Gel 3.5 %w/v</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral gel</DosageForm>
    <ATCs>
      <ATC>QN05AA04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Acepromazine maleate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/012/001</DrugIDPK>
    <LicenceNumber>VPA23462/012/001</LicenceNumber>
    <ProductName>Sedanol 40 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>28/02/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Azaperone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/008/001</DrugIDPK>
    <LicenceNumber>VPA10816/008/001</LicenceNumber>
    <ProductName>Sedastart 1 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>23/04/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10816/009/001</DrugIDPK>
    <LicenceNumber>VPA10816/009/001</LicenceNumber>
    <ProductName>Sedastop 5 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Le Vet BV</PAHolder>
    <AuthorisedDate>28/05/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV03AB90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Atipamezole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/057/001</DrugIDPK>
    <LicenceNumber>VPA10989/057/001</LicenceNumber>
    <ProductName>SEDATOR, 1.0 mg/ml, solution for injection for cats and dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>26/09/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/050/001</DrugIDPK>
    <LicenceNumber>VPA10989/050/001</LicenceNumber>
    <ProductName>Sedaxylan, 20 mg/ml solution for injection for dogs, cats, horses and cattle</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>02/05/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/007/001</DrugIDPK>
    <LicenceNumber>VPA10509/007/001</LicenceNumber>
    <ProductName>Sedecalm 1 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>05/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Medetomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22812/002/001</DrugIDPK>
    <LicenceNumber>VPA22812/002/001</LicenceNumber>
    <ProductName>Sedectin 20 mg/ml solution for injection for cattle, horses, dogs and cats</ProductName>
    <PAHolder>Interchemie Werken De Adelaar Eesti AS.</PAHolder>
    <AuthorisedDate>26/03/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/013/001</DrugIDPK>
    <LicenceNumber>VPA10454/013/001</LicenceNumber>
    <ProductName>Sedivet 10 mg/ml Solution for Injection for horses</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>29/03/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM93</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Romifidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/056/003</DrugIDPK>
    <LicenceNumber>VPA10774/056/003</LicenceNumber>
    <ProductName>Selames 120 mg spot-on solution for dogs 10.1–20.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/055/001</DrugIDPK>
    <LicenceNumber>VPA10774/055/001</LicenceNumber>
    <ProductName>Selames 15 mg spot-on solution for cats and dogs = 2.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/056/004</DrugIDPK>
    <LicenceNumber>VPA10774/056/004</LicenceNumber>
    <ProductName>Selames 240 mg spot-on solution for dogs 20.1–40.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/056/001</DrugIDPK>
    <LicenceNumber>VPA10774/056/001</LicenceNumber>
    <ProductName>Selames 30 mg spot-on solution for dogs 2.6–5.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/056/005</DrugIDPK>
    <LicenceNumber>VPA10774/056/005</LicenceNumber>
    <ProductName>Selames 360 mg spot-on solution for dogs 40.1–60.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/055/002</DrugIDPK>
    <LicenceNumber>VPA10774/055/002</LicenceNumber>
    <ProductName>Selames 45 mg spot-on solution for cats 2.6–7.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/055/003</DrugIDPK>
    <LicenceNumber>VPA10774/055/003</LicenceNumber>
    <ProductName>Selames 60 mg spot-on solution for cats 7.6–10.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/056/002</DrugIDPK>
    <LicenceNumber>VPA10774/056/002</LicenceNumber>
    <ProductName>Selames 60 mg spot-on solution for dogs 5.1–10.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/006</DrugIDPK>
    <LicenceNumber>VPA22664/144/006</LicenceNumber>
    <ProductName>SELAPRO 120 mg spot-on solution for medium dogs (10.1–20.0 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/001</DrugIDPK>
    <LicenceNumber>VPA22664/144/001</LicenceNumber>
    <ProductName>SELAPRO 15 mg spot-on solution for dogs and cats (&lt; 2.5 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/007</DrugIDPK>
    <LicenceNumber>VPA22664/144/007</LicenceNumber>
    <ProductName>SELAPRO 240 mg spot-on solution for large dogs (20.1–40.0 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/004</DrugIDPK>
    <LicenceNumber>VPA22664/144/004</LicenceNumber>
    <ProductName>SELAPRO 30 mg spot-on solution for very small dogs (2.6–5.0 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/008</DrugIDPK>
    <LicenceNumber>VPA22664/144/008</LicenceNumber>
    <ProductName>SELAPRO 360 mg spot-on solution for very large dogs (40.1–60.0 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/002</DrugIDPK>
    <LicenceNumber>VPA22664/144/002</LicenceNumber>
    <ProductName>SELAPRO 45 mg spot-on solution for cats (2.6–7.5 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/003</DrugIDPK>
    <LicenceNumber>VPA22664/144/003</LicenceNumber>
    <ProductName>SELAPRO 60 mg spot-on solution for large cats (7.6–10.0 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/144/005</DrugIDPK>
    <LicenceNumber>VPA22664/144/005</LicenceNumber>
    <ProductName>SELAPRO 60 mg spot-on solution for small dogs (5.1–10.0 kg)</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/10/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/008/001</DrugIDPK>
    <LicenceNumber>VPA10846/008/001</LicenceNumber>
    <ProductName>SELECTAN 300 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>15/02/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01BA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Florfenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/054/003</DrugIDPK>
    <LicenceNumber>VPA10774/054/003</LicenceNumber>
    <ProductName>Selehold 120 mg spot-on solution for dogs 10.1–20.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/053/001</DrugIDPK>
    <LicenceNumber>VPA10774/053/001</LicenceNumber>
    <ProductName>Selehold 15 mg spot-on solution for cats and dogs = 2.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/054/004</DrugIDPK>
    <LicenceNumber>VPA10774/054/004</LicenceNumber>
    <ProductName>Selehold 240 mg spot-on solution for dogs 20.1–40.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/054/001</DrugIDPK>
    <LicenceNumber>VPA10774/054/001</LicenceNumber>
    <ProductName>Selehold 30 mg spot-on solution for dogs 2.6–5.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/054/005</DrugIDPK>
    <LicenceNumber>VPA10774/054/005</LicenceNumber>
    <ProductName>Selehold 360 mg spot-on solution for dogs 40.1–60.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/053/002</DrugIDPK>
    <LicenceNumber>VPA10774/053/002</LicenceNumber>
    <ProductName>Selehold 45 mg spot-on solution for cats 2.6–7.5 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/053/003</DrugIDPK>
    <LicenceNumber>VPA10774/053/003</LicenceNumber>
    <ProductName>Selehold 60 mg spot-on solution for cats 7.6–10.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/054/002</DrugIDPK>
    <LicenceNumber>VPA10774/054/002</LicenceNumber>
    <ProductName>Selehold 60 mg spot-on solution for dogs 5.1–10.0 kg</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/062/002</DrugIDPK>
    <LicenceNumber>VPA10815/062/002</LicenceNumber>
    <ProductName>Selgian 20 kg, Film coated tablets</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN06A</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selegiline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/062/003</DrugIDPK>
    <LicenceNumber>VPA10815/062/003</LicenceNumber>
    <ProductName>Selgian 40 kg, Film coated tablets</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/11/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN06A</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selegiline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/062/001</DrugIDPK>
    <LicenceNumber>VPA10815/062/001</LicenceNumber>
    <ProductName>Selgian 8 kg, Film coated tablets</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN06A</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Selegiline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/006/002</DrugIDPK>
    <LicenceNumber>VPA10836/006/002</LicenceNumber>
    <ProductName>SEMELCEF 1000 mg tablets for dogs</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>28/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefadroxil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/006/001</DrugIDPK>
    <LicenceNumber>VPA10836/006/001</LicenceNumber>
    <ProductName>SEMELCEF 200 mg tablets for dogs and cats</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>28/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB05</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefadroxil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/005/001</DrugIDPK>
    <LicenceNumber>VPA10539/005/001</LicenceNumber>
    <ProductName>Sensiblex 40 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>30/06/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02CX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Denaverine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/257/001</DrugIDPK>
    <LicenceNumber>VPA10996/257/001</LicenceNumber>
    <ProductName>SLICE 2 mg/g premix for medicated feeding stuff for Atlantic salmon</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>27/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP54AA06</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Emamectin benzoate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10465/004/001</DrugIDPK>
    <LicenceNumber>VPA10465/004/001</LicenceNumber>
    <ProductName>Sodium Chloride 0.9 g/100 ml B. Braun Vet Care solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats</ProductName>
    <PAHolder>B. Braun Melsungen AG.</PAHolder>
    <AuthorisedDate>04/10/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/003/001</DrugIDPK>
    <LicenceNumber>VPA10791/003/001</LicenceNumber>
    <ProductName>Sodium Salicyl  800 mg/g powder for oral solution for cattle (calves) and pigs</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>14/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QN02BA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium salicylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/054/001</DrugIDPK>
    <LicenceNumber>VPA10989/054/001</LicenceNumber>
    <ProductName>Solacyl 1000 mg/g, powder for oral solution for cattle and pigs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>29/08/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QN02BA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium salicylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/064/001</DrugIDPK>
    <LicenceNumber>VPA10989/064/001</LicenceNumber>
    <ProductName>Solamocta 697 mg/g powder for use in drinking water for chickens, ducks and turkeys</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>01/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/150/001</DrugIDPK>
    <LicenceNumber>VPA22664/150/001</LicenceNumber>
    <ProductName>Solantel 200 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP52AG09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/128/001</DrugIDPK>
    <LicenceNumber>VPA22664/128/001</LicenceNumber>
    <ProductName>Solantel 50 mg/ml Oral Suspension for Sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/08/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AG09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/069/001</DrugIDPK>
    <LicenceNumber>VPA10988/069/001</LicenceNumber>
    <ProductName>Soloxine 0.1 mg Tablet</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/069/002</DrugIDPK>
    <LicenceNumber>VPA10988/069/002</LicenceNumber>
    <ProductName>Soloxine 0.2 mg Tablet</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/069/003</DrugIDPK>
    <LicenceNumber>VPA10988/069/003</LicenceNumber>
    <ProductName>Soloxine 0.3 mg Tablet</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/069/004</DrugIDPK>
    <LicenceNumber>VPA10988/069/004</LicenceNumber>
    <ProductName>Soloxine 0.5 mg Tablet</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/069/005</DrugIDPK>
    <LicenceNumber>VPA10988/069/005</LicenceNumber>
    <ProductName>Soloxine 0.8 mg Tablet</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/011/001</DrugIDPK>
    <LicenceNumber>VPA10555/011/001</LicenceNumber>
    <ProductName>Soluchlor 150 mg/g Oral Powder for Calves</ProductName>
    <PAHolder>Interchem (Ireland) Limited</PAHolder>
    <AuthorisedDate>07/12/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01AA03</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Chlortetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/027/001</DrugIDPK>
    <LicenceNumber>VPA10810/027/001</LicenceNumber>
    <ProductName>Soluclin 25 mg/ml oral solution for cats and dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>14/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/072/001</DrugIDPK>
    <LicenceNumber>VPA10989/072/001</LicenceNumber>
    <ProductName>Soludox 500 mg/g powder for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>09/02/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/043/001</DrugIDPK>
    <LicenceNumber>VPA22622/043/001</LicenceNumber>
    <ProductName>Solupam 5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>29/03/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05BA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/060/001</DrugIDPK>
    <LicenceNumber>VPA22664/060/001</LicenceNumber>
    <ProductName>Solvasol Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>14/06/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin Sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/031/001</DrugIDPK>
    <LicenceNumber>VPA10454/031/001</LicenceNumber>
    <ProductName>Solvent for cell associated poultry vaccines</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>18/11/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QV07AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances xsi:nil="true" />
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Diluent</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/014/001</DrugIDPK>
    <LicenceNumber>VPA10516/014/001</LicenceNumber>
    <ProductName>SOMNIPRON 10 mg/ml Solution for injection for horses and cattle</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>24/03/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Detomidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/018/001</DrugIDPK>
    <LicenceNumber>VPA22622/018/001</LicenceNumber>
    <ProductName>Somulose 400 mg/ml + 25 mg/ml solution for injection</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>06/10/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CB02</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Secobarbital sodium</ActiveSubstance>
      <ActiveSubstance>Cinchocaine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/007/001</DrugIDPK>
    <LicenceNumber>VPA10539/007/001</LicenceNumber>
    <ProductName>Spasmalgan compositum 500 mg/ml + 4 mg/ml Solution for injection for horses, cattle, pigs and dogs</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>29/05/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03DB04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metamizole sodium monohydrate</ActiveSubstance>
      <ActiveSubstance>Hyoscine butylbromide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Spasmolytic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/010/001</DrugIDPK>
    <LicenceNumber>VPA23462/010/001</LicenceNumber>
    <ProductName>Spasmipur 20 mg/ml solution for injection</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>10/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03BB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Hyoscine butylbromide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Spasmolytic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/006/001</DrugIDPK>
    <LicenceNumber>VPA23462/006/001</LicenceNumber>
    <ProductName>Spasmium comp. 500 mg/ml + 4 mg/ml solution for injection</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>18/09/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03DB04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metamizole sodium monohydrate</ActiveSubstance>
      <ActiveSubstance>Hyoscine butylbromide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Spasmolytic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/060/001</DrugIDPK>
    <LicenceNumber>VPA10815/060/001</LicenceNumber>
    <ProductName>Spectam Injectable 10 % w/v</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01XX04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spectinomycin dihydrochloride pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/059/001</DrugIDPK>
    <LicenceNumber>VPA10815/059/001</LicenceNumber>
    <ProductName>Spectam Scour Halt Oral Solution 50 mg/ml</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01XX04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spectinomycin dihydrochloride pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/065/001</DrugIDPK>
    <LicenceNumber>VPA10387/065/001</LicenceNumber>
    <ProductName>Spirovac</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>28/02/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Leptospira borgpetersenii, serovar Hardjo, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/032/002</DrugIDPK>
    <LicenceNumber>VPA10475/032/002</LicenceNumber>
    <ProductName>Spizobactin 1,500,000 IU/250 mg chewable tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>15/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ51RF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spiramycin </ActiveSubstance>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/032/003</DrugIDPK>
    <LicenceNumber>VPA10475/032/003</LicenceNumber>
    <ProductName>Spizobactin 3,000,000 IU/500 mg chewable tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>15/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ51RF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spiramycin </ActiveSubstance>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/032/001</DrugIDPK>
    <LicenceNumber>VPA10475/032/001</LicenceNumber>
    <ProductName>Spizobactin 750,000 IU/125 mg chewable tablets for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>15/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ51RF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Spiramycin </ActiveSubstance>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/004/001</DrugIDPK>
    <LicenceNumber>VPA10475/004/001</LicenceNumber>
    <ProductName>Sporimune 50 mg/ml oral solution for cats and dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>19/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QL04AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/118/001</DrugIDPK>
    <LicenceNumber>VPA22664/118/001</LicenceNumber>
    <ProductName>Spotinor 10 mg/ml Spot-on Solution for cattle and sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>05/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Deltamethrin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/014/001</DrugIDPK>
    <LicenceNumber>VPA10454/014/001</LicenceNumber>
    <ProductName>Sputolosin Oral Powder 5 mg/g</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1990</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QR05CB90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dembrexine hydrochloride monohydrate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/052/002</DrugIDPK>
    <LicenceNumber>VPA10988/052/002</LicenceNumber>
    <ProductName>STABOX 500 mg/g Powder for Oral Solution for Pigs</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/052/001</DrugIDPK>
    <LicenceNumber>VPA10988/052/001</LicenceNumber>
    <ProductName>Stabox 5g Premix for medicated feeding stuff</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>11/07/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/066/001</DrugIDPK>
    <LicenceNumber>VPA10387/066/001</LicenceNumber>
    <ProductName>Startect Dual Active Oral Solution for Sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA52</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Derquantel</ActiveSubstance>
      <ActiveSubstance>Abamectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/036/001</DrugIDPK>
    <LicenceNumber>VPA10782/036/001</LicenceNumber>
    <ProductName>STENOROL CRYPTO 0.5 mg/ml oral solution for calves</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>24/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP51AX08</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Halofuginone Base (As lactate salt)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10465/005/001</DrugIDPK>
    <LicenceNumber>VPA10465/005/001</LicenceNumber>
    <ProductName>Sterofundin Vet Care, solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats</ProductName>
    <PAHolder>B. Braun Melsungen AG.</PAHolder>
    <AuthorisedDate>17/04/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Bibliographic application (Article 22 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>L-malic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10396/002/001</DrugIDPK>
    <LicenceNumber>VPA10396/002/001</LicenceNumber>
    <ProductName>Stimovar Injection lyophilisate and solvent for solution for injection</ProductName>
    <PAHolder>Laboratorios Ovejero S.A.U.</PAHolder>
    <AuthorisedDate>15/06/1993</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for infusion</DosageForm>
    <ATCs>
      <ATC>QG03GA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine serum gonadotrophin for veterinary use</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/082/001</DrugIDPK>
    <LicenceNumber>VPA10987/082/001</LicenceNumber>
    <ProductName>Strantel Plus Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>18/12/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/082/002</DrugIDPK>
    <LicenceNumber>VPA10987/082/002</LicenceNumber>
    <ProductName>Strantel Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>12/04/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/037/001</DrugIDPK>
    <LicenceNumber>VPA10810/037/001</LicenceNumber>
    <ProductName>Stresoron 40 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>11/07/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Azaperone</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/002/001</DrugIDPK>
    <LicenceNumber>VPA23340/002/001</LicenceNumber>
    <ProductName>Stromease 25 mg/ml eye drops, solution for dogs and cats</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>17/06/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ATCs>
      <ATC>QS01XA08</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Ocular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22969/002/001</DrugIDPK>
    <LicenceNumber>VPA22969/002/001</LicenceNumber>
    <ProductName>SUBESTIN 25 microgram/ml oral solution for horses</ProductName>
    <PAHolder>Floris Holding BV</PAHolder>
    <AuthorisedDate>19/08/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QR03CC13</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/021/001</DrugIDPK>
    <LicenceNumber>VPA10826/021/001</LicenceNumber>
    <ProductName>Suifertil 4 mg/ml oral solution for pigs</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>16/03/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG03DX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Altrenogest</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/019/001</DrugIDPK>
    <LicenceNumber>VPA10846/019/001</LicenceNumber>
    <ProductName>Suiseng Coli /C Suspension for injection for pigs</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>26/07/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB08</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>F4ab fimbrial adhesin of e.coli</ActiveSubstance>
      <ActiveSubstance>F4ac fimbrial adhesin of e.coli</ActiveSubstance>
      <ActiveSubstance>F5 fimbrial adhesin of e.coli</ActiveSubstance>
      <ActiveSubstance>F6 fimbrial adhesin of e. coli</ActiveSubstance>
      <ActiveSubstance>Lt enterotoxoid of e. coli</ActiveSubstance>
      <ActiveSubstance>Clostridium perfringens, type C toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium novyi, type B toxoid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10395/001/001</DrugIDPK>
    <LicenceNumber>VPA10395/001/001</LicenceNumber>
    <ProductName>Suivac APP emulsion for injection for pigs</ProductName>
    <PAHolder>ChemVet dk A/S</PAHolder>
    <AuthorisedDate>14/10/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB07</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Actinobacillus pleuropneumoniae serotype 2, strain app 2TR98, inactivated</ActiveSubstance>
      <ActiveSubstance>APX I toxoid</ActiveSubstance>
      <ActiveSubstance>APX II toxoid</ActiveSubstance>
      <ActiveSubstance>APX III toxoid</ActiveSubstance>
      <ActiveSubstance>Actinobacillus pleuropneumoniae serotype 9, strain app 9KL97, inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/005/001</DrugIDPK>
    <LicenceNumber>VPA10665/005/001</LicenceNumber>
    <ProductName>Sulfaprex Premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/034/001</DrugIDPK>
    <LicenceNumber>VPA10810/034/001</LicenceNumber>
    <ProductName>Sulfequine (333 mg/g + 67 mg/g) oral paste for horse</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>11/07/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral paste</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/033/001</DrugIDPK>
    <LicenceNumber>VPA10990/033/001</LicenceNumber>
    <ProductName>Sulfoprim 150 mg/g Premix for medicated feeding stuff</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/05/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/025/001</DrugIDPK>
    <LicenceNumber>VPA10990/025/001</LicenceNumber>
    <ProductName>Sulfoprim 21% Premix for Medicated Feed</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/018/001</DrugIDPK>
    <LicenceNumber>VPA10987/018/001</LicenceNumber>
    <ProductName>Sulpha No.2 Powder for Oral Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01EQ03</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadimidine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10555/005/001</DrugIDPK>
    <LicenceNumber>VPA10555/005/001</LicenceNumber>
    <ProductName>Sulphamet 40/200 Solution for Injection</ProductName>
    <PAHolder>Interchem Ireland Ltd</PAHolder>
    <AuthorisedDate>18/04/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/150/001</DrugIDPK>
    <LicenceNumber>VPA10987/150/001</LicenceNumber>
    <ProductName>Sumex 1 %w/v solution for injection for cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/06/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/151/001</DrugIDPK>
    <LicenceNumber>VPA10987/151/001</LicenceNumber>
    <ProductName>Sumex 1% w/v solution for injection for pigs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>28/06/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/160/001</DrugIDPK>
    <LicenceNumber>VPA10987/160/001</LicenceNumber>
    <ProductName>Sumex 5 mg/ml Pour on Solution for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10203/002/001</DrugIDPK>
    <LicenceNumber>VPA10203/002/001</LicenceNumber>
    <ProductName>Summer Dip 100 mg/ml Concentrate for dip emulsion for sheep.</ProductName>
    <PAHolder>Hygeia Chemicals Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip emulsion</DosageForm>
    <ATCs>
      <ATC>QP53AF03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
      <RoutesOfAdministration>Dipping</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dimpylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/031/001</DrugIDPK>
    <LicenceNumber>VPA22020/031/001</LicenceNumber>
    <ProductName>Supaverm Oral Suspension</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>27/04/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC09</ATC>
      <ATC>QP52AG09</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Closantel sodium dihydrate</ActiveSubstance>
      <ActiveSubstance>Mebendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/116/001</DrugIDPK>
    <LicenceNumber>VPA22664/116/001</LicenceNumber>
    <ProductName>Sureseal 2.6 g Intramammary Suspension for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/032/001</DrugIDPK>
    <LicenceNumber>VPA22020/032/001</LicenceNumber>
    <ProductName>Surolan Ear Drops and Cutaneous Suspension</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>17/08/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous suspension</DosageForm>
    <ATCs>
      <ATC>QD01AC52</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Auricular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
      <ActiveSubstance>Polymyxin b sulfate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antifungal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10817/004/001</DrugIDPK>
    <LicenceNumber>VPA10817/004/001</LicenceNumber>
    <ProductName>Surricoxx 400 mg/ml Solution for use in drinking water for chickens, turkeys, ducks and guinea fowls</ProductName>
    <PAHolder>V.M.D.</PAHolder>
    <AuthorisedDate>07/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QP51AX09</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amprolium hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Guinea fowl</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/069/001</DrugIDPK>
    <LicenceNumber>VPA10387/069/001</LicenceNumber>
    <ProductName>Suvaxyn MH-One Emulsion for injection for pigs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AB13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Mycoplasma hyopneumoniae, inactivated, strain p-5722-3</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/033/001</DrugIDPK>
    <LicenceNumber>VPA22622/033/001</LicenceNumber>
    <ProductName>Sympagesic 500 mg/ml + 4 mg/ml solution for injection for horses, cattle, pigs and dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>26/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA03DB04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Metamizole sodium monohydrate</ActiveSubstance>
      <ActiveSubstance>Hyoscine butylbromide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Spasmolytic</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/065/001</DrugIDPK>
    <LicenceNumber>VPA10815/065/001</LicenceNumber>
    <ProductName>Syncroprost, 0.250 mg/ml solution for injection for cattle, horses, pigs and goats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>16/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cloprostenol sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/011/002</DrugIDPK>
    <LicenceNumber>VPA10475/011/002</LicenceNumber>
    <ProductName>Synthadon 10 mg/ml solution for injection for cats and dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>10/10/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AC52</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Methadone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/072/001</DrugIDPK>
    <LicenceNumber>VPA10387/072/001</LicenceNumber>
    <ProductName>Synulox Bolus 500 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/073/001</DrugIDPK>
    <LicenceNumber>VPA10387/073/001</LicenceNumber>
    <ProductName>Synulox Lactating Cow Intramammary suspension</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>28/11/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RV01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/074/002</DrugIDPK>
    <LicenceNumber>VPA10387/074/002</LicenceNumber>
    <ProductName>Synulox palatable tablets 200 mg/50 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/074/001</DrugIDPK>
    <LicenceNumber>VPA10387/074/001</LicenceNumber>
    <ProductName>Synulox palatable tablets 40 mg/10 mg</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/075/001</DrugIDPK>
    <LicenceNumber>VPA10387/075/001</LicenceNumber>
    <ProductName>Synulox Ready to Use Injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22962/001/001</DrugIDPK>
    <LicenceNumber>VPA22962/001/001</LicenceNumber>
    <ProductName>SynVet-50; 50 mg solution for  injection for horses</ProductName>
    <PAHolder>Equi Pharma Ltd</PAHolder>
    <AuthorisedDate>18/07/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM09AX01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intraarticular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium hyaluronate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/011/001</DrugIDPK>
    <LicenceNumber>VPA10495/011/001</LicenceNumber>
    <ProductName>Syvac Ery Parvo emulsion for injection for pigs</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI09AL01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Porcine parvovirus, strain PVP-7, Inactivated</ActiveSubstance>
      <ActiveSubstance>Erysipelothrix rhusiopathiae, serotype 2, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/063/001</DrugIDPK>
    <LicenceNumber>VPA10989/063/001</LicenceNumber>
    <ProductName>TAF SPRAY 28.5 mg/g Cutaneous Spray, Solution</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ATCs>
      <ATC>QD06AX</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamphenicol</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Mink</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10660/004/001</DrugIDPK>
    <LicenceNumber>VPA10660/004/001</LicenceNumber>
    <ProductName>Taneven LC 3 g intramammary suspension for cattle</ProductName>
    <PAHolder>WDT - Wirtschaftsgenossenschaft deutscher Tierarzte eG,</PAHolder>
    <AuthorisedDate>24/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CE09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/151/001</DrugIDPK>
    <LicenceNumber>VPA22664/151/001</LicenceNumber>
    <ProductName>Taurador 10 mg/ml Solution for Injection for cattle, sheep &amp; pigs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>22/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doramectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/111/001</DrugIDPK>
    <LicenceNumber>VPA22664/111/001</LicenceNumber>
    <ProductName>Taurador 5 mg/ml Pour-on Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>29/11/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA03</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Doramectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/130/001</DrugIDPK>
    <LicenceNumber>VPA22664/130/001</LicenceNumber>
    <ProductName>Tauramox 5 mg/ml Pour-On Solution for Cattle</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/028/001</DrugIDPK>
    <LicenceNumber>VPA10980/028/001</LicenceNumber>
    <ProductName>Telmitraxx 4mg/ml oral solution for cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>04/08/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QC09CA07</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/033/001</DrugIDPK>
    <LicenceNumber>VPA10475/033/001</LicenceNumber>
    <ProductName>Temprace 0.5 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>25/05/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05AA04</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Acepromazine maleate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/076/001</DrugIDPK>
    <LicenceNumber>VPA10387/076/001</LicenceNumber>
    <ProductName>Terramycin Aerosol Spray for sheep</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Cutaneous spray, suspension</DosageForm>
    <ATCs>
      <ATC>QD06AA03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/052/001</DrugIDPK>
    <LicenceNumber>VPA10990/052/001</LicenceNumber>
    <ProductName>Terrexine DC 250 mg Intramammary Suspension for Dry Cows</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>05/07/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51DB90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalonium dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/023/001</DrugIDPK>
    <LicenceNumber>VPA10990/023/001</LicenceNumber>
    <ProductName>Terrexine LC Intramammary Suspension for lactating cows</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
      <ActiveSubstance>Kanamycin monosulphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/150/001</DrugIDPK>
    <LicenceNumber>VPA10996/150/001</LicenceNumber>
    <ProductName>Tetanus Antitoxin Behring</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>09/04/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI04AM02</ATC>
      <ATC>QI05AM01</ATC>
      <ATC>QI07AM</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intrathecal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Equine serum protein</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological- Antiserum</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/068/001</DrugIDPK>
    <LicenceNumber>VPA22033/068/001</LicenceNumber>
    <ProductName>Tetracure 200 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>05/02/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/032/001</DrugIDPK>
    <LicenceNumber>VPA22033/032/001</LicenceNumber>
    <ProductName>Tetroxy 10 % Solution for Injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/044/001</DrugIDPK>
    <LicenceNumber>VPA22033/044/001</LicenceNumber>
    <ProductName>Tetroxy LA 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/033/002</DrugIDPK>
    <LicenceNumber>VPA10815/033/002</LicenceNumber>
    <ProductName>Therios 300 mg palatable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>16/04/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/033/001</DrugIDPK>
    <LicenceNumber>VPA10815/033/001</LicenceNumber>
    <ProductName>Therios 75 mg Chewable Tablets for Cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/033/003</DrugIDPK>
    <LicenceNumber>VPA10815/033/003</LicenceNumber>
    <ProductName>Therios 750 mg palatable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>16/04/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/006/001</DrugIDPK>
    <LicenceNumber>VPA10475/006/001</LicenceNumber>
    <ProductName>Thiafeline 2.5 mg Film-coated Tablets for Cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/006/002</DrugIDPK>
    <LicenceNumber>VPA10475/006/002</LicenceNumber>
    <ProductName>Thiafeline 5 mg Film-coated Tablets for Cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/060/001</DrugIDPK>
    <LicenceNumber>VPA10989/060/001</LicenceNumber>
    <ProductName>Thyforon flavoured 200 microgram tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/060/002</DrugIDPK>
    <LicenceNumber>VPA10989/060/002</LicenceNumber>
    <ProductName>Thyforon flavoured 400 microgram tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/060/003</DrugIDPK>
    <LicenceNumber>VPA10989/060/003</LicenceNumber>
    <ProductName>Thyforon flavoured 600 microgram tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10989/060/004</DrugIDPK>
    <LicenceNumber>VPA10989/060/004</LicenceNumber>
    <ProductName>Thyforon flavoured 800 microgram tablets for dogs</ProductName>
    <PAHolder>Eurovet Animal Health B.V.</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/023/001</DrugIDPK>
    <LicenceNumber>VPA10810/023/001</LicenceNumber>
    <ProductName>Thyrasol 5 mg/ml, Oral solution for cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>23/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/028/001</DrugIDPK>
    <LicenceNumber>VPA10810/028/001</LicenceNumber>
    <ProductName>Thyron vet 200 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/028/002</DrugIDPK>
    <LicenceNumber>VPA10810/028/002</LicenceNumber>
    <ProductName>Thyron vet 400 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/028/003</DrugIDPK>
    <LicenceNumber>VPA10810/028/003</LicenceNumber>
    <ProductName>Thyron vet 600 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/028/004</DrugIDPK>
    <LicenceNumber>VPA10810/028/004</LicenceNumber>
    <ProductName>Thyron vet 800 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/127/001</DrugIDPK>
    <LicenceNumber>VPA22664/127/001</LicenceNumber>
    <ProductName>Thyronorm 5 mg/ml Oral Solution for Cats</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>10/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QH03BB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamazole </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/029/001</DrugIDPK>
    <LicenceNumber>VPA10810/029/001</LicenceNumber>
    <ProductName>Thyrotab 200 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/029/002</DrugIDPK>
    <LicenceNumber>VPA10810/029/002</LicenceNumber>
    <ProductName>Thyrotab 400 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/029/003</DrugIDPK>
    <LicenceNumber>VPA10810/029/003</LicenceNumber>
    <ProductName>Thyrotab 600 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/029/004</DrugIDPK>
    <LicenceNumber>VPA10810/029/004</LicenceNumber>
    <ProductName>Thyrotab 800 µg Tablets for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>08/12/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/023/001</DrugIDPK>
    <LicenceNumber>VPA10475/023/001</LicenceNumber>
    <ProductName>Thyroxanil 200 microgram tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>24/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/023/002</DrugIDPK>
    <LicenceNumber>VPA10475/023/002</LicenceNumber>
    <ProductName>Thyroxanil 600 microgram tablets for dogs and cats</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>24/06/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/019/001</DrugIDPK>
    <LicenceNumber>VPA22622/019/001</LicenceNumber>
    <ProductName>Tialin 125 mg/ml solution for use in drinking water for pigs, chickens and turkeys</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>20/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/019/002</DrugIDPK>
    <LicenceNumber>VPA22622/019/002</LicenceNumber>
    <ProductName>Tialin 250 mg/ml solution for use in drinking water for pigs, chickens and turkeys</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>20/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/002/001</DrugIDPK>
    <LicenceNumber>VPA10534/002/001</LicenceNumber>
    <ProductName>Tilmodil 300 mg/ml Solution for Injection for cattle and sheep</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/004/002</DrugIDPK>
    <LicenceNumber>VPA10782/004/002</LicenceNumber>
    <ProductName>Tilmovet 100 g/kg Premix for medicated feeding stuff for pigs and rabbits</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>13/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/011/001</DrugIDPK>
    <LicenceNumber>VPA10782/011/001</LicenceNumber>
    <ProductName>Tilmovet 100 mg/g granules for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>06/11/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/004/001</DrugIDPK>
    <LicenceNumber>VPA10782/004/001</LicenceNumber>
    <ProductName>Tilmovet 200 g/kg Premix for medicated feeding stuff for pigs and rabbits</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>13/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/003/001</DrugIDPK>
    <LicenceNumber>VPA10782/003/001</LicenceNumber>
    <ProductName>Tilmovet 250 mg/ml Concentrate for Oral Solution for pigs, chickens, turkeys and cattle (calves)</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/032/001</DrugIDPK>
    <LicenceNumber>VPA10782/032/001</LicenceNumber>
    <ProductName>Tilmovet 300 mg/ml Solution for Injection for cattle and sheep</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>24/05/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/004/003</DrugIDPK>
    <LicenceNumber>VPA10782/004/003</LicenceNumber>
    <ProductName>Tilmovet 40 g/kg Premix for medicated feeding stuff for pigs and rabbits</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>13/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tilmicosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/012/001</DrugIDPK>
    <LicenceNumber>VPA22693/012/001</LicenceNumber>
    <ProductName>Tizoval 6 mg/g Premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/019/001</DrugIDPK>
    <LicenceNumber>VPA10983/019/001</LicenceNumber>
    <ProductName>Tolfedine 40 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>12/08/1993</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tolfenamic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/018/001</DrugIDPK>
    <LicenceNumber>VPA10983/018/001</LicenceNumber>
    <ProductName>Tolfedine 6 mg tablets</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>12/08/1993</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AG02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tolfenamic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/018/002</DrugIDPK>
    <LicenceNumber>VPA10983/018/002</LicenceNumber>
    <ProductName>Tolfedine 60 mg tablets</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>12/08/1993</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QM01AG02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tolfenamic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/006/001</DrugIDPK>
    <LicenceNumber>VPA10790/006/001</LicenceNumber>
    <ProductName>TOLFEDOL, 40 mg/ml, solution for injection for cattle, pigs, cats and dogs</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tolfenamic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/023/001</DrugIDPK>
    <LicenceNumber>VPA10521/023/001</LicenceNumber>
    <ProductName>Tolfine</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tolfenamic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/017/001</DrugIDPK>
    <LicenceNumber>VPA10521/017/001</LicenceNumber>
    <ProductName>Tolfine 80 mg/ml solution for injection for cattle</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>26/08/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QM01AG02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tolfenamic acid</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>N.S.A.I.D.</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/026/001</DrugIDPK>
    <LicenceNumber>VPA10774/026/001</LicenceNumber>
    <ProductName>Tolracol 50 mg/ml oral suspension for pigs, cattle and sheep</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>05/12/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/007/002</DrugIDPK>
    <LicenceNumber>VPA10774/007/002</LicenceNumber>
    <ProductName>Toltarox 50 mg/ml oral suspension for cattle</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>15/11/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/007/001</DrugIDPK>
    <LicenceNumber>VPA10774/007/001</LicenceNumber>
    <ProductName>Toltarox 50 mg/ml oral suspension for pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/080/001</DrugIDPK>
    <LicenceNumber>VPA10987/080/001</LicenceNumber>
    <ProductName>TOPIMEC 0.8 mg/ml Oral Solution for Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>17/07/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/159/001</DrugIDPK>
    <LicenceNumber>VPA10987/159/001</LicenceNumber>
    <ProductName>Topimec 5 mg/ml Pour-on Solution</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/157/001</DrugIDPK>
    <LicenceNumber>VPA10987/157/001</LicenceNumber>
    <ProductName>Topimec Injection 10 mg/ml solution for injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/02/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/099/001</DrugIDPK>
    <LicenceNumber>VPA10987/099/001</LicenceNumber>
    <ProductName>Topimec Super Solution for Injection</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>14/10/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/079/001</DrugIDPK>
    <LicenceNumber>VPA10387/079/001</LicenceNumber>
    <ProductName>Torbugesic 10 mg/ml Solution for Injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/080/001</DrugIDPK>
    <LicenceNumber>VPA10387/080/001</LicenceNumber>
    <ProductName>Torbuphanol Vet 10 mg/ml solution for injection for injection for horses, dogs and cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>09/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/038/001</DrugIDPK>
    <LicenceNumber>VPA10475/038/001</LicenceNumber>
    <ProductName>Torphadine 10 mg/ml solution for injection for dogs, cats and horses</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>28/10/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/009/001</DrugIDPK>
    <LicenceNumber>VPA10826/009/001</LicenceNumber>
    <ProductName>Torphasol 10 mg/ml solution for injection for horses</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butorphanol tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/080/001</DrugIDPK>
    <LicenceNumber>VPA10996/080/001</LicenceNumber>
    <ProductName>Toxovax</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>18/08/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI04AN01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toxoplasma gondii tachyzoites s48</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/039/001</DrugIDPK>
    <LicenceNumber>VPA22622/039/001</LicenceNumber>
    <ProductName>Tralieve 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10475/034/001</DrugIDPK>
    <LicenceNumber>VPA10475/034/001</LicenceNumber>
    <ProductName>Tralieve 50 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Le Vet Beheer B.V.</PAHolder>
    <AuthorisedDate>16/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/039/002</DrugIDPK>
    <LicenceNumber>VPA22622/039/002</LicenceNumber>
    <ProductName>Tralieve 80 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/003/001</DrugIDPK>
    <LicenceNumber>VPA23340/003/001</LicenceNumber>
    <ProductName>Tramadog 50 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>13/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22873/006/001</DrugIDPK>
    <LicenceNumber>VPA22873/006/001</LicenceNumber>
    <ProductName>TRAMADOG 50 mg tablet for dogs</ProductName>
    <PAHolder>Axience</PAHolder>
    <AuthorisedDate>29/07/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/031/004</DrugIDPK>
    <LicenceNumber>VPA10810/031/004</LicenceNumber>
    <ProductName>Tramatab 120 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>02/02/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/031/001</DrugIDPK>
    <LicenceNumber>VPA10810/031/001</LicenceNumber>
    <ProductName>Tramatab 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>02/02/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/031/002</DrugIDPK>
    <LicenceNumber>VPA10810/031/002</LicenceNumber>
    <ProductName>Tramatab 50 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>02/02/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/031/003</DrugIDPK>
    <LicenceNumber>VPA10810/031/003</LicenceNumber>
    <ProductName>Tramatab 80 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>02/02/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/038/002</DrugIDPK>
    <LicenceNumber>VPA10990/038/002</LicenceNumber>
    <ProductName>Tramazole 100 mg/ml oral suspension for cattle and sheep</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>09/01/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/038/001</DrugIDPK>
    <LicenceNumber>VPA10990/038/001</LicenceNumber>
    <ProductName>Tramazole 25 mg/ml oral suspension for cattle and sheep</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>09/01/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC11</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Albendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/037/002</DrugIDPK>
    <LicenceNumber>VPA10980/037/002</LicenceNumber>
    <ProductName>Tramcoat 20 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/037/003</DrugIDPK>
    <LicenceNumber>VPA10980/037/003</LicenceNumber>
    <ProductName>Tramcoat 40 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/037/001</DrugIDPK>
    <LicenceNumber>VPA10980/037/001</LicenceNumber>
    <ProductName>Tramcoat 8 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/037/004</DrugIDPK>
    <LicenceNumber>VPA10980/037/004</LicenceNumber>
    <ProductName>Tramcoat 80 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/038/001</DrugIDPK>
    <LicenceNumber>VPA10980/038/001</LicenceNumber>
    <ProductName>Tramsan 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/038/002</DrugIDPK>
    <LicenceNumber>VPA10980/038/002</LicenceNumber>
    <ProductName>Tramsan 80 mg chewable tablets for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>19/01/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/112/001</DrugIDPK>
    <LicenceNumber>VPA10988/112/001</LicenceNumber>
    <ProductName>Tramvetol 50 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/111/001</DrugIDPK>
    <LicenceNumber>VPA10988/111/001</LicenceNumber>
    <ProductName>Tramvetol 50 mg tablets for dogs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN02AX02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22969/003/001</DrugIDPK>
    <LicenceNumber>VPA22969/003/001</LicenceNumber>
    <ProductName>Tranquiline 35 mg/ml Oral Gel for Dogs</ProductName>
    <PAHolder>Floris Holding BV</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral gel</DosageForm>
    <ATCs>
      <ATC>QN05AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Acepromazine maleate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10462/001/001</DrugIDPK>
    <LicenceNumber>VPA10462/001/001</LicenceNumber>
    <ProductName>Triazole Fluke and Worm Drench</ProductName>
    <PAHolder>Pharvet (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AE51</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/167/001</DrugIDPK>
    <LicenceNumber>VPA10987/167/001</LicenceNumber>
    <ProductName>Tribamec Duo 50 mg/ml + 1 mg/ml Oral Suspension for Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/01/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/146/002</DrugIDPK>
    <LicenceNumber>VPA10987/146/002</LicenceNumber>
    <ProductName>Tribex 100 mg/ml Oral Suspension for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/146/001</DrugIDPK>
    <LicenceNumber>VPA10987/146/001</LicenceNumber>
    <ProductName>Tribex 50 mg/ml Oral Suspension for Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/286/001</DrugIDPK>
    <LicenceNumber>VPA10996/286/001</LicenceNumber>
    <ProductName>Tribovax 10 suspension for injection for cattle and sheep</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>10/09/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clostridium Perfringens Type A, Alfa Toxoid</ActiveSubstance>
      <ActiveSubstance>CLOSTRIDIUM PERFRINGENS TYPE B, BETA TOXOID</ActiveSubstance>
      <ActiveSubstance>Clostridium Perfringens Type C, Beta Toxoid</ActiveSubstance>
      <ActiveSubstance>CLOSTRIDIUM PERFRINGENS TYPE D, EPSILON TOXOID</ActiveSubstance>
      <ActiveSubstance>clostridium chauvoei, inactivated</ActiveSubstance>
      <ActiveSubstance>Clostridium novyi toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium septicum toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium tetani toxoid</ActiveSubstance>
      <ActiveSubstance>Clostridium sordellii toxoid</ActiveSubstance>
      <ActiveSubstance>CLOSTRIDIUM HAEMOLYTICUM, TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/260/001</DrugIDPK>
    <LicenceNumber>VPA10996/260/001</LicenceNumber>
    <ProductName>Tribovax T suspension for injection for cattle</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>14/01/2005</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clostridium chauvoei, strain 3796, Inactivated</ActiveSubstance>
      <ActiveSubstance>C. haemolyticum</ActiveSubstance>
      <ActiveSubstance>C. haemolyticum cells</ActiveSubstance>
      <ActiveSubstance>C.noyvi B </ActiveSubstance>
      <ActiveSubstance>C. noyvi B cells</ActiveSubstance>
      <ActiveSubstance>C.septicum CN3204 (3U/ml)</ActiveSubstance>
      <ActiveSubstance>C.septicum CN368(7U/ml)</ActiveSubstance>
      <ActiveSubstance>C.tetani </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10804/006/001</DrugIDPK>
    <LicenceNumber>VPA10804/006/001</LicenceNumber>
    <ProductName>Tricaine Pharmaq 1000 mg/g Powder for Solution for Fish Treatment</ProductName>
    <PAHolder>PHARMAQ AS</PAHolder>
    <AuthorisedDate>08/03/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for solution for fish treatment</DosageForm>
    <ATCs>
      <ATC>QN01AX93</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Water-borne use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tricaine methane sulfonate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Atlantic salmon</Species>
      <Species>Other fish</Species>
      <Species>Trout</Species>
      <Species>Carp</Species>
      <Species>Ornamental fish</Species>
      <Species>Seabass</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22715/006/001</DrugIDPK>
    <LicenceNumber>VPA22715/006/001</LicenceNumber>
    <ProductName>Trichovec lyophilisate and solvent for suspension for injection for cattle</ProductName>
    <PAHolder>Animal Health Distributors Limited</PAHolder>
    <AuthorisedDate>11/04/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI02AP01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trichophyton verrucosum, strain Bodin 1902, Live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Exempt</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/059/001</DrugIDPK>
    <LicenceNumber>VPA10987/059/001</LicenceNumber>
    <ProductName>Triclaben 100 mg/ml oral suspension for Cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/058/001</DrugIDPK>
    <LicenceNumber>VPA10987/058/001</LicenceNumber>
    <ProductName>Triclaben 50 mg/ml oral suspension for Sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10803/002/001</DrugIDPK>
    <LicenceNumber>VPA10803/002/001</LicenceNumber>
    <ProductName>Trigoderm 5 mg/g + 1 mg/g gel for dogs</ProductName>
    <PAHolder>Dechra Veterinary Products A/S</PAHolder>
    <AuthorisedDate>19/03/2004</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QD07CC01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fusidic acid</ActiveSubstance>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/026/001</DrugIDPK>
    <LicenceNumber>VPA10810/026/001</LicenceNumber>
    <ProductName>Trilotab 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/026/004</DrugIDPK>
    <LicenceNumber>VPA10810/026/004</LicenceNumber>
    <ProductName>Trilotab 120 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/026/005</DrugIDPK>
    <LicenceNumber>VPA10810/026/005</LicenceNumber>
    <ProductName>Trilotab 150 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/026/002</DrugIDPK>
    <LicenceNumber>VPA10810/026/002</LicenceNumber>
    <ProductName>Trilotab 30 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/026/003</DrugIDPK>
    <LicenceNumber>VPA10810/026/003</LicenceNumber>
    <ProductName>Trilotab 60 mg chewable tablets for dogs</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/035/001</DrugIDPK>
    <LicenceNumber>VPA10521/035/001</LicenceNumber>
    <ProductName>Trimediazine Plain Oral Powder</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/048/001</DrugIDPK>
    <LicenceNumber>VPA10990/048/001</LicenceNumber>
    <ProductName>Trioxyl 500 mg/g powder for use in drinking water for chickens, turkeys, ducks and pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>27/01/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/010/001</DrugIDPK>
    <LicenceNumber>VPA10990/010/001</LicenceNumber>
    <ProductName>Trioxyl LA 150mg/ml Suspension for Injection</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/037/001</DrugIDPK>
    <LicenceNumber>VPA10990/037/001</LicenceNumber>
    <ProductName>Trippel-Oxy 150 mg/ml solution for injection for cattle, sheep and pigs</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1998</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01AA06</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/041/001</DrugIDPK>
    <LicenceNumber>VPA10980/041/001</LicenceNumber>
    <ProductName>Triquest 333 mg/ml + 67 mg/ml oral suspension for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>31/05/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/038/002</DrugIDPK>
    <LicenceNumber>VPA10810/038/002</LicenceNumber>
    <ProductName>Trisulfin vet 100 mg/500 mg chewable tablet for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>19/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/038/001</DrugIDPK>
    <LicenceNumber>VPA10810/038/001</LicenceNumber>
    <ProductName>Trisulfin vet 25 mg/125 mg chewable tablet for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>19/06/2026</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01EW10</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfadiazine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/141/001</DrugIDPK>
    <LicenceNumber>VPA10987/141/001</LicenceNumber>
    <ProductName>Troscan 100 mg film coated tablet for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>10/02/1994</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AX01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Nitroscanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/141/002</DrugIDPK>
    <LicenceNumber>VPA10987/141/002</LicenceNumber>
    <ProductName>Troscan 500 mg film coated tablet for Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AX01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Nitroscanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10534/009/001</DrugIDPK>
    <LicenceNumber>VPA10534/009/001</LicenceNumber>
    <ProductName>Trovex 1 mg/ml suspension for injection for cattle, horses, pigs, cats and dogs</ProductName>
    <PAHolder>Emdoka</PAHolder>
    <AuthorisedDate>12/11/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QH02AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone isonicotinate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Corticosteroid</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10495/008/001</DrugIDPK>
    <LicenceNumber>VPA10495/008/001</LicenceNumber>
    <ProductName>TROXXAN 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Laboratorios Syva S.A.</PAHolder>
    <AuthorisedDate>14/05/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/056/001</DrugIDPK>
    <LicenceNumber>VPA10990/056/001</LicenceNumber>
    <ProductName>TruSeal 2.6 g Intramammary suspension for cattle</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>06/09/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Informed Consent application (Article 21 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Teat Dip/Seal</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/051/001</DrugIDPK>
    <LicenceNumber>VPA10990/051/001</LicenceNumber>
    <ProductName>Trymox LA 150 mg/ml Suspension for Injection for Cattle, Sheep, Pigs, Dogs and Cats</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>12/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23440/001/002</DrugIDPK>
    <LicenceNumber>VPA23440/001/002</LicenceNumber>
    <ProductName>Tsefalen 1000 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Nextmune Italy S.r.l.</PAHolder>
    <AuthorisedDate>09/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23440/001/003</DrugIDPK>
    <LicenceNumber>VPA23440/001/003</LicenceNumber>
    <ProductName>Tsefalen 50 mg/ml Powder for Oral Suspension for Dogs up to 20 kg and Cats</ProductName>
    <PAHolder>Nextmune Italy S.r.l.</PAHolder>
    <AuthorisedDate>04/12/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23440/001/001</DrugIDPK>
    <LicenceNumber>VPA23440/001/001</LicenceNumber>
    <ProductName>Tsefalen 500 mg film-coated tablets for dogs</ProductName>
    <PAHolder>Nextmune Italy S.r.l.</PAHolder>
    <AuthorisedDate>09/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QJ01DB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10526/001/001</DrugIDPK>
    <LicenceNumber>VPA10526/001/001</LicenceNumber>
    <ProductName>Tuberculin PPD Kit</ProductName>
    <PAHolder>Prionics Lelystad - B.V.,</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI02AR01</ATC>
      <ATC>QI02AR02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bovine tuberculin PPD</ActiveSubstance>
      <ActiveSubstance>Avian tuberculin PPD</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10790/011/001</DrugIDPK>
    <LicenceNumber>VPA10790/011/001</LicenceNumber>
    <ProductName>TUDOMAX, 10 mg/g, powder for use in drinking water/milk</ProductName>
    <PAHolder>SP Veterinaria, S.A.</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ATCs>
      <ATC>QR05CB02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bromhexine</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Duck</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/058/001</DrugIDPK>
    <LicenceNumber>VPA10774/058/001</LicenceNumber>
    <ProductName>Tulaxa 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>08/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/058/002</DrugIDPK>
    <LicenceNumber>VPA10774/058/002</LicenceNumber>
    <ProductName>Tulaxa 25 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>09/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/146/001</DrugIDPK>
    <LicenceNumber>VPA22664/146/001</LicenceNumber>
    <ProductName>Tulieve 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>03/07/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/022/001</DrugIDPK>
    <LicenceNumber>VPA10509/022/001</LicenceNumber>
    <ProductName>Tullavis 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>09/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/021/001</DrugIDPK>
    <LicenceNumber>VPA10509/021/001</LicenceNumber>
    <ProductName>Tullavis 25 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>09/10/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/057/001</DrugIDPK>
    <LicenceNumber>VPA10774/057/001</LicenceNumber>
    <ProductName>Tuloxxin 100 mg/ml solution for injection for cattle, pigs and sheep</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>08/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/057/002</DrugIDPK>
    <LicenceNumber>VPA10774/057/002</LicenceNumber>
    <ProductName>Tuloxxin 25 mg/ml solution for injection for pigs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>13/11/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA94</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tulathromycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/078/001</DrugIDPK>
    <LicenceNumber>VPA10454/078/001</LicenceNumber>
    <ProductName>TUR-3 emulsion for injection for turkeys</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>21/12/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI01CA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Newcastle disease virus, strain Ulster 2C, Inactivated</ActiveSubstance>
      <ActiveSubstance>Avian paramyxovirus 3, strain PMV3, Inactivated</ActiveSubstance>
      <ActiveSubstance>Turkey rhinotracheitis virus, strain VCO3, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/072/002</DrugIDPK>
    <LicenceNumber>VPA10774/072/002</LicenceNumber>
    <ProductName>Twinox 200 mg/50 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/072/001</DrugIDPK>
    <LicenceNumber>VPA10774/072/001</LicenceNumber>
    <ProductName>Twinox 40 mg/10 mg chewable tablets for cats and dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10774/072/003</DrugIDPK>
    <LicenceNumber>VPA10774/072/003</LicenceNumber>
    <ProductName>Twinox 400 mg/100 mg chewable tablets for dogs</ProductName>
    <PAHolder>Krka, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>11/06/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01CR02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/033/001</DrugIDPK>
    <LicenceNumber>VPA22020/033/001</LicenceNumber>
    <ProductName>Tylan 200, 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/034/002</DrugIDPK>
    <LicenceNumber>VPA22020/034/002</LicenceNumber>
    <ProductName>Tylan G250 Premix for medicated feeding stuff</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>14/05/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/034/003</DrugIDPK>
    <LicenceNumber>VPA22020/034/003</LicenceNumber>
    <ProductName>Tylan G50 Premix for medicated feedingstuff</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin phosphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/020/001</DrugIDPK>
    <LicenceNumber>VPA22020/020/001</LicenceNumber>
    <ProductName>Tylan Soluble Powder for Oral Solution</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10981/004/001</DrugIDPK>
    <LicenceNumber>VPA10981/004/001</LicenceNumber>
    <ProductName>Tylo 200 mg/ml solution for injection</ProductName>
    <PAHolder>Kela n.v.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10791/020/001</DrugIDPK>
    <LicenceNumber>VPA10791/020/001</LicenceNumber>
    <ProductName>Tylogran, 1000 mg/g, granules for use in drinking water/milk for cattle (calves), pigs, chickens and turkeys</ProductName>
    <PAHolder>Dopharma Research B.V.</PAHolder>
    <AuthorisedDate>23/12/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Powder for use in drinking water/milk</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10402/007/001</DrugIDPK>
    <LicenceNumber>VPA10402/007/001</LicenceNumber>
    <ProductName>Tylolab tartrate 200,000 IU/ml solution for injection</ProductName>
    <PAHolder>Labiana Life Sciences, S.A.</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/005/001</DrugIDPK>
    <LicenceNumber>VPA10980/005/001</LicenceNumber>
    <ProductName>Tylosin 200 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10464/001/001</DrugIDPK>
    <LicenceNumber>VPA10464/001/001</LicenceNumber>
    <ProductName>TYLOSIN BIOVET JSC 200 mg/ml solution for injection for cattle, sheep, goats and pigs</ProductName>
    <PAHolder>BIOVET Joint Stock Company,</PAHolder>
    <AuthorisedDate>31/05/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10983/060/001</DrugIDPK>
    <LicenceNumber>VPA10983/060/001</LicenceNumber>
    <ProductName>Tylucyl 200 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Vetoquinol Ireland Limited</PAHolder>
    <AuthorisedDate>06/05/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01FA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tylosin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/016/001</DrugIDPK>
    <LicenceNumber>VPA10454/016/001</LicenceNumber>
    <ProductName>Ubrolexin intramammary suspension for lactating dairy cows</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>26/10/2007</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RD01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin monohydrate</ActiveSubstance>
      <ActiveSubstance>Kanamycin monosulphate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10832/002/001</DrugIDPK>
    <LicenceNumber>VPA10832/002/001</LicenceNumber>
    <ProductName>Ubropen 600 mg intramammary suspension for lactating cows</ProductName>
    <PAHolder>Vetcare Oy</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51CE09</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/049/001</DrugIDPK>
    <LicenceNumber>VPA10990/049/001</LicenceNumber>
    <ProductName>Ubroseal blue Dry Cow 2.6 g intramammary suspension for cattle</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>02/02/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QG52X</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bismuth subnitrate, heavy </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/001/001</DrugIDPK>
    <LicenceNumber>VPA10454/001/001</LicenceNumber>
    <ProductName>Ubrostar Red 100 mg/280 mg/100 mg Intramammary Suspension for cattle</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>23/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intramammary suspension</DosageForm>
    <ATCs>
      <ATC>QJ51RC25</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramammary use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Penethamate hydriodide </ActiveSubstance>
      <ActiveSubstance>Benethamine penicillin </ActiveSubstance>
      <ActiveSubstance>Framycetin sulphate </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10400/003/001</DrugIDPK>
    <LicenceNumber>VPA10400/003/001</LicenceNumber>
    <ProductName>UISCE-JECT, 100 % v/v, solvent for parenteral use</ProductName>
    <PAHolder>Duggan Veterinary Supplies Limited</PAHolder>
    <AuthorisedDate>15/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ATCs>
      <ATC>QV07AB</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Water for injections</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/045/001</DrugIDPK>
    <LicenceNumber>VPA22664/045/001</LicenceNumber>
    <ProductName>Ultrapen LA 300 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/12/1997</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Procaine benzylpenicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/003/001</DrugIDPK>
    <LicenceNumber>VPA10990/003/001</LicenceNumber>
    <ProductName>Unicillin 300 mg/ml Suspension for Injection</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1987</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QJ01CE09</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Benzylpenicillin procaine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10794/001/001</DrugIDPK>
    <LicenceNumber>VPA10794/001/001</LicenceNumber>
    <ProductName>Uniferon 200 mg/ml Solution for Injection for pigs (piglets)</ProductName>
    <PAHolder>Pharmacosmos A/ S</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB03AC</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Iron dextran</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Licensed Retailer</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10516/001/001</DrugIDPK>
    <LicenceNumber>VPA10516/001/001</LicenceNumber>
    <ProductName>Unisol 100 mg/ml solution for injection for cattle and pigs</ProductName>
    <PAHolder>Vetpharma Animal Health S.L.</PAHolder>
    <AuthorisedDate>06/05/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/013/001</DrugIDPK>
    <LicenceNumber>VPA10846/013/001</LicenceNumber>
    <ProductName>UNISTRAIN PRRS lyophilisate and solvent for suspension for injection for pigs</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>01/03/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI09AD03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intradermal use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live attenuated prrsv, strain vp-046 bis</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10990/026/001</DrugIDPK>
    <LicenceNumber>VPA10990/026/001</LicenceNumber>
    <ProductName>Univet Multidose Fluke and Worm Drench</ProductName>
    <PAHolder>Univet Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AE51</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Rafoxanide</ActiveSubstance>
      <ActiveSubstance>Levamisole hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/110/001</DrugIDPK>
    <LicenceNumber>VPA10987/110/001</LicenceNumber>
    <ProductName>Unomec 5 mg/ml Pour-on Solution for beef and dairy cattle</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/119/001</DrugIDPK>
    <LicenceNumber>VPA10987/119/001</LicenceNumber>
    <ProductName>Unomox 1 mg/ml oral solution for sheep</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>25/08/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP54AB02</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Moxidectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/029/001</DrugIDPK>
    <LicenceNumber>VPA10980/029/001</LicenceNumber>
    <ProductName>Uriphex 50 mg/ml oral solution for dogs</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG04BX91</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phenylpropanolamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10826/024/001</DrugIDPK>
    <LicenceNumber>VPA10826/024/001</LicenceNumber>
    <ProductName>Utertab 2000 mg intrauterine tablet for cattle</ProductName>
    <PAHolder>aniMedica GmbH</PAHolder>
    <AuthorisedDate>17/08/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Intrauterine tablet</DosageForm>
    <ATCs>
      <ATC>QG51AA02</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intrauterine use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tetracycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10836/005/001</DrugIDPK>
    <LicenceNumber>VPA10836/005/001</LicenceNumber>
    <ProductName>VALEMAS 50 mg/ml solution for injection for cattle, sheep, goats, pigs, dogs and cats.</ProductName>
    <PAHolder>FATRO S.p.A.</PAHolder>
    <AuthorisedDate>07/06/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01MA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Enrofloxacin </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/082/001</DrugIDPK>
    <LicenceNumber>VPA10387/082/001</LicenceNumber>
    <ProductName>VANGUARD 7</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QI07AI02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine distemper virus strain N-CDV (live, attenuated)</ActiveSubstance>
      <ActiveSubstance>Canine adenovirus type 2 virus, strain manhattan (live, attenuated)</ActiveSubstance>
      <ActiveSubstance>Canine parainfluenza type 5 virus, strain NL-CPI-5 (live, attenuated)</ActiveSubstance>
      <ActiveSubstance>Canine parvovirus strain NL-35-D (live, attenuated)</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/083/001</DrugIDPK>
    <LicenceNumber>VPA10387/083/001</LicenceNumber>
    <ProductName>Vanguard CPV solution for injection for dogs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live canine parvovirus strain NL-35-D</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/084/001</DrugIDPK>
    <LicenceNumber>VPA10387/084/001</LicenceNumber>
    <ProductName>VANGUARD CPV-L.</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI07AI05</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Live canine parvovirus strain NL-35-D</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Mixed Vaccine (L &amp; A)</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/085/001</DrugIDPK>
    <LicenceNumber>VPA10387/085/001</LicenceNumber>
    <ProductName>Vanguard Lepto-ci</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QI07AB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Leptospira icterohaemorrhagiae inactivated</ActiveSubstance>
      <ActiveSubstance>Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/285/001</DrugIDPK>
    <LicenceNumber>VPA10996/285/001</LicenceNumber>
    <ProductName>Vecoxan 2.5 mg/ml Oral Suspension for lambs and calves</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ03</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Diclazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10482/002/001</DrugIDPK>
    <LicenceNumber>VPA10482/002/001</LicenceNumber>
    <ProductName>Veloxa Chewable Tablets for Dogs</ProductName>
    <PAHolder>LAVET Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel</ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10482/003/001</DrugIDPK>
    <LicenceNumber>VPA10482/003/001</LicenceNumber>
    <ProductName>Veloxa XL Chewable Tablets for Dogs</ProductName>
    <PAHolder>LAVET Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel</ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/018/001</DrugIDPK>
    <LicenceNumber>VPA10454/018/001</LicenceNumber>
    <ProductName>Ventipulmin Granules 16 micrograms/gram</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QR03CC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/019/001</DrugIDPK>
    <LicenceNumber>VPA10454/019/001</LicenceNumber>
    <ProductName>Ventipulmin Solution for Injection 30 micrograms/ml</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QR03CC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/020/001</DrugIDPK>
    <LicenceNumber>VPA10454/020/001</LicenceNumber>
    <ProductName>Ventipulmin Syrup 25 micrograms/ml</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1988</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ATCs>
      <ATC>QR03CC13</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/045/001</DrugIDPK>
    <LicenceNumber>VPA10980/045/001</LicenceNumber>
    <ProductName>Ventiquin 25 microgram/ml oral solution for horses</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>02/05/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QR03CC13</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clenbuterol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Respiratory Tract preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/097/001</DrugIDPK>
    <LicenceNumber>VPA10387/097/001</LicenceNumber>
    <ProductName>Versican Plus Bb Oral lyophilisate and solvent for oral suspension for dogs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>19/08/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for oral suspension</DosageForm>
    <ATCs>
      <ATC>QI07AE01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bordetella bronchiseptica, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/098/001</DrugIDPK>
    <LicenceNumber>VPA10387/098/001</LicenceNumber>
    <ProductName>Versican Plus BbPi IN nasal drops, lyophilisate and solvent for suspension for dogs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>25/08/2020</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for nasal administration</DosageForm>
    <ATCs>
      <ATC>QI07AF01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Nasal use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Bordetella bronchiseptica, live</ActiveSubstance>
      <ActiveSubstance>Canine parainfluenza virus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/087/001</DrugIDPK>
    <LicenceNumber>VPA10387/087/001</LicenceNumber>
    <ProductName>Versican Plus P lyophilisate and solvent for suspension for injection for dogs</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AD01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Canine parvovirus, live</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Live Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/088/001</DrugIDPK>
    <LicenceNumber>VPA10387/088/001</LicenceNumber>
    <ProductName>Versifel FeLV,suspension for injection for cats</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>29/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI06AA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated feline leukaemia virus(FeLV) subtypes A, B and C </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10387/086/001</DrugIDPK>
    <LicenceNumber>VPA10387/086/001</LicenceNumber>
    <ProductName>Versiguard Rabies, suspension for injection</ProductName>
    <PAHolder>Zoetis Belgium S.A.</PAHolder>
    <AuthorisedDate>13/11/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ATCs>
      <ATC>QI07AA02</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Inactivated rabies virus, strain vnukovo-32</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Ferrets</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23340/006/001</DrugIDPK>
    <LicenceNumber>VPA23340/006/001</LicenceNumber>
    <ProductName>Vetbromide 600 mg tablets for dogs</ProductName>
    <PAHolder>Domes Pharma</PAHolder>
    <AuthorisedDate>22/01/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QN03AX91</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Potassium bromide</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/010/001</DrugIDPK>
    <LicenceNumber>VPA10665/010/001</LicenceNumber>
    <ProductName>VeteCorH 1000 IU/ml lyophilizate and solvent for solution for injection for cattle, horses, sheep, goats, pigs, cats and dogs</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>02/05/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QG03GA01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application - other (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Gonadotrophin, chorionic</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Goats</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/008/001</DrugIDPK>
    <LicenceNumber>VPA10665/008/001</LicenceNumber>
    <ProductName>Veteglan 0.075 mg/ml Solution for injection for cows, sows and mares</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QG02AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>D-cloprostenol sodium salt</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10810/016/001</DrugIDPK>
    <LicenceNumber>VPA10810/016/001</LicenceNumber>
    <ProductName>Vetemex 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>CP-Pharma Handelsgesellschaft mbH</PAHolder>
    <AuthorisedDate>01/02/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Maropitant</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/003/001</DrugIDPK>
    <LicenceNumber>VPA10665/003/001</LicenceNumber>
    <ProductName>Veterelin 4 microgram/ml solution for injection for cattle, horses, pigs and rabbits</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QH01CA90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buserelin acetate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/028/001</DrugIDPK>
    <LicenceNumber>VPA10815/028/001</LicenceNumber>
    <ProductName>Vetergesic Multidose, 0.3 mg/ml, solution for injection for dogs and cats</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>17/08/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN02AE01</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/085/001</DrugIDPK>
    <LicenceNumber>VPA10988/085/001</LicenceNumber>
    <ProductName>Vetflurane 1000 mg/g Inhalation vapour, liquid</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Inhalation vapour, liquid</DosageForm>
    <ATCs>
      <ATC>QN01AB06</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Inhalation use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Isoflurane </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Chinchilla</Species>
      <Species>Dogs</Species>
      <Species>Ferrets</Species>
      <Species>Gerbil</Species>
      <Species>Guinea pig</Species>
      <Species>Hamster</Species>
      <Species>Horses</Species>
      <Species>Mouse</Species>
      <Species>Ornamental birds</Species>
      <Species>Rat</Species>
      <Species>Reptiles</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22693/014/001</DrugIDPK>
    <LicenceNumber>VPA22693/014/001</LicenceNumber>
    <ProductName>Vetimec 6 mg/g Premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>ECO Animal Health Europe Limited</PAHolder>
    <AuthorisedDate>10/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/021/001</DrugIDPK>
    <LicenceNumber>VPA22622/021/001</LicenceNumber>
    <ProductName>Vetivex 1 (9 mg/ml) solution for infusion for cattle, horses, dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>09/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/022/001</DrugIDPK>
    <LicenceNumber>VPA22622/022/001</LicenceNumber>
    <ProductName>Vetivex 11 (Hartmann's) solution for infusion for cattle, horses, dogs and cats</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>09/08/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ATCs>
      <ATC>QB05BB01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Sodium (S) - lactate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Electrolytes</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/022/001</DrugIDPK>
    <LicenceNumber>VPA10454/022/001</LicenceNumber>
    <ProductName>Vetmedin 0.75 mg/ml solution for injection for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>22/08/2014</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/023/001</DrugIDPK>
    <LicenceNumber>VPA10454/023/001</LicenceNumber>
    <ProductName>Vetmedin 1.25 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>05/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/023/005</DrugIDPK>
    <LicenceNumber>VPA10454/023/005</LicenceNumber>
    <ProductName>Vetmedin 1.5 mg/ml oral solution for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>10/03/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application – change in pharmaceutical form (Article 19(1)(a) of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/023/004</DrugIDPK>
    <LicenceNumber>VPA10454/023/004</LicenceNumber>
    <ProductName>Vetmedin 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>29/11/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/023/002</DrugIDPK>
    <LicenceNumber>VPA10454/023/002</LicenceNumber>
    <ProductName>Vetmedin 2.5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>05/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/021/001</DrugIDPK>
    <LicenceNumber>VPA10454/021/001</LicenceNumber>
    <ProductName>Vetmedin 5 mg capsules</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>01/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/023/003</DrugIDPK>
    <LicenceNumber>VPA10454/023/003</LicenceNumber>
    <ProductName>Vetmedin 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>05/11/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/024/001</DrugIDPK>
    <LicenceNumber>VPA10454/024/001</LicenceNumber>
    <ProductName>Vetmedin Chew 1.25 mg chewable tablets for dogs.</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>17/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/024/004</DrugIDPK>
    <LicenceNumber>VPA10454/024/004</LicenceNumber>
    <ProductName>Vetmedin Chew 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>17/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/024/002</DrugIDPK>
    <LicenceNumber>VPA10454/024/002</LicenceNumber>
    <ProductName>Vetmedin Chew 2.5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>17/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10454/024/003</DrugIDPK>
    <LicenceNumber>VPA10454/024/003</LicenceNumber>
    <ProductName>Vetmedin Chew 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Boehringer Ingelheim Vetmedica GmbH</PAHolder>
    <AuthorisedDate>17/04/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/005/002</DrugIDPK>
    <LicenceNumber>VPA10782/005/002</LicenceNumber>
    <ProductName>Vetmulin 100 g/kg premix for medicated feeding stuff for pigs, chickens, turkeys and rabbits</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/010/001</DrugIDPK>
    <LicenceNumber>VPA10782/010/001</LicenceNumber>
    <ProductName>Vetmulin 100 mg/g oral granules for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Not Currently Available</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/009/002</DrugIDPK>
    <LicenceNumber>VPA10782/009/002</LicenceNumber>
    <ProductName>VETMULIN 125 mg/ml Solution for use in drinking water for pigs and chickens</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>04/04/2019</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for use in drinking water</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/008/001</DrugIDPK>
    <LicenceNumber>VPA10782/008/001</LicenceNumber>
    <ProductName>VETMULIN 162 mg/ml Solution for Injection for pigs</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>30/10/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/005/001</DrugIDPK>
    <LicenceNumber>VPA10782/005/001</LicenceNumber>
    <ProductName>Vetmulin 20 g/kg premix for medicated feeding stuff for pigs, chickens, turkeys and rabbits</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In-feed use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Rabbits</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10782/002/001</DrugIDPK>
    <LicenceNumber>VPA10782/002/001</LicenceNumber>
    <ProductName>Vetmulin 450 mg/g granules for use in drinking water for pigs, chickens and turkeys</ProductName>
    <PAHolder>Huvepharma NV</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QJ01XQ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>In drinking water use</RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiamulin hydrogen fumarate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
      <Species>Pigs</Species>
      <Species>Turkeys</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22664/109/001</DrugIDPK>
    <LicenceNumber>VPA22664/109/001</LicenceNumber>
    <ProductName>Vetofol 10 mg/ml Emulsion for Injection for Cats and Dogs</ProductName>
    <PAHolder>Norbrook Laboratories (Ireland) Limited</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX10</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/001</DrugIDPK>
    <LicenceNumber>VPA22622/023/001</LicenceNumber>
    <ProductName>Vetoryl 10 mg hard capsules for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/009</DrugIDPK>
    <LicenceNumber>VPA22622/023/009</LicenceNumber>
    <ProductName>Vetoryl 120 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/06/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/004</DrugIDPK>
    <LicenceNumber>VPA22622/023/004</LicenceNumber>
    <ProductName>Vetoryl 120 mg hard capsules for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/006</DrugIDPK>
    <LicenceNumber>VPA22622/023/006</LicenceNumber>
    <ProductName>Vetoryl 20 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/06/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/010</DrugIDPK>
    <LicenceNumber>VPA22622/023/010</LicenceNumber>
    <ProductName>Vetoryl 20 mg hard capsules for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>22/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/007</DrugIDPK>
    <LicenceNumber>VPA22622/023/007</LicenceNumber>
    <ProductName>Vetoryl 30 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/06/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/002</DrugIDPK>
    <LicenceNumber>VPA22622/023/002</LicenceNumber>
    <ProductName>Vetoryl 30 mg hard capsules for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/005</DrugIDPK>
    <LicenceNumber>VPA22622/023/005</LicenceNumber>
    <ProductName>Vetoryl 5 mg hard capsules for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>30/04/2021</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/008</DrugIDPK>
    <LicenceNumber>VPA22622/023/008</LicenceNumber>
    <ProductName>Vetoryl 60 mg chewable tablets for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>28/06/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application - known active substance (Article 8 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22622/023/003</DrugIDPK>
    <LicenceNumber>VPA22622/023/003</LicenceNumber>
    <ProductName>Vetoryl 60 mg hard capsules for dogs</ProductName>
    <PAHolder>Dechra Regulatory B.V.</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ATCs>
      <ATC>QH02CA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Trilostane</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/049/001</DrugIDPK>
    <LicenceNumber>VPA10815/049/001</LicenceNumber>
    <ProductName>Vetrimoxin 50mg/g Premix for medicated feeding stuff for pigs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>08/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QJ01CA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10539/008/001</DrugIDPK>
    <LicenceNumber>VPA10539/008/001</LicenceNumber>
    <ProductName>Vey Tosal 100 mg/ml + 0.05 mg/ml solution for injection for horses, cattle, dogs and cats</ProductName>
    <PAHolder>Veyx-Pharma GmbH</PAHolder>
    <AuthorisedDate>22/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX99</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Butaphosphan (Butafosfan)</ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/263/001</DrugIDPK>
    <LicenceNumber>VPA10996/263/001</LicenceNumber>
    <ProductName>Vidalta 10 mg prolonged-release tablets for cats</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>09/12/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carbimazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/263/002</DrugIDPK>
    <LicenceNumber>VPA10996/263/002</LicenceNumber>
    <ProductName>Vidalta 15 mg prolonged-release tablets for cats</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>09/12/2011</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QH03BB01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Carbimazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10509/016/001</DrugIDPK>
    <LicenceNumber>VPA10509/016/001</LicenceNumber>
    <ProductName>Vigophos 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses and dogs</ProductName>
    <PAHolder>Industrial Veterinaria S.A.</PAHolder>
    <AuthorisedDate>09/03/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA12CX99</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
      <ActiveSubstance>Butaphosphan (Butafosfan)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10846/016/001</DrugIDPK>
    <LicenceNumber>VPA10846/016/001</LicenceNumber>
    <ProductName>VIMCO emulsion for injection for ewes and female goats</ProductName>
    <PAHolder>Laboratorios Hipra S.A.</PAHolder>
    <AuthorisedDate>29/09/2017</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ATCs>
      <ATC>QI03AB</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Staphylococcus aureus SP140 CP8 strain, inactivated, expressing biofilm components</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Immunological - Inactivated Vaccine</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25326/001/001</DrugIDPK>
    <LicenceNumber>VPA25326/001/001</LicenceNumber>
    <ProductName>Vimectanin DUO 50 mg/ml + 1 mg/ml oral suspension for sheep</ProductName>
    <PAHolder>Pharma VIM Kft.</PAHolder>
    <AuthorisedDate>08/11/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Triclabendazole</ActiveSubstance>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/086/001</DrugIDPK>
    <LicenceNumber>VPA10988/086/001</LicenceNumber>
    <ProductName>VIRBAGEST 4 mg/ml oral solution for pigs</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>28/05/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QG03DX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Altrenogest</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Hormone</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/105/001</DrugIDPK>
    <LicenceNumber>VPA10988/105/001</LicenceNumber>
    <ProductName>Virbamec Injectable Solution 10 mg/ml</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/106/001</DrugIDPK>
    <LicenceNumber>VPA10988/106/001</LicenceNumber>
    <ProductName>VIRBAMEC Pour-On solution for cattle 5 mg/ml</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA01</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/108/001</DrugIDPK>
    <LicenceNumber>VPA10988/108/001</LicenceNumber>
    <ProductName>Virbamec Super Solution For Injection</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QP54AA51</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ivermectin</ActiveSubstance>
      <ActiveSubstance>Clorsulon</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/085/001</DrugIDPK>
    <LicenceNumber>VPA22033/085/001</LicenceNumber>
    <ProductName>VitaBim B1 100 mg/ml Solution for Injection for Cattle and Sheep</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>10/01/2025</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA11DA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/047/001</DrugIDPK>
    <LicenceNumber>VPA22033/047/001</LicenceNumber>
    <ProductName>Vitamin B1 100 mg/ml Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA11DA01</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22033/048/001</DrugIDPK>
    <LicenceNumber>VPA22033/048/001</LicenceNumber>
    <ProductName>Vitamin K1 10 mg/ml Solution for Injection</ProductName>
    <PAHolder>Bimeda Animal Health Limited</PAHolder>
    <AuthorisedDate>01/10/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QB02</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Phytomenadione</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
      <Species>Pigs</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Vitamins and minerals</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10660/002/002</DrugIDPK>
    <LicenceNumber>VPA10660/002/002</LicenceNumber>
    <ProductName>Vitofyllin 100 mg film-coated tablets for dogs</ProductName>
    <PAHolder>WDT - Wirtschaftsgenossenschaft deutscher Tierarzte eG,</PAHolder>
    <AuthorisedDate>11/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propentofylline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10660/002/001</DrugIDPK>
    <LicenceNumber>VPA10660/002/001</LicenceNumber>
    <ProductName>Vitofyllin 50 mg film-coated tablets for dogs</ProductName>
    <PAHolder>WDT - Wirtschaftsgenossenschaft deutscher Tierarzte eG,</PAHolder>
    <AuthorisedDate>11/05/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propentofylline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/127/002</DrugIDPK>
    <LicenceNumber>VPA10996/127/002</LicenceNumber>
    <ProductName>Vivitonin 100 mg film-coated tablets</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>21/09/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QC04AD90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propentofylline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/127/001</DrugIDPK>
    <LicenceNumber>VPA10996/127/001</LicenceNumber>
    <ProductName>Vivitonin 50 mg film-coated tablets</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QC04AD90</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Propentofylline</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/018/001</DrugIDPK>
    <LicenceNumber>VPA23462/018/001</LicenceNumber>
    <ProductName>Vominil 10 mg/ml solution for injection for dogs and cats</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>29/09/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QA04AD90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Maropitant</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/090/001</DrugIDPK>
    <LicenceNumber>VPA10987/090/001</LicenceNumber>
    <ProductName>Voxical Plus Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/090/002</DrugIDPK>
    <LicenceNumber>VPA10987/090/002</LicenceNumber>
    <ProductName>Voxical Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>12/04/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10481/003/001</DrugIDPK>
    <LicenceNumber>VPA10481/003/001</LicenceNumber>
    <ProductName>Vulketan 2.5 mg/g gel for horses</ProductName>
    <PAHolder>Audevard</PAHolder>
    <AuthorisedDate>01/06/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ATCs>
      <ATC>QD03AX90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Ketanserin tartrate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Miscellaneous</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10505/003/001</DrugIDPK>
    <LicenceNumber>VPA10505/003/001</LicenceNumber>
    <ProductName>Wellplus Flavoured tablets for Dogs</ProductName>
    <PAHolder>Divasa-Farmavic S.A.,</PAHolder>
    <AuthorisedDate>13/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA30</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Febantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10203/001/001</DrugIDPK>
    <LicenceNumber>VPA10203/001/001</LicenceNumber>
    <ProductName>Winter Dip 100 mg/ml Concentrate for dip emulsion for sheep</ProductName>
    <PAHolder>Hygeia Chemicals Limited</PAHolder>
    <AuthorisedDate>01/10/1989</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Concentrate for dip emulsion</DosageForm>
    <ATCs>
      <ATC>QP53AF03</ATC>
    </ATCs>
    <LegalBasis>Well-established use application (Article 13a of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Dimpylate</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/108/001</DrugIDPK>
    <LicenceNumber>VPA10987/108/001</LicenceNumber>
    <ProductName>Wormaway 230/20 mg Flavoured Film-Coated Tablets for Cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/07/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/089/001</DrugIDPK>
    <LicenceNumber>VPA10987/089/001</LicenceNumber>
    <ProductName>Wormaway Plus Tablets for dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/089/002</DrugIDPK>
    <LicenceNumber>VPA10987/089/002</LicenceNumber>
    <ProductName>Wormaway Plus XL Tablets For Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>12/04/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Pyrantel embonate </ActiveSubstance>
      <ActiveSubstance>Febantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA23462/017/001</DrugIDPK>
    <LicenceNumber>VPA23462/017/001</LicenceNumber>
    <ProductName>Xylamidor</ProductName>
    <PAHolder>VetViva Richter GmbH</PAHolder>
    <AuthorisedDate>14/07/2023</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10521/036/001</DrugIDPK>
    <LicenceNumber>VPA10521/036/001</LicenceNumber>
    <ProductName>Xylapan 20 mg/ml Solution for Injection</ProductName>
    <PAHolder>Vetoquinol S.A.</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10980/020/001</DrugIDPK>
    <LicenceNumber>VPA10980/020/001</LicenceNumber>
    <ProductName>Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats</ProductName>
    <PAHolder>Alfasan Nederland B.V.</PAHolder>
    <AuthorisedDate>07/10/2022</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ATCs>
      <ATC>QN05CM92</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
      <RoutesOfAdministration>Subcutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Xylazine Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Cattle</Species>
      <Species>Dogs</Species>
      <Species>Horses</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22020/027/001</DrugIDPK>
    <LicenceNumber>VPA22020/027/001</LicenceNumber>
    <ProductName>Young's Vector 12.5 mg/ml Pour-on Solution</ProductName>
    <PAHolder>Elanco GmbH</PAHolder>
    <AuthorisedDate>21/10/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cypermethrin tech. (cis: trans / 80:20)</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA22969/001/001</DrugIDPK>
    <LicenceNumber>VPA22969/001/001</LicenceNumber>
    <ProductName>Z-Itch 40 mg/ml pour-on solution</ProductName>
    <PAHolder>Floris Holding BV</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AC04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Cutaneous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Permethrin (80:20) technical</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Donkey</Species>
      <Species>Horse (non-food producing)</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/060/001</DrugIDPK>
    <LicenceNumber>VPA10987/060/001</LicenceNumber>
    <ProductName>ZANTEL</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
    </ATCs>
    <LegalBasis>Fixed combination application (Article 13b of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/052/001</DrugIDPK>
    <LicenceNumber>VPA10987/052/001</LicenceNumber>
    <ProductName>Zantel Cat and Dog Tablets</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/05/2001</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA51</ATC>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Complete application (stand-alone) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/046/001</DrugIDPK>
    <LicenceNumber>VPA10815/046/001</LicenceNumber>
    <ProductName>Zelys 1.25 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/046/003</DrugIDPK>
    <LicenceNumber>VPA10815/046/003</LicenceNumber>
    <ProductName>Zelys 10 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/046/002</DrugIDPK>
    <LicenceNumber>VPA10815/046/002</LicenceNumber>
    <ProductName>Zelys 5 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QC01CE90</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Pimobendan</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Cardiovascular</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA25433/001/001</DrugIDPK>
    <LicenceNumber>VPA25433/001/001</LicenceNumber>
    <ProductName>Zerocit 50 mg tablets for dogs</ProductName>
    <PAHolder>Ashish Life Science Holding B.V.</PAHolder>
    <AuthorisedDate>11/10/2024</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QP52AA01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 18 of Regulation (EU) 2019/6)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Praziquantel</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/017/001</DrugIDPK>
    <LicenceNumber>VPA10987/017/001</LicenceNumber>
    <ProductName>Zerofen 100 mg/ml Oral Suspension</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>04/01/1991</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/140/001</DrugIDPK>
    <LicenceNumber>VPA10987/140/001</LicenceNumber>
    <ProductName>Zerofen 222.2 mg/g Granules.</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/03/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Companion Animal Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/017/002</DrugIDPK>
    <LicenceNumber>VPA10987/017/002</LicenceNumber>
    <ProductName>Zerofen 25 mg/ml  Oral Suspension</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>05/08/1992</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent application (Article 13c of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/143/001</DrugIDPK>
    <LicenceNumber>VPA10987/143/001</LicenceNumber>
    <ProductName>Zerofen 4 % Premix for medicated feeding stuff</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>15/03/1996</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Premix for medicated feeding stuff</DosageForm>
    <ATCs>
      <ATC>QP52AC13</ATC>
    </ATCs>
    <LegalBasis>Informed consent (abridged application) - Council Directive 81/851/EEC</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fenbendazole</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/109/001</DrugIDPK>
    <LicenceNumber>VPA10987/109/001</LicenceNumber>
    <ProductName>Zeromectin 5 mg/ml Pour-on Solution for beef and dairy cattle, sheep and goats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>22/05/2015</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Pour-on solution</DosageForm>
    <ATCs>
      <ATC>QP54AA04</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Pour-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Eprinomectin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cattle</Species>
      <Species>Goats</Species>
      <Species>Sheep</Species>
    </VetSpecies>
    <VetTherapeuticClass>Endectoparasiticides</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/093/002</DrugIDPK>
    <LicenceNumber>VPA10987/093/002</LicenceNumber>
    <ProductName>Zeronil 134 mg Spot-on Solution for medium dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/093/003</DrugIDPK>
    <LicenceNumber>VPA10987/093/003</LicenceNumber>
    <ProductName>Zeronil 268 mg Spot-on Solution for large dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/093/004</DrugIDPK>
    <LicenceNumber>VPA10987/093/004</LicenceNumber>
    <ProductName>Zeronil 402 mg Spot-on Solution for extra large dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/094/001</DrugIDPK>
    <LicenceNumber>VPA10987/094/001</LicenceNumber>
    <ProductName>Zeronil 50 mg Spot-on Solution for cats</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/093/001</DrugIDPK>
    <LicenceNumber>VPA10987/093/001</LicenceNumber>
    <ProductName>Zeronil 67 mg Spot-on Solution for small dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX15</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/126/002</DrugIDPK>
    <LicenceNumber>VPA10987/126/002</LicenceNumber>
    <ProductName>Zeronil Combo 134 mg/120.6 mg Spot-on Solution for Medium Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/126/003</DrugIDPK>
    <LicenceNumber>VPA10987/126/003</LicenceNumber>
    <ProductName>Zeronil Combo 268 mg/241.2 mg Spot-on Solution for Large Dogs.</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/126/004</DrugIDPK>
    <LicenceNumber>VPA10987/126/004</LicenceNumber>
    <ProductName>Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/125/001</DrugIDPK>
    <LicenceNumber>VPA10987/125/001</LicenceNumber>
    <ProductName>Zeronil Combo 50 mg/60 mg Spot-on Solution for Cats and Ferrets</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Ferrets</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10987/126/001</DrugIDPK>
    <LicenceNumber>VPA10987/126/001</LicenceNumber>
    <ProductName>Zeronil Combo 67 mg/60.3 mg Spot-on Solution for Small Dogs</ProductName>
    <PAHolder>Chanelle Pharmaceuticals Manufacturing Limited</PAHolder>
    <AuthorisedDate>20/04/2018</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Spot-on solution</DosageForm>
    <ATCs>
      <ATC>QP53AX65</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Spot-on use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Fipronil</ActiveSubstance>
      <ActiveSubstance>(S)-Methoprene</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Ectoparasiticide</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/202/002</DrugIDPK>
    <LicenceNumber>VPA10996/202/002</LicenceNumber>
    <ProductName>Zitac vet 100 mg tablets for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>27/09/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QA02BA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10996/202/003</DrugIDPK>
    <LicenceNumber>VPA10996/202/003</LicenceNumber>
    <ProductName>Zitac vet 200 mg tablets for dogs</ProductName>
    <PAHolder>Intervet Ireland Limited</PAHolder>
    <AuthorisedDate>27/09/2006</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ATCs>
      <ATC>QA02BA01</ATC>
    </ATCs>
    <LegalBasis>Full application (Article 12(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Alimentary Tract Preparation</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/040/002</DrugIDPK>
    <LicenceNumber>VPA10815/040/002</LicenceNumber>
    <ProductName>Zodon 150 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/038/001</DrugIDPK>
    <LicenceNumber>VPA10815/038/001</LicenceNumber>
    <ProductName>Zodon 25 mg/ml oral solution for cats and dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/040/003</DrugIDPK>
    <LicenceNumber>VPA10815/040/003</LicenceNumber>
    <ProductName>Zodon 264 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10815/040/001</DrugIDPK>
    <LicenceNumber>VPA10815/040/001</LicenceNumber>
    <ProductName>Zodon 88 mg chewable tablets for dogs</ProductName>
    <PAHolder>Ceva Santé Animale</PAHolder>
    <AuthorisedDate>22/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ATCs>
      <ATC>QJ01FF01</ATC>
    </ATCs>
    <LegalBasis>Hybrid application (Article 13(3) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Antibacterial</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/099/002</DrugIDPK>
    <LicenceNumber>VPA10988/099/002</LicenceNumber>
    <ProductName>ZOLETIL 100 (50 mg/ml + 50 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats</ProductName>
    <PAHolder>Virbac</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX99</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiletamine</ActiveSubstance>
      <ActiveSubstance>Zolazepam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10988/099/001</DrugIDPK>
    <LicenceNumber>VPA10988/099/001</LicenceNumber>
    <ProductName>ZOLETIL 50 (25 mg/ml + 25 mg/ml) lyophilisate and solvent for solution for injection for dogs and cats</ProductName>
    <PAHolder>Virbac S.A.</PAHolder>
    <AuthorisedDate>15/04/2016</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Lyophilisate and solvent for solution for injection</DosageForm>
    <ATCs>
      <ATC>QN01AX99</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Intramuscular use</RoutesOfAdministration>
      <RoutesOfAdministration>Intravenous use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Tiletamine</ActiveSubstance>
      <ActiveSubstance>Zolazepam</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Cats</Species>
      <Species>Dogs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Neurological Preparations</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/004/001</DrugIDPK>
    <LicenceNumber>VPA10665/004/001</LicenceNumber>
    <ProductName>Zuritol 25 mg/ml solution for use in drinking water for chickens</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Chickens</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
  <Product>
    <DrugIDPK>VPA10665/007/001</DrugIDPK>
    <LicenceNumber>VPA10665/007/001</LicenceNumber>
    <ProductName>Zuritol 50 mg/ml oral suspension for pigs.</ProductName>
    <PAHolder>LABORATORIOS CALIER S.A.</PAHolder>
    <AuthorisedDate>20/12/2013</AuthorisedDate>
    <ProductType>VM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>AU</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ATCs>
      <ATC>QP51AJ01</ATC>
    </ATCs>
    <LegalBasis>Generic application (Article 13(1) of Directive No 2001/82/EC)</LegalBasis>
    <RoutesOfAdministration>
      <RoutesOfAdministration>Oral use</RoutesOfAdministration>
    </RoutesOfAdministration>
    <ActiveSubstances>
      <ActiveSubstance>Toltrazuril</ActiveSubstance>
    </ActiveSubstances>
    <VetLegalStatus>Prescription Only Medicine</VetLegalStatus>
    <VetSpecies>
      <Species>Pigs</Species>
    </VetSpecies>
    <VetTherapeuticClass>Coccidiostats</VetTherapeuticClass>
  </Product>
</Products>